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ABSTRACT  
 
Personalising Head and Neck Cancer Survivorship: Intervention with the Head and Neck 
Cancer Patients Concerns Inventory in Routine Head and Neck Cancer Outpatient Visits 
 
Naseem Ghazali 
 
The Head and Neck Patients Concerns Inventory (HN-PCI) is a self-completed holistic tool that 
helps patients to disclose items of concern they wish to discuss. The MD study was designed to 
evaluate the roll-out of HN-PCI in subjects who were unfamiliar with it. The primary aim of the 
study was to evaluate HN-PCI can help patients self-disclose concerns. The secondary aims 
were to: (1) categorise HN-PCI items into domains; (2) develop a thematic content analysis; (5) 
examine associations between concerns and distress; (4) examine associations between 
clinicopathological factors with HN-PCI consultations; (5) determine if HN-PCI intervention 
changes consultations and the outcomes of consultations.   
 
Method:  The MD work was divided into 3 sections and undertaken in the following 
order: (1) Pilot study; (2) Domain generation; and (3) Main study. Sections (1) and (2) were 
undertaken designed to support the Main study. In the Main study, patients were recruited 
prospectively to a non-randomised study design composed of 3 blocks. Block 1 constituted 
normal practice i.e. control group, Block 2 constituted patients exposed to HN-PCI but doctors 
were not i.e. control in attention, and Block 3 was the HN-PCI intervention group. The primary 
outcome measures were the number of concern and selected and/or discussed. The secondary 
outcome measures were patient satisfaction with consultation, consultation length, distress level 
and clinical outputs. i.e. clinical decision or action taken related to the consultation.  
 
Result:  In the Pilot study, a content thematic framework was developed. Five domains 
were generated: (A) Physical and functional; (B) Psychological/emotional and spiritual well-
being; (C) Social care/Social well-being; (D) Treatment-related; and (E) Other.  
In the Main study, 365 patients were recruited, producing a matching number of 
audiorecorded consultation i.e. Block 1: 136 patients; Block 2: 78 patients; and Block 3: 111 
patients.  Introduction of HN-PCI generated a trend towards an increased number of concerns 
discussed when compared with control consultations. A broader range of expressed concerns 
was addressed in HN-PCI intervention group. More items within the Psychological/emotional 
and Spiritual well-being Domain were discussed in HN-PCI intervention groups. In the HN-PCI 
intervention groups, doctors were fair to moderately more likely to take on the patient’s agenda 
for discussion by addressing the items selected. These were achieved with a trend towards 
longer consultations. 
Consultations with HN-PCI were significantly associated with certain 
clinicopathological factors.  The HN-PCI intervention group showed higher number of medical 
outputs when compared with control group, suggesting that HN-PCI may facilitate collaborative 
decision-making. Patients with HN-PCI intervention showed a trend towards lower levels of 
distress post-consultation and reported significantly higher scores of satisfaction. This study 
also demonstrated that the HN-PCI was able to indirectly predict patients who experienced 
significant distress based on the number of items selected.  
 
Conclusions 
HN-PCI was able to help patients disclose a wider range of concerns in cohorts unfamiliar with 
the tool. Its use is associated with changes in the content of consultations, suggesting a more 
patient-concern focused consultation. This is possible to create a personalised, patient-centred 
HNV visit using the HN-PCI. However, there remain service-based barriers to fully realizing 
the HN-PCI tool in personalising HNC patient’s survivorship trajectory.   
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CHAPTER 1 
1.0. INTRODUCTION 
1. 1. Cancer survivorship
The widely held, deep-rooted perception of cancer as “a death sentence” [Ardnt et al, 
2007] is now challenged by contemporary evidence of falling cancer-related mortality 
rates [Seigel et al, 2011]. Advances in cancer management means that cancer is no 
longer regarded as a terminal illness for many patients. Assimilation of novel 
therapeutic developments into the standard of care for many cancers has successfully 
cured cancer or transformed its course into a long-term or chronic condition. Where 
long-term survival is now expected, the accompanying downside is that many will live 
with a host of cancer treatment after-effects that may significantly impact upon their 
health status and quality of life (QOL). Thus, a cancer diagnosis is not only life 
changing but also marks the beginning of a challenging journey into a new normality.  
The rising numbers of individuals diagnosed with cancer annually, as well as improving 
survival rates, have led to a sustained increase in the number of cancer survivors [Seigel 
et al, 2012]. There are several definitions of cancer survivors. In the United States of 
America (US), the term “cancer survivor” describes any person who has been diagnosed 
with cancer, from the time of diagnosis through the balance of life [Seigel et al, 2012]. 
In the United Kingdom (UK), the accepted interpretation of the “cancer survivor” 
includes not only those who are living with or beyond cancer, but also the carers and 
families of survivors [Department of Health (DOH), 2010]. “Cancer survivorship” is a 
temporal passage with at least 3 distinct phases, including the time from diagnosis to the 
end of initial treatment, the transition from treatment to extended survival, and long-
term survival [Mullan, 1985], and incorporates a range of experiences from those 
undergoing primary treatment and post-treatment remission to those who have achieved 
cure, and those with advanced or active disease [DOH, 2010].  
In the US, there were an estimated 13.7 million cancer survivors at the start of 2012 
[Seigel et al, 2012]. The majority (64%) of these survivors were diagnosed 5 years or 
more, and nearly one-half (45%) were aged 70 years or older [Seigel et al, 2012]. In the 
UK, there are an estimated 2 million cancer survivors, or approximately 3.3% of the UK 
 17 
population [Maddams et al, 2008]. Indeed, 10% of those aged over 65 years in the UK 
currently are cancer survivors [Maddams et al, 2008]. The numbers of cancer survivors 
are expected to increase to nearly 18 million by 2022 in the US [Seigel et al, 2012], 
while in the UK, an expected rise is predicted at a rate of 3.2% annually  [Maddams et 
al 2008].  
 
The size of this fast-growing trend has unsurprisingly resulted in a paradigm shift in the 
national approach to cancer from “survival” towards “cancer survivorship”, where the 
focus of cancer survivorship is centred on recovery, wellbeing and health following 
completion of treatment [DOH, 2010].  Many survivors, including those who are 
cancer-free, must cope with the chronic effects of treatment, as well as psychological 
concerns, such as, fear of recurrence [Seigel et al, 2012]. In addition, cancer patients 
and survivors face a variety of medical and social concerns dependent on their age, 
comorbid conditions, socioeconomic status, and family/support network. It is 
paramount that survivors and their caregivers have the support and access to services 
they need to resume as normal a lifestyle as they can, after cancer treatment. The shift 
towards cancer survivorship is underpinned by a change in the approach to aftercare 
[Davies & Batehup, 2011] i.e. a need to personalise treatment/care plans by relying on 
self-reported assessments of individual needs and concerns, is critical in empowering 
patients towards self-management [DOH, 2010]. In addition, a greater emphasis is 
placed on the prompt recognition and planning for treatment after-effects, and also for 
the early identification of further disease during the post-treatment period [DOH, 2010].  
 
Interesting parallels can be drawn between the approaches adopted in cancer 
survivorship and the management of chronic conditions. The term “chronic condition” 
encompasses disability and disease conditions that people may ‘live with’ over extended 
periods of time (i.e. > 6 months) [Lawn & Schoo, 2010]. Arguably, post-treatment 
cancer survivors may fall within this definition. The central themes of personalised 
medical care [Abrahams & Silver, 2009; Morton et al, 2009], the use of patient-
reported outcomes/assessments [Her & Kavanaugh, 2012], empowering patients 
towards self-management [Tattersall, 2002; Bodenheimer et al, 2002] and supporting 
self-management that are used in chronic conditions resonates within cancer 
survivorship. This is probably because self-management of persons with chronic 
conditions is amenable to generic approaches based on the understanding that there are 
generic self-management tasks regardless of diagnosis [Lawn & Schoo, 2010].  
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Personalised medical care aims to individualise care by integrating a person’s unique 
clinical, molecular (i.e. genetic, genomic) and environmental information [Ginsburg & 
Willard, 2009]. Clinical and biological data from individual patients are traditionally 
used in oncology treatment decision-making and prognosis. Advances in genomic 
medicine, where information from the genomes and their derivatives are used in clinical 
decision-making, has enabled can more precise guidance in treatment-decision making 
and in the prediction of outcomes [Ginsburg & Willard, 2009]. However, integral to 
personalising medical care are patient-reported outcome (PRO), an important source of 
health status and outcome assessments [Acquandro et al, 2003]. PRO is defined as 
‘any report of the status of a patient’s health condition that comes directly from the 
patient, without interpretation of the patient’s response by a clinician or anyone else’ 
[Food Drug Agency (FDA), 2009, page 2]. PRO aids in accomplishing the task of 
assessing individual risks, needs and preferences based on the patient’s own 
perspectives on these issues, which are essential building blocks to personalising care.  
 
Among PRO measures in cancer, health-related quality of life (HRQOL) is the best 
characterised. HRQOL measures are distinguishable by having an evaluative feature to 
a patient’s subjective assessment of the important aspects of their wellbeing i.e. 
symptom impact, functional status, and/or global wellbeing [Lipscomb et al, 2007]. 
Most HRQOL functional measures are multidimensional, designed to reflect multiple 
domains of impact, often including physical, psychological, and social domains 
[Lipscomb et al, 2007]. The development of HRQOL is achieved through strict 
methodological process to produce tools with validated psychometric properties to 
ensure that they are fit for research purposes, in particular, clinical trials [FDA, 2006]. 
This rigid approach means that HRQOL tools are usually applied within a narrowly 
defined objective. 
 
Nevertheless, adopting HRQOL PRO as a tool for routine clinical use is prevalent due 
to its availability and multidimensionality. The HRQOL PROs have been applied in 
routine clinical settings as a way of personalising the care of chronic conditions, 
particularly in appraising and managing the psychosocial concomitants of illness. 
Psychological suffering has been described using terms such as anxiety, worry, concern, 
fear and distress, which are frequently used interchangeably [Anderssen-Segesten et al, 
1989]. Among the associated terminology, distress is considered as an important vital 
 19 
sign in cancer survivorship, and it is often associated with unmet needs among cancer 
survivors [Carlson et al, 2012]. Unaddressed worries, needs and concerns can impact 
the cancer patient’s health status negatively [REF]. The main challenge with identifying 
unmet needs of cancer patients lies in the wide spectrum of potential worries and 
concerns that may be experienced, these are often individualised by the patient’s 
personal circumstances, which may change at different time points of their survivorship. 
In this situation, HRQOL-based assessments may be inadequate. Instead, holistic 
assessments are advocated to help screen for unmet needs of survivors and their 
caregivers [Richardson et al, 2005]. Undertaking timely holistic assessments during 
their survivorship journey may help understand patients’ individual needs, preferences 
and circumstances at particular time points of their journey. Enabling patients to 
disclose their unique needs and concerns using appropriate PROs can facilitate 
discussions that address these issues. Thus, the information gained from this PRO is the 
first step towards delivering personalised care.  
 
 
 
1.2. Head and Neck Cancer  
 
Head and neck cancer (HNC) is a complex disease characterised by clinicopathological 
heterogeneity arising from various anatomical sites, encompassing the oral cavity, 
pharynx (includes the nasopharynx, oropharynx, hypopharynx), larynx, paranasal 
sinuses, and the salivary glands. This disease is the sixth most common cancer 
worldwide, accounting for 3.2% of all malignancies [Jemal et al, 2010]. There is 
considerable geographical variance in HNC incidence worldwide where highest 
reported rates are in some regions of France (e.g., Bas-Rhin, male incidence: 63.58 
cases per 100,000) and in India/central Asia [Seiwert & Cohen, 2005]. In the UK, an 
estimated 7354 new cases of HNC were diagnosed in England and Wales during 2010-
11 [National Head and Neck Cancer Audit (DAHNO), 2012], which has risen from 
the 6,700 cases estimated in 2005-06 [DAHNO, 2007].  
 
The incidence of HNC increases with age, where 98% and 50% of diagnosed patients 
are over 40 and 60 years of age, respectively [Mehanna et al, 2010]. HNC is associated 
with a male preponderance, where the male to female ratio reported by large 
epidemiological studies and national cancer registries varied from 2:1 to 15:1 depending 
on the primary site [Mehanna et al, 2010]. The UK Office for National Statistics 
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(ONS) report on cancer incidence and mortality during the 2008-2010 period indicates 
that the age-standarised incidence for cancers of the lip, mouth and pharynx was 13.6 
and 6.3 per 100,000 for men and women respectively, while for laryngeal cancer, this 
was 5.3 and 1.0 per 100,000 for men and women respectively [ONS, 2012]. A recent 
change in HNC epidemiological trend in the UK has seen a two-fold increase in the 
incidence of oropharyngeal cancer in just over a decade [Oxford Cancer Intelligence 
unit, 2010]. This rise was similarly observed in US [Shiboski et al, 2005] and occurred 
predominantly among the younger age group, which may partially be attributed to 
infection by the Human Papillomavirus (HPV) [Hammerstedt et al, 2006; Mourad et 
al, 2017].  
 
The main aetiological factors in HNC are lifestyle-related, which interact with genetic 
predisposition and other environmental factors. Tobacco (smoked and smokeless types) 
and alcohol usage are established HNC risk factors and are prevalent in 75% of cases 
[Mehanna et al, 2010]. They are often present together and can act more than 
multiplicative in increasing the risk of HNC [Hashibe et al, 2010]. Despite marijuana 
smoking containing carcinogens similar to tobacco smoke, reports from large 
epidemiological studies found that infrequent marijuana smoking does not confer the 
risk of HNC but may carry a moderately high risk among the non-smoking, teetotal 
subgroup of patients [Berthiller et al, 2009].   Betel quid chewing is a major HNC risk 
factor in endemic areas, which is related to exposure to the carcinogenic agent in areca 
nut, a component frequently found in the betel quid mixture [Chen et al, 2008]. Poor 
socioeconomic circumstance is associated with an increased risk of HNC [Conway et 
al, 2010a; 2010b]. The specific socioeconomic factors associated with an increased risk 
of HNC may vary with areas evaluated, indicating modulating effects of other 
environmental factors. For example, socioeconomic circumstances associated with 
higher risk of HNC in Scotland were those living in areas most deprived, the 
unemployed and those with lower levels of education, but multivariate analysis only 
found smoking to be the only significant risk factor [Conway et al, 2010a].    
 
There is increasing substantiation for genetic predisposition in HNC. Large 
observational studies report the occurrence of familial aggregations of HNC, where the 
risk of HNC is estimated to be three- to eightfold in first-degree relatives of HNC 
patients [Jefferies et al, 1999].  In addition, HNC has been reported in several rare 
cancer types that are clearly genetically determined, e.g., Fanconi’s anaemia, 
 21 
Xeroderma pigmentosa, Li-Fraumeni syndrome, where there is a marked increased 
cancer risk amongst gene carriers [Trizna & Schantz, 1992]. More recent molecular 
epidemiology studies report that normal polymorphisms in some genes that mediate 
DNA repair, carcinogen metabolism, and cell cycle control, could increase the risk of 
HNC [Sturgis & Wei, 2002; Cadoni et al, 2012]. 
 
Infection with tumourigenic viruses is an important risk factor for HNC. The Epstein-
Barr virus is associated with nasopharyngeal carcinoma [Chang & Adami, 2006]. More 
recently, there is evidence for Human Papillomavirus carcinogenicity in HNC, 
particularly in oropharyngeal cancers [Kreimer et al, 2005]. Exposure to and 
transmission of virus is attributed to sexual contact, where certain sexual behavior and 
practices are associated with an increased risk for HNC [Heck et al, 2010].  Dietary 
intake can influence the risk of developing HNC. Large epidemiological studies have 
found that the HNC risk may be reduced with dietary intake rich in fresh fruits and 
vegetables [Chuang et al, 2012; Bradshow et al, 2012; Freedman et al, 2008]. The 
risk for HNC is higher with diets containing high-fat and processed meats [Bradshaw 
et al, 2012], and in those with red meat [Chuang et al, 2011]. In addition, 
nasopharyngeal carcinoma is related to a high consumption of salt-preserved fish, a 
traditional staple food with carcinogenic potential in several nasopharyngeal carcinoma-
endemic areas [Chang & Adami, 2006]. Other environmental factors include material 
deprivation, which is associated with a higher incidence and poorer outcomes of HNC 
[O’Hanlon et al, 1996; National Head & Neck Cancer Audit (DAHNO), 2006].  
 
Patients with HNC can present with a variety of symptoms, depending on the primary 
site involved and the resultant functional deficit [Mehanna et al, 2010]. Occasionally, 
some are asymptomatic or present only with cervical node disease associated with an 
unknown primary. Patients with advanced disease at first presentation form a significant 
proportion of cases, particularly in developing countries and in racial/ethnic minorities 
living in developed countries [Kowalski et al, 1994]. However, the vast majority of 
HNC patients present with potentially curable local or locoregional disease, as 
metastatic disease is uncommon [Mehta & Harrison, 2007].  
 
More than 90% of all malignant tumours in the head and neck are squamous cell 
carcinomas (SCC) arising from the lining mucosa [DAHNO, 2007; DAHNO, 2012]. 
HNC SCC spreads preferentially via the lymphatic channels to the regional lymph 
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nodes in the neck, where positive nodal involvement carries a poor prognosis 
[Greenberg et al, 2003]. Cervical metastasis was present in 47% of neck dissection 
material from a large study of newly diagnosed HNC [Woolgar, 2007]. The 
predominant pattern of cervical node spread found was the 'inverted-cone pattern' (67%) 
and the extent of metastasis (both by volume and distribution) was greatest in tumours 
of the oropharynx followed by lateral tongue, ventral tongue and floor of mouth 
[Woolgar, 2007]. Extracapsular spread was present in 29% of cases [Woolgar, 2007] 
and this is particularly significant because extracapsular spread is a reliable predictive 
factor of locoregional recurrence, distant metastasis, and disease-specific mortality 
[Greenberg et al, 2003]. Other pathological factors that carry prognostic significance 
are the primary site involved, tumour size, thickness, and pattern of invasion [Brown et 
al, 2006].  
 
Optimal management of HNC is by a multidisciplinary approach [National Institute of 
Clinical Excellence (NICE), 2004; Perri et al, 2013], where treatment mainstays are 
surgery, radiotherapy and chemotherapy. Decisions about treatment are often complex, 
as this process must weigh up treatment efficacy and likelihood of survival against the 
potential functional and quality of life outcomes [Mehanna et al, 2010]. The head and 
neck region is critical to speech, swallowing, salivation, taste/smell, vision, and is also 
central to body image and personal identity. These functions are frequently impaired by 
disease and the sequelae of treatment. The mode of treatment largely depends on the 
primary site, stage of disease and the patient’s overall health status. In most early stage 
(I and II), single modality therapy by surgery or radiotherapy (RT) is the initial 
treatment of choice, where there is 60–95% chance of cure with local treatment alone 
[Rogers et al, 2003]. On the other hand, multimodality therapy is often utilised for 
locally advanced disease, due to the higher risk of recurrence and development of 
distant metastasis [Seiwert & Cohen, 2005]. For example, surgery combined with 
chemotherapy and RT can improve overall survival in patients with advanced oral 
cancers. Cure rates vary by site and stage, ranging from more than 90% in lip and early 
stage laryngeal cancers to 55% and less for advanced, non-metastatic oral cavity, 
oropharyngeal, hypopharyngeal and laryngeal cancers.  
 
Curative HNC surgery involves complete resection of the primary tumour with adequate 
margins of normal appearing tissues (approximately 1.5 to 2cm) and elective neck 
dissection for locoregional control [Sutton et al, 2003]. Access to the primary site is 
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usually amenable transorally, while in some cases; an additional surgical procedure to 
improve access is required. The surgical defect created may be primarily closed, 
although reconstruction of the surgical defect is often necessary to optimize healing and 
function following tissue loss. The goal of improvements in HNC surgery is to 
overcome the significant functional and cosmetic defects resulting from the traditional 
radical approach. Newer diagnostic techniques, e.g., sentinel node biopsy and 
flurodeoxyglucose-PET scans, can help avoid futile extensive surgery and are 
increasingly used to guide surgical planning [de Bree & Leemans, 2010]. Technical 
developments producing less invasive surgical approaches can spare important 
anatomical structures while maintaining efficient control of local disease. This includes 
the use of selective neck dissection [Robbins et al, 2002; Robbins et al, 2008], sentinel 
node biopsy [Jackson et al, 2017], transoral lasers surgery [Li & Richmon, 2012], 
transoral robotic surgery [Weisnstein et al, 2012] and intraoperative navigation 
technology [Jackson et al, 2017]. In addition, innovations in microvascular tissue 
reconstruction have enabled the repair of complex surgical defects using free-tissue 
flaps with reasonably good cosmetic and functional outcomes [Wehage & Fansa, 
2011]. Despite the obvious functional and cosmetic drawbacks of major radical surgery, 
95.6% of HNC patients who were disease-free at 12 months postoperative FU would 
still opt for surgery due to its cure rates over other treatment option with a possibly 
improved quality of life but with a lower chance of cure [Vartanian & Kowalski, 
2009].  
Overall, RT is utilized in approximately 78% of HNC patients, where it may be 
employed as a single modality treatment, or adjuvant to surgery, and/or in combination 
with systemic agents [Delaney et al, 2005]. Megavoltage external beam RT is usually 
directed to the primary site and the cervical draining lymphatic system. Brachytherapy 
is an alternative method, where localized irradiation is administered through the 
implantation of radiation needles into or in close proximity to the tumour. However, this 
technique is seldom utilised in HNC nowadays. The therapeutic radiation dose to the 
primary site is usually from 50 to 70 Gy, with 40 to 50 Gy delivered to the adjacent 
lymph nodes. While there are many regimes, most protocols administer radiation in 
fractions over a designated time period. Conventional fractionation (CF) regimes 
typically involve single daily fractions of 1.8-2 Gy, 5 days per week for 7 weeks 
[Bourhis et al, 2006]. Non-conventional fractionation (or altered fractionation, AF) 
includes accelerated fractionation and hyperfractionation. The aim of altered 
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fractionated RT is to increase the dose intensity of treatment, either by increasing the 
total dose (hyperfractionation) or by reduction of the overall treatment time 
(acceleration). The MARCH meta-analysis of 15 randomised trials comparing AF with 
CF in non-metastatic HNC found improved survival benefits and better locoregional 
control with AF, where hyperfractionation had the greatest benefit relative to 
accelerated fractionation [Bourhis et al, 2006].  
 
RT is frequently used adjuvant to surgery. Postoperative radiotherapy (PORT) is 
accepted as the standard of care in HNC patients deemed at high risk of recurrence i.e. 
evidence of involved margins at the primary site and the presence of extracapsular 
spread in regional lymph nodes [Huang et al, 1992; Brown et al, 2007]. The role of 
PORT is debatable in a subset of HNC patients who demonstrate other pathological 
characteristics that are suggestive of potential aggressive behavior i.e. showing an 
intermediate risk of recurrence. Brown and coworkers  [2007] found that patients with 
intermediate risk of recurrence who received PORT had poorer 5-year survival rates 
than those receiving surgery alone (54% versus 71%, p=0.002). In addition, the salvage 
rates of those who received surgery alone were significantly better than those who 
received PORT (53% versus 13%, p=0.02). The results of this study seem controversial 
because it contradicts the prevailing view that PORT confers therapeutic advantage in 
reducing the likelihood of recurrence. However, this finding probably reflects the poor 
predictability of using microscopic pathological features in forecasting clinical behavior 
and treatment response. Molecular subtyping of HNC may provide better correlation 
with clinical aggressiveness and therapeutic response. This revolutionary approach has 
been established in breast [Moriya et al, 2010] and prostate cancers [Kachroo & 
Gnanapragasam, 2012].  
 
The concept of ‘organ and function preservation’ is central to the management of 
locally advanced HNC. This concept involves preserving an organ so that it remains 
satisfactorily functional with improved quality of life while maintaining or exceeding 
the survival rates of non-organ preserving strategies i.e. surgery, in locally advanced 
disease [Mehta & Harrison, 2007; Conley et al, 2001]. Traditional ‘organ preservation 
therapeutic strategies’ for locally advanced HNC involves the combined use of RT with 
chemotherapy (CRT). In this scenario, chemotherapy has been used as induction 
treatment, concomitantly with RT, or as adjuvant treatment after radiotherapy.  
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Early clinical trials of induction chemotherapy using cisplatin/fluoroucil followed by 
RT against standard surgical treatment in locally advanced laryngeal and 
hypopharyngeal/pyriform cancers reported organ preservation in about two-thirds of 
survivors, without any significant survival difference between treatment arms [Veterans 
Affair, 1991; Lefebvre et al, 1996]. More contemporary studies of induction 
chemotherapy have used a combination of taxanes with cisplatin and fluorouracil (TPF) 
in locally advanced HNC with promising results. A recent meta-analysis of these studies 
found that TPF induction chemotherapy regime leads to a significant survival advantage 
over a 3 year period with acceptable toxicity rates for patients with locally advanced 
HNC compared with the cisplatin-fluoroucil regime [Qin et al, 2012]. However, this 
regime is relatively new and is not widely used.  
 
The standard of care for locally advanced HNC SCC is concomitant CRT [Bourhis et 
al, 2012]. The MACH-NC meta-analyses of 93 randomised HNC clinical trials found 
that concomitant CRT was associated with an increase in survival of 6.5%, a 12–13% 
improvement in locoregional control, and about a 3% decrease in distant metastases in 
comparison to RT alone over a 5 year period [Pignon et al, 2000; Pignon et al, 2009]. 
Nevertheless, concomitant CRT is associated with a higher incidence of acute and late 
toxicities [Denis et al, 2003].  
 
Advancements in organ preservation strategies aim to reduce toxicity in normal tissues. 
Intensity modulated radiation therapy allows specific tumour targeting whilst 
simultaneously eliminating or substantially reducing the radiation dose to normal 
tissues. This technique delivers high radiation doses directly to cancer cells in a very 
targeted way, much more precisely than is possible with conventional RT, thereby 
reducing RT exposure to non-cancer tissues [Gutiontov et al, 2015].  
 
Local and regional recurrences account for up to 90% of treatment failures after surgery 
and RT. Most studies corroborate that the median time to recurrence is 7.5 months after 
treatment, and 86% of the recurrences occur within 24 months [da Silva et al, 2012]. 
When primary HNC treatment fails from refractory disease or tumour recurrence, 
defining the best therapeutic option is a challenge. The available treatment options 
include re-irradiation [Patel & Salama, 2012] or salvage surgery [Brown et al, 2008]. 
Chemotherapy may be the only remaining option whenever salvage surgery or re-
irradiation is not feasible, but this modality lacks significant or sustained efficacy 
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[Vermorken et al, 2007]. Newer biological agents developed to specifically target 
known dysregulated pathways, may be beneficial in this instance. Clinically tested 
molecular targeted agents in HNC have largely centered on epidermal growth factor 
receptor (EGFR) inhibitors and anti-angiogenic therapies, which include the modulation 
of vascular endothelial growth factor or its receptor. Encouraging results have been 
reported with anti-EGFR therapy, particularly with cetuximab, but targeted therapy 
trials in HNC to date have largely lacked efficacy or are associated with significant 
toxicity [Razak et al, 2010]. With the development of recurrent disease, the 5-year 
survival rate is between 20-30%.  
 
Survival remains the primary outcome measure for HNC treatment. Overall, treatment 
outcomes for HNC are encouraging. In the US, trends estimated from 1975 to 2007 
suggest an improvement in the 5-year survival rates for oral cavity and pharyngeal 
cancers and a slight reduction for laryngeal cancers. The 5-year survival rates during the 
period of 1975-1977, 1987-1989 and the projected rate for 2001-2007 for oral cavity 
and pharynx cancer were 53%, 54% and 63%, respectively; while for laryngeal cancers, 
the 5-year survival rates for the corresponding time periods were 66%, 66% and 63%, 
respectively [Siegel et al, 2012]. Elsewhere, improvements in HNC survival rates have 
also been reported in the UK [Rogers et al, 2003] and in some parts of Europe 
[Guizard et al, 2017]. Improvements in cancer outcomes may be attributed to early 
diagnosis and improvements in HNC management. 
 
Health-related quality of life (HRQOL) is a recognised secondary outcome measure in 
HNC treatment [Verdonck-de Leeuw et al, 2012; Heutte et al, 2016], which is 
determined using validated patient-reported outcome measures [Chandu et al, 2006]. 
HNC-specific validated HRQOL tools are multidimensional covering physical, 
functional and psychosocial domains that may be altered by the disease and treatment 
[Heutte et al, 2016; Pusic et al, 2007; Ringash & Bezjak, 2001]. The treatment 
modalities employed in HNC are potent but toxic. HNC treatment-related toxicities can 
result in varying degrees of symptom burden, functional deficit and facial deformity, 
which associate negatively with HRQOL status. Prospective studies of HRQOL in HNC 
cohorts found that HRQOL is often compromised at diagnosis (baseline), becomes 
worse during the first year post-treatment, and approaches or attains pretreatment levels 
at 12-18 months post-treatment [Hammerlid et al, 2001; Oskam et al, 2013; Chandu 
et al, 2006], which is stable at 5-year follow up (FU). With long-term FU, while there is 
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reasonable HRQOL status, some of the deficits from baseline levels are reportedly due 
to worsening statuses in selected dimensions of general HRQOL status, and in head and 
neck HRQOL–specific dimensions [Oskam et al, 2013]. This deterioration may be 
attributed to continued suffering from various disease- and treatment-related 
impairments many years after treatment, and these contribute towards decreased life 
satisfaction [Mehanna & Morton, 2006; Moore et al, 2014]. Having attained 
survivorship with curative treatment, the need for supportive care is greater than ever 
for HNC patients as they adjust to a new normality.  
 
 
1.3. Head and Neck Cancer Survivorship: Unmet Needs and Concerns 
 
There is high prevalence of unmet need for supportive care, particularly psychosocial 
needs among HNC survivors [Henry et al, 2016; Guilani et al, 2016]. Unmet 
psychosocial needs can negatively impact on HRQOL, and also on many aspects of 
care, from compliance to successful survivorship [Gold, 2012]. HNC survivors and 
their caregivers encounter a whole range of issues, concerns and needs [Rogers et al, 
2009; Wells et al, 2015]. These needs and concerns vary between patients, and also at 
different time point of an individual’s journey. Hence, a personalised approach may be 
better suited to address this problem adequately rather than a ‘one-size-fits-all’ 
approach. 
 
The primary problem with unmet need is uncovering and identifying what these 
concerns and needs are. This requires specifically asking patients what their needs are 
because studies have shown that patients are reluctant to initiate these conversations 
with doctors.  Doctors are beginning to realize that the routine HNC FU clinics offer 
opportunities to identify and address the unmet need in HNC survivorship rather than 
the sole purpose of secondary surveillance [Simcock & Simo, 2016].  
 
Undertaking holistic assessments may be a way of achieving this because this process 
evaluates a diverse range of issues, concerns and needs that patients may have [O’Brien 
et al, 2017; Guilani et al, 2016; Balfe et al, 2016; Well et al, 2015; Rogers et al, 
2009]. This is an area of significant importance in the national cancer survivorship 
strategy, where holistic assessments have become a standard of care for all cancer 
survivors [DOH, 2007; National Cancer Action Team (NCAT, 2011]. It is 
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recommended that holistic assessments are self-completed by patients while in 
conversations with professionals, and there are a range of tools available that can assist 
this process [Richardson et al, 2007]. 
 
There is evidence that the Head and Neck Patients Concerns Inventory (HN-PCI), a 
holistic PRO designed to help HNC patients disclose their concerns during routine HNC 
FU visits. Serving as a prompt sheet, the HNC-PCI can help highlight concerns and 
uncover unmet needs for discussion and may improve patient-doctor communication, 
and promote patient-centred care.  
 
1.4. Significance of this Study 
 
Creating a new way of approaching HNC survivorship that is tailored to patients 
individual circumstances has the potential to improve their post-treatment lives. The 
combination of the type of cancer, its site, the treatment received, the patient’s age at 
diagnosis, length of FU from diagnosis, underlying genetic make-up, concomitant 
comorbidities, personality traits, family and social circumstances all combine to make 
their individual circumstances unique [Davies & Batehup, 2011; Watson et al, 2012].  
 
Screening for individual needs and concerns in the post-treatment phase can play a 
central role in personalising the care they receive during cancer survivorship. 
Identifying unmet needs and patient preferences, understanding their goals and health 
status can help promote a collaborative approach, where patients and doctors work 
together in addressing their concerns. In this way, the shared discussion and decision-
making becomes personalised to the patient [Davies & Batehup, 2011].  
 
Since its introduction, the evidence available relating to the HN-PCI is predominantly 
associated with a single practitioner in a single hospital, where identification of 
individual patient’s unmet needs using this tool has led to discussions that address the 
concern in clinic or resulted in referral to specific services or other professionals 
[Rogers et al, 2009; Ghazali et al, 2012]. With HN-PCI in use, any clinical decision 
made is more likely to be the result of collaborative decision-making based on 
discussions directed by the concerns selected by patients on the HN-PCI. As such, there 
is merit in exploring the introduction of HN-PCI to other doctors and patients within the 
bigger catchment area of the regional HNC unit. This way, it would be possible to 
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evaluate if the clinical impact obtained was due to the tool and not influenced by a 
single practitioner at a single site.  
 
This MD study examines the routine use of HN-PCI by HNC surgeons of two different 
specialties and their patients, who are unfamiliar with the HN-PCI. This study explores 
the potential of this tool in personalising not only the clinic discussions, but also in the 
care received by post-treatment HNC patients. While this study is not designed to 
provide definitive answers, it is hoped that it can inform future practices in improving 
HNC survivorship.  
 
1.5. An overview of MD thesis 
 
An overview of the MD thesis is presented here. Following this brief Introduction 
chapter, the succeeding Chapters 2 and 3 will provide with a greater detail the 
background understanding in the areas pertinent to this study.  
 
Chapter 2 discusses the subject of identifying patients’ concerns and needs during 
survivorship. This chapter provides an overview and description of the key concepts of 
this thesis. The concept of patient-centred care is regarded as the basis for identifying 
patients’ concerns and needs during survivorship. The challenges encountered in 
identifying patients’ needs and concerns during routine outpatient cancer clinics are 
described. An attempt to clarify interchangeable terms i.e. “need”, “concern”, 
“problems”, “issues”, was undertaken. The relationship between “need” and “concern” 
was proposed. This chapter also explores the methods of how needs and concerns have 
been assessed or identified in cancer care, including holistic (needs) assessment, patient-
doctor communication, and the use of prompt sheets. The concept of the ‘Patient 
Concerns Inventory’ was introduced, and this was discussed in context of patient 
empowerment, enablement and self-management. The Head and Neck Cancer Patient 
Concerns Inventory (HN-PCI) was described comprehensively, including its 
development and validation, usage, and the impact of the instrument on clinical 
outcomes. Theoretical models underlying the HN-PCI were proposed as the basis for 
this MD work.  
 
Chapter 3 specifically deals with head and neck cancer survivorship.  A literature 
review was undertaken to explore for gaps in knowledge of the subject, and the chapter 
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summarises current understanding of the key issues that head and neck cancer patients 
and their carers experience during the survivorship trajectory. These issues constitute 
the central theme of this work, and facilitate the development of the thematic framework 
used in content analysis of items of concern from recorded consultations.  
 
Chapter 4 provides an overview of the work carried out in this MD thesis, which was 
composed of three empirical studies i.e. Pilot study, Domain generation study and Main 
study. This chapter provides the rationale for the MD work, its conception, aims and 
summarises each empirical study to provide an understanding of how each study relates 
together.  The patient-reported outcome measures commonly used throughout the 
empirical studies of the MD work are also presented here.  
 
Chapters 5, 6 and 7 detail the three empirical studies undertaken in this thesis. Chapter 5 
relates to the Pilot study. Chapter 6 relates to the Domain generation study. Chapter 7 
deals with the Main study of the thesis. The individual chapters contain the specific 
study aims and objectives, methodology employed, the results and discussion pertaining 
to the three empirical studies. 
 
Chapter 8 provides the main conclusions of the MD thesis. The bibliography and 
appendices sections are cited at the end.  
 
 
  
 31 
CHAPTER 2 
 
2.0. IDENTIFYING THE CONCERNS AND NEEDS OF HEAD AND NECK 
CANCER SURVIVORS  
 
2.1. Introduction 
 
The recent decade has seen significant change to the epidemiological trends in head and 
neck cancer (HNC), where patients are being diagnosed at a younger age with HPV-
positive disease. Longer life expectancy means that many more HNC patients are 
expected to journey into long-term survivorship. While undergoing active treatment, 
patients and their caregivers have direct access to healthcare professionals in dealing 
with their needs and concerns. However, once treatment is completed, access to 
supportive services may be less accessible.  
 
The course of HNC survivorship is not the same for every survivor due to the 
combination of disease heterogeneity, multimodality treatment delivered, and unique 
sociobiological circumstances of the individual patient. Thus, the supportive needs of 
HNC patients are equally diverse, and the inability to identify these needs can result in 
the festering of unmet needs, which can impact on cancer survival and health-related 
quality of life. 
 
Identification of HNC patients’ needs and concerns is the central subject of this MD 
thesis. This chapter explores the key conceptual matters that form the basis of this work. 
The subject matter was initially considered using a broad-brush approach, where 
fundamental ideas were identified. These include ‘patient-centred care in medicine’, the 
concept of ‘need in health care’ and the concept of ‘patient empowerment’. Further 
exploration of these fundamental concepts involved examination of specific details to 
clarify related terminology, and to understand how these concepts transformed into 
healthcare policies e.g. holistic (needs) assessment.  
 
This chapter considers the factors that influence the quality delivery of holistic (needs) 
assessment, particularly the use of patient-reported outcomes (PRO) to enhance the 
communication that occurs during this process.  A theoretical framework is presented to 
explain the role of PROs in the dynamic encounter. The use of PROs is compatible with 
concept of patient empowerment in managing long-term survivors of cancer and in 
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those with chronic illnesses.  
 
Finally, this chapter addresses the concept of Patient Concerns Inventory, its common 
approach based on patient empowerment in those with long-term chronic conditions, 
and its influence in the development of the Head and Neck Cancer Patients’ Concerns 
Inventory (HN-PCI), a PRO that helps patients disclose their concerns. A 
comprehensive review of all published papers relating to HN-PCI was undertaken, and 
provides the background and rationale for this current work.  
 
2.2. Patient-centred care in cancer survivorship 
 
2.2.1. The concept of patient-centred care 
 
‘Patient-centredness’ in medicine was introduced in the mid 1950s [Balint, 1955]. This 
concept suggests that patients should be understood as a unique being, and seen in their 
biopsychosocial entirety [Mead & Bower, 2000]. Central to this approach is where the 
provider ‘tries to enter the patient’s world to see illness through the patient’s eyes’ 
[McWhinney, 1989] and the resultant care provided is ‘closely congruent with, and 
responsive to patients' wants, needs and preferences' [Laine & Davidoff, 1996]. A 
comprehensive definition for patient-centred care is proposed by the US Institute of 
Medicine [Committee on Quality of Health Care in America, 2001] as being care 
with the following characteristics: (a) responsive to consumer needs, values and 
preferences; (b) integrated and coordinated; (c) relieves physical discomfort; (d) 
provides emotional support; (e) allows for the involvement of family and friends; and 
(f) supports the provision of information, communication and education to enable 
patients to understand and make informed decisions about their care.  
 
As new directions and models in health care systems evolve, patient-centred care has 
acquired an increasingly prominent role in achieving quality care for patients and their 
caregivers [Jayadevappa & Chhatre, 2011]. Fundamental to patient-centred care is 
enhanced clinician–patient communication with the primary attributes of compassion, 
empathy, and responsiveness to the needs, values, and expressed preferences of the 
individual patient [Perrochia et al, 2011; Committee on Quality of Health Care in 
America, 2001].  
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Research evidence relating to patient-centred care may be categorised in two ways 
[Lutz & Bowers, 2000]. The first category considers patient-centred care in re-
organisation of services around patients’ needs. This approach considers 
implementation of patient-centredness in restructuring and integration of services 
[Wakefield et al, 1996], and provides the benchmark for delivery of quality care, 
particularly in those with chronic conditions [Harrison et al, 2009]. This approach in 
cancer is exemplified in the incorporation of patient-centred care as a key strategy in 
NHS policy for cancer care services [DOH, 2004], the National Cancer Survivorship 
Initiative [DOH, 2010] and the most recent NHS cancer policy, the Cancer Strategy 
Implementation Plan [NHS England, 2016].   
 
The second category defines patient-centred care as efforts towards understanding and 
meeting patient-perceived needs, priorities, and expectations for health care in clinical 
practice. This approach is influenced by the quality of the interaction between the 
provider and the patient. According to Street et al [2009], the principle functions of 
patient-centered communication are the exchange of information, supporting patients' 
self-management, the management of uncertainty and emotions, decision making and 
enhancing the physician-patient relationship. 
 
 A patient-centred approach is widely acknowledged as a core value in clinician-patient 
interactions in the management of chronic conditions, in primary care settings [Hudon 
et al, 2012], and in cancer care [Zucca et al, 2014].  
 
 
2.2.2. Patient-centred care in cancer 
 
From a practical standpoint, patient-centred care in cancer is unlikely to occur without a 
good understanding of patient needs and factors that influence them [Richardson et al, 
2007]. Communication during cancer care is particularly challenging due to the 
involvement of multiple clinicians over an extended period of time, the emotional and 
psychological impact of the disease, the use of complex multimodality treatments, and 
the uncertainties associated with disease progression and treatment toxicities [Mazor et 
al, 2013; Epstein et al, 2007]. Patient-centred cancer care places a premium on patient-
centred communication skills that facilitate patient’s needs to be articulated, addressed, 
supported and incorporated into the delivery of care in each phase of the cancer care 
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continuum [Committee on Quality of Health Care in America, 2001; Baile & 
Aaron, 2005].  
 
The cancer care continuum demarcates a patient’s cancer experience into six phases, 
namely prevention, screening, diagnosis, treatment, (post-treatment) survivorship, and 
end of life [Epstein et al, 2007]. The patient’s position in the cancer care continuum is 
one of the most important contextual elements that determines the nature of concerns 
raised during clinical encounters [Epstein et al, 2007]. The post-treatment survivorship 
phase is potentially the longest phase in the continuum as it begins immediately after 
treatment and extends to the end of life phase.  Here is where potentially the greatest 
gap between the biomedical perspective i.e. cure or remission, and the patient’s illness 
experience can occur [Epstein et al, 2007]. Through the patient-centred approach, 
meeting patients needs with appropriate supportive care i.e. care that helps patients and 
their family cope with cancer and its treatment [Gysele et al, 2004], can enable patients 
to journey the survivorship trajectory better, as many experience high levels of unmet 
need, particularly unmet psychosocial need [Sanson-Fischer et al, 2000] and 
experience dissatisfaction with their care [McDowell et al, 2010] during this phase.  
 
2.2.3. The oncology outpatient setting  
 
During treatment and the immediate period after can be extremely challenging times for 
HNC patients and the need for supportive care is greatest [Chen et al, 2009A; Chen et 
al 2009B; Chen et al, 2009C; Oskam et al, 2013]. Post-treatment outpatient clinic 
follow-up (FU) appointments are opportunities for patients to gain access to their 
clinicians/surgeons and other members of the HNC multidisciplinary team in addressing 
their concerns, distress and needs for supportive care. However, the clinical encounter 
during these appointments can be demanding for both the patient and clinicians, making 
the task of identifying and addressing patient concerns difficult.  
 
Ghazali & Rogers [2011] outline the multiple challenges faced by patients and doctors 
in undertaking a holistic assessments while attending a busy outpatient oncology clinic, 
where appointments are time-constrained. Patients who attend these clinics may be 
unwell. Some patients have had to travel for long distances from where they live to 
attend centralised cancer clinics. Many experience long waiting times before being seen 
[Clayton & Dudley, 2009]. As a result, some visits are rushed due to demands on 
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meeting hospital transport arrangements. Patients commonly experience psychological 
distress, as many are anxious and fear recurrence, while other experience depression 
[Rogers et al, 2009; Llewellyn et al, 2008].  
 
Patients’ beliefs and social pressures can contribute to why some patients may be 
unwilling to disclose their distress or discuss psychological concerns [Epstein et al, 
2007]. Some patients believe that they should be ‘glad that treatment was successful’, 
and believe that others expect them to feel this way [Epstein et al, 2007]. Some patients 
do not want to appear weak, and the fear of being stigmatised for seeking psychological 
help may prevent them from seeking support [Holland & Bultz, 2007]. Many patients 
fear of being a burden on clinicians who they believe are very busy with more important 
things to address [Zucca et al, 2014]. Patients are reticent in discussing sensitive and 
embarrassing issues, like intimacy [Low et al, 2009] and sexual dysfunction [Rogers et 
al, 2015A]. Those with lowered self-esteem and who have a lack of knowledge or 
information about their condition can find the clinical setting intimidating.  In this 
situation, they are unable to voice their concerns, are reluctant to complain and are 
conscious of taking up valuable consultant time [Rogers et al, 1999]. Thus, patients 
may take a stoical view and are unwilling to disclose their concerns, worries or 
complaints. 
 
Because patients tend not to disclose these concerns spontaneously, clinicians need to 
enquire about their concerns [Epstein et al, 2007]. However, clinicians are under 
pressure to perform cancer surveillance tasks, examine prosthesis/wounds, and provide 
information, advice and reassurances during this small window of opportunity at clinic 
appointments. When given the opportunity, patients have indicated a wide range of 
items of concern they wish to discuss and may wish to do so with the multiple 
healthcare providers they interact with throughout the survivorship phase [Rogers et al, 
2009]. Patients want healthcare providers to enquire about their physical and emotional 
needs [Richardson et al, 2007], and their spiritual wellbeing [Best et al, 2014].  
 
One barrier in assessing patient needs and concerns has been the absence of best 
practices in identifying needs and concerns by healthcare providers [Wen & Gustafson, 
2004]. Assessments can be chaotic and unsystematic, and healthcare providers 
infrequently capture accurately what patients are trying to tell them [Richardson et al, 
2007]. In a survey of HNC clinical nurse specialists (CNS), over three-quarters felt 
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strongly about their personal role in uncovering unmet needs in patients, and their 
preference was to rely on counselling and communication methods to identify patients’ 
concerns rather than structured screening tools [Rogers et al, 2011A]. The extent to 
which needs and concerns are identified this way is likely to depend on the quality of 
that ʻone-to-oneʼ contact, which may not be reliable and consistent across the board. 
Indeed, healthcare providers vary widely in their ability to elicit relevant information, 
and equally, patients vary in their ability to voice their concerns and anxieties 
[Richardson et al, 2007].  
 
Patients with inadequately addressed concerns and/or unrecognised issues may fail to 
get the multidisciplinary supportive care they need. Persistent unmet needs can lead to 
poorer overall health, inefficient use of healthcare [Barg et al, 2007], dissatisfaction 
[McDowell et al, 2010] and poorer health status. In these circumstances, there is benefit 
in introducing a framework-based approach to ensure that the needs and concerns might 
be identified in a standardised and structured manner [Richardson et al, 2010]. 
 
2.3. Conceptual issues related to ‘need’ in health care  
 
Before reviewing the methods of identifying patient concerns and needs, an overview 
on the conceptual issues related to patient needs in health care is presented. The aim of 
this section is to highlight a specific methodological problem in needs-based research in 
cancer i.e. the conceptual uncertainties of defining “needs” and the use of related 
terminology e.g.  “problems”, “concerns”, “issues” [Sanson-Ficher et al, 2000]. It is 
also critical to differentiate between patient needs in health care and health care needs, 
which often refer to population-based needs for health care. Other methodological 
limitations in needs-based research include focusing on patients with a specific type or 
stage of cancer only, or those receiving a particular treatment modality; restricting work 
into specific domains of need rather than a holistic approach; and incomparable data 
obtained from a single treatment centre [Sanson-Ficher et al, 2000]. 
 
The term ‘need’ is frequently used to ascribe the requirement of something because it is 
essential or very important. It is also used to state the necessity or obligatory nature of 
something that is missing [Oxford dictionary, 2008A]. The term conjures a sense of 
urgency and a condition where support or help is required [Oxford dictionary, 2008A]. 
Need is a fundamental and powerful driving force in human existence as the individual 
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strives toward its fulfillment. Karl Marx considers the very essence of man to be 
constituted of his needs [Fetscher, 1973]. However, the universality of human need 
does not automatically provide a common platform for a definition of human needs in a 
wider context of society. A range of definitions of need have been produced through 
different approaches across fields of philosophy, psychology, politics, sociology and 
economics, which may be applicable to their own setting. In medicine, needs are 
primary considerations in the provision of care, where health care professionals are 
accustomed to assessing an individual’s need for care prior to prescribing treatment. 
Medical professionals are also asked to assess the health needs of the population when 
planning for health care services. 
 
Need and its assessment has been described as ‘a conceptually muddled and technically 
difficult’ subject [Stevens & Gabbay, 1991].  Agreement on the definition of need is 
lacking [Asadi-Lori et al, 2003] due to considerable confusion and disagreement about 
the concept of need and health need in the literature and in practice. The following 
discussion provides a broad overview on the different perspectives regarding need, and 
to clarify the relationship between the concepts of need, health, and outcome in health 
care. The areas discussed are: (a) Need as an instrumental concept; (b) Need as socially 
constructed; and (c) Need as an outcome.  
 
2.3.1.  Need as an instrumental concept  
 
Need could be defined as an instrumental concept, i.e. the need for something 
[Lightfoot, 1995]. The concept of need as being instrumental is largely based on the 
philosophical approach to need. In Metaphysics, Aristotle remarks that ‘when life or 
existence is impossible (or when the good cannot be attained) without certain 
conditions, then these conditions are “necessary”; and this cause itself is a kind of 
necessity’. This is to say that all human beings have a need for all that is fundamental to 
the maintenance of life or for a ‘good’ or desirable end state (i.e. tension need). 
Moreover, all preconditions required or instrumental to achieve maintenance of life or 
the ‘good’ end state are considered by default as being needs (i.e. teleological need). 
 
In adopting the instrumental concept of need in health care, James [1999] argues that 
the measurement of ‘real need’ becomes imperative in this model and this immediately 
poses the problem of what ‘end state’ should be achieved as the direct link between 
 38 
need and outcome is explicitly made here.  It is important to distinguish between ‘need’ 
and ‘want’. It may be possible to discern the difference between ‘need’ and ‘want’ in 
commonplace conversation i.e. people can ‘want’ something they do not ‘need’ and 
‘need’ something they do not ‘want’. Fitzgerald [1985] points out that it is possible to 
determine what people want by observing the action of people or asking them but this is 
not so with needs. Individuals are not necessarily the true arbiters of what they truly 
need. 
 
Doyal and Gough (1984) presents a basis by which the distinction between ‘needs’ and 
‘wants’ can be made in their Theory of Human Needs. Need is defined as a particular 
category of goals that is universally aspired i.e. applies to all people. These goals are 
those that everyone shares as a virtue of being human i.e. basic human needs 
[Weatherley, 1996]. ‘Need’ can be used to refer to the ‘strategies’ for attaining goals, 
which in themselves, may be regarded as needs i.e. ‘intermediate needs’. The 
universality of needs also rests upon the principle that these needs ‘must be met if 
humans are to flourish’ and if these needs are unmet, ‘serious harm’ of some objective 
kind, will result. In this context, ‘serious harm’ is defined as a fundamental disablement 
in the pursuit of one’s vision of the good. In contrast to needs, ‘wants’ lack universality 
and are always considered as ‘perceived goals’ or desires derived from an individual’s 
preference or their social/cultural environment, which are justified by reasons which 
have little to do with more general beliefs about the human condition [Doyal & Gough, 
1984].  
 
The demand for an intermediate state, e.g. a health care intervention, may reflect the 
desire to attain the end-state [James, 1999]. Culyer [1976] argues that a focus on the 
need for health should remain central to the definition of the desired end-state, 
particularly as the need for health is considered as a basic human need [Doyal & 
Gough, 1984]. However, the definition of health as a desirable end-state has difficulties. 
Requirement for health is a universal human goal but the nature of health has often been 
debated. The current, widely accepted definition of health is based on the Holistic 
Theory of Health, where health is a holistic state of being i.e. individuals possess 
mental, physical and social capacity to achieve their vital goals in life [Nordenfelt, 
2007]. This theory suggests that to be healthy is a universal state where the individual is 
able to fulfill their most important goals, but because alteration to health develops over 
a continuum, it is possible for health to coexist with disease [Schramme, 2007]. 
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Therefore, illness and disease can exist within health. This redefinition of health is able 
to accommodate the rise in chronic illness states [Huber et al, 2011], including long-
term cancer survivorship.  
 
The World Health Organisation (WHO) adopts this holistic approach to health in its 
definition of health as ‘a state of physical, mental and social well-being, and not merely 
the absence of disease or infirmity’ [WHO, 1948, page 1]. This definition amalgamates 
the traditional biomedical approach (i.e. focus on aetiologic agents, pathological 
processes, and biological, physiological, and clinical outcomes) with the social science 
paradigm, or the "quality-of-life" model (i.e. focus on dimensions of functioning and 
overall well-being), and is used in the UK national health policies, where a ‘quality of 
life approach’ to need for health care was proposed [DOH, 1992].  In their review of 
needs for health care, Asadi-Lari et al [2003] state this definition as being the 
requirement of individuals to enable them to achieve, maintain or restore an acceptable 
level of social independence or quality of life, as defined by particular care agency or 
authority.  
 
The Holistic Theory of Health is not without conceptual problems [Schramme, 2007]. 
A clear conceptual distinction of disease and health remains lacking due to the sole 
reliance on attainment of vital goals as the discerning criteria, which can lead to a broad 
medicalisation of many ‘illness states’. For example, an overly ambitious athlete who 
has not reached the targeted goals may be considered as being in ill health according to 
Nordenfelt’s [Noordenfelt, 2007] definition. Furthermore, the idealised positive notion 
of health according to this theory may not be practically attainable by an individual or 
collectively by society.  
 
2.3.2. Need as socially constructed 
 
Based on phenomenological studies, sociologists define ‘need’ as being socially 
constructed, where it is contingent upon the variables of our social existence [Doyal & 
Gough, 1984; James, 1999].  Thus, need may be defined relative to the different groups 
within society depending on the cultural, social and organisational context [James, 
1999]. In relation to health needs, Bradshaw [1972] considers ‘need’ in two ways based 
on the interaction between the two main groups within the context of health care 
services. Patient-assessed needs are comprised of ‘Felt need’ which refers to the 
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perception of patients when they feel ill, and ‘Expressed needs’ which describes the 
process by which felt need is translated into the demands on health services. External-
assessed needs are composed of ‘Normative need’, which refers to the definition of need 
by professionals (health care and social care professionals) and ‘Comparative need’, 
which is used to compare two or more patients or populations. ‘Normative need’ has 
been the traditional means by which health care is accessed by patients. The role of the 
general practitioner [Wright et al, 1998] and more recently, the Clinical 
Commissioning Group as the gate-keeper to the National Health Service (NHS) 
exemplifies this. In this traditional arrangement, the patient’s needs are judged against 
the ‘infallible’ expert standard.  
 
The rise of consumerism in health care, exemplified by NHS choices [DOH, 2016], 
reflects another aspect of needs as being socially constructed, where the articulated 
experiences of service users provide counterbalance to the views of the professionals. 
James [1999] points out that as service users are increasingly encouraged to define their 
own reality, the list of needs may potentially become endless. This is encouraged by the 
concept of self-improvement or ‘self-actualisation’, which is a popular idea that 
permeates discussions on broad social constructs, such as health, well-being and quality 
of life. This notion is based on a psychological approach to needs proposed by Maslow 
[1943].  
 
In Maslow’s Theory of Human Motivation, needs are arranged in hierarchies of pre-
potency, where the appearance of one need usually rests on the prior satisfaction of 
another, more pre-potent need. Needs are organized into four successive categories of 
universal human needs i.e. physiological, safety, love/acceptance and self-esteem, 
which must be met in turn before the final and highest goal of self-actualisation is 
achieved [Maslow, 1943].  Despite its popularity, there is lack of empirical or 
phenomenological evidence to support the existence of a hierarchical organisation of 
needs [Wahba & Bridwell, 1976]. This model is also criticized for its emphasis on the 
needs of the individual, which may only be relevant in societies where a high value is 
placed on individualism [Cianci & Gambrel, 2003].  
 
2.3.3. Needs from a humanitarian approach  
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The ‘Humanitarian approach’ to need for health care is based on the premise that 
medical care service is required or needed to alleviate human suffering [Donabedian, 
1974]. This approach places prime importance on the management of the sick without 
considering the consequences of limited resources available. Consequently, while the 
end state of health improvement can be achieved, a more vertical distribution of health 
care resources occurs, with those sickly and needy patients consuming most of the 
limited resources.  
2.3.4. Need as a utility approach  
 
When blurring of ‘needs’ and ‘wants’ occur, all ‘needs’ are potentially justifiable even 
though resources are limited. Concerns about this have led some to suggest that need 
should be defined in relation to the procedures available to meet it, to the resources that 
permit those procedures to be used and where benefit can be demonstrated i.e. the utility 
approach [Matthew, 1971; Cochrane, 1976; Acheson, 1976]. This approach is heavily 
based on an economic model.  
 
As a publically-funded body, the supply of health care service via the NHS is free for all 
citizens at the point of access. Therefore, the NHS faces the problem of infinite demand 
meeting finite resources. The economist’s view of ‘anything that is free will be 
demanded infinitely’ has undoubtedly raised significant concerns [Vetter, 2002, page 
375]. However, in the health care setting, health from a holistic perspective is 
considered the desired end-state. The need for health care i.e. the intermediate need for 
health as the desired end-state, represents those needs that can benefit from health care 
services e.g. health education, disease prevention, diagnosis, treatment, rehabilitation, 
terminal care [Wright et al, 1998]. The perception that health care professionals are 
able to assist individuals in bringing benefit to their health lies at the root of their 
demand for health care services.  
 
A more realistic approach to healthcare need, based on an economic principle of cost-
effectiveness, is required to provide a wider distribution of limited resources  [Acheson, 
1978]. The distinct entities of ‘need’, ‘demand’ and ‘supply’ are well founded in the 
economic model of healthcare provision. In this model, ‘Need’ is defined as ‘the 
capacity to benefit from health care’ [Stevens & Gillam, 1998; Wright et al, 1998]. 
This is to say that if the needs for healthcare are to be identified then an effective 
 42 
intervention should be available to meet this demand and results in improved outcomes 
(e.g. health gain) [Wright et al, 1998]. Inevitably, this definition considers needs as 
being present if there are existing services that can offer effective outcomes. Asadi-Lari 
et al [2003] argues that this definition of need places a greater focus on outcomes of 
medical interventions, where objective measures are the preferred method in recording 
progress. This can result in a narrowed scope of measuring benefit, particularly when 
outcomes are generally inversely related to the severity of illness. The perception of 
benefit may vary according to viewpoints (e.g. doctors’ versus patients’ perspectives) 
and may be influenced by external factors (e.g. cultural, research agenda). ‘Demand’ is 
what patients ask for and may be thought of as ‘expressed need’. ‘Supply’ is what 
healthcare service that is provided, which can vary depending on the professional 
expertise available, the political agenda and exiting financial means.  
 
2.4. Meeting Need in Health Care 
 
2.4.1. Defining Unmet Needs in Health Care 
 
Figure 2.1 considers the relationship between need, demand and supply [Wright et al, 
1998] in the common setting of a patient visit to see a clinician. This visit, i.e. shaded 
area of overlap between the patient and health care boxes, represents the interface by 
which the two main groups within the context of healthcare services interact 
[Bradshaw, 1972]. At such a visit, healthcare professionals determine the normative 
need i.e. capacity for patients to benefit from an existing service. When such a service is 
supplied and a beneficial effect is achieved, the normative need is considered met. On 
the other hand, when there is no service to supply and the beneficial effect is not 
attained, the normative need is considered unmet. From a healthcare resources 
perspective, patients with unmet needs are considered ‘non-recipients of beneficial 
healthcare interventions’ [Stevens & Gillam, 1998].  
 
A narrowed, medical intervention-focused definition of need inevitably fails to consider 
the patient’s perspectives. While there is a large body of work relating to unmet needs, 
very few studies define unmet needs specifically. Soothill et al, [2001] proposes a 
‘strict’, patient-reported definition of unmet needs in their survey of the needs of cancer 
patients, whereby significant unmet needs are those needs that patients identify as being 
important, and were perceived to be unsatisfied. On the other hand, ‘unmet needs’, used 
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interchangeably with ‘unmet supportive care needs’, was defined by Carey et al [2011] 
as those needs which lack the level of service or support an individual perceives is 
necessary to achieve optimal well-being. This definition provides a more balanced and 
practical perspective by relating the patient perspectives on the availability of services 
in relation to the satisfaction of their needs.  
 
Figure 2.1. Diagram showing the relationship between needs, demand and supply. The 
shaded area represents the interface between patients and the healthcare professional.  
 
 
 
 
 
 
 
 
 
 
 
 
 
It is recognised that when patients attend a clinical visit, due to barriers that may be 
present, their felt need may not be fully expressed into a demand for healthcare 
intervention or for supportive care. These undisclosed needs are hidden, and it is 
unlikely that healthcare professionals, unaware of its existence, are able to address these 
needs with the appropriate supportive care services. In various studies of cancer 
survivors, unmet needs are prevalent, and are associated with psychological distress and 
poor HRQOL status.  
 
2.4.2. Holistic (needs) assessments 
 
Needs assessment in health care is to gather the information required to bring about 
changes beneficial to the health of the population [Stevens & Gillam, 1998]. On an 
individual level, needs assessment is also defined as the process of collecting 
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information about a patient’s needs and circumstances, making sense of that information 
in order to identify needs and to decide on what support or treatment can be offered, 
tailored to the patient [DOH, 2003]. In the cancer setting, patient needs assessment is an 
agenda driven by NICE Guidance on Improving Supportive and Palliative Care for 
Adults with Cancer [NICE, 2004], the Cancer Reform Strategy [DOH, 2007], National 
Cancer Survivorship Initiative [DOH, 2010] and more recently, the Macmillan 
Recovery Package [Macmillan Cancer Support, 2013], which is endorsed by NHS 
England Five Year Forward View [NHS England, 2014] and the Cancer Taskforce 
Strategy [NHS England, 2017]. The theoretical and practical guidance on the principles 
and practical aspects of this exercise are outlined in documents commissioned by the 
National Cancer Action Team (NCAT) [Richardson et al, 2007A & 2007B; NCAT, 
2011].  
 
In keeping with the holistic approach to health [WHO, 1948], need assessment in health 
requires the assessment to consider the patient wholly i.e. viewing the individual as 
having physical, social, psychological and spiritual aspects of life, all of which are 
closely interconnected. Thus, holistic assessments ‘should consider all aspects of a 
person’s needs and that they are seen as a whole’ [NCAT, 2011; page 5]. The over-
riding purpose of holistic assessments in cancer is to ensure that patients receive 
personalised care that reflects the patients’ health and needs.  
 
Holistic assessment is a process that involves identifying patients concerns or problems 
through an assessment, and addressing these concerns by formulating an action plan 
[NCAT, 2011]. Assessment of needs, concerns or problems involves the patient using a 
suitable self-reported assessment tool that provides a structure for assessment 
conversations with healthcare professionals. This process helps patients realise that their 
concerns are worthy of attention and not out of the ordinary [NCAT, 2011]. Disclosing 
these concerns can create avenues for discussion, and inform them of what support 
service is available to them even when this is not immediately required.  
 
During discussions, some concerns are simply dealt with immediately, for example, the 
visit itself provides space for patients to talk about their concerns/problems, information 
giving and undertaking medical actions i.e. physical examination, requests for 
investigations, prescription of medication [NCAT, 2011].  
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Other concerns may involve patients’ active participation in resolving the concerns i.e. 
self-management, e.g. undertaking self-examination, participating in support groups, 
and adherence to physical rehabilitation programme [NCAT, 2011]. Some concerns 
would require additional input by other professionals through referrals beyond the 
immediate MDT, for example, psychologists, social workers, financial advisors and 
chaplain. Summarising the content and outcomes of the discussion into an action plan 
completes the holistic assessment process (Figure 2.2) [NCAT, 2011].  Discussions 
during holistic assessment can help support patients in day-to-day self-management of 
their condition, and preempt more serious presentation of a problem by enabling 
patients to seek help at an earlier stage [NCAT, 2011]. From the MDT’s perspective, 
holistic assessment can help identify patients who have the greatest and/or most 
immediate need for supportive care, and facilitate a focused and efficient delivery of 
care, as resources are used more effectively [NCAT, 2011].  
 
 
Figure 2.2. Flow chart summarising the holistic assessment process [NCAT, 2011] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.3. Identifying needs and concerns  
 
Best practice guidelines and government policy documents advocate screening cancer 
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patients for supportive care needs at appropriate time points during the cancer 
survivorship trajectory by utilising holistic patient-reported outcome (PRO) measures 
[NICE, 2004; DOH, 2010; National Comprehensive Cancer Network (NCCN), 
2008; Richardson et al, 2007]. The process of holistic assessment relies upon effective 
communication between the patient and their healthcare providers, using a PRO tool, 
which may provide the necessary structure and rigour in to the process of assessment 
[NCAT, 2011].  
2.4.3.1. Communication during patient-doctor encounters 
Communication is regarded an essential component in patient-centred care in cancer 
[Baile & Aaron, 2005]. The basis of effective holistic assessment is good 
communication, which relies upon the ability of doctors/healthcare professionals to ask 
questions with sensitivity that enables patients to disclose their concerns, and in turn, be 
able to listen to, and hear out these concerns with patience and understanding while 
responding appropriately, with empathy and avoid blocking [NCAT, 2011]. Healthcare 
professionals should allow patients to explore their concerns, their unique situation and 
possible solutions. Healthcare professionals are most useful when they are able to 
provide information including advice on self-management, and about existing services 
that are available in addressing their concerns [NCAT, 2011].   
Patients want sensitive, caring and supportive clinicians who provide information that 
they need, when they need it, in a way that they can understand; who listen and respond 
to questions and concerns, and who attempt to understand the patient’s and their 
family’s values, preferences and experience. The patient also plays an essential role in 
discussions so as to achieve a patient-centred approach [Cegala & Post, 2009] but 
patients cannot be relied solely upon to initiate discussions about their concerns because 
of a multitude of patient-related barriers. These barriers include poor health literacy, 
lack of knowledge or information to participate in shared-decision making, and having 
certain health beliefs e.g. fear of distracting the doctor from treating the cancer; belief 
that clinicians are too busy; belief that addressing a particular need is not a core 
component of the clinicians role; belief that the doctor will inquire about important 
aspects of care; desire to be a ‘good patient’; and belief that there is nothing that can 
be done to help a particular symptom’ [Zucca et al, 2014, page 2004]. 
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2.4.3.2. The patient-doctor encounter during routine oncology clinic 
 
Due to the nature of the assessment, it is suggested that the holistic assessment should 
be undertaken in a setting that is comfortable for patients to disclose their concerns. 
Routine post-treatment visits in the oncology outpatient settings are occasions where 
oncology doctors and their patients may communicate in ways that can enhance their 
care. Such appointments are scheduled regularly at planned intervals over a long period 
of survivorship, and may be opportune moments to undertake holistic assessments so as 
to personalise their care.  
 
However, the reality of routine oncology consultations is far from ideal. During routine 
oncology consultations, doctors spend 64-78% of their time discussing 
medical/technical issues [Detmar et al, 2001; Fagerlind et al, 2008]. Meanwhile, 
patients tend to spend equal time between medical/technical issues with HRQOL-related 
issues [Detmar et al, 2001]. It is estimated that patient-centred issues are only 
discussed between 16-48% in these clinics [Detmar et al, 2001; Fagerlind et al, 2008]. 
This occurs despite the overwhelming majority of cancer patients, their family and 
friends preferring a patient-centred approach during consultation [Dowsett et al, 2000]. 
Many patients (60%) have expressed their preference and willingness to discuss 
psychosocial issues with their cancer doctors [Mackenzie et al, 2015]. There is an 
expectation that patients are best positioned to initiate discussions surrounding their 
concerns, and some do [Detmar et al, 2001], particularly when dealing with emotional 
and social concerns [Taylor et al, 2011], and psychological and spiritual/existential 
concerns [Rodriguez et al, 2010]. However, not all patients were willing to discuss 
psychosocial issues with their cancer doctor without the doctor initiating the discussion 
(25%) [Detmar et al, 2000; Zucca et al, 2014]. A smaller proportion of patients (9%) 
express a preference for not discussing psychosocial concerns at all during clinic 
appointments [Taylor et al, 2011].  
 
Understanding the views and preferences of cancer doctors relating to consultations are 
also important, especially if doctors are expected to initiate discussions relating to 
psychosocial concerns.  Overall, cancer doctors are interested in acquiring information 
about their patients’ general well-being and in non-medical areas of their lives, but the 
natural focus is primarily the complex medical issues during visits [Baile et al, 2011; 
Velikova et al, 2007]. Lack of time during appointments and unsuitable environment 
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are often cited as a practical reason why holistic assessments are not undertaken. There 
is fear of ‘opening Pandora’s box’ of problems [Baile et al, 2011]. Some cancer doctors 
express their discomfort in dealing with emotional distress [Fagerlind et al, 2008], and 
feel out of depth from a perception of being inadequately trained to handle psychosocial 
and/or spirituality-related consultations [Baile et al, 2011; Best et al, 2014]. 
Furthermore, some describe embarrassment when having to deal with concerns about 
intimacy and sexuality [Low et al; Rogers et al, 2015].  
 
Doctors in oncology clinics sometimes avoid discussions of psychosocial nature. Some 
defer the initiation of discussions on psychosocial issues to patients [Detmar et al, 
2000; Taylor et al, 2011]. Taylor et al [2011] reported that discussions relating to 
emotional issues in oncology clinics were only undertaken when initiated by patients 
despite 75% doctors expressing willingness to discuss these issues in clinic. Doctors 
found initiating social concerns more comfortable than emotional concerns, because 
many social activities were related to physical functioning [Taylor et al, 2011]. 
Considering these issues, the introduction of a PRO that can help initiate discussions in 
the process of holistic assessment may potentially change the way routine oncology 
clinic discussions are held.   
 
Methods of improving both doctor and patient communication skills during cancer 
consultations may improve the overall quality of discussions. These interventions 
include the use of informational-based tools (i.e. prompt sheets, written summaries and 
audiorecordings of consultations) and coaching/communication skills building at the 
individual and community levels [Parker et al, 2005].  
 
 
2.4.3.3. Prompt sheets   
 
Prompt sheets are often designed in a list format, acting as an aide-mémoire during 
communication. Prompt sheets assist patients in articulating their needs and to get their 
views and message across to the health care provider [Parker et al, 2005]. The list 
could be composed of questions that may assist in information gathering during 
consultation, or tips/suggestions as to how to formulate questions they wish to be 
answered, or as itemized check list that enables patients to indicate their concerns, 
values and preferences relating to their care [Parker et al, 2005]. Prompt lists have 
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been used extensively to aid communication in the oncology setting, and this subject has 
been reviewed elsewhere [Brandes et al, 2016; Miller & Rogers, 2016].  
 
The availability and structured multidimensional format of a health-related quality of 
life (HRQOL) questionnaire makes it an attractive tool to exploit as a prompt sheet for 
screening of problems and communication in routine oncology follow-up clinics. 
HRQOL has been successfully adapted to screen for HNC survivors with significant 
problems, thereby triggering the need for healthcare intervention [Rogers & Lowe, 
2009]. Routine use of HRQOL in oncology follow-up clinic consultations has also aided 
patient-clinician communication [Detmar et al, 2002; Velikova et al, 2002; Velikova 
et al, 2004; Taylor et al, 2010; Takeuchi et al, 2011]. By using HRQOL, more items 
of concern were discussed during patient-clinician consultations in clinic [Velikova et 
al, 2004; Takeuchi et al, 2011], suggesting the HRQOL tools can facilitate the 
expression of felt needs by directing the discussions toward the expressed need, thereby 
improving the efficiency of and satisfaction with the consultation.  
 
There are some limitations in employing HRQOL as a tool to aid patient-clinician 
communication in regular follow-up clinics. Not all HRQOL assessment tools take into 
consideration the individual’s perception of the relative importance of some domains 
over others and this may be reflected in the weight given to specific concerns during 
consultation.  HRQOL questionnaires may be restricted by the wording used and tend to 
focus on symptoms or dysfunction over a short period of time, typically over seven 
days, which only provides a snap-shot assessment of issues that are dynamic in nature.  
 
The rigid structure of some HRQOL assessment tools may not accommodate the 
influence of coping and adaptation that occurs with time. Parallel cognitive and 
emotional processing during coping and adaptation [Levanthal et al, 1980] can result in 
incongruence between the degree of dysfunction and the significance patients place 
upon it [Llewellyn et al, 2007]. For example, patients with significant dysfunction will 
continue to indicate poor HRQOL scores in the related domains due to the way the 
questionnaire is constructed i.e. based on the assumption that poor function results in 
poor QOL, even though the patient has positively adapted to the condition and 
consequently, may not harbour any felt need to discuss this further. Alternatively, a 
patient with very mild dysfunction will score relatively good HRQOL scores but may 
hold significant felt need for supportive care in relation to this. In both scenarios, the 
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HRQOL tool fails to capture the patient’s perception of their success in coping or 
adapting to the dysfunction present.  Consequently, HRQOL tools may miss the 
presence of felt need to discuss the issue during consultation. The significant limitations 
with HRQOL tools in identifying individual patient concerns and priorities prompted 
the development of the Patients’ Concerns Inventory. 
 
2.5. The ‘Patients’ Concerns Inventory’: A conceptual discussion 
 
2.5.1. Similarities of the patient experience in chronic conditions and cancer 
survivorship: The ‘patient empowerment’ approach within patient-centred care 
 
Cancer patients experiencing long-term survivorship bear similarities to those who live 
with irreversible or progressive chronic conditions. In both groups, patients experience 
diverse issues throughout their lives as a result of the disease and/or treatment, where 
the impact upon health outcomes is influenced by individual circumstances, especially 
psychosocial concomitants. Thus, it is useful to consider current concepts that underpin 
the management of chronic disease.   
 
‘Patient empowerment’ is an important psychosocial concept in the management of 
chronic diseases. There is a lack of a universally accepted definition of patient 
empowerment, but most patient empowerment definitions focus on individuals’ capacity 
to make decisions about their health (behaviour) and to have, or take control over 
aspects of their lives that relate to health [McAllister et al, 2012]. It is assumed that 
empowered individuals will be able to: (a) make more rational healthcare decisions to 
maximise their health and wellness; (b) decrease dependence on healthcare services; 
and (c) ultimately contribute to more cost-effective use of healthcare resources.  
 
Improving patients’ capacity to take control of their health and life means that patients 
need to be in a position to understand their disease, the diagnostic process, the treatment 
options and the side-effects, how to take their medications, and be able to cope with 
problems resulting from the disease and its treatment. These can be extremely 
challenging for many patients. Chatzimarkakis [2010] outlines the three principles of 
implementing the patient empowerment concept into practice. These principles are: (1) 
“Empowerment means Enablement”, (2) “Empowered patients need strong partnerships 
with doctors and caregivers”, and (3) “Patient empowerment is a paradigm, not a 
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technique”. In summary, patient empowerment is a (new) model of patient-doctor 
relationship, where patients’ capacity for self-management is enabled by strong 
partnerships with doctors. 
 
Enablement is an inextricable concept related to patient empowerment. 
Chatzimarkakis [2010] assert  “empowerment means enablement” where patients need 
to ‘know’, ‘be able’ and ‘want’ to self-manage. The health care system supports patient 
empowerment by creating an environment of enablement.  Hudon et al, [2010] defines 
enablement process as ‘a professional intervention aiming to recognise, support and 
emphasise the patient’s capacity to have control over their health and life’. Steps to 
provide education and practical training, having tools and equipment for self-
management, and motivational factors for patients to modify their health behaviour 
appropriately in context of self-managing their disease [Chatzimarkakis, 2010].  
 
The quality of partnership between patients and doctors is fundamental to the 
enablement process. Continuity of care can foster the relationship that empowers 
patients because the partnership is negotiated with time, where doctors adjust to 
patients’ capacities and their preferences [Hudon et al, 2012]. Doctors utilise their 
expertise and competencies to provide technical information in a way that patients can 
understand so as to find common ground, while patients are encouraged to participate in 
their own care stimulating them to ask questions, and engaging patients in discussions 
by creating ways through which patients can express their views, needs and concerns 
[Hudon et al, 2012]. One of the ways patients can be encouraged to express their views, 
preferences, needs and concerns is by using patient-reported outcome (PRO) measures.  
 
McAllister et al [2012] considers PROs central to the concept of patient empowerment, 
because empowerment relies on an effective communicative process between health 
professionals and patients, which is the basis of a collaborative, patient-centred 
approach, and a fair and equal relationship [McAllister et al, 2012]. The ultimate goal 
of equitable/collaborative models of clinician-patient interaction based on patient 
empowerment is self-management and shared decision-making [McAllister et al, 
2012].  
 
Health care systems have started to recognise how the concept of patient empowerment 
sits comfortably within the philosophy of patient-centred care. This is particularly 
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evident in the general practice setting, where the care of patients with chronic disease 
commonly takes place. Patient empowerment has been recognised as a characteristic of 
general practice, and is considered to lie within the core competency of person-centred 
care [Rochford, 2015]. The recent introduction of the ‘New Care Models: Empowering 
Patients and Communities’ in relation to the NHS in the UK also reflects this. This 
document outlines the paradigm shift in NHS policy towards personalising care and 
support, where the formation of partnerships through good communications between 
individuals living with long-term condition and their health care practitioners is 
considered the first key principle [NHS England, 2015].   
 
2.5.2. “Patients’ Concern”: Clarifying the terminology in reference to ‘patient 
empowerment’ 
 
Due to the diversity of issues that may be experienced at different time points of their 
lives, patients with chronic conditions must decide if these issues are of ‘concern’ to 
enable self-management and facilitate shared-decision making in managing chronic 
conditions.   
 
From a linguistic standpoint, concern is used to describe ‘worry or anxiety’ [Oxford 
dictionary, 2008B]. The phrase ‘a cause for concern’ echoes a range of related terms 
that express concern: care, disquiet, perturbation, apprehension, fear, unease, alarm, 
trouble, distress, upset, sorrow and grief [Penguin Thesaurus, 2002]. Concern is also 
used in reference to ‘a matter of interest or importance’ [Oxford dictionary, 2008B] 
where a matter is given thought, regard, attention and consideration because it has 
bearing or relevance, and is of consequence.  Thus, the term ‘concern’ conveys an 
acknowledgement that a particular issue (of concern) is personally significant, and may, 
although not always, be associated with an adverse emotional response.  
 
2.5.3.  What is the relationship between needs and concern? 
 
The relationship between patient concern and need in healthcare is not fully understood, 
and the terms are often used interchangeably. According to Bradshaw’s sociological 
theory of need [Bradshaw, 1972], patient-assessed needs are composed of ‘Felt need’ 
which refers to the perception of patients when they feel unwell, and ‘Expressed needs’ 
which describes the process by which felt need is translated into the demands on health 
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services.  
 
Based on this understanding, it is proposed that when patients perceive a particular issue 
is of concern to their wellness, this may be considered as an expression of felt need. The 
consequential effort by patients to seek help from healthcare professionals may be 
considered as expressed need. Not all felt needs are ultimately expressed, as patients 
may choose not to disclose information when asked or given the opportunity to do so. 
However, it is of more significance if patients do not disclose their concerns or felt 
needs not out of choice but because of barriers (external and internal) that exist during 
the interaction between the patient and the health care professional. 
 
2.5.4.What is the idea behind ‘Patients’ Concerns Inventory’? 
 
The use of prompt sheets as a way of identifying patients’ needs and concerns was 
discussed in section 2.4.3.3. The ease by which problems or concerns could be 
expressed by patients using prompt lists has seen the development of several problem- 
or concern-based tools in the oncology setting [Miller & Rogers, 2016]. These include 
the Problems List, which is used in conjunction with the Distress Thermometer, a 
screening tool for distress [Holland & Bultz, 2007] and the Patients Concerns 
Inventory (PCI), which is composed of a checklist of potential problems, issues or 
concerns that patients may experience due to their condition [Rogers et al, 2009].  
 
These problem-based prompt lists are classified as a PRO measure based on the 
definition and criteria outlined by the FDA [2009]. PROs in a prompt sheet format can 
provide a simple but practical patient-reported tool, especially when it is designed to be 
holistic. This is particularly valuable in assisting cancer survivors identify their 
concerns, as holistic PROs considers all the domains of well-being [Synder et al, 
2010].  
 
‘Patients’ Concerns Inventory’ (PCI) is essentially a checklist of key items of concerns 
that a cohort of patients with a particular condition may experience in their lives. It is 
essentially a PRO in a prompt sheet format. The idea of the checklist was to act as an 
aide-mémoire for patients, prompting them to disclose any concerns they may have 
about their condition during their encounter with the health care professionals. In this 
way, the PCI helps identify patient concerns. 
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During the process of completing the PCI, patients scan through the holistic PCI list, 
and discern which ‘felt need’ or concern will ultimately be expressed for attention. This 
thought process asks patients to reflect on the issue, their goals and priorities. The 
importance placed on a particular issue of concern may be relative and temporal. When 
the PCI is completed at regular intervals of their journey, it can provide a unique 
longitudinal record of patients’ concerns at specific time-points [Synder et al, 2010]. 
The process of going through the checklist can also be an educational experience. 
Patients may come to realise that some of the concerns listed are recognised issues that 
other patients with the condition may experience.  
 
Once the PCI is completed, patients gain the opportunity to discuss these concerns 
further with the doctor/health care professionals.  At best, the PCI can enable 
discussions that focus on the patients’ agenda and help patients gain better 
understanding of their concerns, empower patients to become more active participants 
in managing their condition, and facilitate joint decision making to maximise their 
health and wellness.  
 
However, the extent by which the PCI data can empower patients i.e. facilitates 
discussions between patient and clinicians about their concerns, ultimately depends on 
upon the quality of partnership that exists between patients and doctors. The doctors’ 
acceptance of the PCI also plays a key role in this process.  
 
 
2.5.5. What is the theoretical framework for PCI? 
 
A formal theoretical framework for the PCI has never been proposed. There are two 
ways by which the PCI could be considered: (1). As a PRO used in identifying patients’ 
needs and concerns, and (2) As a tool that can enable better communication between 
patients and clinicians. Theoretical frameworks to explain both situations are presented 
as follows: 
 
2.5.5.1. PCI as a PRO in identifying patients’ needs and concerns  
 
Fung & Hays [2008] proposed a hypothesis on the relationship between different types 
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of PROs used during patient-doctor encounters in healthcare (Figure 2.3).  In their 
hypothesis, QOL and patient satisfaction are considered the core endpoints. In their 
hypothesis, PROs occupy the central role in the delivery of quality care during patient-
doctor encounters. 
 
According to this hypothesis, it is possible to identify a patient’s problem during a 
patient-doctor encounter using a PRO. A PRO-based assessment of need i.e. ‘Holistic 
assessment tool’ could help identify patients’ needs and concerns (i.e. number and 
type). The PRO empowers patients by providing the framework to help highlight their 
issues, and to also enable patients to engage with their clinicians in discussions during 
their encounter by focusing on these issues.  
 
By empowering patients, through the identification of their needs and concerns, it is 
possible to then decide the appropriate action through discussions leading to joint 
decision-making, which can improve the quality of care. The quality of care delivered is 
influenced by patient factors, and the technical quality of health care professionals. The 
delivery of good quality of care can be reflected in better patient satisfaction and 
HRQOL. 
 
Figure 2.3. Inter-relationship of PROs and its core outcomes based on Fung & Hays 
[2008] 
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2.5.5.2. PCI as a tool that enables better communication between patients-doctors 
 
The PCI intervention may help overcome some of the known potential barriers at the 
patient-healthcare interface. A model proposed by Feldman-Stewart et al [2005] 
(Figure 2.4) describing the dynamics of the patient-doctor communication during an 
encounter can help understand the role of the PCI in such situations. According to this 
model, the patient and the doctor enters the joint encounter by bringing into this 
encounter with their own agenda. These agenda may be considered the patients’ and 
providers’ primary goals during the communicative process. Internal barriers from 
within both parties may influence this process, as well as external barriers created by the 
environment.  
 
 
Figure 2.4. Conceptual model describing the interaction or communication during a 
consultation in a cancer setting [Feldman-Stewart et al, 2005] Red circle: potential 
role of a PCI 
 
 
 
 
 
 
 
 
 
 
 
 
 
The communication process involves conveying and interpreting messages by both 
parties, which may include expression of felt needs or concerns by patients, and also the 
doctors’ concerns regarding treatment effects or physical problems.  It is generally 
accepted that the quality of the patient-clinician interaction can determine the extent to 
which the concern is identified and addressed [Mead & Bower, 2000] but the quality of 
patient-doctor communication can vary.  
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A tool like a PCI can potentially change the dynamics of the patient-clinician interaction 
by enabling patients’ concerns to be discussed. The PCI can help remind patients of 
their concerns, bring their issues to the attention of clinicians, thereby increasing the 
likelihood that their concerns are ultimately discussed and addressed. Where previously 
patients concerns and needs may have been dwarfed by the doctor’s agenda and goals 
for the consultation, the PCI intervention can attempt to redress the imbalance by 
enabling patients’ to highlight and convey their concerns and needs by reminding them 
of the items for discussion [Synder et al, 2010]. Nevertheless, as highlighted 
previously, this process only works as far as the clinician supports the PCI as part of a 
wider enablement process within the context of patient empowerment.   
 
2.5.6. Application of the Patients Concerns Inventory in clinical settings 
 
The PCI can help foster a collaborative approach as the basis of a personalised cancer 
care partnership. It is thought that the ‘PCI concept’ could be relevant in the 
management of cancer survivors due to similarities of experience shared with patients 
with chronic disease.  
 
The PCI concept was first used in the cancer setting by the introduction of the Head and 
Neck Cancer Patients’ Concerns Inventory. This will be discussed in the following 
section (section 2.6). There is work in progress in adapting a PCI concept in breast 
cancer [Kanatas et al, 2014], neurosurgery and rheumatological conditions [Ahmed et 
al]. The ‘concerns approach’ has also been developed in chronic gastrointestinal 
conditions [Drossman et al, 1991; Jorgensen et al, 2011].  
 
2.6. The Head and Neck Patient Concerns Inventory  
 
This section reviews the literature encompassing the development and introduction of 
the HN-PCI in 2009 until present i.e. July 2017. 
 
2.6.1. Development and Introduction of the HN-PCI 
 
The Head and Neck Patient Concerns Inventory (HN-PCI) was introduced as a site-
specific tool for routine use in the HNC outpatient setting [Rogers et al, 2009]. It was 
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developed together with the Merseyside Region HNC support group and was designed 
to be a holistic, PRO that tries to disclose patients’ needs and concerns by highlighting 
those concerns that they wish to discuss during the outpatient clinic.  
 
To create a broad and holistic format, the content of the PCI was formulated through the 
synthesis of items from various PROs, HRQOL questionnaires, and discussions with 
local and national focus groups of HNC patients and professionals involved in the care 
of HNC patients, namely, the laryngectomy support group, HN support group, HN 
patient research forum, hospital volunteers, ward and outpatient staff and the 
multidisciplinary HNC team. The HN-PCI was first piloted on 1 August 2007 and 
originally introduced with 45 items of concerns and a list of 8 professionals whom 
patients would like to be seen or be referred to, to choose from. Content validity was 
evaluated by the Liverpool HNC support group and as a result of this exercise, a further 
7 items were added in April 2008. 
 
The content-validated HN-PCI (version 1) checklist composed of 45 items of concerns 
(including ‘Anything else’) (Appendix 2), ranging widely from dysfunction to 
psychosocial issues and also regarding the treatment and its after-effects. The HN-PCI 
(version 1) also allowed patients to choose individuals they wish to see or be referred to 
from a range of 15 professionals (including ‘Anyone else’) composed of those from 
HNC multidisciplinary teams to other non-medical professionals [Rogers et al, 2009]. 
In November 2008, a further addition of 10 items resulted in introduction of the HN-
PCI (version 2) composed of 55 items of concern and 15 professionals (Appendix 3). 
The concerns checklist of the HN-PCI (version 2) was described in Rogers et al [2012].   
 
The HN-PCI is administered along with the University of Washington Quality of Life 
version 4 (UWQOL) [Rogers et al, 2002] using touch-screen technology (TST) 
[Millsopp et al, 2006]. The digital TST format is advantageous because this permits 
self-completion of both questionnaires, provides a permanent record that can be 
included in electronic case notes, and can aid in service evaluation and audits. The 
completion time of the HN-PCI-UWQOL package averages 8 minutes of the pre-
consultation waiting time [Rogers et al, 2009A]. The software summarises the HN-PCI 
and UWQOL scores immediately upon completion, allowing the information to be used 
during clinic consultation. The summarised PCI data sheet is printable and may be used 
addendum to the customary clinic letter to the general practitioner, facilitating the 
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continuity of oncology care into the primary setting.  
 
In a cohort of predominantly oral cancer patients in the post-treatment phase, the 5 most 
common concerns highlighted by patients on HN-PCI were the FOR (37%), dental 
health (27%), chewing and eating (24%), pain in the head and neck region (20%) and 
fatigue (19%) [Rogers et al, 2009A]. The median (IQR) number of concerns selected 
was 3 (1–6), range 0–21 with 82% selecting at least 1 item of concern. The three 
professionals patients most commonly selected were: dentist (19%), surgeon (10%) and 
speech and language therapist (10%). The median (IQR) number of professionals 
selected was 0 (0–1), range 0–8 with 42% selecting at least one professional. FOR is not 
an unexpected issue of concern to post-treatment patients, but it is frequently 
unexpressed openly by patients. Thus, concerns and fears of recurrences are seldom 
brought into discussion during consultation, despite this issue being the main concern 
for many patients as shown in this study. This finding insomuch demonstrates the 
permission-giving effect of the HN-PCI.  
 
The HN-PCI prompt sheet format can encourage effective communication during in 
clinic consultations. Patients have commented that the HN-PCI ʻreminds them of points 
they want discussedʼ at the clinic [Rogers et al, 2009A]. Through the checklist acting as 
a prompt, the HN-PCI helps focus and personalise consultations based on the specific 
concerns they have highlighted. The HN-PCI-directed consultation gives the 
clinician/multidisciplinary team a better understanding of the individual patient 
concerns, needs, and preferences, while patients can obtain the information they require 
regarding their concern, so as to help them participate actively in any clinical decision-
making with the clinicians regarding their care.  
 
2.6.2. Impact of HN-PCI on clinical outcomes 
 
One criticism of routine screening of concerns and potential unmet needs in a clinic is 
that it may consequently increase onward referrals, thus, placing a bigger demand on 
existing healthcare services. However, a comparative study on the post-consultation 
referral trends in the time periods before and after introduction of HN-PCI did not show 
any increase in the overall numbers of such referrals [Ghazali et al, 2011]. The main 
reason for this was that the vast majority of HN-PCI-highlighted needs were dealt with 
immediately on the day of consultation because of the presence of multidisciplinary 
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professionals during routine HNC outpatient clinics. This set up allows for a more 
prompt and efficient way of addressing supportive care needs and concerns. Detailed 
examination of the onward referrals made revealed an increased proportion of referrals 
to oral rehabilitation and psychological support, which are services that were not readily 
available during the HNC clinics.  
 
2.6.3. Specific concerns identified by HN-PCI 
 
Data generated from multiple, routine completion of the HN-PCI over time through 
outpatient clinics enabled further appreciation of particular issues experienced by post-
treatment patients with the passage of time. There were two papers specifically relating 
to FOR identified by the HN-PCI, and these papers provided valuable insights into an 
area uncommonly explored in HNC [Rogers et al, 2010; Ghazali et al, 2013B].  The 
HN-PCI enables screening of FOR, being an item in the HN-PCI checklist. All UK-
based HN-PCI-related studies to date indicate that FOR is the most common concern 
that HNC patients would like to be addressed in clinic, a finding that had never been 
previously reported. The ability of the HN-PCI to screen for FOR is extremely valuable 
because there are no predictive clinicopathological characteristics that could allow for 
effective routine screening of FOR [Rogers et al, 2011B]. Compared with a physical, 
symptom-type concern, it is far more difficult to broach a sensitive subject like FOR 
without a clear prompt like the HN-PCI. Using the HN-PCI-UWQOL, the prevalence of 
patients experiencing significant FOR was estimated at 35%, and longitudinal data 
indicates that this fear does not diminish with time [Ghazali et al, 2013B]. Independent 
predictors for significant FOR were personal characteristics of the survivor i.e. reporting 
significant problems with anxiety/mood, age and selecting FOR on PCI [Ghazali et al, 
2013B]. This study indicates the value of the HN-PCI in disclosing a concern that can 
easily be overlooked because it is often undeclared by patients.  
 
Apart from FOR, the HN-PCI-UWQOL combination was used to identify and quantify 
levels of emotional distress in post-treatment HNC patients attending routine FU clinics. 
This study found that the HN-PCI-UWQOL combination highlighted issues of mood, 
anxiety and depression in 10%, 23%, and 10% of patients, respectively [Kanatas et al, 
2012]. In almost one-third of consultations, 44% patients reported significant problems 
with anxiety or mood on the UWQOL or highlighted issues of anxiety/mood/depression 
on the HN-PCI. It was noted that patients who highlighted emotional distress on the 
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HN-PCI frequently required referral for psychological support.  In a more recent 
exploration of emotional distress using the HN-PCI-UWQOL in a larger cohort 
[Kanatas et al, 2015], FOR remained the most common concern selected by patients 
overall, and within the 14-item ‘emotions’ domain. This study found that just over half 
of patients (52%) were likely to choose FOR along with other items in the domain, and 
also other items in the HN-PCI. Patients who chose FOR and other items in the 
emotional domain also tended to be younger and had the poorest HRQOL status. This 
finding indicates that disclosing FOR in association with other emotional concerns may 
indicate the likelihood of a global distress compared with those who choose FOR alone. 
However, this study does not detail the outcomes of the consultations. It is possible that 
patients who report FOR alone could have their need addressed during the visit, but it is 
likely that patients who report FOR and other emotional concerns may require 
additional emotional supportive care to address the unmet needs, and this could place 
additional demand on existing services due to the size of this subset of patients (52%).   
 
The HN-PCI-UWQOL combination screened for self-reported swallowing and/or 
speech problems in HNC patients [Ghazali et al, 2012]. These were prevalent, 
occurring in 39% of consultations involving 48% (n, 97) of patients overall. Of the 97 
patients with self-reported swallowing and/or speech concerns, 74 (76%) were already 
known to the speech and language therapist, while the remaining 23 patients had their 
concerns addressed in the clinic. Three patients (3/23) required a referral for further 
specialized assessment and intervention for their speech and swallowing. This study 
demonstrates the ability of the HN-PCI to capture patients with significant problems 
that may have otherwise fallen through the net. 
 
There are two studies evaluating the use of HN-PCI-UWQOL in screening for issues 
relating to oral health and function in those attending routine HNC clinics. The first is a 
study based in Aintree Hospital where the HN-PCI-UWQOL was used to screen for 
self-reported concerns with ‘Chewing/eating’ and ‘Teeth/dental health’, and the 
UWQOL Chewing domain [Mahmood et al, 2014]. This study found that 57% of 
patients (168/297) had oral health problems composed of those who indicated a 
significant chewing problem (40/297), those who wished to discuss perceived issues 
with their oral health and function but did not have a significant chewing problem 
(115/297), and those who wished to be referred to a dental health professional (i.e. 
dentist, dental hygienist or the oral rehabilitation team). Clinicopathological factors (i.e. 
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advanced staging, oropharyngeal tumours, RT, free-flap surgery, or worse overall 
UWQOL scores) were associated with poorer self-reported chewing function on 
UWQOL. Those reporting significant chewing problems were more likely to experience 
significant problems in other UWQOL domains (i.e. appearance, swallowing, speech, 
taste, saliva, pain and anxiety). Overall, those with self-reported concerns on HN-PCI 
with chewing or teeth concerns were more likely to report other concerns compared 
with those who did not. The dentist was the most frequent professional requested by 
patients with significant problems and concerns regarding their chewing or teeth. 
However, correspondence to the dentist only accounted for 10% of all letters evaluated, 
while correspondence with the oral rehabilitation team occurred in 31-33% of all clinic 
letters involving those with self-reported concerns on the HN-PCI related to their oral 
health and function. This study also showed how the UWQOL and HN-PCI can tease 
out patients with significant problems but who do not wish to discuss these (58%, 
23/40) and those who could chew just as well but still wished to discuss the concern 
(21%, 22/103), providing a window into understanding patients’ preferences in terms of 
discussing certain concerns in the HNC clinic. In the second HN-PCI-UWQOL study 
screening for oral health and function issues of patients attending HNC clinics based in 
the University of Florida [Aguilar et al, 2017], items showing ≥ 10% prevalence that 
were related to oral health and function were salivation, chewing/eating, teeth/dental 
health and mouth opening. Interestingly, salivation was the most common concerns 
highlighted by this cohort, while FOR was the 5
th
 most prevalent item.  
 
In a study screening for self-reported pain in post-treatment period using the HN-PCI-
UWQOL, up to 38% of patients experienced pain, of which 25% experienced 
significant pain [Rogers et al, 2012]. However, 55% who reported a significant 
problem with pain, did not wish to discuss this in clinics. A smaller proportion without 
significant pain problems (13%) wished to discuss pain during their consultation. 
Younger patients (<65 years) and those who received RT were more likely to have pain 
issues. Those with significant pain or those who wanted to discuss pain in clinic had 
greater problems in physical and social-emotional functioning, reported suboptimal 
QOL, and also had more additional HN-PCI items to discuss in clinic compared to those 
without significant pain issues. Those with significant pain, including those who did not 
wish to have this addressed at the clinic, were found to be on a regular prescription of 
analgesia. It is possible that this suggests that the concern is already comfortably self-
managed by patients, or that such patients may prefer to discuss their pain-related 
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concern elsewhere e.g. community setting or in a specialised pain clinic.  
 
Facial disfigurement is a recognised consequence of HNC treatment. However, patients’ 
concerns about appearance are often not discussed in clinic despite facial appearance 
being highly rated against other health-related issues impacting upon quality of life. In a 
HN-PCI-UWQOL study addressing facial disfigurement [Flexen et al, 2012], 14% met 
both the PCI and UWQOL criteria but almost half of those with significant appearance 
issues did not want to discuss this. The main factors associated with those who reported 
concerns about appearance were younger age, females, higher T-stage, and oropharynx 
subsite. Those who wanted to discuss facial disfigurement also frequently highlighted 
other concerns, namely, anxiety, depression, mood, sleeping, and self-esteem. 
 
The combination of the HN-PCI-UWQOL and a single intimacy screening question was 
used to evaluate the prevalence of concerns relating to sexuality and intimacy [Rogers 
et al, 2015A]. This study found that the combined approach identified 31% (55/177) 
reported having ‘Intimacy’ and/or ‘Sexuality’ problems overall, and 14% (24/177) 
indicated having considerable/some concerns. Out of the 24 patients who had 
considerable/some intimacy concerns, the HN-PCI helped identify nine patients who 
wanted the topic to be discussed in clinic. Five out of the nine patients discussed 
intimacy concerns during their visit, where discussions led to onward referrals in four 
patients. This study indicates that while discussion surrounding this sensitive area was 
possible when highlighted by patients, not all of those who highlighted these on the HN-
PCI wanted to discuss them when the matter was broached. Some felt that the clinical 
setting was not appropriate. Nevertheless, the HN-PCI enabled patients the choice to 
highlight a personal and sensitive matter if they so wished, and the tool enabled patients 
and doctors to make a shared decision regarding any clinical decisions/actions to 
address their unmet need as a result of their HN-PCI-facilitated discussions.  
 
The concerns of elderly HNC patients (> 75 years) were studied by evaluating the HN-
PCI responses in this subgroup of patients attending routine HNC follow-up clinics 
[Rogers et al, 2015B]. It was suggested that the elderly may have a general tendency to 
be forgetful and may not recall items of concern for discussion, and their advancing age 
and relatively higher comorbidity rates may present unique sets of concerns. 
Interestingly, this study found that the HRQOL status in the elderly was better than that 
reported by younger patients at the point when the HN-PCI was first completed. The 
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selection profile by the elderly indicated that age did not influence the total number of 
items selected. However, elderly patients selected fewer items relating to the 
‘emotional’ domain, which may be related to the better anxiety and mood scores and 
higher social-emotional subscale scores. More significantly, the > 75years age group 
showed a lower frequency of choosing to discuss FOR than that seen in all other 
younger age. The finding that the elderly are less likely to select FOR was also reported 
by Ghazali et al [2013B] in a longitudinal study of FOR with the HN-PCI. The dentist 
and surgeon were the two health professionals most often selected by elderly patients, 
and this may be unsurprising as ‘Chewing/eating’ and ‘Dental health/teeth’ remained 
high on the list of concerns of HNC patients in general, including the elderly.  
 
There is a higher incidence of HNC in the lower socioeconomic group. It is known that 
patients from the lower socioeconomic group have lowered health literacy and recall of 
symptoms, and frequently have low self-esteem. These factors can be barriers towards 
expressing their needs during hospital visits. Allen et al [2017] undertook a study 
evaluating the influence of socioeconomic status on HN-PCI responses during routine 
HNC clinic visits. Based on the Indices of Deprivation ranks and scores for patients 
resident in England, 54%  (47/87) of patients in this study cohort were living in the most 
deprived quartile of residential areas, with 15 % (13/87) in the 2nd quartile, 18 % 
(16/87) in the 3rd quartile, and 13 % (11/87) in the least deprived 4th quartile of areas, 
at the time of diagnosis. In regard to the HN-PCI selection profile, there were no 
significant differences seen in the number of items of concern or the professionals 
selected by patients between the deprivation quartiles. The two most common items of 
concern were FOR and sore mouth. However, there were significant differences seen in 
the UWQOL items, where patients from the most deprived quartile reported 
significantly more problems with recreation and mood than patients from other 
quartiles. This study suggests that levels of deprivation did not seem to influence 
feasibility of using the HN-PCI-UWQOL in general. The range of concerns of the more 
deprived HNC survivors were not significantly different to others, even though their 
HRQOL status was poorer.   
 
2.6.4. Usage of the HN-PCI 
 
A paper format for the HN-PCI was developed from the TST version [Scott et al, 
2013]. Widespread adoption of the digital-based HN-PCI may be limited by financial 
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and logistical constraints in other clinical units. Furthermore, patient confidentiality and 
data protection issues with electronic data are clinical governance concerns raised by 
other institutions. These provided the rationale for introducing a paper format. In a 
prospective study comparing TST and paper HN-PCI versions [Scott et al, 2013], no 
statistically significant differences were noted between paper and TST in how many 
HN-PCI concerns were selected by patients or discussed in consultation, nor in length of 
consultation. FOR, chewing/eating, dental health, swallowing and salivation issues were 
the 5 most common concerns across both HN-PCI versions. Only a small proportion (< 
10%) encountered difficulties when completing either form of HN-PCI. Based on these 
findings, it was concluded that the paper HN-PCI was an acceptable and fitting 
alternative to the TST version. 
 
At the time of when the current work was developed and planned i.e. October 2010 to 
February 2011, there was only a small collection of published HN-PCI-related studies 
for consideration. These studies were composed of data that were predominately 
generated from a cohort composed of oral cavity cancer survivors, and were based on 
the experience gained by a single physician who had originally introduced this PRO.  
Thereafter, two explorative studies of HN-PCI use by other doctors unfamiliar with the 
HN-PCI were published [Scott et al, 2012; Ghazali et al, 2013A]. The lack of data 
demonstrating the feasibility of using the HN-PCI in other HNC subsites remained. 
While one HN-PCI-related study of various HNC subsites was available, the items of 
concern identified using the paper HN-PCI in that study were not obtained through the 
outpatient setting but rather through a postal survey as part of a service audit exercise 
[Kanatas et al, 2013]. It can be argued that there was no evidence that the HN-PCI 
could be successfully used in a wider clinical setting, testing whether various doctors 
and patients who had never used the HN-PCI, could utilise this tool effectively.  Thus, 
the next critical step in the development of the HN-PCI at that stage was to demonstrate 
that HN-PCI could be rolled out effectively in other HNC clinics outside of the circle of 
familiarity.  This sets the stage for this current doctorate study. 
 
While this current doctorate study was being undertaken, other developments relating to 
the HN-PCI occurred, and these are discussed henceforth. In September 2015, the tenth 
UK nationwide audit of HNC commissioned by the Healthcare Quality Improvement 
Partnership, was published [DAHNO, 2015]. For the first time this annual audit 
exercise evaluated the compliance of HNC units with the Cancer Reform Strategy 
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[DOH, 2007] recommendation regarding patients receiving holistic assessments during 
follow-up visits [NCAT, 2011] over a period from 1 November 2013 to 31 October 
2014. In this audit, the HN-PCI was selected as a standard patient-reported HNC-
specific measure suitable for national comparison based on the tool possessing the 
following features: (1) HNC-specific, (2) designed for routine use during follow-up 
visits, (3) enables patients to raise issues and concerns, (4) signposts access to other 
members of the MDT, and (5) enhances communication, and (6) provides support for 
holistic assessments [DAHNO, 2014]. The audit reported that not all HNC MDTs 
nationwide had used the HN-PCI. It estimated that only 539 patients (11.2%) had filled 
the HN-PCI within 6 months of their diagnosis compared with 754 patients (15.6%) 
who had not. The status was not recorded in 2859 patients (59.2%), and 680 (14.1%) 
patients were classified as being ‘not applicable’.  
 
The underwhelming application of the HN-PCI across-the-board highlighted 
fundamental issues, which suggested barriers to its comprehensive acceptance. A major 
issue is the lack of specific evidence documenting the ability of HN-PCI as a holistic 
assessment tool that could bring about measureable improvement in patient care, and 
also in service delivery. For this to occur, there has to be a meaningful engagement 
between the HNC MDT and the supportive services with the holistic assessment process 
and with the tool selected. In addition, patients’ preferences for participating in holistic 
assessments need to be determined to ensure that this is useful from their perspectives. 
Common to other holistic assessment tools, many healthcare professionals were 
unfamiliar with the process and tools available [NCAT, 2011]. Other barriers to 
professionals’ acceptance relate to their beliefs regarding their direct role in managing 
distress and unmet psychosocial needs.   
 
Exploration of patients’ views regarding the HN-PCI denotes a general favourable 
response [Rogers et al, 2009; Hatta et al, 2014; Rogers & Lowe, 2016; Jungerman 
et al, 2017]. Formal workshops and training sessions have been undertaken since 
November 2012 to provide healthcare professionals the theoretical and practical basis 
for using the HN-PCI [Rogers & Lowe, 2014]. However, there is still a lack of 
definitive guidelines for clinicians in managing concerns identified by the HN-PCI 
[Rogers et al, 2016]. The availability of a comprehensive ‘rehabilitative/supportive 
care’ guideline related to the HN-PCI can reassure cancer care professionals when using 
the tool. Having a template akin to the NCAT Rehabilitative Care Pathways (Head and 
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Neck) [NCAT, 2010] can help clinicians’ in addressing complex biopsychosocial issues 
identified by the HN-PCI. However, the guidelines will depend on the services available 
locally and the critical support of multiprofessionals, who may not be directly related to 
the HNC MDT.   
 
While the gold standard evidence for establishing the HN-PCI as the standard of care is 
still work-in-progress, adoption of the HN-PCI is gaining pace in in the UK. Several 
HNC MDTs are currently involved in a randomised control trial with the HN-PCI 
intervention [Rogers et al, 2016] and other units whose core members of the HNC 
MDT have undergone HN-PCI training have adopted this tool in their local practices.  
Inclusion of the HN-PCI in the 2014 national HNC audit has also resulted in the wider 
acknowledgement of the tool internationally. This development allowed for exploration 
of cross-cultural differences in HNC patients’ concerns and needs.  
 
The first non-UK HN-PCI application was reported in 2014, where the original HN-PCI 
version 1 was modified for use in Malaysia [Hatta et al, 2014]. The modification 
involved merging of several items into a single (i.e. ‘sexuality’ with ‘intimacy’; and 
‘energy levels’ with ‘fatigue’), addition of two new items i.e. ‘health supplements’ and 
‘diet restrictions’ and the removal of two items i.e. ‘mood’ and 
‘temperament/personality’. Furthermore, an attempt to create domains for the HN-PCI 
was undertaken producing 7 domains (i.e. physical status, emotional status, personal 
function, social/family relationships, economic status, diet-related function, and others), 
although the detailed methodology was not provided. The HN-PCI underwent forward-
back translation method to enable cross-cultural adaptation, and was translated into 
Malay, Tamil and Chinese languages for use in a multiethnic cohort in Malaysia In this 
cohort, the top five items of concern were predominantly related to physical and 
functional concerns namely, Chewing/eating (48.6%), Pain in head/neck (43.1%), 
Salivation (30.6%), Limited mouth opening (30.6%) and Fatigue/Tiredness (20%). The 
prevalence of selecting FOR was only 6.9% in this cohort, suggesting a possible 
influence of the East versus Western cultural differences in patients’ responses. This 
study reported high feasibility of the routine use of modified HN-PCI in the Malaysian 
setting. Most interviewed patients reported that the HN-PCI reminded them of the 
problems they needed to discuss, and majority agreed to use the HN-PCI in future visits. 
The majority of surgeons involved in this study felt that the HN-PCI helped guide them 
in addressing patients concerns in a more focused way during consultation [Hatta et al, 
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2014]. 
The HN-PCI (57-item) was recently translated into Portuguese language in a forward-
back translation method, and was successfully adapted and validated in Brazil 
[Jungerman et al, 2017]. Modifications to the HN-PCI checklist were introduced to 
enable better understanding of the items and the terminology for professionals to suit 
the cultural/language and health service setting. The top five most prevalent items of 
concern were FOR (57%), dry mouth (45%), chewing/eating (44%), speech/voice/being 
understood (43%) and swallowing (40%). The median (IQR) number of HN-PCI items 
selected was 8 (5-13), range 0- 42 items, with 89% selecting at least one item of 
concern. The median and range of items selected by this cohort were generally higher 
than that originally reported by Rogers et al [2009A], although the top most prevalent 
concerns selected were similar. The top three specialists selected were speech therapist 
(26%), dentist (24%) and psychologists (18%). The median (IQR) number of specialists 
indicated was 1 (0-2), range 0-8 specialists, with 36% selecting at least one specialist. 
Compared with the findings reported by Rogers et al [2009A], there was a very similar 
selection profile in regard to professionals/specialists by this cohort, and the only 
difference being the selection of psychologists in this cohort. The overall patient 
impression was favourable and authors concluded that there was good user 
acceptability/ feasibility of the HN-PCI Portuguese version.  Finally, the first reported 
use of the HN-PCI in North America was by Aguilar et al [2017] based in University of 
Florida, which was discussed in the previous section on using the HN-PCI in screening 
for oral health and function. The original HN-PCI version 1 was used unmodified in 
their study. This study did not attempt to address the potential cross-cultural and health 
care systems differences. This may explain why no mention was made regarding the 
selection of professionals by patients in their study.  
2.7 Conclusions 
Identification of HNC patients’ needs and concerns during survivorship is the main 
subject matter of this work. This chapter summarises the approach taken in considering 
this subject, where the subject matter was dealt with by an initial broad-brush approach. 
Fundamental ideas regarding patient-centred care in medicine, the concept of ‘need’ in 
healthcare, and the concept of patient empowerment were discussed.  
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Inward exploration of key concepts involved developing specific details, for example, 
clarifying the definition of inter-related terms relating to ‘need’.   Key healthcare 
policies relating to identification of need in healthcare is presented, including holistic 
(need) assessments in cancer. The methods used in identifying patients’ concerns and 
needs were discussed, with particular reference to holistic (needs) assessment, where 
communication can be enhanced with a holistic PRO tool.  
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Chapter 3 
 
3.0. HEAD & NECK CANCER SURVIVORSHIP 
 
3.1. Introduction 
 
With the diagnosis of head and neck cancer (HNC), patients begin their journey into the 
world of cancer survivorship. From this point henceforth, surviving HNC is their 
ultimate primary concern, and the priority is focused on treatment that offers the best 
chance of cure and survival [Rogers et al, 2016C]. However, the treatment options 
available for HNC (discussed in section 1.2), often lead to significant side-effects, 
which can be progressive and life-long. In this situation, well-being exists in the 
presence of disease and infirmary during HNC survivorship. HNC survivors and their 
caregivers will experience a wide range of physical, functional, cognitive and 
psychosocial problems throughout their cancer journey as the combined consequence of 
their disease and its treatment.  
 
This chapter studies the experience of HNC survivors and their caregivers in their 
survivorship journey. The specific aim of this chapter was to provide a current and 
broad knowledge base of the key issues experienced by HNC patients and their 
caregivers, which can facilitate the qualitative work undertaken in this study. 
 
Researchers have explored patients’ and their caregivers’ experience of HNC 
survivorship through two main research methodologies i.e. (1) self-reported health-
related quality of life using various patient–reported outcome (PRO) measures [Rogers 
et al, 2007A; Rogers et al, 2016B] and (2) qualitative interviews [Lang et al, 2013].  
 
3.2. Health-related quality of life in HNC survivorship 
 
3.2.1. The conceptual basis of measuring health and its quality 
 
The World Health Organization (WHO) regards health from a holistic standpoint, which 
is evident from its definition of health i.e. “a state of physical, mental and social well-
being, and not merely the absence of disease or infirmity” [WHO, 1948, page 1]. From 
here, it follows that the measurement of health and the effects of health care must 
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include not only an indication of changes in the frequency and severity of diseases but 
also an estimation of well-being, and this can be assessed by measuring the 
improvement in the quality of life related to health care [WHO, 1997]. In this respect, 
WHO defines quality of life as an “individual’s perception of their position in life in the 
context of the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns” [WHO, 1997, page 1]. 
 
An individual’s quality of life (QOL) is multidimensional in nature, consisting of but 
not limited by, a person’s physical health and functioning, psychological state, level of 
independence, social relationships, occupation and finance, and personal beliefs 
(religion/spirituality) [Saxena & Orley, 1997; Rogers et al, 2016]. These factors 
interact with the salient features of external environment in a complex way that over-
reaches beyond the small area of health care.  
 
Health-related quality of life (HRQOL) may be considered as a component of overall 
QOL that is determined primarily by the person's health and that can be influenced by 
disease and clinical interventions. It is a more specific way of understanding the impact 
of a certain disease on the individual’s QOL [Wilson & Cleary, 1995].  
 
Measuring HRQOL enables healthcare professions to focus upon the assessment of the 
impact of the disease and its treatment on the physical, psychological and social aspects 
[Rogers et al, 2016C]. More specifically, HRQOL information may be valuable in 
helping patients decide on treatment choices, and also in identifying areas of need where 
supportive care interventions may be required [Rogers et al, 2016C].  
 
3.2.2. Measuring QOL and HRQOL 
 
Saxena and Orley [1997] describe the fundamental features of QOL measurement, i.e. 
individuals self-report their QOL assessment using a personal yardstick for judging how 
good or bad their quality of life is. The tool used for QOL assessment considers the 
multidimensional concept of QOL, and consists of a number of domains is necessary to 
derive a comprehensive view of a person's QOL.  
 
Assessment of HRQOL is self-determined by patients, using instruments that ask 
questions about their health status, functional status and overall QOL. Within these 
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broad constructs are questions that address physical health, psychological health, 
physical functioning, social functioning, role functioning, and general well-being.  For 
HRQOL instruments/questionnaires to be useful, it has to demonstrate good 
psychometric performance properties i.e. validity, reliability, and responsiveness to 
change [Linder et al, 2003]. Linder et al [2003] succinctly summarises these 
performance properties as follows: “An instrument is valid if it measures what it is 
purported to measure; reliable if repeated measures under the same conditions give 
similar results; and responsive if an instrument can detect important changes in the 
condition, even if those changes are small. Furthermore, changes should be 
interpretable, so that differences in the score of an instrument can be understood and 
assigned qualitative meaning” (page 391).  
 
3.2.3. HRQOL in HNC survivorship 
 
Rogers et al [2016C] details the fundamentals of HRQOL assessment in HNC. A wide 
range of HNC-specific HRQOL instrument is available, and there is no single ‘gold 
standard’ instrument for use. Each HRQOL instrument carries its own strengths and 
limitations, and the choice and administration of the instrument depends on the purpose 
of the assessment. The assessment can be taken longitudinally, which allows the 
documentation of temporal changes in HRQOL status, or cross-sectionally, where an 
assessment is taken at a single time-point in the survivorship journey.  
 
Laraway & Rogers [2012] classifies HNC-specific HRQOL instruments into four main 
categories: (i) Generic QOL, i.e. those asking about a range of broad issues unspecified 
to cancer; (ii) Cancer-specific QOL, i.e. those addressing issues common to all cancers; 
(iii) HNC-specific QOL, i.e. questionnaires with HNC-specific items; and (iv) HNC-
specific issue i.e. those questionnaires that focus in detail on a particular aspect of HN 
function. 
 
3.2.4. Review of HNC-specific HRQOL studies 
 
HNC-specific HRQOL studies provide a window to understanding the key issues that 
patients and their carers experience in HNC survivorship [Rogers et al, 2016C]. There 
are two in-depth structured literature reviews of QOL-themed studies exploring issues 
relating to HNC self-reported HRQOL, and these reviews considered evidence from 
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papers published during the period of 2000 to 2013 [Rogers et al, 2007A; Rogers et al, 
2016B]. There has not been any updated review of the evidence published after 2013 
other than a summarised list of key issues experienced by patients and their carers in 
HNC survivorship (Table 3.1) [Rogers et al, 2016C]. 
 
Thus, a literature review of QOL-themed studies published after 2013 was undertaken 
in this current work to explore for any new areas of knowledge within the body of 
evidence. This review also provides the knowledge base for the thematic framework 
approach during the assessment of patient concerns in the study.  
 
The literature search methodology undertaken was based on the same methodology 
described in the previous in-depth reviews [Rogers et al, 2007A; Rogers et al, 2016B] 
to provide methodological continuity. The methodology used and the results obtained 
are shown in Appendix 1. Five additional themes i.e. breathing, sleep, taste, smell and 
self-management (Table 3.1) were identified during the literature review. A brief 
discussion of the key issues is presented in the section 3.2.5. 
 
3.2.5. Key issues impacting HNC survivorship 
 
i. Caregivers, children and family 
 
The caregivers (or carers) of cancer patients are considered within the definition of the 
‘cancer survivor’ in the UK [NSCI, 2010]. This definition recognises their role in 
providing support and assistance, thereby easing the burden for patients as they cope 
with the diagnosis and treatment of HNC. In a survey of HNC caregivers, Hanly et al 
[2016] found that the majority were females (76%), were not in paid employment (68%) 
and were caring for their spouses (67%). Females were also the most common primary 
caregivers [Rigoni et al, 2016]. Nightingale et al [2016] observed that the majority of 
caregivers lived with patient (88%) and provide daily care (73%).  
 
The reported caregiving burden is variable. In one cohort, HNC caregivers reported low 
levels of burden [Hanly et al, 2016] while others report a heavy caregiving load 
[Nightingale et al, 2016]. Caregivers of HNC patients also provide emotional and 
instrumental support, most frequently with nutrition and assistance with speech, 
appearance, and addictions [Sterba et al, 2017A]. Experiences looking after 
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trachestomy and tube feeding can be overwhelming for caregivers [Sterba et al, 
2017B].  
 
Table 3.1. Key issues impacting HNC survivorship  
 
Based on Rogers et al, 2016  Issues identified in current review 
Carer  Breathing 
Comorbidity  Sleep 
Coping  Taste 
Dental status  Smell 
Disfigurement  Self-management 
Emotional distress   
Family and children   
Fatigue   
Fear of recurrence   
Financial and work   
Function   
Fungating wounds   
Information   
Intimacy   
Lifestyle choice   
Nutrition   
Osteoradionecrosis   
Pain   
Personality   
Self-esteem   
Socioeconomic Status   
Speech   
Swallowing   
Shoulder   
Trismus   
Unknown   
Xerostomia   
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There are positive aspects of caregiving for cancer patients [Li & Loke, 2013], 
including increased self-identity [Richardson et al, 2016] and attainment of happiness 
[Hanly et al, 2016]. However, many HNC caregivers face challenges. Early studies 
suggest that psychological distress amongst family/caregivers were similar to those of 
patients [Vickery et al, 2003; Zwahlen et al, 2008]. More recent studies confirm that 
the high levels of distress and lowered QOL experienced by patients and caregivers 
were similar [Rigoni et al, 2016].  
 
HNC caregivers report compromised psychosocial functioning, where symptoms of 
depression and anxiety are more prevalent than the normal population  [Longacre et al, 
2012; Nightingale et al, 2016]. HNC caregivers experience moderate to high levels of 
distress [Ross et al, 2010], suffer worry and fear of recurrence (FOR) [Longacre et al, 
2012; Lin et al, 2016; Maguire et al, 2017], feel symptoms of anxiety, depression 
[Terro & Crean, 2017] and report suboptimal mental well-being [Sterba et al, 2017A; 
2017B]. Psychological distress levels of caregivers are high during active treatment 
[Lin et al, 2016; Ross et al, 2010; Badr et al, 2014], which is related to coping with 
the physical effects related to treatment [Badr et al, 2014]. Higher levels of FOR are 
reported in female caregivers, those caring for younger patients, and those with 
survivors who had undergone less extensive forms of surgery [Maguire et al, 2017]. 
Furthermore, higher scores relating to worry and FOR was seen in caregivers who 
reported more loneliness, spent more time caring, and had greater financial stress 
[Maguire et al, 2017].  
 
Not much is understood about the unmet needs of HNC caregivers. Longacre et al 
[2012] suggests that there is a perceived need for social support.  Nightingale et al 
[2016] reports a demand by caregivers for wellness programmes that focus 
predominantly on diet/exercise, cancer education, stress reduction and finances, 
caregiving, and well-being. Such a programme may also help with lifestyle choices 
related to smoking and poor problem-solving ability among patients and caregivers 
[Sterba et al, 2017A; Trunzo et al, 2016].  
 
Nevertheless, Balfe et al [2016]’s study of caregivers’ self-reported unmet supportive 
care needs indicate that HNC caregivers had low levels of unmet needs. The highest 
levels of need were located in the emotional and the health services domains. Managing 
FOR was the most frequently reported individual need. Loneliness and financial stress 
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were consistently and significantly associated with high levels of unmet need in this 
cohort. Hanly et al [2016] also reported on the unmet needs of caregivers, where 
healthcare needs was associated with carer burden, while their happiness was associated 
with psychological needs, healthcare service needs, informational needs, carer 
comorbidity and gender.  
 
There is little known about the longer term impact on caregivers living with significant 
permanent disability in HNC patients. In a prospective study of spouses of 
laryngectomy patients over 3 years, there were high levels of distress, where the 
majority expressed wanting to learn relaxation methods [Meyer et al, 2015]. However, 
the need for psychosocial support and the use of professional support among spouses 
remained stable over time and there was low uptake of their own personal counselling.  
 
ii. Comorbidity 
 
Comorbidity is the presence of additional illnesses unrelated to the malignancy [Paleri 
et al, 2010]. In HNC, tobacco and alcohol abuse contributes greatly to comorbidity 
[Boje et al, 2014], which impacts significantly on the prognosis of HNC [Paleri et al, 
2010]. Large cohort studies show that comorbidity increases the overall mortality in 
HNC [Gollnitz et al, 2016; Boje et al, 2014]. Six comorbidities, namely, congestive 
heart failure, cerebrovascular disease, chronic pulmonary disease, peptic ulcer disease, 
liver disease, and diabetes were significantly associated with reduced survival in HNC 
[Boje et al 2014].  
 
Comorbidity may influence disease-specific survival negatively by way of its 
association with delayed diagnosis, and the presentation of more advanced stage disease 
[Paleri et al, 2010].  Comorbidity can be a determinant factor of HNC treatment, where 
higher comorbidity scores could prompt a less aggressive treatment [Paleri et al, 2010]. 
Furthermore, treatment complications are more frequently seen in patients with high 
comorbidity scores, resulting in a higher demand for health care.   
 
Comorbidity influences HRQOL of HNC survivors. Oozer et al [2008] reported that 
patients with moderate to severe comorbidity had statistically significantly worse QOL 
at the start and at the midpoint of treatment, but not at the end of treatment. In HNC 
survivors, comorbidity score is a significant predictor of both the functional and the 
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general symptom sum HRQOL scores obtained at 18-months follow-up [Osthus et al, 
2013]. Comorbidity accounted for the proportion of variance seen in the functional and 
general symptom sum scores noted in longitudinal HRQOL scores. This study also 
found that lung disease appears to have an important and unique influence on HRQOL 
scores in HNC survivors [Osthus et al, 2013]. Addressing comorbidities during post-
treatment survivorship may require input by the general practitioners and medical 
specialists in the hospital setting.  
 
iii. Coping and personality 
 
Coping and personality are two closely related key issues affecting HNC survivors. 
Coping may be defined as the constantly changing cognitive and behavioral efforts to 
manage specific external or internal demands (and conflicts between them) that are 
appraised as taxing or exceeding the resources of the person [Aarstad et al, 2011]. 
Coping styles include problem-focused, emotional-focused and avoidance coping, 
where more than one style can be used at a time [Aarstad et al, 2011]. Specialised 
types of coping include ‘drinking to cope’, ‘coping by humour’ and ‘coping by religion’ 
[Aarstad et al, 2011].  
 
Sherman et al [2000] found a range of styles employed by HNC patients undergoing 
different phases of treatment (i.e. pretreatment versus on treatment versus post-
treatment at < 6 months and >6 months) including acceptance, active coping and 
religion. Denial, disengagement, and suppression of competing activities were present 
in those receiving or recently completed treatment. This subgroup also employed a 
greater number of coping styles compared with others. 
 
Coping strategies in HNC survivors may also vary according to their level of 
psychological distress experienced. Sherman et al [2000] found that increased distress 
was associated with general denial, behavioural disengagement and emotional 
ventilation. On the other hand, Elani & Allison [2011] found that patients with higher 
levels of anxiety and depression used more "blamed self", "wishful thinking", and 
"avoidance" coping strategies.  
 
The type of coping style can influence HRQOL. Aarstad et al [2002] found that HNC 
patients who showed coping by humour and coping by problem-solving directly 
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predicted low QOL. In the pretreatment phase, while a range of coping styles were 
employed, social support seeking behaviours representing the greatest proportion of 
total coping effort by HNC survivors [List et al, 2002]. Avoidance coping strategies 
resulted in poorer HRQOL in the pretreatment cohort. 
 
The coping style employed may be related to the treatment previously received by HNC 
patients can influence HRQOL outcomes. In a cross-sectional study of coping styles of 
disease-free post-treatment HNC survivors, Aarstad et al [2005] found that using 
emotional focused coping was associated with low HRQOL among those treated with 
surgery only, while this method was associated with increased HRQOL among those 
treated with radiation therapy only. It is suggested that these associations may be 
indirectly related to coping with the treatment side –effects.  
 
When measured longitudinally, avoidance focused, problem focused, drinking to cope 
and coping by humor all predicted HRQOL scores [Aarstad et al, 2008]. Coping by 
resorting to smoking and alcohol in HNC is not uncommon. While this type of 
behaviour carries a risk of adverse outcome to their HNC, patients who have this type of 
coping report good HRQOL.   
 
Personality may be defined as those characteristics of the person that account for 
consistent patterns of feeling, thinking and behavior [Aarstad et al, 2008] and 
represents a person’s stable disposition [Ran et al, 2014]. There are only two studies of 
personality and coping in HNC [Rana et al, 2014; Aarstad et al, 2008]. While both 
studies approach personality from a different theoretical model, the overall findings 
indicate that personality type can influence how patients experience and cope during 
HNC survivorship.  
 
Aarstad et al [2008] evaluated personality based on Eysenck’s model, which considers 
two personality types i.e. neuroticism and extraversion, and coping in HNC survivors. 
High neuroticism, but not extraversion, is associated with a lowered QOL [Aarstad et 
al, 2008].  
 
Rana et al [2014] evaluated personality based on ten personality traits as assessed by 
the Frieburg Personality Inventory in disease-free HNC patients. This study 
demonstrated that certain personality traits correlated with coping styles. For example, 
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lowered life satisfaction, inhibition and strain were predictors of depressive coping 
style. Social orientation and achievement were predictors of active problem-oriented 
coping, where there is seeking of social support or resorting to self-directed problem 
solving as ways of coping. However, this study did not directly relate the type of coping 
style with QOL outcomes.  
 
Hope and optimism are related to post-traumatic growth and benefit finding in HNC 
survivors [Ho et al, 2011; Harding et al, 2014]. Benefit finding was facilitated by 
active coping strategies by patients [Cavell et al, 2016]. In a study of pretreatment 
coping styles in HNC patients, the use of negative coping styles was related to high 
anxiety levels, while low levels of optimism were related to higher levels of depression 
[Horney et al, 2011].  
 
iv. Dental / Oral status and rehabilitation 
 
Dental/oral health is one of the most common concerns of HNC patients [Rogers et al, 
2009; Jungerman et al, 2017]. Post-treatment oral health status can result in negative 
functional and psychological repercussions [Rogers et al, 1999]. Direct damage to the 
oral structures (soft and hard tissues) frequently occurs from surgery, radio- and 
chemotherapy, and indirect damage may also arise from systemic toxicity [Hong et al, 
2010]. HNC treatment can result in the loss of teeth. Dental extractions can occur in 
resectable oral cancer, where teeth are included as part of cancer clearance [Pace-
Balzan & Rogers, 2012].  Teeth with poor prognosis are preemptively removed in view 
of chemo- and radiotherapy because patients with chronic dental disease and poor oral 
hygiene may be at an increased risk for the development of acute odontogenic infections 
and potentially life-threatening systemic infections during periods of chemotherapy-
induced immunosuppression, and to prevent future need for dental extraction in teeth 
located within the radiation fields and the development of osteoradionecrosis [Hong et 
al, 2010]. Soft tissue health, i.e. mucositis (acute and chronic) is also affected by 
xerostomia. Replacement of normal mucosal lining by hair-bearing skin flaps changes 
the oral environment.   
  
Changes to oral status result in multiple oral functional deficits i.e. chewing, swallowing 
and speech functions. Dental status has a persistent impact on subjective QOL [Duke et 
al, 2005].  The loss of teeth is a determinant of patient HRQOL, where reduced self-
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perceived oral health status is associated with greater numbers of missing teeth 
[Korfage et al, 2011]. Loss of teeth is also related to reduction in maximum bite force, 
overall masticatory function and poorer oral status compared with normal populations 
[Speksnijder et al, 2011]. Poor masticatory efficiency affected food choice and social 
life [Pace-Balzan et al, 2009]. Some patients are unable to wear dentures (22%) and 
this compounds poor functional outcomes [Kamstra et al, 2011]. Changes to the shape 
of oral/oropharyngeal soft tissue organs i.e. tongue, cheek and soft palate, can result in 
oral dysfunction due to loss of sensation, and abnormal/poor movement, strength and 
coordination [Kamstra et al, 2011]. Furthermore, loss of teeth and/or the basal bones 
(i.e. mandible or maxilla), can cause significant changes to orofacial appearance, with 
psychosocial implications [Pace-Balzan & Rogers, 2012]. Hassel et al [2011] reported 
the association of psychological distress (depression and/or anxiety) in disease-free 
survivors with poor self-reported oral health status. In a cross-sectional study of oral 
cancer survivors wearing dental prosthesis, 33% were somewhat or extremely 
depressed, 25% were anxious or very anxious, and 15% were both depressed and 
anxious [Pace-Balzan et al, 2008].  
 
As a result of these issues, survivors frequently seek oral rehabilitation [Ghazali et al, 
2012].  Oral rehabilitation strategies include aggressive oral health preventative 
programmes i.e. topical fluoride treatment, chlorhexidine mouth rinses [Hong et al, 
2010], restoration of carious teeth, and prosthetic replacement of lost teeth [Pace-
Balzan & Rogers, 2012]. The mainstay of dental rehabilitation of HNC survivors 
remains the provision of conventional fixed and removable prosthodontic appliances 
[Pace-Balzan & Rogers, 2012]. This process is complicated by the after effects of 
radiotherapy, diminished tongue function, changes to the soft-tissue and hard-tissue 
configuration, the presence and distribution of remaining teeth, the quality of tissue 
support, extent of mouth opening, the maxillomandibular relationship, and the quantity 
and quality of saliva available [Pace-Balzan & Rogers, 2012]. Because of this, not all 
survivors are suited to receive dental rehabilitation. Survivors who are able to receive 
oral rehabilitation are expected to attend multiple visits to the hospital/ dental clinics in 
the course of their treatment. Some require additional surgery to facilitate their oral 
rehabilitation.  
 
Following completion of oral rehabilitation, most survivors report improvement in 
function and oral health-related QOL scores [Dholam et al, 2017]. This study also 
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reported that despite good post-rehabilitation scores, a very small proportion of patients 
i.e. those who received a maxillary obturator still remained embarrassed about 
conversing, refused dinner invitation and lacked self‑ confidence because of 
embarrassment about their dentures. Pace-Balzan et al [2009] also reported this 
previously.   
 
More recent studies document the outcomes and impact of implant-retained prostheses, 
particularly when implants were supported by microvascular bone flap reconstruction. 
Oral rehabilitation with implant-supported dental prostheses after reconstruction of 
segmental maxillofacial defects with vascularized flap resulted in good to excellent 
speech intelligibility and aesthetics [Kumar et al, 2017; Wijbenga et al, 2017].  
 
v. Disfigurement 
 
HNC and its treatment can result in facial disfigurement. Surgical access, curative 
surgical ablation, scarring and radio- and /or chemotherapy-related effects, can result in 
permanent loss of normal contours and integrity. Disfigurement is significantly related 
to a diagnosis of oral cancer, a history of adjunctive radiation, the type of surgical 
procedure performed, the degree of physical dysfunction, and the presence of 
postoperative complications [Katz et al, 2000]. The ability to re-integrate treatment-
related changes into the body image is critical to optimal recovery and QOL after 
treatment [Dropkin, 1999]. About one quarter of HNC survivors have problems with 
appearance following treatment for oral or oropharyngeal cancer, and they rate 
appearance issues quite highly against other HRQOL issues [Rogers et al, 2008; Katre 
et al, 2008; Millsopp et al, 2006], where appearance can affect their activity and/or 
limit their social interactions [Millsopp et al, 2006; Katre et al, 2008].  
 
HNC survivors experience significant negative psychosocial consequences from facial 
deformity. Survivors with greater disfigurement were more depressed [Katz et al, 
2003]. Due to the central role of the face in self-expression and self-identity [Penner, 
2009], changes to facial appearance can significantly influence their sense of body 
image [White, 2000]. In describing the impact of facial disfigurement, Flexen et al 
[2012] notes that the changes to facial appearance can act as persistent reminders of the 
disease, where visible disfigurement can profoundly shape social encounters. The 
distress experienced by a patient upon seeing in the mirror their ‘flawed’ image is re-
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lived through the reflected response of others, even during the briefest of contacts 
[Macgregor, 1990]. Djan & Pennington [2013] purports that the importance of facial 
appearance in self esteem and society’s aversion to visible deformity means that its 
alteration can significantly impact on QOL, so much so HNC patients may fear facial 
disfigurement more than disease recurrence. 
 
However, patient’s concerns relating to appearance can go largely unrecognised in the 
outpatient clinics as patients are reluctant to burden clinicians with concerns about 
appearance and clinicians show poor awareness of patients’ concern with disfigurement 
[Djan & Pennington, 2013]. Millsopp et al
 
[2006] reported that 41% of HNC disease-
free survivors were concerned with appearance and yet only seven patients (7/114, 
6.1%) had appearance mentioned in their notes whilst only four (4/114, 3.5%) were 
considered for intervention.  
 
Patients with appearance concerns are often overwhelmed with anxiety, distress, 
depression, and employ negative coping strategies [Dropkin, 2001]. Patients with 
disfigurement issues may benefit from further refinement surgery, prosthetic 
rehabilitation, participation in support groups, camouflage techniques including medical 
tattooing [Drost et al, 2017], and other holistic therapy, such as massage and in 
particular, psychosocial interventions, including education via self-help publications, 
social skills course, counselling and cognitive behavioural therapy [Bessel, 2007].
 
The 
opportunity for patients to discuss their body image issues in clinic must be facilitated 
to allow their rehabilitative needs to be addressed.  
 
vi. Emotional distress and fear of recurrence (FOR) 
 
In a systematic review of psychological variables associated with quality of life 
following primary treatment for head and neck cancer, Dunne et al [2017] found that 
distress-related variables (depression, anxiety, distress) were most frequently 
investigated, and mostly reported negative associations with QOL outcomes in HNC 
survivorship. Emotional distress is experienced throughout the survivorship trajectory, 
where depression [Humphris & Rogers, 2004; Telfer et al, 1993; Espie et al, 1989; 
Wu et al, 2016], anxiety [Telfer et al, 1993; Espie et al, 1989; Chen et al, 2010; Chen 
et al, 2009A Chen et al, 2009C; Wu et al, 2016] and mood disorders [Espie et al, 
1989] are prevalent among HNC survivors. Over time, the experience of distress, 
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anxiety and depression changes with time [Wu et al, 2016; Ninu et al, 2016, where 
improvement in post-treatment cohorts is generally reported [Neilson et al, 2013]. 
Various studies have identified specific factors that are related with/or predictive of 
distress, anxiety and/or depression in the HNC cohort [Mucke et al, 2015; Almstahl et 
al, 2016; Moubayed et al, 2015;], and the heterogeneity seen within and between 
studies suggest that assessment on an individual basis may be the most practical 
approach in understanding the prevalence, its potential association with other key HNC 
survivorship issues, and the overall impact of these emotional problems at specific time 
points during the survivorship trajectory.  
 
Fear of recurrence (FOR) is a critical and central issue for patients because it relates to 
their survival. HNC patients and their caregivers fear cancer recurrence [Humphris et 
al, 2003; Hodges & Humphris, 2009; Rogers et al, 2010; Ghazali et al, 2012; Wells 
et al, 2015; Maguire et al, 2017] but this fear is infrequently disclosed [Rogers et al, 
2010] and may cause significant psychosocial morbidity and affect their HRQOL 
negatively [van Liew et al, 2014; Lin et al, 2016]. Significant FOR occurs commonly 
among HNC survivors [Rogers et al, 2010]. When assessed longitudinally, 20% of 
patients reported significant FOR intermittently, whereas 30% experienced it 
consistently [Ghazali et al, 2012]. FOR has been shown to correlate with anxiety and 
mood [Rogers et al, 2016A], and occurred more frequently in  those who continued to 
smoke after treatment [van Liew et al, 2014]. In addition, FOR is also associated with 
those who had poorer function and with those who felt that the information provided by 
health care professionals were inadequate [Handschel et al, 2012].  
 
There is an increasing drive towards distress screening in HNC. Distress screening is 
often undertaken simultaneously with uncovering unmet needs through the process of 
holistic assessment [NCAT, 2011]. In a study surveying distress and unmet needs of 
post-treatment HNC survivors, one quarter reported experiencing significant distress, 
and the most common unmet need was psychological [Henry et al, 2014]. A higher 
level of overall unmet needs was found in patients who were divorced, had a high level 
of anxiety, in poor physical condition, or had a diminished emotional QOL [Henry et 
al, 2014]. A similar proportion of post-treatment HNC survivors reported clinically 
significant distress (22%) in a study by Bornbaum et al [2011], where distress was 
correlated with the presence of symptoms and HRQOL status. Krebber et al [2016] 
used touch-screen based screening tool for distress in HNC survivors and found that 
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29% of survivors reported psychological distress, where 19% fulfilled the criteria for 
significant distress and were undergoing psychological support. Wells et al [2015] 
found that one-third of post-treatment HNC survivors experienced moderate to severe 
distress, where 75% had at least one unmet need. The most common concerns and 
unmet needs included oral and eating problems, FOR and fatigue.  
 
There are fewer studies evaluating levels of distress in patients HNC at pre-treatment 
than those currently undergoing treatment.  Chen et al, [2009] suggests that the 
proportion of patients with distress may be higher in cohorts undergoing active 
treatment compared with those in the post-treatment group. Ichikura et al [2016] 
observes the persistence of psychological distress in hospitalized HNC patients, which 
correlated with their physical issues.  
 
A range of psychosocial intervention have been proposed and evaluated to address the 
psychosocial distress [Semple et al, 2013]. While not all HNC survivors would accept 
professional intervention for their distress, some of those with significant distress were 
willing to consider psychological support [Shiraz et al, 2014].  
 
vii. Fatigue 
 
Fatigue is a common issue faced by cancer survivors. There is relatively little evidence 
base available on the experience of fatigue by HNC survivors. However, fatigue was 
one of the top five most common concerns of HNC survivors, accounting for one-fifth 
of those studied [Rogers et al, 2009].  
 
Aynehchi et al [2013] found that cancer stage and comorbidity significantly correlated 
with fatigue in HNC survivors. The correlation of advanced cancer stage with fatigue 
was also reported by Silviera et al [2015] in a study of HNC patients that underwent 
non-surgical treatment i.e. chemoradiotherapy and/or radiotherapy. Veldhuis et al 
[2016] found that the oropharyngeal subsite treated by non-surgical means correlated 
with fatigue. Singer et al [2014] noted that post-laryngectomy patients never recovered 
their fatigue scores to pretreatment. Sawada et al [2012] noted that patients reporting 
fatigue along with depression increased during the course of radical radiotherapy. 
Jereczek-Fossa et al [2007] showed a similar pattern in their cohort receiving 
radiotherapy, where fatigue scores peaked at 6 weeks of radiotherapy improved 
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thereafter. Fatigue was also reported in those who received postoperative radiotherapy 
[Ch’ng et al, 2014] and those who received chemoradiotherapy [Ackerstaff et al, 
2012; Pan et al, 2017]. Pre-radiotherapy fatigue score, induction and/or concomitant 
chemotherapy, and need of cortisone during radiotherapy (p < 0.005) were correlated 
with higher post-radiotherapy fatigue level [Jereczek-Fossa et al, 2007]. Fatigue was 
the most common symptom of patients who were referred for palliative care [Ullgren et 
al, 2017]. Fatigue correlated with other key issues of HNC survivorship, including sleep 
disturbance/apnoea [Loth et al, 2017], distress [Krebber et al, 2016], and swallowing 
function [Silviera et al, 2014].  
 
Interventions to reduce fatigue have been evaluated. Treatment with epoetin alfa was 
not found to influence fatigue in HNC patients treated by radiotherapy [Hoskin et al, 
2009]. Intervention with ‘guarana’, a plant-based dietary supplement with stimulant 
effects, did not improve the management of fatigue [Martins et al, 2016].  More 
recently, Xiao et al [2016] showed that inflammation could mediate the development of 
fatigue in survivors.  
 
viii. Financial burden and employment 
 
There are very few studies documenting the issues of financial burden and employment 
in relation to HNC survivorship. At diagnosis, more than half of UK HNC patients 
interviewed reported suffering financially, particularly in those who were retired, and 
whose occupation was directly affected by HNC [Rogers et al, 2012C]. A similar 
proportion of patients reported a decrease in their QOL as a result of the financial 
impact of the disease, which was most common in the unemployed, and in those whose 
work was affected by cancer [Rogers et al, 2012C]. 
 
The financial burden of UK HNC survivors and the impact on HRQOL was explored by 
Rogers et al, 2012B]. The most notable financial costs of moderate or large burden to 
patients were petrol, home heating, change in the type of food, and loss of earnings. 
Loss of income due to medical condition was significant in 15%. Patients with worse 
physical and socio-emotional functioning experienced more notable financial burden, 
and had more difficult life circumstances in the past month. In addition, this subgroup 
also had greater financial difficulty, and suffered loss of income due to their condition 
in the previous week. Furthermore, they reported more dissatisfaction with how well 
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they took care of their own financial needs and were more likely to have sought 
statutory benefits.  
 
Egestad et al, [2015] undertook an evaluation of the financial impact on HRQOL in 
Norwegian HNC patients, whose healthcare system is based on general taxpayer 
revenues. While this healthcare system is similar to the UK healthcare system, HNC 
patients did not report any significant financial difficulties at the end of treatment 
compared with the their status before commencement of treatment [Egstad et al, 2015]. 
However, they observed a trend of increasing financial difficulties during treatment in 
males, and those < 65 years i.e. before age of retirement.  
 
Some survivors need help with managing their financial burden. About a quarter of 
patients reported moderate to significant dissatisfaction with how they addressed their 
financial burden [Rogers et al, 2012C]. Adequate help and information about finance 
was only received in a quarter of patients. Within this subgroup, financial advice/help 
was twice more frequently received by those who were fully employed (39%) compared 
with the unemployed (18%) [Rogers et al, 2012B]. Only two-thirds of survivors 
surveyed claimed benefits, where the most common benefits claimed were Disability 
Living Allowance and Incapacity Benefit. This study highlights the importance of 
providing patients with information about financial help in alleviating their financial 
burden.   
 
Regarding employment, the majority of HNC patients (83-92%) were in employment at 
the time of their diagnosis [Agarwal et al, 2017; Verdonck et al, 2010]. Up to three-
quarters (66-71%) returned to work after treatment [Agarwal et al, 2017; Verdonck et 
al, 2010] and the median time to work was 6 months  [Verdonck et al, 2010]. Agarwal 
el al [2017] found that family structure (<2 male children, and eldest child age <20 
years), a higher level of education (vocational or professional training), and the female 
gender were associated with higher return to work. Verdonck et al [2010] found that 
oral dysfunction, loss of appetite, deteriorated social functioning, and high levels of 
anxiety were barriers for HNC survivors returning to work after treatment. Furthermore, 
in previously employed HNC survivors who returned to employment, most resumed the 
same work, while others went into adapted work and/or into a different job. HNC 
survivors who returned to work had better global QOL and seemed to cope with the 
side-effects of treatment, including coughing and sticky saliva [Agarwal et al, 2017]. 
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However, Terkawi et al [2017] reported that chronic pain interferes with normal work 
in post-treatment HNC survivors. 
 
Koch et al [2015] evaluated employment and psychological factors in HNC survivors 
and found that current unemployment among was associated with harder physical work 
before cancer diagnosis, surgical treatment, and current risky alcohol consumption. This 
group of patients also reported decreased functional and social well-being and 
depression scores.  
 
ix. Information 
 
Information needs are important issues to HNC survivors [Semple & McGowan, 
2002], and this is recognised by the government’s drive for cancer patients to receive 
high quality information. Need for information is important at each stage of 
survivorship, especially when there is a sudden change in their disease status. 
Information can also be used as a form of intervention during survivorship, e.g. 
information about lifestyle choices relating to risk behaviour is valuable in secondary 
prevention [Semple & McGowan, 2002].  
 
Many HNC survivors felt unprepared for the long-term lifestyle changes that occurred 
when their experience was evaluated retrospectively [Newell et al, 2004]. Satisfaction 
with information relates to the comprehensiveness of the information provided [Semple 
& McGowan, 2002]. The quality of information and satisfaction with the information 
provided was predictive of psychological distress (depression) [Llewellyn et al, 2006].  
 
In a substantial review of informational needs and experiences of HNC survivors, 
Ziegler et al [2004] recommended that improvement to information giving is critical in 
light of the significant psychosocial and other functional disturbance reported among 
those who underwent surgery. Rogers et al [2015C] recently introduced a patient 
information sheet on the expected HRQOL outcomes based on a large, long-term 
database of HRQOL scores of HNC, and proposed that this HRQOL-based information 
can help patients decide on treatment options as they consider the potential after-effects 
of treatment on their quality of life based on the experience of other patients with 
similar clinicopathological and treatment characteristics.  
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Patients who have undergone surgery and their caregivers reported feeling adequately 
prepared about the surgery procedure [Newell et al, 2004]. This was similarly reported 
by HNC patients who were undergoing surgery in a prospective study of information 
given at presurgery, and in its relationship with HRQOL [Bozec et al, 2016]. This study 
found that HNC patients felt satisfied in all areas related to information, and this 
correlated with the HRQOL.  
 
Llewellyn et al, [2006] studied the information received in the post-treatment period, 
where disease-free HNC patients reported being generally satisfied with information 
given. The key areas of information required by survivors related to support groups, 
financial advice and the long-term affects of treatment on ability to work, physical 
functioning and QOL. In a more recent work by Jabbour et al [2017], the majority of 
HNC patients surveyed across multiple institutions reported that the information 
received concerning the disease process (76%), prognosis (67%) and treatment (77%) 
were sufficient. However, half of patients reported receiving little or no information 
regarding coping with stress and anxiety, while more than half received minimal 
information about psychosexual health (56%) or the availability of patient support 
group (56%).  
 
Jabbour et al [2017] also evaluated the methods by which patients’ accessed/received 
the information. The majority of this cohort expressed a preference for a multiple mode 
of access to the information delivery (72%), while the rest preferred one-to-one 
modality, or internet-based information. In a large survey of informational needs and the 
preferred modality for delivery in a Canadian HNC cohort (n, 450), the top preferred 
educational modalities reported by patients were teaching with healthcare professionals 
and through pamphlets [Papadakos et al, 2017].  
 
The value of written or similar forms of information as a reference for patients has been 
evaluated. In the palliative setting, Ullgren et al [2017] noted that patients were more 
satisfied when given written information regarding their self-care compared with those 
who did not receive the information in written form. There is an on-going clinical trial 
evaluating the DVD intervention of information for HNC patients and their caregivers 
[Parker et al, 2016].   
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Best et al [2015] evaluated the quality of information available on the internet for 
patients with HNC, and found that only 17.5% of websites evaluated partially or fully 
achieved the Journal of American Association of Medicine (JAMA) benchmarks criteria 
on the quality of medical information on the internet [Silberg et al, 1997]. This finding 
was similar to a previous survey undertaken in 2008 [Ni Riordain & McCreary, 2008]. 
Another survey using similar methodology for information regarding oral cancer also 
found that the majority of websites did not meet the JAMA criteria [Lopez-Jornet & 
Camacho-Alonso, 2008], indicating a need for vigilance by survivors when using these 
websites.  
 
Support groups are excellent sources of information and support for survivors, who 
derive personal experience of others who have been diagnosed and treated that health 
care professionals are not able to provide.  Vakharia et al [2008] evaluated the impact 
of support groups in HNC patients, and found that patients who participated in the HNC 
support group exhibited significantly better scores in the domains of eating, emotion, 
and pain as well as in the global QOL, compared with those patients who did not 
participate. Utilisation of web-based support groups can also provide similar 
improvements in HRQOL. Algtewi et al [2017] reported that participation in online 
support groups was found to be associated with better HRQOL either directly or 
indirectly through decreasing depression, anxiety and the negative adjustment 
behaviours and increasing self-efficacy and empowerment of the users. 
 
In view of identifying gaps for improvement, Fang & Heckman, [2016] undertook a 
literature review of informational needs for HNC patients and observed several areas 
where information was reported inadequate or deficient by patients. These include 
informational needs of caregivers/family, lifestyle choices, particularly regarding 
smoking and alcohol dependency, involvement in clinical trials and information relating 
to HPV-related cancers. Other studies have also reported information gaps in areas 
relating to financial help [Rogers et al, 2016C]. Lack of information regarding diet and 
food was documented in laryngectomy cohorts [Lennie et al, 2001] and in obese HNC 
patients undergoing radiotherapy [Egestad et al, 2015].  
 
x. Intimacy and sexuality 
 
In cancer literature, sexuality and intimacy have been used interchangeably. According 
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to the WHO, “sexuality is a central aspect of being human throughout life and 
encompasses sex, gender identities and roles, sexual orientation, eroticism, pleasure, 
intimacy and reproduction. Sexuality is experienced and expressed in thoughts, 
fantasies, desires, beliefs, attitudes, values, behaviours, practices, roles and 
relationships. While sexuality can include all of these dimensions, not all of them are 
always experienced or expressed. Sexuality is influenced by the interaction of 
biological, psychological, social, economic, political, cultural, ethical, legal, historical 
and religious and spiritual factors”  (page 1) [WHO, 2005]. In a review of sexuality 
and intimacy after cancer, Hordern [2008] notes that the term ‘‘intimacy’’ is rarely 
defined as a separate entity to sexuality, and is frequently been used as an euphemism 
for sexual function. However, HNC patients consider intimacy as multifaceted, relating 
to relationships, personal identify and re-establishing social networks [Rogers et al, 
2015].  
 
There is very little evidence available on the subject of intimacy and sexuality in HNC. 
The prevalence of intimacy and sexuality issues are unknown. In a study of unmet needs 
of psychological issues in HNC survivors, changes in sexual relationships, as well as 
changes in sexual feelings, were two of the most common unmet needs [Henry et al, 
2013]. Moreno et al [2012] reported that all patients in their study reported that HNC 
negatively impacted their sexual relationships, while Singer et al [2008] reported that 
just over half of post-laryngectomy patients reported worse sex life after the diagnosis 
of HNC.  Low et al [2009] reports that one-third of those answering the intimacy and 
sexuality questions reported substantial problems with sexual interest and enjoyment, 
and one-quarter reported problems with intimacy. Poor scores with sexuality were 
associated with distress [Krebber et al], in patients with trismus [Lee et al, 2015], in 
those with poor nutritional status [He et al, 2017] and predicted poor HRQOL [Bajwa 
et al, 2016]. 
 
Individuals with impaired sexuality have poorer QOL. However, the predictors of poor 
QOL related to sexuality/intimacy are not uniformly agreed across papers. Low et al 
[2009] and Rogers et al [2015B] showed that a younger age reported more problems 
but this was not noted in others [Singer et al, 2008; Moreno et al, 2012]. Regarding 
gender, males indicated a higher prevalence of problems [Low et al, 2009] but no 
gender-based differences were noted in other studies. Singer et al [2008] reported that 
more advanced tumours were related to higher sexual impairment but this was not noted 
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by others [Low et al, 2009]. As HNC survival continues to improve, and patients are 
increasingly diagnosed with HNC at a younger age, there will be an increased need to 
support the unmet need relating to sexuality and intimacy of survivors of this disease. 
 
xi. Lifestyle choices 
 
It is estimated 35-50% of HNC patients were engaged in smoking at diagnosis [Bloom 
et al, 2015]. Most HNC survivors attempt to quit but a substantial proportion relapse 
and resume smoking. This carries the risk for adverse outcomes, including reduced 
treatment efficacy and poorer survival rates [Simmons et al, 2013]. In a longitudinal 
survey of HNC survivors at 1-year post-surgery, 60% of patients who smoked during 
the week prior to surgery had resumed smoking compared to only 13% who were 
abstinent prior to surgery. Predictors of smoking relapse in those who smoked before 
surgery included lower quitting self-efficacy, higher proneness to depression, and 
having greater fears about cancer recurrence [Simmons et al, 2013]. Continuous post-
surgery abstinence was associated with lower levels of depressive symptoms [Bloom et 
al, 2015], indicating that smoking cessation/abstinence in HNC survivors can result in 
better psychological well-being. HNC survivors who continue to smoke after treatment 
report higher levels of distress and FOR [Hodges & Humphris, 2009; van Liew et al, 
2017]. 
 
In regard to alcohol usage in HNC patients, Potash et al, [2010] reported that 45% of 
HNC survivors continued to drink alcohol after treatment, and 21% of this group were 
categorised as problem drinkers. At 12-months follow up, these survivors showed good 
HRQOL status, which was generally related to better oral health-related QOL scores. 
This study concluded that patients were more likely to indulge in alcohol drinking 
because of their good oral function, rather than alcohol drinking being directly related to 
the good HRQOL status.  However, problem drinkers had 12-month eating scores in the 
low-functioning category, and this suggests the likelihood that alcohol dependency and 
its self-medicating properties may have contributed to why it very difficult for these 
individuals to quit drinking despite experiencing pain and/or poor oral functioning 
associated with swallowing [Potash et al, 2010].  
 
A smaller prevalence of problem drinkers was found in a group of post-laryngectomy 
survivors, where 7% reported having alcohol-dependence [Danker et al, 2011]. When 
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compared with non-alcohol dependent patients, this group had reported significantly 
higher levels of anxiety, problems in coping with illness, increased psychosocial care 
needs, fatigue, shortness of breath, diarrhoea and a worse emotional functioning level. 
Their alcohol consumption was independent of tumour stage, employment status, social 
class, the time interval since laryngectomy, and type of voice substitute. This study 
suggests that exploration of individual drinking behaviour may be valuable in 
addressing this problem adequately.  
 
Psychological intervention and providing information regarding the risk of indulging in 
risk habits may be beneficial in managing patients’ lifestyle choices. While the focus 
has predominantly been on smoking and alcohol,  the abuse of other substances that 
may also increase the risk of HNC by HNS survivors e.g. opium [Bakshaee et al, 2017; 
Razmpa et al, 2014] and betel quid chewing, may also need similar attention.  
Christensen et al [1999] reported that continued smoking after HNC treatment was 
predicted by the interaction of behaviour specific self-blame and perceived control. 
Patients who attributed the cause of their HNC to their past substance use exhibited a 
lower likelihood of smoking but only if they also held the expectancy that their future 
cancer-related health was contingent on their own behaviour. Among patients not 
holding the belief that cancer recurrence was contingent on their own actions, self-
blame was associated with a higher probability of continued smoking. Self-blame and 
perceived control had no effect on continued alcohol use. This study shows the 
importance of addressing health beliefs of patients. Coping styles also influence 
patients’ relationship with smoking and alcohol dependence. In a study of coping styles 
in problem drinkers, Petric et al [2011] reported that problem drinkers of alcohol with 
HNC resorted to different defence mechanisms to life compared with problem drinkers 
who did not have malignancy.  
 
xii. Nutrition 
 
Patients with HNC are at risk of malnutrition because of the combination of cancer 
involvement of the upper digestive tract, the disease process and its treatment [Talwar 
et al, 2016]. Cancer cachexia may be present at diagnosis. It is a cancer-induced 
syndrome where there is decreased appetite, weight loss, metabolic alterations and an 
inflammatory state that cannot be fully reversed by conventional nutritional support and 
leads to progressive functional impairment [Talwar et al, 2016]. In addition, HNC 
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patients may have long-standing dietary habits and detrimental lifestyle factors, 
particularly alcohol abuse that may exacerbate their risk of malnutrition [Talwar et al, 
2016].  
 
Their nutritional status may be worsened by treatment, which can reduce patients’ 
appetite overall. Treatment can result in delayed return to oral intake, reduction in 
normal nutritional intake due to mucositis, pain and eating dysfunction (including 
dysphagia, mastication inefficiency and dry sticky saliva) [Farhangfar et al, 2014], and 
altered taste due to changes in salivary flow [Bressen et al, 2017]. These issues can lead 
to critical weight loss, which can occur in 20% of cases [Jager-Wittnaar et al, 2009]. 
Poor oral health and function is associated with malnutrition in HNC [Barrios et al, 
2014].  
 
Tube feeding support in patients with swallowing problems can be temporary in many, 
but a small proportion would require the tube permanently. Problems with tube feeding 
care and refeeding syndrome can occur [Talwer et al, 2016]. The presence of feeding 
tubes and enteral feeding in HNC survivors were not are associated with HRQOL 
changes [Ehrsson et al, 2015] but HNC survivors with long-term gastrostomy tube 
(PEG) reported poor HRQOL [Rogers et al, 2007]. Patients with PEGs reported 
significant deficits in all HRQOL domains and a much poorer QOL compared to 
patients without PEGs. The major problems reported by these patients were not PEG-
related issues, but relate to interference with family life, intimate relationships, social 
activities, and hobbies [Rogers et al, 2009]. 
  
HNC survivors’ weight and nutritional status changes can be influenced by the type of 
treatment received. Nutritional status decreased during IMRT treatment, which was 
accompanied with a reduction in HRQOL status [He et al, 2017]. The factors predicting 
nutritional status were multifactorial including the use of immunotherapy, tumour stage, 
the use of concurrent chemotherapy, pretreatment dental status, problems with 
sexuality, sensory deficits, and xerostomia [He et al, 2017].  In patients receiving 
IMRT, Ma et al [2017] reported a positive correlation between comprehensive 
nutritional status with QoL scores of functional and global QoL scales in patients.  
 
Weight loss is a common problem encountered in post-treatment HNC patients despite 
aggressive nutritional support. There is a large variation in the reported value of 
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nutritional intervention to prevent weight loss. However, a recent meta-analysis of 
randomised control trials of nutritional intervention in relation to radiotherapy in HNC 
found that there was no evidence for weight changes after radiotherapy, nor was there 
significant changes related to HRQOL by these intervention [Roussel et al, 2017]. 
Increased use of nutritional supplements in HNC was associated with trismus [Lee et al, 
2015], and depression [Wu et al, 2016].  
 
Weight loss is associated with depression in HNC survivors [van Liew et al, 2017], 
aspiration and HRQOL [Campbell et al, 2004]. Languis et al [2013] evaluated the 
influence of weight loss on HRQOL, where weight loss >10% was significantly 
associated with poor global QOL, reduced social eating and social contact. Petruson et 
al [2005] observes a similar finding but suggests that HRQOL status may predict 
survivors who will develop weight loss.  
 
xiii. Osteoradionecrosis (ORN) 
 
ORN is a major late complication of radiotherapy, representing a severe and significant 
wound healing deficiency. In ORN, there is devitalized bone, which may or may not be 
exposed through an ulcerated mucosa. ORN is associated with significant symptom 
burden. The associated symptoms and signs include pain, swelling, cellulitis, trismus, 
neuropathic pain, paraesthesia, fistula formation, and chronic purulent drainage [Oh et 
al, 2009; Jacobson et al, 2010; Chronopoulos et al, 2015]. When there is absence of 
exposed bone, patients often present with pain. The frequency of symptoms and signs 
can vary with the severity of ORN [Chronopoulos et al, 2015]. Patients may also often 
experience other radiation-related complications including xerostomia, dysgeusia, 
dysphagia and decreased tongue mobility [Horiot et al, 1981]. These issues compound 
ORN-related problems, creating an extremely challenging situation for patients, leaving 
some patients physically and emotionally disabled [Jacobson et al, 2010].  
 
ORN is associated with a poor HRQOL score [Rogers et al, 2015A]. Patients 
experiencing pain with ORN reported worse scores for appearance, activity, recreation, 
swallowing, and chewing. Patients who had more severe grades of ORN and underwent 
major mandibular resection and reconstruction continued to report relatively poor 
HRQOL scores. This study suggests that survivors who develop ORN were unlikely to 
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hugely benefit from active radical intervention, even though conservative treatment was 
unlikely to change their predicament either.  
 
xiv. Pain  
 
The head and neck area is highly sensitive to pain due to rich innervation and the 
confinement of many anatomical structures to a small space [Macfarlane et al, 2012]. 
In a systematic review of pain in HNC patients, Macfarlane et al, [2012] reports that 
survivors experience high levels of pain prevalence, which can be as high as 85% of 
those diagnosed with squamous cell carcinoma. The prevalence of pain may be 
influenced by the subsite, where patients with oral cavity and oropharyngeal subsites 
experienced pain in 60-70%.  There are some factors associated with higher levels of 
pain, including age, gender, sociodemographic factors, the use of smoking/alcohol, 
psychological, cancer-related and treatment-related factors [Macfarlane et al, 2012].  
 
The experience of pain improves with time but does not diminish completely even at 
long-term follow up. Just over a third of disease-free HNC patients self-reported pain 
issues, with 25% having significant pain problems despite medications, and about 13% 
self-reporting lesser or no problems with pain but wishing to discuss pain [Rogers et al, 
2012]. Pain experienced by HNC patients may have a detrimental impact on their 
general well-being [Chaplin & Morton, 1999], cause dysfunction [Chua et al, 1999; 
Chen et al, 2011] and distress [Bjordhal et al, 1999; Epstein et al, 2009], is associated 
with poor sleep quality [Shuman et al, 2010] and poor health-related quality of life 
[Macfarlane et al, 2012], can mark the onset of malignant transformation [Lam & 
Schimdt, 2011] and recurrence [Schrapf et al, 2009], and reduces survival rate [Sato et 
al, 2011]. Although the impact of pain in HNC patients is significant, its management is 
difficult [Sist et al, 2000] and often inadequate [Williams et al, 2010]. 
 
xv. Self-esteem  
 
 
Self-esteem may be defined as the summary judgement of everything a person can 
assess about him/herself, and these judgements concerns five main areas, namely, who 
one is (i.e. personal philosophy of life and character), what one does, what one has, the 
different levels in how one appears and to whom or what one is attached to [Bailey et 
al, 2003]. The final outcome of weighing of negative against positive judgment in the 
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categories/areas will produce a value of self-esteem, which can be noted as low or high. 
Self-esteem is influenced by self-identify, body image, and social roles. All of these 
areas are affected by HNC. Disorders to self-esteem may include development of 
shame, stigma, self-hatred, self-harm and social isolation.  
 
A proportion of HNC patients have preexisting low self-esteem at diagnosis and without 
intervention this may influence the HRQOL outcomes during treatment. Kobayashi et 
al [2008] reported that patients with low self-esteem were more likely to experience 
psychological distress during active treatment compared with those with high self-
esteem. Patients who have undergone total laryngectomy were more often observed to 
have problems regarding depression, anxiety, self-esteem and sexual functions 
[Batıoğlu-Karaaltın et al, 2017].  
 
Issues relating to disfigurement and body image [Rhoten et al, 2013]; loss of 
speech/impaired communication; failure to return to work after treatment; changes to 
relationships and intimacy; and social isolation can all lead to lowered self-esteem in 
HNC survivors. Continuing low self-esteem can impact upon the disclosure of concerns 
and needs by HNC survivors during the post-treatment period [Rogers et al, 2009]. 
This may lead to distress due to unmet needs and impacts upon their HRQOL.  
 
HNC is associated with a negative stereotype image due to its association with 
addiction, substance abuse and risky sexual behaviour, and this can be stigmatising. 
HNC patients develop strategies to preserve their self-esteem by distancing i.e. 
construing oneself as dissimilar to a negatively-stereotyped group. Devins et al [2015] 
showed that self-perception of a negative stereotype was associated with poor sense of 
general well-being and distancing may be a productive strategy by patients.  
 
xvi. Sleep 
 
Sleep disturbances are a common complaint in cancer patients. The prevalence of sleep 
disturbance in HNC survivors is unknown but there is evidence to indicate that HNC 
patients are at even greater risk for sleep disorders than other cancer patients [Mcmillan 
et al] secondary to its association with pain [Terkawi et al], depression [McCall et al], 
nicotine and alcohol use [Zhang et al; Lobo et al], obstructive sleep apnea [Huyett et 
al, 2017; Loth et al, 2017], surgical alterations or radiation therapy, and xerostomia 
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[Jellema et al, 2007]. Li et al [2017] reported that sleep quality was worse in 
posttreatment patients who received neck dissection, scored poorly in mental and 
psychological domains. Shuman et al, [2010] also notes that pain, xerostomia, 
depression, presence of a tracheotomy tube, comorbidities, and younger age were 
significant predictors of poor sleep at 1-year following HNC diagnosis. The 
consequences of poor sleep include fatigue and poor HRQOL.  
 
xvii. Sociodemographic 
 
The prevalence of HNC survivors residing in the most deprived areas is estimated at  
37% [Rylands et al, 2016A]. HNC patients from lower socio-economic backgrounds 
have worse outcomes of survival and HRQOL [Wooley et al, 2006]. In addition, HNC 
survivors from lower socioeconomic group living in deprived neighbourhoods were 
more likely to develop second primary malignancies [Rietzel et al, 2012]. Ryland et al 
[2016B] recently reported that those residing in more deprived areas had worse QOL 
outcomes in regard to social-emotional functioning and overall QOL but not in regard to 
physical oral function. 
 
Lower level of education is related to less likelihood of returning to employment after 
HNC treatment [Agarwal et al, 2017]. Low levels of education may also influence the 
way HNC-related information is delivered [Papakados et al, 2017] and the impact this 
information has on HRQOL [Bozec et al, 2016]. Survivors with higher levels of 
education had a more positive attitude towards online self-management intervention 
[Jansen et al, 2015] while lower education level were less satisfied with online self –
care education programmes in HNC survivorship [Cnossen et al, 2016]. 
 
Patients with high educational attainment and those who lived alone reported impaired 
QOL [Rana et al, 2015]. Marital status may positively influence HRQOL status in 
HNC survivors [Bilal et al, 2015]. Jenewein et al [2008] observed that self-reported 
overall QOL is considerably high in post-treatment HNC patients living in stable 
relationships compared to those who were not. 
 
xviii. Speech  
 
Speech is an integral means by which humans engage in social contact. Along with 
voice, speech forms the most important daily communication tool, shapes a person’s 
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identity and personality and contributes to well-being and overall QOL
 
[Jacobi et al, 
2010]. Speech difficulties encompass problems with speech production, intelligibility 
and acceptability of speech and inadequacy of speech in everyday life situations. These 
have significant psychosocial impact.  
 
Oral cancer patients are particularly prone to speech dysfunction post-treatment. Despite 
organ preservation protocols, pharyngeal and laryngeal function is altered by treatment 
[Rinkel et al, 2014]. The problems reported encompass speech intelligibility, 
articulation, voice quality (hoarse voice), poor communication, and the associated 
psychosocial complications including social isolation, low self-esteem, inability to 
return to work and poor sleep. These problems continue and extend into long-term 
survivorship, with impacts on their long-term HRQOL [Rinkel et al, 2014; Kraaijenga 
et al, 2016; Meyer et al, 2004].  
  
xix. Swallowing 
 
Swallowing dysfunction is a multidimensional symptom-complex in which patients can 
experience a range of mechanical difficulties of bolus transfer through the oral cavity 
and pharynx, and also present with ineffective chewing and bolus formation, nasal 
regurgitation, oral leakage and aspiration
 
[Wallace et al, 2000]. It can also significantly 
impact on overall and specific areas of HRQOL, including emotional, self-esteem, 
social functioning and is consequently, a survivorship issue [Rinkel et al, 2014]. It is 
one of the top ten most common concerns of HNC, with a prevalence of 18% [Rogers 
et al, 2009]. Radiation-induced pharyngoesophageal fibrosis, mucositis and dryness 
may account for the dysphagia experienced [Eisbruch et al, 2004] and improvement in 
delivery of radiotherapy i.e. IMRT can help reduce the severity of these effects [Roe et 
al, 2010].  
 
Dysphagia is also related to other key issues including intake of food, nutritional status 
and aspiration. This may be exacerbated when dysphagia results in permanent 
dependence on tube feeding. Intervention with swallowing exercises may be considered 
as a preventative and/or therapeutic measure.  
 
xx. Shoulder  
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Shoulder function is an important outcome after treatment. Patients who undergo 
surgery, particularly neck dissection (ND), are at risk of developing shoulder 
dysfunction. This is the result of damage to the accessory nerve, and denervation of the 
trapezius and sternocleidomastoid muscles. Loss of function in these muscles can impair 
shoulder movement and the development of secondary problems at the shoulder joint 
and the cervicofacial complex, e.g. adhesive capsulitis, rotator cuff impingement, and 
myofascial pain [Eickmeyer et al, 2014]. Damage to the cervical plexus can cause 
neuropathic pain in the neck region. Nerve damage results in reduced range of shoulder 
and neck motion, decreased the performance in activities of daily living, contributes to 
chronic pain and poor sleep. Subjective complaints of shoulder dysfunction and pain 
have a large impact on QOL. Shoulder dysfunction may also occur following non-
surgical intervention, where radiation-induced fibrosis can cause changes in the 
musculature, innervation and joint.  
 
Limiting the extent of ND, i.e. preservation of the accessory and cervical plexus nerves, 
preservation of sternocleidomastoid muscle and avoidance of Level 2B dissection in 
certain HNC subsites, is related to better shoulder symptomatology [Gazaro et al, 
2015; Nibu et al, 2010; Umeda et al, 2010]. Eickmeyer et al [2014] studied long-term 
shoulder outcomes in survivors with 5 years disease-free status. Patient who had their 
accessory nerve sacrificed during ND had significantly poorer scores for disfigurement, 
level of activity, recreation and/or entertainment, speech and shoulder disability, and 
willingness to eat in public, and functional well-being. Furthermore, QOL scores were 
also reduced in the group who showed objective shoulder restriction. 
 
When compared with HNC patients who did not undergo ND, those who received ND 
reported lower quality of life [Spalthoff et al, 2017]. The burdens reported by those 
who had less aggressive ND i.e. selective ND (SND) was lesser than those who 
underwent more aggressive ND procedure i.e. modified radical ND (MRND) or radical 
ND (RND). There were meaningful differences between the SND, MRND, and RND 
groups and those who did not undergo ND group in impairments in speech intelligibility 
for strangers and familiar persons, ingestion and swallowing, tongue mobility, opening 
of the mouth, lower jaw mobility, neck mobility, and shoulder and arm movement. 
Many patients with ND faced a lower functional status and negative professional and 
financial consequences.  
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These findings are significant for consideration during HNC treatment decision -making 
in the management of the neck, particularly in the scenario where there is no clinical 
evidence of regional involvement. In this instance, the option of avoiding ND in favour 
of ‘wait and watch’ policy or the option of a less aggressive option of sentinel node 
biopsy may be considered against the social and personal preference of patients. 
Shoulder exercise may be useful intervention to improve long-term shoulder outcomes 
in HNC survivors.  
 
xxi. Trismus  
 
Trismus is difficulty or restricted in mouth opening, and it is a recognised complication 
of the disease and its treatment i.e. surgery and/or radiotherapy treatment. Trismus can 
have a negative consequential impact on oral/dental health, chewing, swallowing, 
orofacial appearance, nutritional status and the psychosocial. While the objective 
definition can vary, a maximal interincisal opening < 3.5cm is generally the accepted 
cut off point, and the prevalence of trismus based on this criteria is approximately 38% 
[Scott et al, 2011]. When the masticatory muscles, in particular the pterygoid muscles, 
are involved by surgery and/or lie within the radiation fields, post-treatment scarring 
can predispose to trismus. Its development is usually progressive, and intervention by 
mouth opening exercises has been shown to help to reduce the severity of trismus.  
 
xxii. Xerostomia and dysguesia 
 
Xerostomia is a term used to describe the subjective symptoms of a dry mouth deriving 
from a lack of saliva [Pinna et al, 2015]. In the context of HNC, xerostomia is often the 
consequence of treatment e.g. radiotherapy and chemotherapy, but xerostomia may be 
preexist HNC diagnosis due to a range of causes including physiological reduction due 
to age, side effects of medication, and medical comorbidity i.e. autoimmune and other 
metabolic conditions [Pinna et al, 2015].   
 
Radiation-induced damage to the salivary glands results in impairment of both the 
quantity and quality of saliva produced, and virtually all patients who receive 
radiotherapy will have xerostomia, albeit showing varying degrees of severity 
[Chambers et al, 2004]. Xerostomia causes oral discomfort and pain, increased dental 
caries and oral infection, dysgeusia, difficulty speaking and swallowing, and insomnia 
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[Chambers et al, 2004; Jellema et al, 2007]. This significantly impairs QOL and can 
compromise nutritional intake and continuity of cancer therapy. Patients with 
xerostomia experience distress, which is related to emotional functioning, sticky saliva 
and dyspnoea [Almstahl et al, 2016]. 
 
The natural progression is worsening of xerostomia immediately after completion of 
treatment. This continues well into 6-9 months post-treatment, after which salivary 
production recovers and salivary flow may return to pretreatment levels by 12-18 
months. The changes are reflected also in HRQOL scores. Altered saliva-related 
symptoms are one of the most predictive factors for poor global QOL and HRQOL in 
HNC survivors. Treatment options that can reduce radiotherapy exposure to salivary 
glands e.g. IMRT, should be considered to reduce the impact of xerostomia on HRQOL.  
 
 
3.3. Qualitative studies of HNC survivorship 
 
There is comparatively less known about the patient’s lived experience of HNC 
compared with the larger body of evidence on how HNC impacts upon QOL [Lang et 
al, 2013]. 
 
3.3.1. Qualitative studies 
 
Qualitative research methods involve the systematic collection, organisation, and 
interpretation of textual material derived from talk or observation. It is used in the 
exploration of meanings of social phenomena as experienced by individuals themselves, 
in their natural context [Malterud, 2001].  
 
3.3.2. Qualitative studies of HNC survivorship 
 
Qualitative studies exploring the patients and their carers’ day-to-day realities with 
HNC may provide an insight into how patients experience the survivorship journey. In a 
systematic and meta-synthesis review of multiple qualitative studies (1993-2011) 
reporting on HNC patients’ lived experience, Lang et al [2013] identified six core 
concepts of the actuality of living with HNC emerged including ‘uncertainty and 
waiting’, ‘disruption to daily life’, ‘the diminished self’, ‘making sense of the 
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experience’, ‘sharing the burden’ and ‘finding a path’. This systematic review provided 
the basis for exploring the findings of succeeding qualitative studies published after 
2013.  
 
The dual concept of ‘uncertainty and waiting’ relates to the situation of ‘being in limbo, 
i.e. the uncertainty of living with the disease and of the future, where patients oscillate 
between hope and despair’ (page 2651), while ‘waiting’ represents ‘an urgent need to 
feel something is being carried out’ (page 2652) during their diagnostic, treatment and 
survivorship phases, which can aggravate anxiety and diminish hope [Lang et al, 2013]. 
‘Disruption to daily life’ encompasses the global impact of HNC on aspects of their 
lives i.e. emotionally, physically and socially; and the sense of losing control, having 
fear and experiencing worry [Lang et al, 2013]. The disruption including the impact of 
symptoms [Molassiotis & Rogers, 2012] e.g. pain [Schaller et al, 2015; Pattison et al, 
2016], mucositis [Kartin et al, 2014], forces patients to adjust and cope with a new 
normality, and life-long disruptions are tangible due to facial disfigurement, continuing 
physical disability, dysfunction (e.g. dysphagia, speech impediment, reduced hearing), 
pain and FOR [Furness et al, 2006; Lang et al, 2013; Ganzer et al, 2015; Nund et al, 
2015; Mortensen et al, 2012].  
 
HNC survivors often describe the theme of ‘the diminished self’, which encompasses 
the losses of identify [Crossley et al, 2003], confidence, self-esteem and self-image as a 
result of the diagnosis and/or treatment of HNC [Lang et al, 2013]. There is guilt for 
acquiring the disease [Bjorkland et al, 2009], stigmatisation [Hu et al, 2009; Mertl et 
al, 2017; Mortensen et al, 2012], and a sense of social rejection by relative/friends due 
to the illness. Their sense of self-esteem is strongly related to the ability to communicate 
i.e. speech and hearing difficulties knock their confidence [Mortensen et al, 2012]. 
Loss of ability to gain pleasure out of life, including eating, hobbies, travelling and 
doing sports and other activities related to loss of strength and fatigue, reduces their 
sense of self and result in withdrawal from social situations [Ganzer et al; 2015; 
Mortensen et al, 2012]. Some patients felt that the loss of enjoyment and inability to 
gain pleasure out of things in life is ‘worse than being dead’ [Mortensen et al, 2012].  
 
Patients also acquire a new identity i.e. cancer patient/survivor, who inhabits the 
unfamiliar and disorientating hospitals, where there is a feeling of vulnerability. 
Returning to work is one way of re-structuring the disruption of their normality and also 
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reinforces their sense of identity [Issakson et al, 2016; Dewa et al, 2017]. However, 
anxieties about returning to work were also expressed including the fear of accidentally 
spitting at others during speech, and the inability to communicate effectively 
[Mortensen et al, 2012].  
 
Despite the difficulties, patients describe ‘making sense of the experience’ as a core 
experience of HNC, and these are the continual attempts to understand their cancer and 
what is happening to them. This results in acquiring new beliefs about their disease, 
experiencing fear and developing expectations, re-assessing their life priorities, and 
striving to manage the uncertainties inherent to the disease henceforth [Lang et al, 
2013]. This theme is reflected in how some patients managed xerostomia, where they 
had to find their own solutions for their problems when they perceived help from 
professionals were not forthcoming [Jiang et al, 2017]. This was also seen in patients 
who were making sense of their HPV-positive status, by understanding its impact on 
their partners [Baxi et al, 2013] and in reducing the stigmatization of HNC as being a 
‘lifestyle disease’ [Mortensen et al, 2012].  
 
As a way of coping with the disease, HNC patients seek emotional and practical support 
by developing supportive connections with their immediate circle of family/friends, and 
also from a wider network of people, including health care professionals, support groups 
and others through the internet i.e. ‘sharing the burden’ [Lang et al, 2013]. Lang et al 
[2013] notes that in the relationship with healthcare professionals, ‘patients have a great 
need to feel acknowledged, both as a person and as one who is suffering i.e. to have 
their suffering recognised, but patients are selective about what they disclose and seek 
help for, and often hide their distress, e.g. downplaying the difficulties of coping with 
treatment side effects’ (page 2657).  In this sense, it is critical that the relationship with 
healthcare professional is one that instills hope, maintains self-worth and counteracts the 
vulnerability [Lang et al, 2013]. Laryngectomy patients describe having digital based-
communication adjuncts e.g. instant messaging, email, web-based support groups and 
video messaging helps their communication and ability to gain psychosocial support 
[Dooke et al, 2012]. At the end of treatment or the secondary surveillance period, some 
HNC patients experience a sense of aloneness in managing their everyday life with the 
loss of regular contact with the healthcare professional [Lang et al, 2013]. Some 
patients are not able to process their new normality and resort to negative coping 
strategies, e.g. drinking alcohol. Failure to regain former intimacy in relationships has 
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resulted in divorce [Mortensen et al, 2012]. 
  
The core theme of ‘Finding a path’ relates to the patient’s reflection of life beyond the 
diagnosis and/or treatment of HNC, where the future is often viewed as changed or 
diminished [Lang et al, 2013]. In this respect, a range of responses are reported 
including, focusing on the present i.e. ‘living in the here and now’ [Bjorkland et al, 
2009]; adaptation to a new normality; acceptance of their mortality [Chou et al, 2007]; 
meaning- and benefit-finding [Chou et al, 2007; Thambyrajah et al, 2010]; adoption 
of a ‘battling’ attitude, i.e. fighting the cancer, not giving into the disease, rejection of 
the victim complex; changing to a more positive lifestyle i.e. exercise, better eating, 
cessation of risk habits and turning to religion/spiritual practices [Chou et al, 2007; 
Agrawal et al, 2010]. The bitter-sweet experience of HNC among survivors has also 
been described as ‘a blessing and a curse’, where the experience entails a deeper 
positive change from within to enable them to move forward n their lives [Swore-
Fletcher et al, 2012]. Making new meanings of being in the world after HNC is 
important in patients’ sense of being human [Roing et al, 2009].  
 
3.4. Stages of HNC survivorship 
 
Based on the derived evidence discussed in the preceding sections of this chapter, a 
summary of key issues faced by HNC survivors based on specific phases of 
survivorship is presented. 
 
3.4.1. At diagnosis 
 
HNC and their caregivers may already be experiencing a multitude of symptoms related 
to HNC (e.g. pain, altered sensation, weight loss, trismus) and dysfunction (e.g. 
swallowing and speech difficulties). Furthermore, there maybe significant lifestyle 
issues that impact on comorbidity, and socioeconomic issues that predispose these 
patients to more advanced disease and poorer outcomes.  
 
With confirmation of diagnosis, HNC survivors will experience significant 
psychological distress, particularly anxiety, worry and depression [Chen et al, 2009A; 
Chen et al, 2010]. This will impact on their immediate family. The cancer diagnosis 
will be considered a threat to their survival and they seek quick solutions to overcome 
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this.  Treatment decision-making will require patients to handle complex information, 
which may be difficult in patients from low socioeconomic background. Multiple 
hospital visits for various assessments, including dental and medical status, can impact 
upon their work and finances.   
 
3.4.2. Peritreatment 
 
The phase during treatment can be an extremely challenging time for HNC patients and 
is when the need for supportive care is greatest [Chen et al, 2009C; Oskam et al, 
2013]. During treatment, patient and their caregivers continue to experience significant 
levels of distress, where the severity of distress may increase as active treatment 
progresses. Coping with treatment side-effects and worrying about the cancer response 
to treatment contributes to this distress. Loss of self through permanent changes to their 
facial appearance, the inability to speak and swallow normally can be significantly 
distressing. Sleep deprivation, inability to swallow normal food, loss of appetite and the 
systemic side-effects of chemoradiotherapy can result in fatigue, and depression. 
Prolonged hospitalisation can occur after surgery. This can occur due to the 
combination of the surgical complications, poor wound healing, patient comorbidities, 
and social circumstances where safe discharge cannot be guaranteed. At discharge, 
patients and their caregivers can be overwhelmed by the huge amount of information 
given regarding after-care.  It is not uncommon for overall QOL and HRQOL scores to 
be at the lowest point during this time.  
 
3.4.3. Posttreatment 
 
Patients and their caregivers are not always able to imagine the potential impact of post-
treatment changes, and may be under-prepared at this stage, which can be the longest 
phase during survivorship. Post-treatment HNC patients report varying levels of distress 
but most feel moderate to severe distress [Chen et al, 2009A; Chen et al, 2009B; 
Henry et al, 2014; Wells et al, 2015]. However, distress may be brought about by 
different things to different people, and it is critical that distress screening and holistic 
assessments are done repeatedly as appropriate during this long phase of survivorship.  
 
Many will experience unmet needs, where the highest unmet needs are psychological 
[Henry et al, 2014]. They will also experience reduction in physical functioning of 
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activities of daily living, where pain is a limiting factor towards physical rehabilitation, 
sleep and recovery [Chen et al, 2011]. Commonly reported problems were FOR, 
eating/chewing, dental health, fatigue and pain but overall, there were diverse concerns 
[Rogers et al, 2009; Wells et al, 2015]. Chen et al [2009A] reported high levels of 
unmet needs in the following needs domains: psychological, physical and daily living, 
health system/informational and patient care and support needs i.e. needs related to 
health care providers showing sensitivity to physical and emotional needs, privacy and 
choices. The highest level of unmet need was in the "physical and daily living" domain 
[Chen et al, 2009A].  
 
Most concerns and problems are experienced keenly in the first two years of post-
treatment survivorship. It is also the critical period where HNC recurrence frequently 
occurs. Regular surveillance for recurrence is as important as holistic assessments to 
support HNC patients. Addressing FOR is a very important aspect during this phase, 
and different interventions may be considered depending upon the severity of FOR.  
 
Addressing lifestyle issues and global rehabilitation (i.e. psychological, physical and 
functional) are key issues during this phase. Nutritional assessments alongside 
swallowing evaluation and therapy are critical in the months after treatment completion. 
Patients may need to undergo smaller scale surgery as part of their rehabilitation. 
Supporting caregivers in their attempts to assist in HNC patients’ after-care is 
important, particularly with information and education about diet, care of wounds/tubes, 
lifestyle choices. Supporting caregivers’ psychological needs is also vital.  
 
Supporting patients in returning to employment after treatment is important for their 
self-esteem and overall QOL, especially in the younger group. Financial difficulties can 
be an important issue for those having to pay for their treatment, the retired patient, and 
in caregivers who may have a reduced capacity to work due to their caregiving 
commitments. Involvement in HNC patient support groups may be beneficial to many 
patients, particularly laryngectomy patients.  Patients need to be informed and 
counselled about the poor quality of information on HNC available on the world-wide 
web.  
 
3.4.4. Long-term follow up 
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With time, the need for supportive care gradually changes, and the emphasis moves 
toward wellness. The perceived need for supportive care is higher at the time of 
treatment compared with at long-term follow-up [Oskam et al, 2013]. Long-term HNC 
patients and their carers report low levels of unmet need, where the highest needs 
remained in the emotional domain [Balfe et al, 2016]. Interestingly, the supportive 
needs of the carer may become more conspicuous at long-term follow up [Balfe et al, 
2016]. Qualitative studies indicate that the quantity and quality of concerns recedes with 
time [Mortensen et al, 2012] as patient cope and transition into their new normality. 
Self-management may be appropriate in this group of patients who may be discharged 
from routine follow up at 5-years post-treatment. However, FOR can remain a persistent 
problem in some patients.   
 
Long-term side effects of radiation, particularly ORN and oesophageal strictures, can be 
a feature of long-term survivorship. While many would advocate conservative treatment 
in addressing these conditions, surgery may still be undertaken as a last resort to 
overcome significant HRQOL issues related to these conditions.  
 
3.4.5. End of life 
 
A substantial proportion of HNC patients will succumb to their disease, and the end of 
life phase in their journey presents with unique challenges for care. Some of the newly 
diagnosed HNC patients will not receive radical treatment because they have either 
declined treatment, or are unable to receive radical treatment due to a combination of 
having advanced disease, significant comorbidity, poor performance status and 
advanced age. These patients go on to receive best supportive care.  
 
Kowalski & Carvahlo [2000] documented the natural progression of HNC in those 
receiving best supportive care until their death, and observes that half of untreated HNC 
patients will die within 4 months of their diagnosis, but some patients survived up to 4 
years. The majority of HNC patients who died of their disease show gradual 
deterioration over the months, and may suffer from various physical and psychological 
distresses with a completely compos mentis state [Roland & Bradley, 2014]. 
 
General principles of palliative care apply to HNC patients, where there is emphasis on 
alleviating pain, symptom control and enabling patients to live with dignity, respect and 
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QOL [Sestherhan et al, 2008]. Other than pain, the other symptoms experienced by 
HNC include nausea/vomiting, constipation, weight loss, psychological problems (i.e. 
anxiety, anger, withdrawal), ‘acute confusional state’, and fatigue [Cocks et al, 2017; 
Roland & Bradley, 2014]. Specific issues relating to HNC patients can include airway 
obstruction/stridor, dysphagia, communication issues (i.e. speech and hearing issues), 
oral problems (e.g. candidiasis, dry mouth, oral ulcers), nasal obstruction and facial 
nerve palsy causing weepy eyes, corneal abrasion and facial droopiness [Goldstein et 
al, 2008]. The presence of a trachestomy tube, feeding tube and maxillary obturator may 
be in place to deal with these issues.  
 
Care of the oral cavity and the palliative HNC patient’s oral health are important 
considerations of caregivers [Ezenwa et al, 2016]. HNC patients with inoperable 
recurrences can result in fungating wounds that can be malodorous, and create an 
orocutaneous fistula that is accompanied by salivary leak.  Furthermore, recurrences in 
the neck can erode surrounding structures and predispose to a catastrophic hemorrhage 
via carotid artery blow out. Involvement of a multidisciplinary team, in particular, the 
palliative care professionals, can assist in undertaking holistic assessment and provide a 
suitable palliative care plan [Cocks et al, 2016].  
 
In some instances, palliative surgery and/or radiotherapy are appropriate [Cocks et al, 
2017]. Roland & Bradley [2014] list the most common reasons for undertaking 
palliative surgery, namely, nutritional support i.e. placement of gastrostomy tube; 
debulking of tumour; and placement of tracheostomy. Other reasons include closure of 
fistula, arresting haemorrhage, palliative embolization, photodynamic therapy, nerve 
ablation for pain control and tarsorrhaphy for corneal protection. Palliative radiotherapy 
is appropriate for local pain control and for painful bone metastasis [Cocks et al, 2017].  
 
Patient and family involvement is critical in making decisions about the on-going 
management of symptoms/problems and in undertaking palliative surgery/radiotherapy. 
The overriding concern is maintenance of patient dignity, honouring the wishes of 
family and there is an emphasis in creating full understanding of all parties involved as 
to what the goals of treatment are at all times [Sciubba, 2016]. ‘Do not attempt 
cardiopulmonary resuscitation’ orders/code should be completed and discussed with the 
patient and/or family [Cocks et al, 2017].   At this stage, family members prefer full 
patient involvement in decision-making, but this may not always be the patients’ point 
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of view, which is divided among those wanting autonomy and those wanting passive 
acceptance [O’sullivan & Higginson, 2016].  
 
Because of the uncertainty of death even in the palliative stage, this phase may be 
prolonged i.e. months rather than days in some patients. The main concerns of the 
patients at this stage were caregiver burden and symptom control [O’Sullivan & 
Higginson, 2016]. However, many also suffer from psychological distress, ranging 
from anger, anxiety, depression and mood disturbances, which are related significantly 
to existential issues. Existential distress is common among cancer survivors at the end 
of life [Peteet & Balboni, 2013]. According to Sciubba [2016], addressing the 
psychosocial and spiritual needs is necessary in the preparation for death as to make a 
"good death".  
 
A significant change in circumstances in this survivorship phase is the stage where 
patients’ stable condition deteriorates, which may signify the closeness to death. The 
ideal scenario at the terminal point of their life is for patients to receive a ‘good death’. 
This is defined as death that is pain-free, peaceful, and dignified, at a place of choosing 
with the relatives present and without futile heroic interventions [Cohen et al, 2001]. 
The choice of place of death is an important aspect for consideration, although not much 
is known about the preferences of HNC patients. Only one study of HNC patient 
preference for end of life care is available in a Taiwanese cohort, where the preference 
to die at home or in the hospice was more common among males, those who reside in 
the capital city, and those who had received opioids [Kuo et al, 2017]. 
 
Some patients’ and their family’s preference is to meet death at the hospice. The most 
common symptoms of HNC patients admitted to the hospice were weight loss, followed 
by pain, cough, dysphagia, difficulties with feeding and communication [Lin et al, 
2011]. Changes to pain symptom control can result in change to morphine dosage, 
where this correlated with survival time after hospice admission [Lin et al, 2011]. At 
the terminal stage, patients exhibit restlessness, followed by somnolence and 
irreversible coma. This can be distressing for caregivers, family and some hospital 
nursing staff, who are not accustomed to caring for dying patients [Sasterham et al, 
2008].  
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However, the reality of HNC death is far from ideal. In Taiwan, the majority of HNC 
patients die in hospital [Kou et al, 2017]. In a UK-based study of the deaths of HNC 
patients over a time period, most died in an acute HNC ward, and the reason suggested 
for this is because the deterioration occurred unexpectedly and rapidly, and the hospital 
seemed to be the most appropriate place to address their complex care needs 
[Kamisetty et al, 2014]. In another UK study, only 22% of patients had family 
members present at the time of death, and 35% did not have their resuscitation status 
documented [Ethunandan et al, 2005]. 
 
3.5. Conclusions 
 
 
This chapter summarises the key issues HNC patients experience during their 
survivorship. In this journey, patients suffer significantly as a result of the disease and 
its treatment in many areas of their lives. Patients will journey through different stages 
of survivorship with the passage of time and may experience an abrupt change in their 
journey with a change in their disease status.  
 
A review of the current HRQOL-related literature highlighted minor gaps in knowledge 
of the key issues experienced by HNC survivors, where more recent evidence focused 
on several new issues, e.g. sleeping, breathing, taste, smell, and self-management. 
Qualitative studies of patients’ lived experience with HNC provided a different albeit 
valuable insight into their survivorship journey.  
 
The review undertaken in this chapter allowed consolidated of new and existing 
evidence into a broad knowledge base of the key issues experienced by patients and 
their carers in HNC survivorship that is current. This can facilitate the thematic 
framework approach during the assessment of patient concerns during consultation in 
this study.   
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CHAPTER 4 
 
4.0.  MD STUDY OVERVIEW 
 
This chapter presents the background of the MD study, including the rationale for the 
MD study, its conception, aims, and structure. The MD study is made up of 3 separate 
empirical studies i.e. the Main study and 2 other empirical studies that were undertaken 
to support the Main study.  
 
A summary of each section/study is presented in this chapter, so as to provide a general 
overview of the MD work, and the flow of the work undertaken (Table 4.1). In 
addition, the patient-reported outcome measures that were commonly employed in the 3 
empirical studies are also introduced in this chapter.  
 
4.1.  Background of the MD study 
4.1.1.  Rationale for the MD study 
 
At the time this study was formulated circa October 2010, published HN-PCI 
data were limited to the original paper describing the PRO in August 2009 
[Rogers et al, 2009A]. In this exploratory work, Rogers et al [2009A] the 
presented data consisting only of self-reported patients’ concerns and self-
selection of health care professionals patients wanted to speak to. This paper 
concluded that the HN-PCI ‘helps focus the consultation onto patients’ need’ 
even though there were no empirical data to support this other than comments 
obtained from patient feedback.    
 
In addition, this pilot study data were obtained from the practice of one 
individual doctor from one surgical specialty within a single HNC unit. 
Evidence to suggest that the HN-PCI could be used and applied extensively was 
lacking. Consequently, the reported success of HN-PCI in identifying patients’ 
concerns could arguably be related to the enabling character of that doctor or to 
the characteristics of a specific patient cohort, rather than the instrument per se.  
Finally, Rogers et al [2009A] concluded with a recommendation for 
‘undertaking a ‘roll-out’ study involving other doctors in HNC clinics’.  
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4.1.2.  Conception of the MD study  
  
This study was primarily designed to evaluate the operationality of the HN-PCI 
as a PRO in helping to identify patients’ concerns in subjects (patients and 
doctors) who are unfamiliar with the tool. The main question asked was: “Can 
the HN-PCI be used by other doctors and patients in other HNC clinics to help 
disclose patients’ concerns?” 
 
According to Fung and Hayes’ [2008] framework for PROs (section 2.5.5.1), 
PROs help to identify patients’ needs and concerns during patient—doctor 
encounters. If patients reveal their concerns by using the PRO, this indicates that 
the PRO is able to identify their concerns, and this could be measured by 
quantifying the number and type of concerns identified by the PRO used. This 
method of quantifying self-reported concerns’ via PROs has been established in 
other like studies [Heaven & McGuire, 1998; Parker et al, 2005] as well as the 
original HN-PCI study [Rogers et al, 2009A].  
 
Another question of research interest suggested by the original paper [Rogers et 
al, 2009A] was: “Does the HN-PCI help focus the consultation to patients’ 
need?” 
 
Feldman-Stewart et al [2005] model considers the interaction between the 
patient and the clinician as a two-way exchange of conveying and interpreting 
messages (section 2.5.5.1; Figure 2.4).  Based on this model, the HN-PCI may 
fulfill an enabling role by bringing up or focusing on the patients’ agenda i.e. 
their concerns during the consultation. It was postulated that if the HN-PCI can 
facilitate a more patients concern focused consultation, this may be reflected by 
a corresponding increase in the quantity of predisclosed items (i.e. self-selected 
on HN-PCI before the consultation) discussed during the consultation. It may be 
possible to examine this association by quantifying the number and type of 
concerns that patients and doctors discuss in consultation provided that the 
method of evaluation is robust and standardised, and comparing this with the 
self-reported items.  
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The term ‘discussion of concern’ during consultation needs clarifying. 
‘Discussion of a concern’ during consultation may be considered as a ‘two-way 
exchange of conveying and interpreting messages’ suggested by Feldman-
Stewart et al [2005]. It was recognised and acknowledged that the quality of the 
‘discussion’ about the items of concern can vary considerably due to the 
influence of other factors e.g. patient-related factors, doctor-related factors, and 
environmental factors. This study was not designed to evaluate how the HN-PCI 
could influence the quality of the patient-doctor communication that occurred 
during consultations. This study was not intended to assess patient-doctor 
communication i.e. the behavioural and observational components through 
analysis of the recorded medical encounter for the purpose of coding behaviour 
using recognised observational instruments with respect to task and 
socioemotional behaviours [Ha & Longnecker, 2010].   
 
Having identified patients’ concerns, secondary evaluation can be undertaken to 
test the associations of other variables with patients’ concerns, and also the 
impact of patients’ concerns on distress, length of consultations, clinic outputs, 
QOL status and patient satisfaction with the consultation.  
 
4.2.  Aims of the MD study 
 
4.2.1.  Primary Aim  
 
The primary aim of this study was to evaluate the feasibility of using the HN-
PCI in identifying the concerns of patients who were unfamiliar with the 
instrument in a multicenter setting, by measuring the number and type of self-
reported concerns, and the concerns that were discussed during consultations.  
 
In this study, a patient’s ‘concern’ was defined as ‘‘a patient generated issue of 
current importance’’ [Heaven & McGuire, 1998]. In terms of ‘current 
importance’, this study defines ‘currency’ as any concern that is raised by 
patients on the day of consultation, either by self-reporting on HN-PCI or by 
discussion with doctor during consultation.  
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The definition of patient’s concern adopted in this study is meant to provide a 
broad understanding of issues that are highlighted by patients and/or discussed 
during their visit. This definition does not consider a ‘concern’ as inherently 
emotively negative or positive, other than how it is experienced and expressed 
by the patient on the day of consultation.  
 
4.2.2.  Secondary Aims  
 
4.2.2.1. Undertake qualitative analysis using a thematic framework approach and 
content analysis to facilitate robust data collection and analysis for scoring 
patients’ concerns and other outcome measures in the transcribed recordings of 
consultation;  
 
4.2.2.2. Develop domains for the HN-PCI; 
 
4.2.2.3. Evaluate the relationship between patients’ concerns with distress; 
 
4.2.2.2. Test the associations between clinicopathological factors with patients’ 
concerns;  
 
4.2.2.3. Determine the impact of HN-PCI intervention on outcomes of the 
consultation/encounter/visit i.e. length of consultation, patient satisfaction with 
consultation, clinic outputs, and HRQOL;  
 
4.2.2.4. Determine the impact of the HN-PCI intervention on the content of the 
consultation.  
 
 
4.3.  Outline of the MD study 
 
The MD work consists of 3 individual studies, which were undertaken in a time-line in 
the order shown: 
a. Pilot study 
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b. HN-PCI Domain Generation  
c. Main study 
 
The Pilot and Domain Generation studies were undertaken prior to the Main study to 
facilitate the latter.  A summary of each study is presented in the next sections of this 
chapter. A summary of the Main study methodology is presented first to enable the Pilot 
and the Domain generation studies to be understood in context. More detailed 
descriptions of each study are found in Chapters 5, 6 and 7.    
 
4.4.  Main study: A Summary of the Methodology 
 
Subjects:   A cohort consisting of four surgeons from two different surgical 
specialties working in two different centres, and their patients, who were unfamiliar 
with the HN-PCI, were recruited to the study.  
 
Study design:   A prospective, non-randomised study was planned and 
undertaken in 3 successive stages/blocks. The first block represented the ‘control’ 
group, where the HN-PCI was not used at all, and provided a baseline understanding of 
normal practice.  The second block represented the ‘control in attention’ group, where 
patients completed the HN-PCI but the information was not available to the doctor 
during consultation. The third block represented the ‘intervention’ group, where patients 
completed the HN-PCI and both doctors and patients were able to access the 
information during consultation.  
 
Data collected:  The main data collected i.e. patients’ concerns, consisted of those 
provided by the patients through self-completion of HN-PCI, and also from the data 
derived during consultations, which were audiorecorded, transcribed and evaluated 
using a qualitative methodology. Other data collected were clinicopathological 
information, consultation length, and other PRO data.  
 
Statistical analysis:  The main statistical analysis was undertaken to determine the 
number and types of concerns identified and discussed. Associated analyses were 
undertaken to evaluate the secondary aims of the study i.e. relationships between 
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patients’ concerns and other variables including clinicopathological data, length of 
consultation, clinic outputs, distress, HRQOL and patient satisfaction scores.   
 
4.5.  Overview of the Pilot Study 
 
Rationale:  Data about patients’ concerns that were discussed during consultations 
reported in previous HN-PCI studies relied upon the evaluation by a single assessor who 
was present during the consultation. This method is unreliable as it depends upon the 
interpretation of one individual only, and it is neither reproducible nor standardised.  
 
To address this problem, the Main study design selected a more rigorous method of data 
collection and evaluation by adopting a qualitative method of assessment. This method 
involves audiorecording and transcribing the consultations, and having two independent 
assessors evaluate the transcribed consultations using a thematic framework approach. 
 
Aim:   The primary aim of the Pilot study was to test the feasibility of the 
method of data collection and data evaluation planned for the Main study. This includes 
a trial of the audiorecording equipment and the process of audiorecording, testing the 
logistics of questionnaire administration and its return, and the development of a robust 
and reliable way of scoring the items discussed during consultation through a thematic 
framework approach and content analysis.  
 
Methodology: The subjects (patients and doctor) recruited to this study were from a 
convenience sample familiar with the HN-PCI. The Pilot study design was based the 
Block 3 ‘intervention’ part of the Main study, where patients completed the HN-PCI 
before consultation and both patients and the doctor were able to access the information 
during consultation.  
 
Patients filled in the HN-PCI (version 2), as well as all the other PROs planned for the 
Main study, before their consultations. Their consultations were audiorecorded, and 
transcribed. Patients were also given the post-consultation PROs to be used during the 
Main study for completion. Two assessors (including an experienced qualitative 
researcher) individually evaluated the transcribed consultation based on a thematic 
framework approach, and the level of agreement was determined to maintain scientific 
rigour.  
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Significant results impacting on Main study:  The thematic framework approach 
and content analysis in assessing patients’ concerns during consultation was feasible, 
and assessors showed very good levels of agreement. Two new items of patients’ 
concern were identified during the Pilot study. These were incorporated into the HN-
PCI (version 2), creating the HN-PCI (version 3) with 57 items of concern and 15 
professionals (Appendix 4). 
 
4.6. Overview of the Domain Generation study 
 
Rationale:   The holistic nature of the HN-PCI ensures that the total number of the 
items of concerns listed is relatively high (range, 55-57 items). This presents a technical 
difficulty in undertaking statistical analyses; particularly when addressing the secondary 
aims of the Main study i.e. to explore associations between patients’ concerns and other 
variables.   The study would require a significant number of recruited patients if 
individual HN-PCI items were considered as a single variable during statistical 
analyses, which would not be achievable in the timeframe set out for the MD work.  
 
Having domains, where related items of concern are grouped together, can permit a 
more systematic method of summarising HN-PCI findings. It can facilitate comparative 
evaluations, and helps to construct an overall picture of the inter-relationship of various 
concerns in a defined cohort.  
 
Aim:   The primary aim of this study was to group related items of concern 
listed in the HN-PCI into domains, so as to facilitate statistical analysis of the Main 
study. This is particularly relevant when exploring the possible associations between 
patients’ concerns and other variables.   
 
Methodology: A Delphi approach was undertaken by a group of 10 healthcare 
professionals involved in the care of HNC patients who formed a convenience sample. 
Several rounds of consultation by this group suggested domains and groupings for the 
HN-PCI items.  Moderation by the researcher finalised these into the accepted domains.  
 
Significant results impacting on Main study:  Five domains were generated for 
HN-PCI (version 3). These domains were not used in the HN-PCI questionnaire 
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administered to patients during the Main study. The domain groupings were only used 
during statistical analysis of the Main study results.  
 
4.7.  Patient-Reported Outcome Measures used in the MD study 
 
4.7.1. Head & Neck Patient Concerns Inventory (HN-PCI) 
 
The HN-PCI was the intervention evaluated in this study.  The HN-PCI (version 
2) containing 55 items of concerns and 15 professionals was used in the Pilot 
study.  
 
At the conclusion of the Pilot study, two additional items of concern were 
identified and these were incorporated into the HN-PCI (version 2). The new 
checklist i.e. HN-PCI (version 3) contained 57 items of concern and 15 
professionals. The HN-PCI (version 3) was subsequently used in the domain 
generation exercise and also in the main study (Appendix 4).  
 
4.7.2.  University of Washington Quality of Life, version 4 (UWQOL) 
 
The UWQOL is a validated HRQOL questionnaire (Appendix 8) [Hassan & 
Weymuller, 1998; Rogers et al, 2002].
 
The UWQOL comprises 12 domains, 
scaled from 0 (worst) to 100 (best) according to the hierarchy of response.  
 
The UWQOL has two subscale composite scores
 i.e. ‘Physical function’ and 
‘Social-emotional function’ and a single six-point ‘overall’ QOL measure 
[Rogers et al, 2010].  ‘Physical function’ is the simple average of the 
swallowing, chewing, speech, saliva, taste and appearance domain scores whilst 
‘Social-emotional function’ is the simple average of the activity, recreation, 
pain, mood, anxiety and shoulder domains. In regard to the single item overall 
QOL scale, respondents were asked to consider not only physical & mental  
health, but also other factors, such as family, friends, spirituality or personal 
leisure activities important to their enjoyment of life.   
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To allow incorporation of UWQOL into routine clinical practice viz. screening 
for dysfunction, a ‘significant problem’ was considered present in a particular 
UWQOL domain when it fulfills either of the following criteria: (1) scores 
beyond a cut-off point specified in a domain,  (2) (for some domains only) a 
score adjacent to the cut-off and respondents indicating the particular domain as 
being important during the previous week [Rogers & Lowe, 2009B]. This is 
detailed in the Table 4.2 
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Table 4.1. Summary of MD study. The 3 empirical studies (Main study, Pilot study, Domain generation study) are shown in context of the aims of the 
overall MD study  
    
 Where is this 
addressed? 
Method PROs used Outcomes 
OVERALL MD STUDY:   
Primary Aim  
1. To evaluate the feasibility of using the 
HN-PCI in identifying the concerns of 
patients’ who were unfamiliar with the 
instrument in a multicenter setting, by 
measuring the number and type of self-
reported concerns, and the concerns that 
were discussed during consultations. 
 
Main study Prospective, non-
randomised study composed 
of 3 successive study 
blocks: Blk 1 “control”; Blk 
2 “control in attention”; Blk 
3 “HN-PCI v3 
intervention”. All 
consultations were recorded 
and transcribed. 
At pre-consultation: 
Blocks 1: 
UWQOLv4; DT 
Blocks 2 and 3: 
UWQOLv4; DT;  
HN-PCI v3 
 
Post-consultation: 
PROC; DT; PSQ-MD 
Described in Chapter 7 
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 Where is this 
addressed? 
Method PROs used Outcomes 
OVERALL MD STUDY:  
Secondary Aims  
1. Undertake qualitative analysis using a 
thematic framework approach and 
content analysis to facilitate robust data 
collection and analysis for Main study 
Pilot study 
 
Undertaken 
before the 
Main study 
Prospective study based on 
Block 3 of Main study. 
Convenience sample of 
surgeon and patients 
familiar with HN-PCI. 
PROs are completed before 
and after consultations. 
Consultations recorded and 
transcribed. Qualitative 
analysis of transcriptions.  
At pre-
consultation: 
UWQOLv4; DT;  
HN-PCI v2 
Post-consultation: 
PROC; DT; PSQ-
MD 
 
Described in Chapter 5. 
 
1. Successful trial of audiorecording equipment 
and transcription 
2. Development of thematic framework 
approach and content analysis to evaluate 
transcribed consultation 
3. Development of HN-PCI v3 
 
2. Develop domains for the HN-PCI  Domain 
generation 
study 
 
Undertaken 
before the 
Main study 
Delphi method. 
Convenience sample of 10 
health care professionals, 
moderated by researcher. 3 
rounds of consultations, 
level of agreement set to 
>70%.  
 
HN-PCI v3 Described in Chapter 6. 
Developed 5 domains for HN-PCI v3 i.e.  
(A) Physical & functional well-being; (B) Social 
care/Social well-being, (C) Psychological & 
Emotional well-being /Spirituality; (D) 
Treatment-related; and (E) Others. This is used 
in the analysis of results of the Main study.  
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 Where is this 
addressed? 
Method PROs used Outcomes 
3. Evaluate the relationship between 
HN-PCI data and levels of self-
reported distress. 
 
Main study Statistical analysis of 
variable 
HN-PCI v3; DT; 
UWQOL 
Described in Chapter 7 
4. Test the associations between 
clinicopathological factors with 
patients’ concerns identified by the 
HN-PCI intervention. 
 
Main study Statistical analysis of 
variables 
 Described in Chapter 7 
5. Determine the impact of HN-PCI 
intervention on outcomes i.e. length 
of consultation, patient satisfaction 
with consultation, clinic outputs, and 
HRQOL. 
 
Main study Compare ‘Control’ group 
with HN-PCI intervention 
groups 
 
 Described in Chapter 7 
6. Determine the impact of the HN-PCI 
intervention on content of 
consultation. 
Main study Compare the self-reported 
concerns with the concerns 
discussed during in the HN-
PCI intervention groups.  
 Described in Chapter 7 
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Table 4.2. UWQOL criteria for ‘significant problem’ [Rogers & Lowe, 2009B].  
 
UWQOL domain Score Score + importance 
Pain 0, 25 50 + importance 
Appearance 0, 25 50 + importance 
Activity 0, 25 50 + importance 
Recreation 0, 25 50 + importance 
Swallowing  0, 30  
Chewing 0  
Speech 0, 30  
Shoulder 0 30 + importance 
Taste 0 30 + importance 
Saliva 0 30 + importance 
Mood 0, 25 50 + importance 
Anxiety 0 or 30  
 
The UWQOL has been validated against several established patient-reported 
outcome measures [Pusic et al, 2007]. It showed good correlation with the 
European Organization for Research and Teaching Centre global Quality of Life 
(EORTC QLQC-30) and the HN subsite-specific questionnaire (H&N-35). 
Against the Sickness Impact Profile and Karnofsky scale, UWQOL showed high 
reliability, validity, responsiveness and acceptability. Internal consistency 
reliability demonstrated Cronbach alpha > 0.7; and intrarater test-retest 
reliability was > 0.8 in all domains [Pusic et al, 2007].  
 
 
4.7.3.   Distress thermometer (DT) 
 
The DT is a single item self-report measure of distress [Roth et al, 1998] 
(Appendix 9). Since its introduction, the DT has been used worldwide 
[Donovan et al, 2014] both routinely in clinical practice and in research to 
detect significant distress in various types of cancer diagnoses [Jacobsen et al, 
2005; Kier et al, 2008; Hegel et al, 2006; Patrick-Miller et al, 2004; Hegel et 
al, 2008]. It is scaled from 0 (no distress) to 10 (severe distress) in a 
thermometer layout to rate the level of distress experienced.  
 
As a short screening tool for measuring distress, the DT has been validated 
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against established tools, where suitable cut-off points were determined using 
the receiver operating curve for optimal sensitivity and specificity. A cut-off DT 
score of ≥ 4 is used to denote level of significant distress as it correlates with 
optimal sensitivity and specificity to the established cut-offs for significant 
distress for the Hospital Anxiety Depression Scale, HADS (sensitivity, 0.77; 
specificity, 0.68) and the Brief Symptom Inventory, BSI-18 (sensitivity & 
specificity, 0.7) in a multisite cancer cohort [Jacobsen et al, 2005]. With a cut-
off score of 4, other studies also found optimal combination of sensitivity and 
specificity against HADS scores [Ozlap et al 2007; Shim et al, 2008] and with 
the EORTC QLQ-C30 [Ozlap et al, 2007]. In addition, this cut-off is able to 
identify patients reporting elevated levels of physical, emotional, practical, and 
family problems [Donovan et al, 2004; Jacobsen et al, 2004; Kier et al, 2008].  
 
The DT has also been validated for distress screening in the UK [Gessler et al, 
2008] in this large, prospective study. When the DT cut off point was set to 4 vs 
5, the sensitivity against HADS was 79%, specificity 81%; against General 
Health Questionnaire-12 (GHQ-12,) sensitivity was 63%, specificity 83%; and 
against BSI-18, sensitivity was 88%, specificity74%. 
 
4.7.4.  Princess Margaret Hospital Patient Satisfaction with Physician (PSQ-MD) 
 
The Princess Margaret Hospital Patient Satisfaction with Doctor Questionnaire, 
PSQ-MD is a patient-reported outcome measure used to quantify patient 
satisfaction with a visit-specific consultation [Loblaw et al, 1999] (Appendix 
10). It has been validated for evaluating patient satisfaction with patient-doctor 
consultations in an oncology outpatient setting [Loblaw et al, 2004], with a 
Cronbach α score of 0.94. This 24-item questionnaire is scored using a four-
point Likert-type response. Patients responded to statements from “strongly 
disagree” to “strongly agree,” scoring 1 to 4. For items that elicit negative 
responses, scores are reversed. Each patient’s score is an average of 24 equally 
weighted responses. 
 
4.7.5.  Non-validated patient-reported outcomes of consultation  
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One non-validated questionnaire (Appendix 11) was used after the consultation 
to determine patient’s perception of (a) what their concerns were; (b) the extent 
to which these concerns were addressed; (c) if they were able to see or be 
referred to the professional they had wanted to see; and (d) the degree of 
fulfillment felt by the patient from the consultation. Questions (b) and (d) were 
gauged using a Likert-type scale. The first question was recorded in a free text 
form and question (c) was a binary yes/no response.  
 
 
Ethics approval for the entire MD study was granted from the North West Research 
ethics committee (study reference: 11/H1002/7). The study research ethics application 
including patient information sheet, patient consent form, and letter of research ethics 
approval are located in the Appendix.    All the PROs used in the MD study including 
the versions of the HN-PCI, are also available in the Appendix.  
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CHAPTER 5 
5.0.   PILOT STUDY 
 
5.1.1. Introduction 
A Pilot study was undertaken to test the feasibility of undertaking the Main 
study. This work was published in a peer-reviewed journal [Ghazali et al, 
2013A]. (Appendix 13). 
 
5.2.  Aims of study 
 
5.2.1. Develop a thematic framework approach and content analysis to score 
items discussed during consultations for agreement and standardisation; 
5.2.2. To test the audiorecording equipment, the process of audiorecording 
during consultation and the transcription of recordings;  
5.2.3. To determine and compare the number of items highlighted on the HN-
PCI with those discussed,  
5.2.4. To report the clinical outcomes and satisfaction reported by patients. 
 
5.3.  Material and Method 
 
5.3.1. Subjects 
Patients were prospectively recruited were from those attending routine clinics 
of one OMF surgeon from 1 February to 15 May 2011. The OMF surgeon was 
trained and very familiar with the HN-PCI.  
 
Recruitment to the Pilot study was based on the following criteria: The inclusion 
criteria were (1) diagnosis of HNC; and (2) disease-free survivors who have 
completed primary treatment of at least 6 weeks. The exclusion criteria were (1) 
pre-treatment HNC; (2) HNC patients with palliative status; and (3) non-HNC 
diagnosis.  
 
 
 127 
On the day of appointment, patients were approached for recruitment in the 
waiting area while they were waiting for their appointment. Informed consent 
was formalised using the study consent form (Appendix 7) prior to data 
collection. 
  
5.3.2. Patient-reported outcome measure 
 
The HN-PCI (version 2) was used in this study. There were 55 items of concern 
and 15 professionals on the checklist (Appendix 4). The UWQOL, DT, PSQ-
MD and other PROCs have been described previously in sections 4.7.   
 
5.3.3. Study design 
 
Recruited patients were given the preconsultation PROs to complete before their 
consultation. Patients completed the UWQOL and HN-PCI (version 2) using the 
TST-format. Both questionnaires were written as Microsoft Access-based 
software application packages and were filled in using a touch-screen computer 
linked to the hospital mainframe. After completion, the clinician retrieved a 
summarised report [Rogers et al, 2009]. On one occasion when the touch-screen 
computer was inaccessible (hardware malfunction), 6 paper versions of the 
UWQOL-HN-PCI were used. The complted HN-PCI (version 2) was available 
to both the patient and the doctor during consultation.  
 
The consultation was audiorecorded using a Tascam DR-100 (TEAC UK Ltd., 
Watford, UK) recorder. The handling of the Tascam recorder was undertaken by 
the OMF surgeon.  Audiorecording began at the start of the consultation and 
ends at the completion of the consultation. Each recorded consultation was saved 
on an individual file in MP3 format. 
 
Patients are given the post-consultation questionnares consisting of the DT, 
PROC and the PSQ-MD, along with a stamped-envolope addressed to the 
researcher. Patients were instructed to complete the questionnaires and return 
them within 1 week following their consultation. Patients were contacted by a 
postcard reminder and latterly by a telephone call reminder, if the FU survey 
forms were not received at 2- and 4-weeks respectively, following consultation.  
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5.3.4. Transcription of recorded consultations 
 
All identifiable information relating to the surgeon and patients were removed to 
maintain confidentiality. Only recordings of complete consultations were used 
and transcribed. Transcription was undertaken by medical secretaries at Aintree 
University Hospital. Each transcription was checked for accuracy by researcher 
(NG). 
 
5.3.5. Clinical outcomes 
 
The clinical outcomes measured in this study were: 
 
a.  Clinic outputs: Clinical outputs are the clinical decision or action 
taken related to the consultation, and are broadly considered as medical or non-
medical clinical decisions/actions [Velikova et al, 2004]. Medical actions 
comprised of physical examination, being placed on the waiting list for 
operations to aid rehabilitation, symptomatic or supportive medical treatment, 
investigations, and referrals. Non-medical actions included provision of 
information, advice on lifestyle, strategies for coping, and reassurance.  
 
b.  Length of consultation:  This was measured from the duration of 
audiorecording of each consultation (minutes).  
 
5.3.6. Patient satisfaction 
 
Patient satisfaction was measured using the PROC (including PSQ-MD, and 
non-validated questionnaire). An overall PSQ-MD score is obtained by the sum 
of the individual 24-item scored. (section 4.7.4 and 4.7.5) 
 
5.3.7. Thematic Coding Framework and Content Analysis 
 
The aim of developing the thematic coding framework in this study was to 
create a standardised evaluation of spoken phrases or terms used by patients and 
clinicians during consultation. This method was specifically devised to enable a 
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thematic framework based content analysis of the consultation in relation to the 
outcomes measures of the Main study i.e. patients’ concerns, health care 
professionals, and clinic outputs.   
 
The development of the thematic coding framework [Miles & Huberman, 
1994] involves several steps (Table 5.1). Based on the principles described by 
Miles & Huberman [1994], the process of developing the thematic coding 
framework and content analysis in this study was undertaken as follows:  
   
1. The first stage is “Familiarisation”.  
This involves becoming acquainted and conversant with the themes related 
to patients concerns, health care professionals and clinic outputs, by listening 
to the audiorecordings and reading through the transcripts.  
 
2. The second stage is “Identification of Thematic Framework”.  
This involves formally constructing the individual themes that will make up 
the framework. This is based on existing knowledge or evidence obtained 
through a literature review (Chapter 3) and/or established medical practices. 
For example, some themes could be derived from the HN-PCI checklist, and 
other themes were derived from Chapter 3, while themes surrounding clinic 
outputs were based on accepted conventional practices in oncology. The 
themes were expanded, by providing words or terms that explain or have 
similar meanings within a theme. For example, ‘lethargy’, ‘exhausted’, ‘run 
down’ could be considered individual codes, but were related under the 
theme of ‘Fatigue/Tiredness’.  The thematic framework forms the basis of a 
standardised coding definition.  
 
3. The third stage is “Indexing”.  
This involves both assessors evaluating the transcriptions independently 
using the thematic coding i.e. directed content analysis. The areas of the 
transcription were highlighted in the text, and the corresponding theme is 
annotated in the margin for indexing.  
 
4. The fourth stage is “Charting”.  
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The annotated themes that are indexed are charted to report the findings i.e. a 
list of all the identified themes in the transcription. Both assessors undertook 
this independently.  
 
5. The final stage is “Mapping and Interpretation”.  
This involves tabling and mapping the themes identified to allow better 
understanding of how individual themes relate to one another. This global 
analysis of themes also provided an understanding of how the items of 
concerns were handled during the consultation.  
 
From this exercise, it is possible to ascertain if the item of concern was 
simply mentioned in passing or expanded during the interaction. A concern 
was considered ‘discussed’ when there was evidence of expansion of themes 
or themes inter-relating in the transcription. As indicated in Chapter 4 
(Overview of MD study) section 4.1.2, this content analysis based on a 
thematic framework was not designed to analyse the quality of the patient-
doctor communication.  
 
Once the final stage is undertaken, both assessors meet to evaluate 
agreement for each transcription. This is detailed in the next section 5.3.8. 
Scientific Rigour.  
 
5.3.8.  Scientific Rigour 
 
The reliability of qualitative data analysis i.e. rigour was enhanced with an 
independent assessment of transcripts by an additional skilled qualitative 
researcher (BR) and comparing agreement between raters for agreement of 
themes identified [Mays & Pope, 1995].  
 
When the content analyses of all transcriptions were completed and available, 
assessor agreement was determined, where both raters (NG and BR) evaluated 
every 1 of 4 transcriptions selected randomly.  
 
Assessor agreement was determined as follows. When an item was identified by 
one and missed by the other, it was discussed until resolved. This involved 
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building a holistic picture of the patient or clinician, or both, on which to base 
analysis of the words used, and to identify key ideas and themes that were 
ultimately agreed by both assessors. This is particularly relevant in regard to 
‘item missed’ that were not in the HN-PCI-based framework, which were 
carefully considered for the potential of new codings for addition to the HN-
PCI-based thematic framework. However, for the purpose of this pilot study, 
these items were considered under ‘Others’. The overall level of agreement per 
consultation assessed was derived as a percentage from the formula: number of 
‘item agreed’ / total number of items identified. 
 
This evaluation also enabled formation of an agreed thematic framework, which 
was used by one assessor (NG) to evaluate the remaining number of 
transcriptions included in this study. 
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Table 5.1. The steps undertaken in developing the thematic coding framework and 
content analysis 
 
Step Definition Process undertaken 
1. 
Familiarisation 
The process through which 
the researcher becomes 
familiarised with the datum. 
 
1. Listening to the audio-recordings 
2. Reading through the transcripts 
2. Generating 
codes  
The process of putting tags, 
labels or names against pieces 
of data.  
 
Sorting out descriptive and 
pattern codes.  
 
Develop operational 
definitions for codes based on 
HN-PCI checklist 
 
 
Start codes are listed based on HN-PCI 
checklist.  Pattern codes are generated. 
Test pattern codes against new data. 
Generation of other descriptive codes 
i.e. not on the HN-PCI checklist. 
 
Memoing was also undertaken to record 
ideas and potential relationships of 
codes as they are being analysed.  
 
 
3. Identifying 
themes 
Identification of portions or 
sections of the data that 
correspond to a particular 
theme 
 
 
 
Portions of data representing a theme 
were identified by highlighting this in 
the text, with the corresponding theme 
annotated in the margin for indexing 
purposes. 
 
 
4. 
Construction 
of thematic 
framework 
Indexed data is organised into 
charts i.e. the portions of 
highlighted text are organised 
systematically, to identify the 
best way to report the 
findings. 
 
 
Evaluate how themes support data and 
the overarching theoretical premise. 
 
At this stage, the framework can be 
tentative and open to further changes 
for refinement based on logical and 
intuitive thinking. 
 
5. Integration 
and 
interpretation 
Analysis of key 
characteristics as laid out in 
tables. 
The indexed themes from the 
transcription were tabled according to 
types of themes identified.  
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5.4. Results 
 
63 consultations of 56 patients derived from 6 clinics were eligible for this 
study. 67% (42 consultations) were enrolled whilst 33% (21) were missed. The 
losses resulted from lack of opportunity to recruit during a busy clinic (14/21) 
and refusal to participate (7/21). Those enrolled were on average 5 years 
younger (mean 61.6 versus 66.4 years) at clinic than those missed and in regard 
to primary diagnosis, they had more advanced T-stage (i.e. T3-4) tumours (38% 
versus 15%) but less flap surgery (29% versus 61%); otherwise there were no 
notable differences in the demographic and clinicopathological data.  
 
Of the 42 enrolled consultations of 40 patients, 69% (29) were males, and mean 
(SD) age was 61.6 (11.3) years. The primary diagnosis was SCC for 37. The 
primary tumour site was: oral (28), pharyngeal (11), salivary (2) and skin (1).   
The pathological disease staging was: Stage 1 (14), Stage 2 (12), Stage 3 (8) and 
Stage 4 (8). The primary treatment received was: surgery (34), primary radiation 
and/or chemo-radiotherapy (7), flap surgery as part of treatment (12) and 
adjuvant post-operative radiotherapy (14). The median (IQR) time from first 
diagnosis to study clinic consultation was 22 (10-53) months.  
 
5.4.1. Patient-reported concerns on HN-PCI 
 
HN-PCI data was available from all 42 consultations (TST, 36; paper, 6). The 
mean number of concern and of professionals highlighted on the PCI was 5.52 
and 0.50 respectively, with median (IQR) of 4 (2-8) and 0 (0-1). Almost all 
(88%, 37/42) selected at least one HN-PCI concern whilst a minority (38%, 
16/42) selected at least one healthcare professional. HN-PCI concerns chosen by 
at least 20% were FOR (33%, 14), Dental health/teeth (31%, 13), Swallowing 
(29%, 12), Chewing (26%, 11), Speech/Voice/Being understood (21%, 9), Pain 
in head and neck (21%, 9), and Pain elsewhere (21%, 9). The only healthcare 
professional selected by at least 10% was dentist (21%, 9).  
 
5.4.2. Audiorecordings 
 
Overall, the audiorecording equipment was found to be ‘fit-for-purpose’ after a 
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short learning curve. Recordings were complete in 19 consultations from 42 
consultations (45%). The recordings that were rejected were either due to ‘an 
incomplete recording’ or ‘no recording at all’. The reasons for this were lack of 
consent (12 cases), seeing a different surgeon (5 cases), forgetting to record (3 
cases) and equipment failure (3 cases).  
 
There were some differences between those with audiorecordings and those 
without audiorecodings (Table 5.2). Patients with audiorecordings were 5 years 
younger on average (mean, 59 versus 64 years), and were closer to the time they 
were treated (median, 16 versus 45 months) and fewer had had adjuvant 
postoperative RT (16% Versus 52%). There were no notable differences in 
number of HN-PCI items selected before consultation (median 4, IQR 3-8 versus 
median 4, IQR 1-8) or in the number of HN-PCI health professions selected.   
 
 
 
Table 5.2.  Characteristics of the 19 with consultation audio recorded transcripts and 23 
without transcripts 
  WITH 
TRANSCRIPT 
 
WITHOUT 
TRANSCRIPT 
 
P 
Value
* 
Age Mean (SD) 59 (13) years 64 (9) years 0.14 
 % 65 years & over 32% (6/19) 39% (9/23) 0.85 
Sex % male 58% (11/19) 78% (18/23) 0.28 
pT % 3-4 32% (6/19) 17% (4/23) 0.48 
pN % Positive 42% (8/19) 17% (4/23) 0.16 
pStage % 3-4 47% (9/19) 30% (7/23) 0.42 
Diagnosis % scc 95% (18/19) 83% (19/23) 0.47 
Tumour site % oral 63% (12/19) 70% (16/23) 0.91 
Treatment % surgery 79% (15/19) 83% (19/23) 0.76 
 % flap 21% (4/19) 35% (8/23) 0.52 
 % adjuvant PORT 
/ RND 
16% (3/19) 52% (12/23) 0.03 
Months from 
diagnosis to clinic 
Median (IQR) 16 (8-34) 45 (16-76) 0.02 
# HN-PCI items Median (IQR) 4 (3-8) 4 (1-8) 0.54 
# HN-PCI healthcare 
professionals 
Median (IQR) 0 (0-1) 0 (0-1) 0.16 
UWQOL physical 
function subscale 
score 
Median (IQR) 75 (62-95) 76 (59-88) 0.73 
UWQOL social-
emotional function 
subscale score 
Median (IQR) 83 (53-91) 80 (65-91) 0.89 
 
*t-test (age), chi-squared test with Yates correction or Mann-Whitney test as appropriate 
 
Abbreviations: PORT, postoperative RT; scc: squamous cell carcinoma; RND, radical neck dissection 
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5.4.3. Thematic Content Analysis  
 
The main assessor (NG) reviewed all 19 transcriptions. From these, 5 
transcriptions were randomly selected to assure scientific rigour independently 
by two assessors (NG and BR) (Table 5.3).  The rate of overall rate of 
agreement between the main assessor (NG) and second assessor (BR) was 
80.2%.  
 
The thematic content analysis in this study identified potentially new themes for 
coding including themes of ‘well-being’, ‘dizziness’, ‘skin rash’ and ‘further 
surveillance’. 
 
 
 
Table 5.3. Thematic content analysis and level of agreement between 2 
assessors.  
 
 Consultations SUM 
1-5 1 2 3 4 5 
Total number of items 17 15 14 15 20 81 
Missed items 2 4 2 4 1 13 
Change definition of coding 1 1 1 0 0 3 
Agreement 14 10 11 11 19 65 
Percentage agreement 82.3% 66.7% 78.5% 73.3% 95.0% 80.2% 
 
 
 
5.4.4. Clinical outcomes  
 
The median length of consultation analyed by audiorecording was 8.4 minutes 
(IQR, 5.6-10.3 minutes).  
 
In terms of clinic output, the median number of clinical decisions/actions taken 
during consultations was 2.8 (range, 2-5). Non-intervention action was the 
predominant decision made with ‘further surveillance appointment’, ‘provision 
of information’ and ‘reassurance’ being the most common action taken. Onward 
referrals occurred in only 2/19 (11%) consultations.    
 
5.4.5. Comparison of self-reported data with those discussed 
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The mean number of items of concern and professionals highlighted on the HN-
PCI was 5.95 and 0.74 respectively, with median IQR of 4 (3-8) and 0 (0-1). In 
contrast, content analysis of the consultation audiorecordings gave a mean 
number of 6.47 and 2.63 respectively, median 6 (4-9) and 3 (1-4).  
 
A contrast between what patients selected on the HN-PCI and the content of 
their discussions is shown in Figure 5.1 and 5.2. There were clearly more items 
discussed than raised on the HN-PCI particularly in regard to health care 
professionals. Of the HN-PCI items, ‘FOR’ was prominent in being selected on 
the HN-PCI by 42% (8/19) patients and being discussed with 47% (9/19) 
patients.  
 
The detailed breakdown of FOR is as follows: FOR was selected on the HN-PCI 
but was not discussed (2 patients), FOR was discussed despite having not 
selected this on HN-PCI (3 patients) and FOR selected and discussed (6 
patients). Table 5.4 summaries these relationships in more detail for the 20 most 
cited items.  
 
5.4.6. Patient-reported post-consultation outcomes 
 
Post-consultation questionnaires were distributed following 22 consultations (15 
patients), of which 11 were audio-recorded. Post-consultation questionnaires 
were distributed following 15 consultations, of which 11 were audio-recorded. 
Questionnaire returns for 15 patients were completed within a median of 1 day 
(range, 0- 12 days from consultation day). 93% (14) felt that they were able to 
see the professional or individual they had hoped to see on the consultation day.  
 
Other post-consultation results are summarised in Table 5.5. The vast majority 
of responses described positive experiences, i.e. patients were agreeing to 
statements on the PSQ-MD indicating satisfaction with consultation and 
disagreeing with those that contradict satisfaction.  
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Figure 5.1. Items were selected on the HN-PCI (LEFT graph) and which items were noted from the audio recordings of the consultations (RIGHT 
graph) (19 cases)  
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Figure 5.2. Healthcare professionals were selected on the HN-PCI (LEFT graph) and 
which were noted from the audio recordings of the consultations (RIGHT graph) (19 
cases) 
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Table 5.4. The 20 items shown here are those that involved 4 or more (ie. >20%) of the 
19 cases, whereas health professionals shown are all those noted on the HN-PCI or in 
consultation.   
 
 
 On HN-
PCI 
Discussed On HN-
PCI  
& not 
discussed 
On HN-
PCI & 
Discussed 
Not on 
HN-PCI 
but 
discussed 
Fear of recurrence 8 9 2 6 3 
Others* 0 12 0 0 12 
Chewing 5 7 1 4 3 
Dental health 4 6 1 3 3 
Swallowing 6 5 1 5 0 
Saliva 4 6 1 3 3 
Pain in H&N 4 5 4 0 5 
Anxiety 4 6 1 3 3 
PEG 3 5 0 3 2 
Speech 4 5 1 3 2 
Activity 3 4 1 2 2 
Sleeping 4 3 1 3 0 
Mood 5 2 4 1 1 
Swelling 2 4 1 1 3 
Appearance 2 4 0 2 2 
Depression 5 1 4 1 0 
Weight 1 4 1 0 4 
Lifestyle 1 5 0 1 4 
Mucus 4 1 3 1 0 
Mobility 4 1 4 0 1 
SUM over these 20 items 73 95 31 42 53 
SUM over the other 35 items 40 28 28 12 16 
SUM over all 55 items 113 123 59 54 69 
General practitioner 2 11 0 2 9 
Dentist 5 7 3 2 5 
Other** 1 8 1 0 8 
Oncologist 2 6 1 1 5 
Speech & Language Therapist 0 5 0 0 5 
Emotional support therapist 0 4 0 0 4 
Oral Rehabilitation 0 3 0 0 3 
Social worker 2 1 1 1 0 
Dietician 0 2 0 0 2 
Psychologist 0 2 0 0 2 
Physiotherapist 1 0 1 0 0 
Clinical nurse specialist 0 1 0 0 1 
Surgeon 1 0 1 0 0 
SUM over all these health professionals 14 50 8 6 44 
 
*Wellbeing (7), wellbeing & dizziness (1), new cancer (1), jaw deformity (1), altered sensation (1), 
skin rash (1) 
 
**Psychiatrist (1), dermatologist (1), financial advisor (2), alcohol nurse (1), ENT consultant (1), 
medical specialty doctor (1), respiratory consultant (1) 
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Table 5.5. Post-consultation questionnaire results for 15 patients, comprising of the PSQ-MD and the non-validated questionnaire specific to this study 
 
 Strongly 
Agree 
Agree Disagree Strongly disagree 
Does not 
apply 
%positive response* 
PSQ-MD     
I will follow the doctor’s advice because I think s/he is absolutely right. 11 3 - - 1 100% (14/14) 
The doctor did not take my problems very seriously. - - 4 10 1 100% (14/14) 
The doctor considered my individual needs when treating my condition. 10 3 - 1 1 93% (13/14) 
The doctor did not give me all the information I thought I should have been given. - - 4 10 1 100% (14/14) 
The doctor went straight to my medical problem without greeting me first. - - 3 12  100% (15/15) 
The doctor used words I did not understand. 1 - 5 9  93% (14/15) 
There was not enough time to tell the doctor everything I wanted. 1 - 5 8 1 93% (13/14) 
I feel the doctor did not spend enough time with me. - - 3 12  100% (15/15) 
It seemed to me that the doctor was not really interested in my emotional well-being. - - 3 12  100% (15/15) 
I really felt understood by my doctor. 11 4 - -  100% (15/15) 
After my last visit with my doctor, I feel much better about my concerns. 5 8 1 - 1 93% (13/14) 
The doctor was not friendly to me. - - 2 13  100% (15/15) 
I understand my illness much better after seeing this doctor. 5 6 1 - 3 92% (11/12) 
This doctor was interested in me as a person and not just my illness. 10 4 - 1  93% (14/15) 
I feel I understand pretty well the doctor’s plan for helping me. 8 4 - 2 1 86% (12/14) 
I would not recommend this doctor to a friend. 1 - - 14  93% (14/15) 
The doctor seemed to brush off my questions. - - 1 14  100% (15/15) 
The doctor should have told me more about how to care for my condition. 2 - 2 10 1 86% (12/14) 
After talking with the doctor, I have a good idea of what changes to expect in my health over 
the next few weeks and months. 
6 6 - - 3 100% (12/12) 
The doctor told me to call back if I had any questions or problems. 9 4 1 - 1 93% (13/14) 
I felt the doctor was being honest with me. 11 4 - -  100% (15/15) 
The doctor explained the reason why the treatment was recommended for me. 7 5 - - 3 100% (12/12) 
It seemed to me that the doctor was not really interested in my physical well-being. - - 1 14  100% (15/15) 
The doctor should have shown more interest. - - 2 13  100% (15/15) 
       
Non-validated questions specific to this study:       
How would you rate the extent to which these concerns were addressed?  8 7    100% (15/15) 
To what degree would you agree to the statement: My expectations of the consultation were 
fulfilled in the most recent outpatient visit.  
10 4 - 1  93% (14/15) 
To what degree would you agree to this statement: I felt the PCI was intrusive  2 - 8 5  87% (13/15) 
To what degree would you agree to the statement: I felt the PCI was unhelpful  - 1 8 6  93% (14/15) 
 
 
* Strongly agree / agree, OR strongly disagree / disagree, as appropriate and applicable  
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5.5. Discussion 
This main aim of this Pilot study was to develop a standardised method of 
evaluating the content of consultations through a thematic framework -based 
content analysis. This involved accurately recording of the consultation using a 
reliable audiorecording device, precise transcription of the recording, 
development of a thematic framework approach to content analysis, and 
applying scientific rigour of the content analysis method.  
 
This study observed that the audiorecording equipment was “fit for purpose”. 
Failure to record consultation was predominantly due to issues unrelated to the 
handling of the equipment i.e failure to consent (12/23, 52%) and others (5/23, 
22%).  Equipment failure (3/23, 13%) and Surgeon did not record (3/23,13%) 
were both due to initial unfamiliarity with the equipment. The handling of the 
equipment improved after a short learning curve.  Professional medical 
secretaries, who were experienced and reliable, accurately transcribed the 
audiorecordings.  
 
This study developed a method of content analysis of the transcriptions using a 
thematic framework [Miles & Huberman, 1994]. The method employed in this 
study was suitable for exploring consultations of patients whose needs and 
concerns are diverse, because it considered the themes within the experience of 
the subjects involved. Other valuable features of this approach were dynamism 
(i.e. allows for amendments to the thematic framework during the analytical 
process), systematic (i.e. permits standardised approach to handling data) and 
comprehensive (facilitates a full review of the datum). Using this approach, 
more items were discussed in comparison to those highlighted originally by 
patients. This is may be in part due to the introduction of new themes that were 
not found in the HN-PCI (version 2) checklist .  
 
The new themes identified relating to patients’ concern include ‘Dizziness’ and 
‘Skin rash’, and these were not part of the original HN-PCI (version 2) checklist 
in this study.  Under the theme of ‘Dizziness’, the coding included the words 
‘dizziness’, ‘light-headedness’, ‘giddy’, ‘woozy’ and ‘vertigo’. The theme ‘Skin 
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rash’ includes the words describing skin symptoms e.g. ‘rash’, ‘eczema’ and 
‘dry, flaky skin’. In regard to clinic output, the theme ‘Further surveillance’ was 
identified and incorporated into the existing thematic  framework for use in 
further studies.  
 
Another new theme identified during the development of the thematic 
framework in this study was ‘Well-being’. This theme was the most frequently 
discussed during the clinical encounters. The complexity of the linguistic 
implications of the term ‘well-being’ is recognised. ‘Well-being’ may be 
considered as a social construct that is fluid and subject to primary cultural 
judgment [Ereaut et al, 2008]. To provide an operational definition for coding, 
‘well-being’ was deliberated as the subjective notion of how well a person's life 
is going, and the words used to categorise this theme includes ‘doing well’, 
‘feeling great in me-self’ and ‘super’. The frequency with which this theme is 
discussed may reflect an overall expression of how well a patient feels he/she 
has coped with their condition and thereby does not have any items of concerns. 
In others, this could simply be an automatic response to enquiries about their 
condition because in these patients, further exploratory HN-PCI-led discussions 
identified various items of concerns. Fagerlind et al, [2008] also identified the 
‘well-being’ theme in their qualitative evaluation of audiorecordings of routine 
HNC clinic consultations.  
 
The increased number of items discussed in comparison to those highlighted 
may also be related to how the HN-PCI is used during consultation. This process 
is observed through the mapping of the themes derived from individual 
transcripts. One way is by association of themes. This is exemplified in an 
excerpt from the consultation with patient JC: 
 
Surgeon:   You mentioned on the computer about Anxiety.. 
Patient:  I’ve always been anxious.. 
Surgeon:  …and the fear of it coming back. Have you seen Jimmy in the 
past? The emotional support therapist? 
Patient:  Yeah, I’ve seen him. Its just that, over this last year I’ve buried 
me mum, buried me dad, buried me brother..  
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This patient did not indicate FOR but instead indicated anxiety on the HN-PCI. 
The clinician was able to bring up the issue of FOR based on the understanding 
of the association of anxiety with FOR [Rogers et al, 2011; Ghazali et al, 
2013B], thereby allowing the patient the opportunity to disclose this concern if 
he/she so wished. Other thematic associations include swallowing-PEG tube, 
saliva-chewing-swallowing and FOR-depression.  
 
Another way is based on the permission-giving impact of the HN-PCI. This is 
exemplified in an excerpt from the consultation with patient AR: 
 
Surgeon:  Did you mention about appearance (on the HN-PCI)? 
Patient:  It’s just that I feel great about my appearance now, you know. 
Now I’m back to me confidence again. And it’s really fine. 
Surgeon:  You feel stronger, you mean? 
Patient:  Yeah, much, much. As I said to you before, I was worried sick 
about it coming back again and all this, that is still at the back of 
me mind. (But) It’s (now) not a major issue or anything.  
Surgeon:  Do you think about it a lot? 
Patient:  No, not a lot.. 
 
This patient did not indicate FOR on the HN-PCI on this occasion but had done 
so in the past. But having done so in the past has allowed the patient to freely 
bring this issue up once again for discussion. This example also demonstrates 
another way the HN-PCI can increase the number of items discussed, which is 
by further exploration of one HN-PCI-highlighted item would lead on to 
uncovering other hidden issues of concern.  
 
Some items were infrequently indicated on the HN-PCI but were frequently 
touched upon during consultations, for example, ‘Relationships’. Other items 
may have been indicated on the HN-PCI but not discussed. This may be due to 
the patients selecting too many items at one time, particularly when significant 
distress is experienced [Ghazali et al, 2012] and/or when restrictions to clinic 
time may have prevented these items to be broached. In this situation, the HN-
PCI can sign-post the patients who may need more time for unpacking of these 
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concerns. This could be provided by seeing the Clinical Nurse Specialist after 
the consultation with the doctor.  
 
A higher number of professionals were discussed during the consultation in 
comparison to what was indicated on the HN-PCI. This finding may reflect the 
lack of understanding on the part of patients regarding each professional’s scope 
of practice or expertise, and also not knowing what services are available to 
them. For example, in patient TD: 
 
Surgeon:  You mentioned about financial side as well, do you need some 
help with that as well? 
Wife:  Well, we’ve been trying to sort something out with our mortgage 
now. It does seem like we’re going round in circles. 
Surgeon:  Absolutely. So you don’t need anyone from this end to see you? 
Wife:  Is it possible you can get help from here (hospital)? 
Surgeon:  Yes, that’s right. 
Wife:  Well, I just want to see if we can get this one first. 
 
The nature of the multidisciplinary team approach, and the important role played 
by the GP in the community, has also resulted in more professionals being 
discussed during consultations. This is evident in the frequency with which the 
GP and oncologist is mentioned in consultations. However, this has not resulted 
in an increase in the number of referrals (2 per 19 patients seen) in comparison 
to a previous study (21 per 100 patients seen) [Ghazali et al, 2011].  
 
Regarding patient satisfaction with consultations, the results indicate that the 
majority of patients were satisfied with the consultation. Although patient 
satisfaction surveys are thought to favour the clinician, visit-specific scales 
measure different attributes than those that ask respondents to integrate their 
perceptions over the duration of the patient–physician relationship [Epstein et 
al, 2006]. However, the PSQ-MD visit-specific oncology patient satisfaction 
questionnaire has never been used in HNC setting and precludes any potential 
comparisons in other cohorts to be made. This early data provides a measure of 
its feasibility and an understanding of how this questionnaire could translate into 
a real measure of satisfaction. 
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The limitations of this pilot study relates to the small numbers of transcriptions 
available for statistical analysis of the results obtained. However, it was a 
feasibility study to test methods of recruitment, audio-recording process and data 
collection from the transcribed recordings. Furthermore, the choice of a visit-
specific oncology patient satisfaction with consultation has never been used in a 
HNC setting and precludes any potential comparisons in other cohorts to be 
made.  
 
5.6. Conclusions 
 
In conclusion, the Pilot study showed that the audiorecording of consultations 
and its transcription was a reliable method for data collection for further 
analysis. The Pilot study also developed a standardised method for content 
analysis of consultations using the thematic framework approach.  Analyses of 
the Pilot study findings suggest that more items of concerns’ were discussed in 
comparison to those self-selected by patients. This observation was also noted in 
regard to health care professionals. Meaningful conclusions could not be made 
from the data regarding clinical outcomes and patient satisfaction due to the 
small numbers obtained in this study. These issues will be addressed in the Main 
study.  
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CHAPTER 6 
6.0. GENERATION OF HN-PCI DOMAINS 
6.1. Introduction 
 
The two new items of concern identified during the Pilot study i.e. ‘Dizziness’ 
and ‘Skin Rash’ [Ghazali et al, 2013A] was incorporated into the HN-PCI, 
creating a new version i.e. HN-PCI (version 3) with 57 items of concern and 15 
professionals (Appendix 4). However, the current HN-PCI (version 3) or 
previous versions are not organised or grouped into categories or domains.  
 
Previous reporting of patients’ expressed needs/concerns identified using HN-
PCI have been summarised as an extensive bar chart and this is often 
cumbersome due to the long checklist of individual items [Rogers et al, 2009A; 
Rogers et al, 2012; Ghazali et al; 2013B]. Alternatively, HN-PCI results are 
sometimes presented as a list of all selected items or the top most ranked items 
[Scott et al, 2013; Flexen et al, 2012; Jungerman et al, 2017]. While this is 
succinct, the narrowed focus on more common concerns can result in missing 
less frequently reported but nonetheless significant concerns, e.g. regret of 
treatment.  
 
It is hypothesised that having domains can permit a more systematic method of 
summarizing HN-PCI findings, facilitates comparative evaluations and helps to 
construct an overall picture of the inter-relationship of various concerns in a 
defined cohort. This work has been published in a peer-reviewed journal 
[Ghazali et al, 2015] (Appendix 14).  
 
6.2.  Aim of study  
 
The primary aim was to generate domains for the HN-PCI (version 3) through a 
systematic methodology.  
 
The secondary aim of this study was to apply the domains to an existing 
database of HN-PCI data established at the OMF department, Aintree University 
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Hospital, and evaluate the associations between HN-PCI data with demographic 
and clinical parameters.  
 
6.3  Materials and Method 
 
6.3.1. Domain generation 
 
The Delphi method [Linstone & Turnoff, 1975; Powell, 2003] of achieving 
consensus was used. A convenience panel of experts was set up ad hoc through 
selection of 10 healthcare workers caring for HNC patients within the 
Merseyside and Cheshire HNC service. The panel of experts consisted of two 
doctors, two Clinical Nurse Specialists, one Speech & Language therapist plus 
three outpatient clinic nurses, one research nurse and one HN-PCI hospital 
volunteer. 
 
Domain generation was undertaken in a 3-step process (Figure 6.1). Participants 
were given a sheet of paper, indicating the specific task according to the stage of 
the process. They were instructed to complete the task within 7 days of its 
receipt and to post their responses in with a self-return envelope addressed to the 
researcher (NG). The researcher was blinded to the identity of the participant. 
All 10 participants took part at each stage of the process (100% response rate).  
 
In order to achieve a consensus in Rounds 2 and 3, a minimal percentage of 70% 
agreement among panelists had to be established per item based on the 
recommendation by Sumsion [1998]. When an item achieved <70% agreement, 
the checklist with the related items was re-distributed until the expected level of 
agreement was achieved.  
 
 
6.3.2. Application of domains to existing HN-PCI data 
 
 
The HN-PCI database was started in 1 August 2007 with the introduction of the 
HN-PCI in routine clinical practice [Rogers et al, 2009A]. The database also 
includes HN-PCI data completed as part of a wider HNC service audit [Kanatas 
et al, 2013]. Relationships between HNC-PCI domain and patient/clinical 
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characteristics were investigated for the 674 patients completing the HN-PCI for 
the first time, with statistical significance obtained using Fishers Exact test (two 
by two tables) or chi-squared test (three by two or four by two tables) as 
appropriate.  Because of the large number of significance tests performed, 
statistical significance was regarded as p<0.01.  
 
 
Figure 6.1. Step-wise process of domain generation 
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6.4.  Results 
 
6.4.1. Domain generation 
 
Round 1:  The suggested category headings suggested by panelists at Round 
1 are shown in Table 6.1. These items were analysed and distilled into 5 groups 
based on thematic considerations by researcher (NG), namely, (A) Physical and 
functional well-being; (B) Social care/Social well-being, (C) Psychological and 
Emotional well-being /Spirituality; (D) Treatment-related; and (E) Others. These 
were subsequently used as the HNC-PCI domain headings.  
 
Round 2:  Table 6.2 shows the frequency by which each category heading 
was chosen by each panelist per item at the first stage of Round 2. 100% 
agreement was seen in 21/57 items (36.8%) (category A: 14/21; C: 6/21; and E: 
1/21). However, most items (87%, 50/57) showed an agreement ≥ 70%. Seven 
items with < 70% agreement at this stage were ‘Appearance’, 
‘Dependents/Children’, ‘PEG tube’, ‘Speech/voice/being understood’, 
‘Sexuality’, ‘Regret about treatment’, and ‘Relationships’. Round 2 was repeated 
once when the minimum level of agreement was reached (Table 6.3).  
  
Round 3:  At the first stage of Round 3, 100% agreement was achieved in 
almost all items (94%, 53/57). This was repeated once and ≥ 70% agreement 
was achieved at the second stage of Round 3 in the remaining items. Table 6.4 
shows the final consensus reached in Round 3 for the items within final domain. 
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Table 6.1. Suggested categories by 10 panelists and facilitated by researcher 
 
 
Items suggested for 
category headings by 
panelists 
 
Frequency 
(n=10) 
Thematic 
category 
Suggested categories after 
collation by researcher 
 
Fitness 2 A Physical and functional well-
being Rehabilitation 2 A 
Physical 7 A 
Social care/support 4 B Social care / Social well-being 
Practical 1 B 
Lifestyle 1 B 
Support 6 B 
Social life 3 B 
Spiritual 5 C Psychological and Emotional 
well-being / Spirituality Emotional 8 C 
Feelings 6 C 
Treatment 4 D Treatment-related 
Treatment-related 4 D 
Side-effects 8 D 
Body image 1 E Others 
Personal 2 E 
Symptoms 1 E 
Illness 1 E 
Others 7 E 
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Table 6.2. Suggested category headings and agreement by 10 panelists after Round 2 (continued next page) 
 
 PCI item 1 2 3 4 5 6 7 8 9 10 Agreement 
1. Activity A A A A B B A A A B A (70%); B (30%) 
2 Angry C C C C C C C C C C C (100%) 
3 Anxiety C C C C C C C C C C C (100%) 
4 Appearance C B B C B C A B A B B (50%); C (30%); A (20%) 
5 Appetite A A A A A A A A C A A (90%); C (10%) 
6 Bowel habit A A A A A A A A A A A (100%) 
7 Breathing A A A A A A A A A A A (100%) 
8 Cancer treatment D D D D D D D A D D D (90%); A (10%) 
9 Carer B A E C B B B B B B B (70%); C, E, A (10% each) 
10 Chewing/eating A A A A A A A A A B A (90%); B (10%) 
11 Coping  C C C C B C C C C C C (90%); B (10%) 
12 Coughing A A A A A A A A A A A (100%) 
13 Dental health/teeth A C A A A A A A A A A (90%); C (10%) 
14 Dependents/children B C E C B B B B E B B (60%); C (20%); E (20%) 
15 Depression C C C C C C C C C C C (100%) 
16 Dry mouth A A A A A A A A A A A (100%) 
17 Energy levels C A A A A C A A C A A (70%); C (30%) 
18 Fatigue/tiredness C A A A A C A A A A A (80%); C (20%) 
19 Fear of the cancer coming back C C C C C C C C C C C (100%) 
20 Fear of adverse events C C C C C C C C C C C (100%) 
21 Financial/ benefits B B B E B B C B B B B (80%); C, E (10% each) 
22 Hearing A C A A A A A A A B A (80%); B (10%); C (10%) 
23 Home care/district nurse B B B E B B A B B B B (80%); A, E (10% each) 
24 Indigestion A A A A A A A A A A A (100%) 
25 Intimacy C C E C C C C B C B C (70%); B (20%); E (10%) 
26 Lifestyle issues B B B E B B B A B A B (70%); A (20%); E (10%) 
27 Memory C C A C C C C C C C C (90%); A (10%) 
28 Mobility A A A A A A C B A A A (80%); C,B (10% each) 
29 Mood C B C C C C C C C C C (90%); B (10%) 
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 PCI item 1 2 3 4 5 6 7 8 9 10 Agreement 
30 Mouth opening A A A A A A A A A A A (100%) 
31 Mucus A A A A A A A A A A A (100%) 
32 Nausea A A A A A A B A A A A (100%) 
33 Pain in head and neck A A A A A A C A A A A (90%); C (10%) 
34 Pain elsewhere C A A A A A C A A A A (80%); C (20%) 
35 PEG tube D A A D A D D B E D D (50%); A (30%); B, E (10% each)  
36 Recreation B B B B B B A B B B B (90%); A (10%) 
37 Regret about treatment D C D D C C D C D D D (60%); C (40%) 
38 Relationships C C B C B C C B B B C (50%); B (50%)  
39 Regurgitation A A A A A A A A A A A (100%) 
40 Salivation A A A A A A A A A A A (100%) 
41 Self-esteem C C C C C C A C C C C (90%); A (10%) 
42 Sexuality C C C C E C B B C B C (60%); B (30%); E (10%) 
43 Shoulder A A A A A A A A A A A (100%) 
44 Sleeping C A A A A A A B C A A (70%); C (20%); B (10%) 
45 Smell A B A A A B A A A A A (80%); B(20%) 
46 Sore mouth A A A A A A A A A A A (100%) 
47 Speech/voice/being understood C B A A B B B B A B B (60%); A 30%); C (10%) 
48 Spiritual/religious aspects C C C C C C C C C C C (100%) 
49 Support for my family B B B C B B B B E B B (80%); C, E (10% each) 
50 Swallowing A A A A A A A A A A A (100%) 
51 Swelling A A A A A A B A A A A (90%); B (10%) 
52 Taste A A A A A A A C A A A (90%); C (10%) 
53 Temperament and personality C B C C C C C E C C C (80%); B,E (10% each) 
54 Vomiting/sickness A A A A A A B A A A A (90%); B (10%) 
55 Weight C A A A A A C A A A A (80%); C (20%) 
56 Wound healing D D D D D A A D D D D (80%); A (20%) 
57 Anything else E E E E E E E E E E E (100%) 
 
 153 
Table 6.3. Suggested category headings and agreement between panelists after repeating Round 2 (Pink rows showing items that had agreement < 
70% in previous round) continued next page 
 
 PCI item 1 2 3 4 5 6 7 8 9 10 Agreement 
1. Activity A A A A B B A A A B A (70%); B (30%) 
2 Angry C C C C C C C C C C C (100%) 
3 Anxiety C C C C C C C C C C C (100%) 
4 Appearance C C C A C A C C C A C (80%); A (30%) 
5 Appetite A A A A A A A A C A A (90%); C (10%) 
6 Bowel habit A A A A A A A A A A A (100%) 
7 Breathing A A A A A A A A A A A (100%) 
8 Cancer treatment D D D D D D D A D D D (90%); A (10%) 
9 Carer B A E C B B B B B B B (70%); C, E, A (10% each) 
10 Chewing/eating A A A A A A A A A B A (90%); B (10%) 
11 Coping  C C C C B C C C C C C (90%); B (10%) 
12 Coughing A A A A A A A A A A A (100%) 
13 Dental health/teeth A C A A A A A A A A A (90%); C (10%) 
14 Dependents/children B C B C B B B B B B B (80%); (20%) 
15 Depression C C C C C C C C C C C (100%) 
16 Dry mouth A A A A A A A A A A A (100%) 
17 Energy levels C A A A A C A A C A A (70%); C (30%) 
18 Fatigue/tiredness C A A A A C A A A A A (80%); C (20%) 
19 Fear of the cancer coming back C C C C C C C C C C C (100%) 
20 Fear of adverse events C C C C C C C C C C C (100%) 
21 Financial/ benefits B B B E B B C B B B B (80%); C, E (10% each) 
22 Hearing A C A A A A A A A B A (80%); B (10%); C (10%) 
23 Home care/district nurse B B B E B B A B B B B (80%); A, E (10% each) 
24 Indigestion A A A A A A A A A A A (100%) 
25 Intimacy C C E C C C C B C B C (70%); B (20%); E (10%) 
26 Lifestyle issues B B B E B B B A B A B (70%); A (20%); E (10%) 
27 Memory C C A C C C C C C C C (90%); A (10%) 
28 Mobility A A A A A A C B A A A (80%); C, B (10% each) 
29 Mood C B C C C C C C C C C (90%); B (10%) 
30 Mouth opening A A A A A A A A A A A (100%) 
31 Mucus A A A A A A A A A A A (100%) 
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 PCI item 1 2 3 4 5 6 7 8 9 10 Agreement 
32 Nausea A A A A A A B A A A A (100%) 
33 Pain in head and neck A A A A A A C A A A A (90%); C (10%) 
34 Pain elsewhere C A A A A A C A A A A (80%); C (20%) 
35 PEG tube D A D D A D D D D D D (80%); A (20%)  
36 Recreation B B B B B B A B B B B (90%); A (10%) 
37 Regret about treatment D C D D C D D C D D D (70%); C (30%) 
38 Relationships C C B C B B B B B B C (30%); B (70%)  
39 Regurgitation A A A A A A A A A A A (100%) 
40 Salivation A A A A A A A A A A A (100%) 
41 Self-esteem C C C C C C A C C C C (90%); A (10%) 
42 Sexuality C C C C C C B B C B C (70%); B (30%) 
43 Shoulder A A A A A A A A A A A (100%) 
44 Sleeping C A A A A A A B C A A (70%); C (20%); B (10%) 
45 Smell A B A A A B A A A A A (80%); B (20%) 
46 Sore mouth A A A A A A A A A A A (100%) 
47 Speech/voice/being understood C B B A B B B B A B B (70%); A (20%); C (10%) 
48 Spiritual/religious aspects C C C C C C C C C C C (100%) 
49 Support for my family B B B C B B B B E B B (80%); C, E (10% each) 
50 Swallowing A A A A A A A A A A A (100%) 
51 Swelling A A A A A A B A A A A (90%); B (10%) 
52 Taste A A A A A A A C A A A (90%); C (10%) 
53 Temperament and personality C B C C C C C E C C C (80%); B,E (10% each) 
54 Vomiting/sickness A A A A A A B A A A A (90%); B (10%) 
55 Weight C A A A A A C A A A A (80%); C (20%) 
56 Wound healing D D D D D A A D D D D (80%); A (20%) 
57 Anything else E E E E E E E E E E E (100%) 
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Table 6.4. Results of Round 3. (Yellow rows showing items with agreement < 100%) 
A: Agree; D: Disagree 
 
 PCI item A D   PCI item A D 
A Physical and functional 
well-being 
   C Psychological/ 
Emotional/ 
Spirituality well-being 
  
1. Activity 100%   4 Appearance  70% 30% 
5 Appetite 100%   2 Angry 100%  
6 Bowel habit 100%   3 Anxiety 100%  
7 Breathing 100%   11 Coping  100%  
10 Chewing/eating 100%   15 Depression 100%  
12 Coughing 100%   19 Fear of the cancer 
coming back 
100%  
13 Dental health/teeth 100%   20 Fear of adverse events 100%  
16 Dry mouth 100%   25 Intimacy 100%  
17 Energy levels 100%   27 Memory 100%  
18 Fatigue/tiredness 100%   29 Mood 100%  
22 Hearing 100%   41 Self-esteem 100%  
24 Indigestion 100%   42 Sexuality 100%  
28 Mobility 100%   48 Spiritual/religious 
aspects 
100%  
30 Mouth opening 100%   53 Temperament and 
personality 
100%  
31 Mucus 100%       
32 Nausea 100%   D Treatment-related   
33 Pain in head and neck 100%   8 Cancer treatment 100%  
34 Pain elsewhere 100%   37 Regret about treatment 100%  
39 Regurgitation 100%   35 PEG tube  80% 20% 
40 Salivation 100%   56 Wound healing 100%  
43 Shoulder 100%       
44 Sleeping 100%   E Others   
45 Smell 100%   57 Anything else 100%  
46 Sore mouth 100%   
50 Swallowing 100%   
51 Swelling 100%   
52 Taste 100%   
54 Vomiting/sickness 100%   
55 Weight 100%   
     
B Social care/ Social well-
being 
   
9 Carer 100%   
14 Dependents/children 100%   
21 Financial/ benefits 100%   
23 Home care/district nurse 100%   
26 Lifestyle issues 100%   
36 Recreation 100%   
38 Relationships 90% 10%  
47 Speech/voice/being 
understood 
70% 30%  
49 Support for my family 100%   
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6.4.2. Application of domain 
 
The 674 patients analysed had a mean age of 64 years (SD, 11) and 67% 
(449/674) were male. Primary diagnosis was made between 1 August 2007 and 
31 December 2011 (median, May 2007; IQR, October 2004 to December 2008) 
and was SCC for 91% (616). Tumour site was oral cavity for 50% (340/674), 
pharyngeal for 25% (170/674), laryngeal for 17% (115/674), other HNC 
locations for 6% (40/674), unknown for 1% (9/674). Cancer TN-stage was 
advanced T3-4 for 25% (164/647), and N-positive for 28% (180/652). Primary 
treatment was surgery alone for 50% (335/674), surgery with adjuvant RT for 
33% (225/674), (chemo)RT alone for 14% (96/674), and unknown for 3% 
(18/674). Of those treated with surgery, 42% (237/560) had free-flaps (179 soft 
tissue, 58 composite). The median time from primary surgery (or from primary 
diagnosis if no surgery) to first completion of the HN-PCI was 32 (IQR, 14-58) 
months, n=660. Most (70%, 472) completed the HN-PCI only once at a median 
(IQR) 39 (range, 20-69) months. Just under one-third (30%, 202) completed it 
more than once. 
 
For those 674 completing the HN-PCI for the first time, 81% selected items in 
the Physical and Functional well-being domain, 30% in the Social care/Social 
well-being domain, 58% in the Psychological and Emotional well-
being/Spiritual domain and 15% in the Treatment-related domain (Table 6.5). 
‘Other’ items raised by patients were relative rare at 4%. On subsequent HN-
PCI completions, more patients chose not to select items, evident for all domains 
and reflected through to both the number of domains and domain combinations 
selected. Specifically, on first HN-PCI, 11% did not select any HN-PCI item and 
on subsequent HN-PCI completions this had doubled to 23%. 
 
Relationships between domain selection and patient/clinical characteristics were 
investigated for 674 patients completing the HNC-PCI for the first time (Table 
6.6). Younger patients (<65 years) were more likely to select items within the 
Psychological and Emotional well-being/Spiritual domain (66% versus 48% for 
65+ years), and also items in the Social care/Social well-being domain (36% 
versus 24% for 65+ years). Of borderline statistical significance was that more 
women than men (64% versus 55%) chose items in the Psychological and 
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Emotional well-being/Spiritual domain. Patients having surgery alone as 
primary treatment were less likely to select within the Physical and Functional 
well-being domain (74%) than patients having surgery-RT combination (89%) 
or (chemo)RT alone (86%). Patients with surgery-RT combination were also 
more likely (39%) to select within the Social care/Social well-being domain than 
other patients. More patients with laryngeal tumours selected within the Social 
care/Social well-being domain. There were no notable patterns of association 
seen with other clinicopathological parameters with domains. 
 
 
 
 
Table 6.5. HN-PCI item response grouped by domain 
 
 Items chosen 
First PCI  
(674 patients) 
Subsequent PCI 
(602 PCI from 202 
patients) 
Domain A: Physical and functional 
well-being 
0 19% (128) 30% (181) 
1 18% (122) 17% (104) 
2 14% (92) 15% (88) 
3-4 21% (139) 17% (105) 
5-9 23% (153) 18% (106) 
10 or more 6% (40) 3% (18) 
Domain B: Social care / Social well-
being 
0 70% (470) 80% (480) 
1 23% (156) 15% (92) 
2 or more 7% (48) 5% (30) 
Domain C: 
Psychological/Emotional/Spirituality 
well-being 
0 42% (286) 57% (343) 
1 29% (197) 22% (133) 
2-3 20% (132) 13% (81) 
4 or more 9% (59) 7% (45) 
Domain D: Treatment related 
0 85% (573) 93% (557) 
1 13% (85) 7% (40) 
2 or more 2% (16) <1% (5) 
NUMBER OF DOMAINS 
SELECTED 
None 11% (76) 23% (140) 
One 26% (177) 32% (191) 
Two 35% (236) 28% (170) 
Three 22% (150) 15% (88) 
ALL Four 5% (35) 2% (13) 
MAIN DOMAIN 
COMBINATIONS SELECTED 
None 11% (76) 23% (140) 
A only 20% (137) 26% (155) 
A&C only 26% (172) 21% (125) 
A&B&C only 17% (115) 11% (68) 
Other combinations 26% (174) 19% (114) 
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Table 6.6: HN-PCI domains selected on first use of HNC-PCI (N=674), by patient characteristics  
 
Items chosen  Patients 
Domain A:  
Physical and 
functional 
well-being P value 
Domain B: 
Social care 
/ Social 
well-being P value 
Domain C: 
Psychological/Em
otional/Spiritualit
y well-being P value 
Domain 
D: 
 Treatment 
related P value 
ALL 
PATIENTS 
 674 81% (546)  30% (204)  58% (388)  15% (101)  
Gender 
Male 449 82% (370) 
0.21 
31% (139) 
0.60 
55% (245) 
0.03 
16% (71) 
0.43 
Female 225 78% (176) 29% (65) 64% (143) 13% (30) 
Age in years 
<55 129 82% (106) 
0.40 
35% (45) 
0.007 
60% (78) 
<0.001 
18% (23) 
0.06 
55-64 242 84% (203) 36% (87) 69% (166) 19% (45) 
65-74 209 78% (163) 22% (46) 49% (103) 11% (22) 
75+ 94 79% (74) 28% (26) 44% (41) 12% (11) 
Primary 
treatment 
Surgery & RT 225 89% (201) 
<0.001 
39% (87) 
0.005 
58% (130) 
0.83 
15% (34) 
0.52 Surgery alone 335 74% (249) 26% (87) 56% (188) 14% (47) 
Chemo/RT alone 96 86% (83) 28% (27) 59% (57) 19% (18) 
Free-flap  
(if surgery) 
No free-flap 312 79% (245) 
0.27 
30% (94) 
0.65 
59% (183) 
0.69 
14% (44) 
0.60 Soft 179 84% (151) 32% (57) 55% (98) 17% (30) 
Composite 58 83% (48) 36% (21) 59% (34) 12% (7) 
Months from 
surgery (or 
diagnosis if no 
surgery) 
Within 12 months 149 81% (121) 
0.83 
32% (48) 
0.57 
59% (88) 
0.02 
21% (31) 
0.13 
12-23 months 124 83% (103) 34% (42) 69% (85) 15% (19) 
24-59 months 230 79% (182) 30% (68) 54% (124) 13% (29) 
60+ months 157 82% (128) 27% (42) 51% (80) 13% (20) 
Diagnosis 
SCC 616 81% (502) 
0.35 
31% (190) 
0.53 
57% (351) 
0.55 
16% (97) 
0.22 
Other 50 76% (38) 26% (13) 62% (31) 8% (4) 
 Tis, T1 256 78% (200) 
0.06 
30% (77) 
0.35 
57% (147) 
0.20 
15% (39) 
0.97 
Tstage 
T2 227 81% (183) 27% (62) 54% (122) 15% (34) 
T3, T4 164 87% (143) 34% (56) 63% (103) 16% (26) 
Nstage N0 472 79% (375) 
0.19 
31% (145) 
0.67 
57% (269) 
0.97 
14% (65) 
0.04  N1 70 84% (59) 30% (21) 57% (40) 11% (8) 
 N2-3 110 86% (95) 26% (29) 58% (64) 23% (25) 
Tumour location 
Oral 340 79% (268) 
0.20 
32% (109) 
0.002 
55% (187) 
0.43 
14% (47) 
0.73 
Pharyngeal 170 86% (147) 21% (36) 59% (101) 18% (30) 
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Laryngeal 115 79% (91) 42% (48) 57% (66) 15% (17) 
Other H&N 40 83% (33) 25% (10) 68% (27) 15% (6) 
           
Items chosen  Patients 
Domain A:  
Physical and 
functional 
well-being P value 
Domain B: 
Social care 
/ Social 
well-being P value 
Domain C: 
Psychological/Em
otional/Spiritualit
y well-being P value 
Domain 
D: 
 Treatment 
related P value 
UWQOL 
Physical 
function 
subscale score 
<50 78 95% (74) 
<0.001 
45% (35) 
<0.001 
67% (52) 
0.006 
32% (25) 
<0.001 
50-74 230 89% (205) 35% (81) 62% (143) 13% (31) 
75-89 141 86% (121) 27% (38) 60% (84) 13% (18) 
90-100 204 65% (132) 21% (43) 48% (98) 11% (23) 
UWQOL 
Social-
emotional 
subscale score 
<50 68 97% (66) 
<0.001 
50% (34) 
<0.001 
81% (55) 
<0.001 
29% (20) 
0.001 
50-74 205 93% (190) 39% (79) 67% (137) 17% (35) 
75-89 199 83% (165) 26% (52) 57% (114) 13% (25) 
90-100 182 62% (112) 18% (32) 39% (71) 9% (17) 
UWQOL  
overall QOL 
Outstanding/V 
Good 
243 71% (173) 
<0.001 
21% (52) 
<0.001 
44% (107) 
<0.001 
12% (28) 
0.001 Good 224 83% (186) 29% (65) 59% (133) 15% (33) 
Fair 131 95% (124) 40% (52) 73% (95) 15% (19) 
Poor/V Poor 47 96% (45) 51% (24) 77% (36) 34% (16) 
UWQOL 
‘problem’ as 
identified from 
UWQOL 
algorithm* 
Pain 115 97% (111) <0.001 39% (45) 0.03 75% (86) <0.001 23% (27) 0.006 
Appearance 65 92% (60) 0.02 48% (31) 0.002 85% (55) <0.001 28% (18) 0.005 
Activity 87 93% (81) 0.003 47% (41) <0.001 64% (56) 0.20 29% (25) <0.001 
Recreation 49 94% (46) 0.02 49% (24) 0.005 76% (37) 0.01 24% (12) 0.06 
Swallowing 88 92% (81) 0.005 41% (36) 0.02 58% (51) 0.99 28% (25) <0.001 
Chewing 55 91% (50) 0.07 40% (22) 0.13 62% (34) 0.57 40% (22) <0.001 
Speech 41 95% (39) 0.02 63% (26) <0.001 73% (30) 0.05 32% (13) 0.005 
Shoulder 65 97% (63) <0.001 40% (26) 0.09 69% (45) 0.05 28% (18) 0.005 
Taste 74 93% (69) 0.004 34% (25) 0.50 62% (46) 0.45 26% (19) 0.009 
Saliva 138 93% (129) <0.001 26% (36) 0.34 64% (89) 0.07 20% (28) 0.06 
Mood 87 97% (84) <0.001 53% (46) <0.001 87% (76) <0.001 20% (17) 0.20 
Anxiety 88 93% (82) 0.002 44% (39) 0.003 81% (71) <0.001 22% (19) 0.07 
 
P values: Fishers exact or chi-squared test as appropriate * Significant problem trigger criteria (see Table 5.1) Results for those not triggered by the algorithm are not shown in the above table.  
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6.5.   Discussion 
 
 
Development of the HN-PCI checklist involved a combination of item 
generation from the medical literature of various HRQOL items, and item 
selection for the checklist based on discussions with various patient and 
professional bodies [Rogers et al, 2009A]. Because the HN-PCI was designed 
as a prompt for disclosing concerns, psychometric development of the tool was 
not undertaken as it was not required. Furthermore, as a new concept, the 
theoretical framework underlying the PCI was evolving. Therefore, the urgency 
of identifying appropriate categories or domains for the HN-PCI was not 
immediate at the time of its inception.  
 
Subgrouping items within distinct domains can help researchers use domains as 
a way of exploring the inter-relationships of domains and ultimately construct an 
overall picture to explain a phenomenon or answer a research question 
[Atkinson & Abu el-Haj, 1996]. While primarily a prompt sheet, the HN-PCI 
is designed to be holistic and when combined with other psychometric PROs, 
can inform clinicians as a screening tool for levels of distress [Ghazali et al, 
2017], and HRQOL status [Rogers et al, 2002; 2009B; 2010]. Further 
understanding of the PCI concept, particularly with the HN-PCI, in a wider 
cancer survivorship setting will benefit from having similar domains that reflect 
the holistic nature of the HN-PCI.  
 
Hatta et al [2014] attempted to generate domains for the HN-PCI they have 
modified to meet with cross-cultural differences for use in feasibility study in a 
multiethnic cohort in Malaysia. The modification includes the combination of 
related HN-PCI items into a single item (e.g. Fatigue/Tiredness and Energy 
levels) and the introduction of two new items relating to dietary (i.e. ‘Health 
supplements’ and ‘Diet restrictions’). There were 7 domains suggested i.e. 
physical status, emotional status, personal function, social/family relationships, 
economic status, diet-related function, and others. Categorisation of items into 
seven main domains allowed for descriptive analyses intended in their study. 
However, the process and rigour of generating the domains was not detailed in 
their paper.  
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Five HN-PCI domains were generated from this exercise. The ‘Physical and 
Functional well-being’ dimension consisted of items covering activity (of daily 
living), physical symptoms (including pain) and functional impairment. The 
‘Social care/Social well-being’ domain involved areas relating to practical 
support where help may be needed, access to medical support and care, financial 
security (including occupation), involvement of family and friends, lifestyle 
choices, interactions in social settings i.e. recreational or social groups. The 
‘Psychological and Emotional well-being/Spiritual’ domain assessed issues 
relating to psychological adjustments, feelings toward diagnosis/treatment, the 
influence of diagnosis/treatment on personality and sexual relationships, and 
religious/spiritual fulfillment. Two additional domains were created to account 
for items that were deemed ‘Treatment-related’ and a single item domain of 
‘Others’ to account for any potential items that have not been considered, such 
as Informational needs. The domains generated fulfilled the national 
recommendations for holistic assessment tools
 
by having items that assess 
domains of physical, social and occupational, psychological and spiritual well-
being [Richardson et al, 2007]. 
 
Arguably, the generated HN-PCI domains may be considered a reflection of the 
healthcare professional’s opinion on how individual patient concerns may be 
addressed, which is framed in reference to the potential services on offer. 
Individual difference in interpretation of a concern by professionals regarding an 
item may have also been complicated by the complex nature of the disease and 
treatment-related changes related to HNC. This may have posed a challenge 
during the process of achieving consensus, e.g., ‘Appearance’ could relate to 
concerns about physical and function, or the psychological distress experienced 
with disfigurement, or the impact of facial appearance on social well-being 
and/or reflecting patient interest in further treatment. Any disagreement between 
participants have had was addressed by the Delphi process used in this study. 
The process was augmented by enabling each participant to provide their view’s 
impersonally through the post, and its reliability was increased by a reasonable 
sized expert panel, and with repeated rounds [Fink et al, 1984].  
 
In this study, the highest frequency of concerns was encountered within the 
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Physical and Functional wellbeing (81%), followed by the Psychological and 
Emotional wellbeing/Spiritual (53%) and Social care/social wellbeing (30%) 
domains. An overall reduction in the number of items selected across all 
domains was observed longitudinally. The results are valuable data for 
comparison with the forthcoming results of the main study.  
 
Treatment modality is associated with concerns within the Physical and 
Functional domain. Recognised RT-related complications may account for the 
less likelihood of surgery only patients in highlighting concerns within this 
domain. Younger patients (<65years) were more likely to voice concerns in 
Psychological and Emotional well-being/Spiritual, and Social care/Social well-
being domains. This may have significant implications in supportive care 
planning considering the rising oropharyngeal cancer incidence in younger 
populations [Mourad et al, 2017]. The direct impact of laryngeal disease and 
treatment on voice/speech, communication, swallowing and breathing may 
explain the higher number of expressed concerns under the Social care/Social 
well-being domain. 
 
This study suggests a clear association between poor HRQOL outcomes with 
perceived needs/concerns of long-term HNC survivors in remission (median FU, 
34 months; IQR, 14-58). HNC patients more likely to select HN-PCI items for 
discussion during consultation were those who reported poor overall QOL, poor 
UWQOL Physical function and Socio-emotional function outcomes, and those 
screened as having significant problems on UWQOL. This finding indicates that 
concerns, based on their disclosure via HN-PCI, are related to HRQOL status in 
HNC patients.  The clustering pattern of certain perceived needs and their 
association with HRQOL outcomes can help healthcare professionals identify at-
risk patients who may benefit from tailored supportive care to improve HRQOL 
outcomes. 
 
One study limitation relates to the Delphi methodology. Firstly, selection of the 
expert panel did not include patients, and therefore, their input, as users of the 
tool, were not considered. Secondly, a universally agreed proportion of the level 
of agreement for consensus does not exist for the Delphi, as the range of 
reported values are between 51-80% [Hasson et al, 2000]. The proportion of 
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level of agreement for consensus used in this study was 70%, which is based on 
previous recommendation [Sumsion, 1998]. While Green et al [1999] 
suggested 80%, the decision to set to the level of 70% for this study was 
achieved on balance by considering the study characteristics i.e. sample 
numbers, the aim of the work and resources available.  Another limitation to this 
study relates to the inherent variability in the individual interpretation of the 
items on the checklist, which may introduce bias in this work, while at the 
clinical level, miscommunication could occur. There may be some merit in 
providing additional information to guide HN-PCI users on what each item 
refers to. Without a standardized definition for guidance, a certain amount of 
ambiguity may exist at the pre-consultation stage. However, any vagueness 
could be cleared up during consultation as the HN-PCI itself can facilitate 
patient-doctor communication [Rogers et al, 2009]. 
 
Examination of the association between HN-PCI with HRQOL status is limited 
by a cross-sectional design.  A baseline level of perceived need at diagnosis or in 
the immediate post-treatment was unavailable for comparison. A glimpse of 
possible changing trend of needs over time is offered because the vast majority 
(70%) completed the HNC-PCI only once. In addition, other reported factors 
that can influence perceived need, including comorbidity, psychological state, 
education level, socioeconomic status, may also be considered in future 
prospective studies. 
 
6.6.  Conclusions 
 
HN-PCI item categorisation into 5 domains can help summarise future HN-PCI 
data in a way that may present and help understand trends better. This study 
found that certain clinical-pathological factors are associated with the 
presentation of perceived needs/concerns in specific domains. Close associations 
between HNC-PCI domains with HRQOL outcomes were observed. Further 
work may help clarify some of the emerging trends identified and evaluate the 
potential for HN-PCI as a routine screening tool for HRQOL status. 
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Chapter 7: 
7.0.  MAIN STUDY 
This chapter contains the work relating to the Main study. The chapter is considered 
under the following sections:  Study Aims and Objectives, Study Hypothesis, 
Methodology, Results and Discussion. 
 
7.1.  Study aims  
7.1.1.  The primary aim of this study was to evaluate the HN-PCI as a tool for 
identifying patient concerns during routine outpatient consultations in a 
cohort of subjects unfamiliar with the tool. 
 
7.1.2.  The secondary aims of this study were: 
 a. Describe the characteristics of a ‘normal’ consultation visit i.e. when 
HN-PCI was not used routinely, to provide baseline values before 
introduction of the HN-PCI.  
The characteristics evaluated were the distress levels, HRQOL 
scores, the concerns discussed during consultation, length of 
consultation, level of patient satisfaction and the clinic output. 
 
b. Evaluate the impact of HN-PCI intervention on clinical outcomes 
routine HNC visits. 
Compare ‘Control’ group with HN-PCI intervention groups to 
evaluate consultation length, clinic output and patient 
satisfaction. 
   
c. Examine the relationship between patients’ concerns with cancer-
related distress.  
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Cancer-related distress is defined as an "unpleasant emotional 
experience of a psychological (cognitive, behavioural, 
emotional), social, and/or spiritual nature that may interfere with 
the ability to cope effectively with cancer, its physical symptoms, 
and its treatment” [NCCN, 2010]. 
 
d. Examine the associations between clinicopathological factors and 
patients’ concerns.  
 
e. Explore the impact of HN-PCI intervention on patient-doctor 
encounter. 
Compare the self-reported concerns against the concerns 
discussed during the consultation in the HN-PCI intervention 
groups.  
 
7.2.  Study hypothesis 
The study hypotheses are: 
 
7.2.1. The HN-PCI can help identify patients’ concerns in cohorts unfamiliar 
with the instrument;  
7.2.2. The HN-PCI intervention will raise more items and/or a broader range of 
concerns: 
7.2.2.1.The HN-PCI intervention will increase the number of concerns 
discussed during consultations; 
7.2.2.2. The HN-PCI intervention will increase the type of concerns 
discussed during consultations; 
7.2.3. The HN-PCI will result in more congruence between self-reported 
concerns and those discussed during consultation; 
7.2.4. The HN-PCI intervention will change the characteristics of consultations: 
7.2.4.1.  Consultations will lengthen 
7.2.4.2.  Clinical outputs will increase in number 
7.2.4.3.  Patients will be more satisfied with consultations 
7.2.5. Patients’ concerns are related to distress 
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7.2.6. Patients’ concerns are not related to clinicopathological factors  
 
7.3.  Study methodology 
7.3.1.   Patient-reported outcome measures 
 
The PROs used in the main study are the HN-PCI (version 3), UWQOL DT, 
PSQ-MD and PROC. These have been discussed in section 4.7. Administration 
of the PROs to patients depends on the Main study design (section 7.2.2).  
 
7.3.2.  Main Study Design 
 
A prospective, non-randomised study design was used. The study was set up 
into three individual study blocks organised sequentially (Appendix 12).   
 
(a) Block 1 (Control group): Block 1 represents ‘normal’ practice, where 
patients are not asked to complete the HN-PCI before their consultation.  
(b) Block 2 (Control in attention group):  In Block 2, patients were asked to 
complete the HN-PCI at the pre-consultation stage but the HN-PCI 
questionnaire was withheld from clinicians during consultation.  
(c) Block 3 (Intervention group): In Block 3, patients were asked to complete 
the PCI at the pre-consultation stage and the HN-PCI questionnaire was 
passed on to the clinicians before the patient entered the consultation room 
and was made available for use during the consultation.  
Recruitment continued until the target recruitment number was achieved and 
study recruitment closed. Patient recruitment into the study blocks followed the 
order of the date of their clinic attendance. The study commenced with 
recruitment into Block 1. Recruitment to each block continued until the target 
recruitment number was achieved based on proposed sample size (section 
7.3.4.), whereby the succeeding block commenced.  
 
All recruited patients completed the DT and UWQOL before they entered the 
clinic consultation. The intervention with the HN-PCI was completed in the 
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second and final blocks.  All questionnaires were administered in a paper 
format.  
 
7.3.3.  Study Participants 
Study participants comprised of surgeons and patients.  
 
Surgeons:  A convenience sample of four consultant HNC surgeons without 
prior experience of using the HN-PCI i.e. two Oral & Maxillofacial (OMF) 
surgeons and two Otolaryngology, Head and Neck (ENT) surgeons, were invited 
to participate in this study. All participating surgeons were given a Microsoft 
Power Point demonstration covering the study protocol and how the HN-PCI is 
used before the start of the study.  
 
Patients:  Patient recruitment was based on the inclusion and exclusion 
criteria. The inclusion criteria were (1) diagnosis of HNC; (2) disease-free 
survivors who have completed primary treatment of at least 6 weeks; and (3) 
have never used the HN-PCI before. The exclusion criteria were (1) pre-
treatment HNC; (2) HNC patients with palliative status; and (3) non-HNC 
diagnosis.  
 
Details regarding patient sample size calculation and recruitment are explained 
in the sections 7.3.4 and 7.3.5, respectively.  
 
7.3.4. Study Sample Size Calculation 
 
Statistical power analysis was performed a priori to ensure an adequate 
estimated study number recruitment capable of detecting a significant effect 
while reducing both types I and II errors. Previously published results in a 
similar study population [Rogers et al, 2009] indicated that the items raised on 
the HN-PCI at pre-consultation can vary considerably up to about 40% (range, 
5-25%). It was not known how many of these would be discussed during the 
consultation.  
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Initial sample size calculations indicated 400 per block to detect a clinically 
significant impact based on percentages between groups with 80% power and 
5% significance level (α). Typically this number would allow differences in 
outcome such as 30% versus 40%, 20% versus 29%, 15%versus 23%, 10% 
versus 17% and 5% versus 11% to be detected at p<0.05 with 80% power 
should they exist. Numerical data comparisons generally require fewer numbers 
and so would be guaranteed by the same sample size calculations.   
 
The study sample size has to balance recruitment of adequate patient numbers to 
detect moderately sized differences should they exist with the logistics of 
completing the study in a reasonable time scale and 200 per block was chosen as 
the pragmatic compromise. For 200 per group, the power to detect such 
differences in outcome as those specified here would have been about 50%. For 
108 per group (the 'reality') the power was about 30%. 
 
7.3.5.  Study Recruitment 
 
The study was conducted in 1 February 2011 to 9 January 2013 the HNC 
outpatient clinics of two NHS Hospitals Trusts run by two OMF surgeons at the 
University Hospital Aintree, Liverpool, and two ENT surgeons at the Whiston 
hospital, St Helens. The study opened once research ethics approval was 
obtained from the North West Research ethics committee (study reference: 
11/H1002/7; Appendix 5). 
 
Potential patients were identified from the outpatient clinic patient list of each 
participating consultant. Eligible patients were identified based on the inclusion 
and exclusion criteria in the study protocol (section 7.2.3).  All eligible patients 
were sent the study patient information sheet (Appendix 6) together with their 
clinic appointment letter 6 weeks before the appointment date. On the day of 
appointment, once the patient has been booked into the clinic, eligible patients 
were approached in the waiting area. Patients were asked if they received both 
the letter of invitation to the study as well as the patient information sheet 
(Appendix 6). Upon acknowledgement of receipt of both documents, patients 
were asked if they wished to participate in the study. Patients who expressed 
their wish to participate were invited to a private room, and the process of 
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obtaining formal informed consent was undertaken using the study consent form 
(Appendix 7) before data was collected. Patients who declined to participate 
were recorded.  
 
7.3.6.  Recording of Clinic Consultations 
 
The method used in the Main study was established in the Pilot study (section A 
Tascam DR-100 (TEAC UK Ltd., Watford, UK) recorder was used to record 
each consultation in MP3 format. The interview was recorded by the doctor 
from the start of consultation, defined as the moment patient entered the 
consultation room, until the end of the consultation, defined as the moment the 
patient left the room. All patient and doctor identifiable information was 
removed to maintain confidentiality. Only recordings of complete consultations 
were used and transcribed.  
 
7.3.7.  Patient-reported Outcomes of Consultation (PROC) 
 
At the end of the consultation, patients were given FU survey questionnaires by 
the researcher (NG) consisting of the DT, PSQ-MD and a non-validated 
questionnaire (section 4.7.5) together with a stamped return-addressed envelope 
for completion at home. Patients were instructed to complete the questionnaires 
and return them within 1 week following their consultation. Patients were 
contacted by a postcard reminder and latterly by a telephone call reminder, if the 
FU survey forms were not received at 2- and 4-weeks respectively, following 
consultation.   
 
7.4.  Data Collection 
 
7.4.1.  Clinical data 
 
Relevant clinical data were obtained from the Liverpool HNC database and 
patient hospital records. The data collected include demographic data (age, 
gender), definitive diagnosis, tumour characteristics (primary site, T-stage, N-
stage, overall TNM stage) and treatment details (type of surgery and surgical 
date; radiotherapy (dosimetry, addition of chemotherapy).  
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The data were collected in a database using the Microsoft Office Excel software 
(version 2007) i.e. Main study database. The data were exported into SPSS, and 
analysed in SPSS v19. 
 
7.4.2.  Data from audiorecordings of consultations 
 
All audiotaped consultations were transcribed word-for-word by medical 
secretaries at Aintree University Hospital. Each transcription was evaluated for 
accuracy by the researcher (NG).  The transcribed audiotaped consultations were 
content analysed using a thematic coding framework using the method 
established in the Pilot study (Chapter 5).  
 
 7.4.3. Data from PROs 
 
All the data obtained from the PROs used in the Main study were input into the 
Main study database described previously (section 7.4.1). 
 
7.5.   Study Outcome Measures 
 
The variables chosen for outcome measures selected were based on standard 
outcome measures used for prompt sheet interventions previously established in 
the literature [Parker et al, 2005; Rogers et al, 2009A]. 
 
7.5.1.  Primary outcome measure   
a. Number and category of items of concerns 
 
7.5.2. Secondary outcome measures 
a. Number of professionals requested 
b. Patient satisfaction with consultation (discussed in section 5.3.6) 
c. Length of consultation (discussed in section 5.3.5) 
d. Distress levels (discussed in section 4.7.3)  
e. Clinical output (discussed in section 5.3.5) 
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 7.6.   Statistical Analysis   
 
 7.6.1.  Main statistical analysis  
 
Summary statistics of the quantitative and categorical data of each block were 
computed. These include the number of items discussed, satisfaction scores, 
distress levels, types of items discussed and types of clinical decision made and 
referral practices.  
 
7.6.2.  Hypothesis testing 
 
Comparative analysis between the study blocks was performed to test the null 
hypothesis (H0) i.e. there is no difference between the blocks (Block 1 versus 
Block 2 versus Block 3) in what is being measured, in a two-tailed test with a 
significance level set at 5% (P-value <0.05).  
 
For numerical data, e.g. length of consultation, distress level, number items of 
concern discussed, number of healthcare professionals selected and number of 
clinical decisions made, the Kruskal-Wallis test (between 3 blocks) or the Mann-
Whitney test (between 2 blocks) was used. For categorical data, e.g. types of 
items discussed, types of clinical decision made, the chi-squared test (3 blocks) 
or Fisher's exact test (2 blocks) was used.  
 
To examine the relationship between significant distress and other variables, 
Fishers Exact test, the chi-squared test or Mann-Whitney analysis were applied 
as appropriate.    
 
Comparative analysis was also undertaken to determine if the HN-PCI 
influenced the content of consultations by measuring the level of agreement 
between what items the patient selected on the HN-PCI and what was actually 
discussed during clinic consultations. The Kappa coefficient of agreement was 
calculated and the interpretation of Kappa used is shown in Table 7.1.  
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Table 7.1. Interpretation of kappa values [Oxford handbook of medical 
statistics] 
 
 
 
 
 
 
 
 
 
In addition, McNemar test was undertaken to evaluate the shift of proportions of 
items selected by patients on HN-PCI against the proportion of items discussed. 
 
7.6.4.  Subgroup analysis of the intervention group  
 
These are secondary analyses to identify if any patient features stratified by 
HRQOL, primary site, clinicopathological stage, sociodemographic, treatment or 
specialty may associate with the study outcome measures in the intervention 
block. For numerical outcomes the Mann Whitney or Kruskal-Wallis test was 
used. For categorical outcomes, the Fisher’s exact test or chi-squared test was 
used. 
 
Multiple statistical testing was undertaken in the main study and the subgroup 
section. Due to the number of tests performed, the statistical significance was 
regarded as p<0.01. It is recognised that in smaller samples, clinically significant 
differences may not be statistically significant. Therefore, interpretation of these 
tests was taken on balance between what is observed from descriptive data and 
how likely any differences seen or something more extreme could have occurred 
if the assumptions underlying the Null hypothesis were true.  
 
7.7.   Study Reliability  
 
The reliability of the data obtained in the main study was assured by the use of 
standardized validated tools for comparison, rigorous sample recruitment, and 
Value of 
Kappa 
Strength of agreement 
<0.00 Poor (worse than chance) 
0.00-0.20 Slight 
0.21-0.40 Fair 
0.41-0.60 Moderate 
0.61-0.80 Good 
0.81-1.00 Very good 
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the method of data collection was developed and tested during the pilot work, 
where inter-rater agreements are reported.  
 
7.8  Results 
 
7.8.1.  Overview of Results 
 
The main study opened for recruitment on 15 June 2011 and closed on 9 January 
2013 (Block 1 recruitment: 15 June 2011 to 23 Nov 2011; Block 2 recruitment: 
23 Nov 2011 to 25 April 2012; and Block 3 recruitment: 25 April 2012 to 9 
January 2013). 
 
A total of 261 patients were recruited to the study across the 3 study blocks, 
which generated 346 consultations. 61 patients appeared more than once during 
the entire study, either in the same block or across different blocks due to the 
nature of regular repeat attendances to the follow-up clinic. 
 
According to protocol any between block duplication was acceptable but any 
within block duplication was not as it undermines the assumption of 
independence of the unit of analysis within block. Therefore, for subsequent 
analyses if there was within block duplication then only the first consultation 
was included. Thus, there were 261 patients (325 consultations) recruited in all. 
 
In Block 1, from 182 eligible patients, 136 patients (74.7%) were recruited, 
resulting in 136 consultations.  In Block 2, from 110 eligible patients, 78 
patients (70.9.%) were recruited, resulting in 78 consultations. In Block 3, from 
155 patients, 111 patients (71.6%) were recruited, resulting in 111 consultations.  
 
 
7.8.2.  Baseline data 
 
7.8.2.1. Baseline clinical characteristics  
 
The baseline clinical characteristics of study participants across the 3 Blocks are 
shown in Table 7.2. No significant differences were seen between blocks 
regarding the clinical characteristics of participants, indicating that the three 
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Blocks are reasonably comparable groups. The distribution of patients seen by 
the respective surgeons is shown in Table 7.3.  
 
Table 7.2. Baseline characteristics  
 
  Block 1 
(n=136) 
Block 2 
(N=78) 
Block 3 
(n=111) 
P 
value* 
Sex Male 69% (94) 68% (53) 66% (73) 
0.76 
 Female 29% (40) 31% (24) 34% (38) 
 Not known 2% (2) 1% (1) -  
Age Mean (SD) 62.1 (13.8) 64.5 (11.4) 65.0 (11.1) 
0.36 
 Median (IQR) 63 (54-71) 64 (58-73) 65 (59-73) 
 <55 27% (37) 15% (12) 14% (15) 
0.13 
 55-64 25% (34) 36% (28) 35% (39) 
 65-74 32% (44) 31% (24) 33% (37) 
 75+ 14% (19) 15% (12) 16% (18) 
 Not known 2% (2) 3% (2) 2% (2)  
Specialty OMF 50% (68) 65% (50) 50% (55) 
0.07 
 ENT 50% (68) 35% (27) 50% (56) 
 Not known - 1% (1) -  
Tumour site Oral 34% (46) 46% (36) 33% (37) 
0.47 
 Oro-pharyngeal 21% (29) 19% (15) 22% (24) 
 Laryngeal 18% (24) 17% (13) 23% (25) 
 Other 27% (37) 18% (14) 23% (25) 
Histology SCC 85% (116) 86% (67) 84% (93) 
0.83 
 Not SCC 15% (20) 13% (10) 16% (18) 
 Not known - 1% (1) -  
Overall  1 30% (41) 28% (22) 31% (34) 
0.96 
P stage 2 19% (26) 19% (15) 17% (19) 
 3 10% (13) 8% (6) 13% (14) 
 4 29% (39) 31% (24) 29% (32) 
 Not known 13% (17) 14% (11) 11% (12)  
Primary Surgery only 44% (60) 54% (42) 41% (45) 
0.47 Treatment Surgery + RT/CRT 39% (53) 33% (26) 41% (46) 
 RT/CRT only 14% (19) 10% (8) 15% (17) 
 Not known 3% (4) 3% (2) 3% (3)  
Free-flap No surgery 14% (19) 10% (8) 15% (17) 
0.36  Surgery without FF 58% (79) 56% (44) 62% (69) 
 Surgery with FF 25% (34) 31% (24) 18% (20) 
 Not known 3% (4) 3% (2) 5% (5)  
Years from 
Primary 
diagnosis to 
consultation 
Median (IQR) 2.2 (0.9-3.8 2.4 (1.2-3.8) 2.3 (1.3-3.7) 0.64 
< 1 year 27% (37) 21% (16) 17% (19) 
0.35 1.0-2.9 years 35% (47) 40% (31) 44% (49) 
≥ 3 years 37% (50) 38% (30) 38% (42) 
Not known 2% (2) 1% (1) 1% (1)  
 
*chi-squared comparing blocks for categorical data after excluding the not known 
category; Kruskal-Wallis test comparing blocks for age in years and for years from 
primary diagnosis to study consultation.  
 
Abbreviation: OMF, oral & maxillofacial; ENT: otorhinolaryngology; SCC, squamous 
cell carcinoma; RT, radiotherapy; CRT, chemoradiotherapy, FF, free flap 
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Table 7.3. Distribution of patients according to the respective surgeons 
 
Surgeon 
Block 1 
(n=136) 
Block 2 
(N=78) 
Block 3 
(n=111) 
A 34% (46) 42% (33) 23% (26) 
B 16% (22) 22% (17) 26% (29) 
C 24% (32) 10% (8) 22% (24) 
D 26% (36) 23% (18) 29% (32) 
 
 
7.8.2.2. Baseline Distress Thermometer (DT) scores 
 
The levels of self-reported distress recorded at recruitment using the DT are 
shown in Table 7.4. The mean DT scores for Blocks 1, 2 and 3 were 2.7, 2.5 
and 3.0, respectively, while the median (IQR) scores were 2 (0-5) for every 
Block. The proportion of patients reporting severe distress (DT scores, 6-10) in 
Blocks 1,2 and 3 were 18%, 18% and 20%, respective. Overall, the 3 groups 
were comparable (Kruskal-Wallis test of DT scores between blocks, P=0.58).  
 
 
Table 7.4. Baseline Distress Thermometer scores 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
DT score Block 1 
(n=136) 
Block 2 
(N=78) 
Block 3 
(n=111) 
0 No distress 35% (48) 35% (27) 32% (35) 
1 10% (13) 14% (11) 8% (9) 
2 11% (15) 10% (8) 13% (14) 
3 12% (16) 9% (7) 11% (12) 
4 5% (7) 6% (5) 5% (6) 
5 9% (12) 8% (6) 12% (13) 
6 6% (8) 3% (2) 5% (5) 
7 5% (7) 12% (9) 5% (6) 
8 5% (7) 3% (2) 4% (4) 
9 1% (1) 1% (1) - 
10 Extreme distress 2% (2) - 6% (7) 
Mean 2.7 2.5 3.0 
Median (IQR) 2 (0-5) 2 (0-5) 2 (0-5) 
% ≥ 4 32% (44) 32% (25) 37% (41) p,0.70 
% ≥ 6 18% (25) 18% (14) 20% (22) 
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7.8.2.3. Baseline University of Washington Quality of Life (UWQOL) scores 
 
The baseline UWQOL data recorded at recruitment are shown in Tables 7.5-7.7. 
Overall, there were no significant statistical differences seen in UWQOL data 
between Blocks. UWQOL status was comparable between study blocks.  
 
Table 7.5 shows the individual scores, composite subscores and QOL scores, 
which were similar between blocks.  
 
Table 7.6 shows the section of issues that were important to patients in the last 7 
days. Table 7.7 shows the range of ‘significant problem’ based on the UWQOL 
algorithm. In both Tables 7.7 and 7.8, there were few differences between 
blocks.   
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Table 7.5. Baseline UWQOL showing the scores, composite subscores and QOL scores 
 
 
Block 1 
(n=136) 
Block 2 
(N=78) 
Block 3 
(n=111) 
 
 
Mean 
SE of 
Mean Mean 
SE of 
Mean Mean 
SE of 
Mean 
P value* 
Physical function subscale score 76.3 1.7 77.3 2.2 76.4 1.9 0.95 
Appearance 79.2 1.9 80.8 2.5 81.8 1.9 0.74 
Swallowing 80.1 1.9 84.7 2.3 81.6 2.1 0.32 
Chewing 73.2 2.7 69.9 3.6 69.4 3.2 0.63 
Speech 80.4 2.0 82.8 2.4 83.5 1.8 0.64 
Taste 75.5 2.6 75.5 3.3 73.4 3.0 0.93 
Saliva 69.1 3.0 69.9 3.9 68.8 3.3 0.96 
Social - Emotional subscale score 75.8 1.6 79.6 1.8 74.9 1.7 0.22 
Pain 77.6 2.3 79.5 2.6 77.7 2.2 0.88 
Activity 71.5 2.1 76.9 2.5 68.5 2.2 0.06 
Recreation 75.2 2.1 78.5 2.3 71.8 2.4 0.25 
Shoulder 81.3 2.5 85.5 3.0 79.7 2.7 0.21 
Mood 76.1 2.4 82.1 2.5 75.9 2.5 0.26 
Anxiety 73.2 2.5 75.3 2.9 75.9 2.4 0.89 
Compared to the month before you 
developed cancer, how would you rate 
your health-related quality of life? 
56.1 2.4 56.7 2.8 60.1 2.9 0.55 
In general, would you say your health-
related quality of life during the past 7 
days has been 
61.3 2.0 62.3 2.2 59.3 1.8 0.48 
Overall QOL during the past 7 days 64.4 2.1 62.1 2.3 61.8 1.8 0.47 
 
*Kruskal-Wallis test of distribution of scores between blocks 
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  Block 1 
(n=136) 
Block 2 
(N=78) 
Block 3 
(n=111) 
P value* 
Physical 
function 
subscale 
score 
Mean (SD) 76.3 (19.6) 77.3 (19.3) 76.4 (19.7) 
0.95 
Median (IQR) 78 (63-95) 82 (65-95) 78 (63-95) 
<50 8% (11) 6% (5) 10% (11)  
50-59 9% (12) 8% (6) 14% (15)  
60-69 18% (25) 24% (19) 7% (8)  
70-79 15% (21) 9% (7) 21% (23)  
80-89 18% (24) 19% (15) 11% (12)  
90-100 32% (43) 33% (26) 38% (42)  
Social - 
Emotional 
subscale 
score 
Mean (SD) 75.8 (19.2) 79.6 (16.2) 74.9 (17.9) 
0.22 
Median (IQR) 80 (65-91) 83 (70-93) 78 (63-91) 
<50 10% (14) 5% (4) 12% (13)  
50-59 10% (14) 8% (6) 6% (7)  
60-69 11% (15) 10% (8) 17% (19)  
70-79 18% (24) 24% (19) 23% (25)  
80-89 24% (32) 23% (18) 16% (18)  
90-100 27% (37) 29% (23) 26% (29)  
 
         *Kruskal-Wallis test of distribution of scores between blocks 
 
 
 
 
Table 7.6: UWQOL selection of issues importance 
 
 Block 1 
(n=136) 
Block 2 
(N=78) 
Block 3 
(n=111) 
P value* 
Appearance 13% (18) 8% (6) 11% (12) 0.46 
Swallowing 28% (38) 18% (14) 26% (29) 0.25 
Chewing 15% (21) 18% (14) 18% (20) 0.83 
Speech 20% (27) 14% (11) 17% (19) 0.56 
Taste 11% (15) 13% (10) 16% (18) 0.49 
Saliva 29% (39) 38% (30) 26% (29) 0.19 
Pain 22% (30) 17% (13) 16% (18) 0.44 
Activity 10% (13) 5% (4) 11% (12) 0.38 
Recreation 7% (9) 5% (4) 5% (5) 0.76 
Shoulder 16% (22) 13% (10) 12% (13) 0.57 
Mood 12% (16) 8% (6) 11% (12) 0.64 
Anxiety 13% (18) 12% (9) 16% (18) 0.63 
Count   ZERO 17% (23) 26% (20) 16% (18)  
ONE 18% (24) 15% (12) 25% (28) 0.22** 
TWO 18% (25) 24% (19) 16% (18)  
THREE 47% (64) 35% (27) 42% (47)  
 
*chi-squared comparing blocks; **Kruskal-Wallis comparing number of 
domains selected as important 
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Table 7.7: UWQOL algorithm ‘significant problem’ 
 
 Block 1 
(n=136) 
Block 2 
(N=78) 
Block 3 
(n=111) 
P value* 
Appearance 9% (12) 8% (6) 5% (5) 0.41 
Swallowing 9% (12) 6% (5) 8% (9) 0.82 
Chewing 7% (10) 8% (6) 11% (12) 0.60 
Speech 8% (11) 6% 5) 5% (6) 0.70 
Taste 10% (14) 10% (8) 14% (16) 0.55 
Saliva 24% (32) 23% (18) 21% (23) 0.86 
Pain 19% (26) 14% (11) 14% (15) 0.43 
Activity 8% (11) 4% (3) 11% (12) 0.22 
Recreation 9% (12) 5% (4) 10% (11) 0.48 
Shoulder 11% (15) 9% (7) 9% (10) 0.83 
Mood 16% (22) 6% (5) 13% (14) 0.12 
Anxiety 18% (25) 17% (13) 17% (19) 0.94 
Count   ZERO 39% (53) 46% (36) 41% (46)  
ONE 25% (34) 26% (20) 23% (25)  
TWO 13% (18) 12% (9) 14% (16) 0.44** 
THREE 10% (13) 8% (6) 9% (10)  
FOUR 9% (12) 5% (4) 8% (9)  
FIVE or more 4% (6) 4% (3) 5% (5)  
 
*chi-squared comparing blocks; **Kruskal-Wallis comparing number of 
significant problem domains 
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7.8.2.4. Baseline HN-PCI data  
 
 
Based on the study design, baseline self-reported HN-PCI data were available only 
from Blocks 2 and 3. The numbers of items selected based on HN-PCI domains are 
shown in Table 7.8, while a detailed list of the items selected are shown in Table 
7.9 (items of concern) and Table 7.10 (professionals).   
 
When HN-PCI domains were considered, the most common items of concern 
reported fell into the Physical and functional well-being domain (i.e. Block 2, 69% 
and Block 3, 65%), followed by the Psychological/emotional and Spiritual well-
being domain (i.e. Block 2, 37% and Block 3, 43%). When the number of HN-PCI 
items selected was considered, the mean and median (IQR) values in Block 2 were 
3.15 and 2 (1-5) and in Block 3 were 3.79 and 2 (0-6), respectively. When the 
number of professionals selected was considered, the mean and median (IQR) 
values in Block 2 were 0.41 and 0 (0-1), and in Block 3 were 0.39 and 0 (0-1), 
respectively. In summary, the number of HN-PCI items chosen by patients (by 
domain and individual items) and the number of professional selected were 
comparable between blocks (Mann-Whitney, p >0.16). 
 
In Block 2, the five most common items of concern selected were dry mouth 
(23%), FOR (21%), dental health/teeth (19%) chewing (18%) and mouth opening 
(17%). In Block 3 the five most common item of concern selected were FOR 
(31%), dry mouth (25%), fatigue/tiredness (22%), swallowing (21%) and pain in 
head and neck (16%). These accounted for the marginal differences seen in the 
individual items selected by patients between the two blocks, which were not 
statistically significant.  The surgeon was the professional most selected by patients 
in both blocks.  
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Table 7.8: Number of HN-PCI items selected 
 
 Block 2 
(N=78) 
Block 3 
(n=111) 
P 
value* 
 %1 or 
more 
Mean Median (IQR) 
%1 or 
more 
Mean 
Median 
(IQR) 
 
Physical and 
functional well-being 
69% 
(54) 
2.32 2 (0-3) 65% (72) 2.78 2 (0-5) 0.74 
Treatment related 9% (7) 0.10  0 (0-0) 10% (11) 0.10 0 (0-0) 0.85 
Social care and social 
well-being 
8% (6) 0.10 0 (0-0) 14% (16) 0.16 0 (0-0) 0.16 
Psychological 
emotional and spiritual 
well-being 
37% 
(29) 
0.63 0 (0-1) 43% (48) 0.75  0 (0-1) 0.53 
Total number of HN-
PCI items selected 
82% 
(64) 
3.15 2 (1-5) 75% (83) 3.79 2 (0-6) 0.72 
Total number of HN-
PCI health 
professionals selected 
35% 
(27) 
0.41 0 (0-1) 28% (31) 0.39 0 (0-1) 0.41 
 
     *Mann-Whitney test comparing Blocks 2 & 3 in the number of HN-PCI items selected.  
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Table 7.9: Selection of HN-PCI items  
 
 Block 2 (N=78) Block 3 (n=111) 
Activity 4% 5% 
Angry 3% 3% 
Anxiety 5% 8% 
Appearance  6% 5% 
Appetite 1% 7% 
Breathing 5% 4% 
Bowel habit (diarrhoea or constipation) 5% 6% 
Cancer treatment 3% 6% 
Carer - - 
Chewing/eating 18% 14% 
Coping - - 
Coughing - 10% 
Dental health/teeth 19% 13% 
Dependents/children - - 
Depression 4% 5% 
Dry mouth 23% 25% 
Energy levels 1% 8% 
Fatigue/tiredness 14% 22% 
Fear of the cancer coming back 21% 31% 
Fear of adverse events 1% 4% 
Financial / benefits - 2% 
Hearing 13% 9% 
Home care/district nurse support 1% - 
Indigestion 1% 5% 
Intimacy 4% 2% 
Lifestyle issues (smoking/alcohol) 1% 1% 
Memory 6% 8% 
Mobility 3% 5% 
Mood 6% 5% 
Mouth opening 17% 11% 
Mucus production 13% 10% 
Nausea - 1% 
Pain in head and neck 13% 16% 
Pain elsewhere 8% 8% 
PEG tube 4% 2% 
Recreation - - 
Regret about treatment 1% - 
Regurgitation 1% 2% 
Relationships - 2% 
Salivation 9% 12% 
Self-esteem 3% 2% 
Sexuality 3% 1% 
Shoulder 6% 11% 
Sleeping 6% 15% 
Smell 1% 1% 
Sore mouth 14% 12% 
Speech/voice/being understood 8% 9% 
Spiritual /religious aspects - 1% 
Support for my family - 3% 
Swallowing 13% 21% 
Swelling 13% 6% 
Taste 3% 11% 
Temperament and personality 1% 2% 
Vomiting/sickness - - 
Weight 8% 10% 
Wound healing 3% 2% 
Anything else* 6% 4% 
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* Anything else (items of concern) 
 
Block 2 
(N=78) 
Block 3 
(n=111) 
  
 Blood test results 1 
Difficulties in blowing air 1 
Issues about permanent non-
peroral intake status 
1 
Itchy skin, tingly lip 1 
Vision 1 
Total 5 
 
 
  
 Blank 2 
Depression 1 
Itchy skin 1 
Total 4 
 
 
 
 
 
Table 7.10: Selection of professionals  
 
  
 Block 2 
(N=78) 
Block 3 
(n=111) 
Chaplain - - 
Clinical nurse specialist - 4% 
Dental hygienist - 1% 
Dentist 8% 4% 
Dietician 1% 3% 
Nursing staff 1% - 
Occupational therapist - - 
Oral rehabilitation team 1% - 
Physiotherapist 4% 3% 
Radiotherapist/oncologist 4% 2% 
Speech and language therapist 3% 1% 
Social worker - - 
Surgeon 13% 14% 
Family doctor 4% 6% 
Clinical psychologist 1% 2% 
Emotional support therapist 1% 1% 
Financial advisor - - 
Anyone else* - 
3% 
 
 
 * Anyone else (professionals) 
  
Block 2 
(N=78) 
Block 3 
(n=111) 
- 
  
   
blank 
1 
Pain team 1 
PEG nurse 1 
Total 3 
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7.8.3. Characteristics of clinic consultations  
 
 
Evaluations of the clinic consultation were based on the recorded consultations at the 
time of the visit. Because of repeat visits to the outpatient clinics, duplications i.e. 
different recordings related to an individual patient at different attendances, could 
occur. When duplications occurred within each Block, these were not accepted for 
evaluation because inclusion of this data could undermine the assumption of 
independence of the unit of analysis within block. However, any duplication made at 
different time-points between blocks was included. Therefore, from a total of 261 
patients recruited to this study, a total of 325 consultations (i.e. Block 1, 136 
consultations; Block 2, 78 consultations and Block 3, 111 consultations) were 
expected. 
 
7.8.3.1. Audiorecordings 
 
When the study closed, a total of 262 audiorecordings were made from 325 
consultations (84%), and the individual breakdown per Block is shown in Table 
7.11.. 10% of audiotape recordings were unavailable in Block 3, 19% in Block 1 and 
28% in Block 2. The differences were statistically significant (p=0.007). The reasons 
why audiorecording was unavailable are detailed in Table 7.12. 
 
Table 7.11. Number of audiorecordings made in each study Block 
 
 Block 1 
(n=136) 
Block 2 
(n=78) 
Block 3 
(n=111) 
P 
value* 
Audiotaped examined recording 81%  
(107) 
72%  
(55) 
90%  
(100) 
0.007 
 
*chi-squared test 
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Table 7.12. Reasons why audiorecording was not done or unavailable 
 
 
Block 1 
(n=29/136) 
Block 2 
(N=23/78) 
Block 3 
(n=11/111) 
 Not known 1 2 2 
Equipment error 2 4 0 
Surgeon forgot to record 13 12 7 
Patient left clinic before consultation 1 0 1 
Recurrence, stop tape 0 0 1 
Saw other doctor 12 5 0 
Total 29 23 11 
 
 
7.8.3.2. Length of consultation 
 
The length of consultation was determined from the start and end time of the 
audiorecordings. Details of the length of consultation (seconds) according to Blocks 
are shown in Table 7.13.  
 
The mean length of consultation in Blocks 1,2 and 3 was 354 seconds (5.9 minutes), 
307 seconds (5.1 minutes) and 425 seconds (7.1 minutes). The distributions were not 
statistically significant, but the trend suggests that full implementation of the HN-
PCI intervention had increased lengths of consultations (Table 7.13).  
 
Distribution of individual consultations within each Block is shown in Table 7.14. 
 
 
Table 7.13: Length of clinic consultation based on study Blocks (seconds) 
 
 
Block 1 
(n=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
P 
value** 
Median (IQR) score 268 (193-401) 283 (192-
376) 
333 (192-509) 
0.17 
Mean 354 307 425 
% < 2min (120s) 5% (5) 2% (1) 4% (4)  
121-240s 38% (41) 38% (21) 34% (34)  
241-360s 26% (28) 27% (15) 15% (15)  
361-480s 13% (14) 18% (10) 16% (16)  
>8min (480s) 18% (19) 15% (8) 31% (31)  
**Kruskal-Wallis test 
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Table 7.14. Dot plot demonstrating the length of each audiorecorded consultation in 
Blocks   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.8.3.3. ‘Items of patients’ concern’ and ‘patient request for professionals’ discussed at 
consultation 
 
The items of concern discussed in the audiorecorded consultations were examined and 
coded by a single researcher (NG) using the thematic framework developed in the Pilot 
study (section 5.3.7). Another researcher (BR) independently evaluated coding for 1 in 
4 transcriptions in the same manner for the patient completed HN-PCI and transcription 
of the audiorecording of the consultation. Comparison was then made for coding of 
themes undertaken by NG and BR. Assessor agreement was evaluated for all items 
coded and is shown in Table 7.15.   
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Table 7.15: Inter-assessor agreement for thematic coding of items for transcribed 
audiorecordings 
 
 Block 1 Block 2 Block 3 
Inter-rater agreement for 
coding (%) 
95.2% 97.6% 100% 
 
 
The items of patients’ concern and professionals discussed by patients are detailed in 
Table 7.16. The mean (median; IQR) total number of concerns discussed was 3.64 (3; 
2-5) in Block 1, 2.85 (2; 1-4) in Block 2 and 4.62 (3; 2-6) in Block 3. While the 
differences were not statistically significant (p=0.12), there was a trend towards higher 
numbers of concerns discussed with full implementation of HN-PCI. There were 
notable increases in discussion of the certain items of concern during consultations with 
HN-PCI intervention, including FOR (p<0.001), fatigue/tiredness (p<0.001), energy 
levels (p=0.004) and dry mouth (p=0.01). The breakdown of individual items of 
concern discussed is shown in Table 7.17.  
 
The mean (median; IQR) number of discussions about requests for other health 
professionals was 0.74 (0; 0-1) in Block 1, 0.49 (0;0-1) in Block 2 and 0.60 (0; 0-1) in 
Block 3. While the differences seen were not statistically significant, there was a trend 
suggesting a lowered rate of discussion regarding referrals/requests for other healthcare 
professionals with the HN-PCI intervention. However, there was notable increase in the 
requests for the CNS (p=0.003) and a notable reduction in the requests for oral 
rehabilitation specialists (p< 0.001). The breakdown of patient request for professionals 
is shown in Table 7.18. 
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Table 7.16. Number of items discussed during consultations according to HN-PCI domains 
 
 Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) P 
value*  %1 or 
more 
Mean 
Median 
(IQR) 
%1 or 
more 
Mean 
Median 
(IQR) 
%1 or 
more 
Mean 
Median 
(IQR) 
Physical and 
functional well-being 
 
79% (84) 1.99 2 (1-3) 73% (40) 1.65 1 (0-2) 81% (81) 2.76 2 (1-4) 0.04 
Treatment related 
 
59% (63) 0.65 1 (0-1) 67% (37) 0.71 1 (0-1) 55% (55) 0.60 1 (0-1) 0.45 
Social care and social 
well-being 
 
43% (46) 0.63 0 (0-1) 33% (18) 0.33 0 (0-1) 36% (36) 0.50 0 (0-1) 0.18 
Psychological and 
emotional well-being / 
spirituality  
 
26% (28) 0.36 0 (0-1) 13% (7) 0.16 0 (0-0) 41% (41) 0.76 0 (0-1) <0.001 
Total number of HN-
PCI items discussed 
 
96% (103) 3.64 3 (2-5) 93% (51) 2.85 2 (1-4) 95% (95) 4.62 3 (2-6) 0.12 
Total number of HN-
PCI health 
professionals 
discussed 
 
47% (50) 0.74 0 (0-1) 38% (21) 0.49 0 (0-1) 40% (40) 0.60 0 (0-1) 0.28 
 
*Kruskal-Wallis  test comparing Blocks in the number of PCI items selected.  
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Table 7.17: Individual items discussed at consultation  
 
 
Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
Chi-squared test  
P value 
Activity  9% (10) 5% (3) 18% (18) 0.04 
Angry 1% (1) - 3% (3) 0.28 
Anxiety  5% (5) 4% (2) 12% (12) 0.07 
Appearance 8% (9) 4% (2) 7% (7) 0.52 
Appetite 5% (5) - 7% (7) 0.14 
Breathing 5% (5) 2% (1) 6% (6) 0.49 
Bowel habit (diarrhoea or 
constipation) 
1% (1) 5% (3) 5% (5) 0.18 
Cancer treatment 53% (57) 62% (34) 48% (48) 0.26 
Carer 4% (4) 2% (1) 4% (4) 0.76 
Chewing/eating 11% (12) 18% (10) 16% (16) 0.42 
Coping 4% (4) 2% (1) 8% (8) 0.18 
Coughing 7% (7) 2% (1) 9% (9) 0.22 
Dental health/teeth 21% (23) 27% (15) 25% (25) 0.69 
Dependants/children 3% (3) - 4% (4) 0.33 
Depression 3% (3) - 4% (4) 0.33 
Dry mouth 7% (8) 9% (5) 24% (24) 0.01 
Energy levels 1% (1) 2% (1) 10% (10) 0.004 
Fatigue/tiredness 3% (3) - 18% (18) <0.001 
Fear of the cancer coming back 8% (9) 5% (3) 30% (30) <0.001 
Fear of adverse events 3% (3) 2% (1) 1% (1) 0.64 
Financial / benefits 2% (2) - 2% (2) 0.58 
Hearing 1% (1) 7% (4) 6% (6) 0.09 
Home care/district nurse support 1% (1) 2% (1) 1% (1) 0.87 
Indigestion - - 1% (1) - 
Intimacy - - - - 
Lifestyle issues (smoking/alcohol) 20% (21) 11% (6) 11% (11) 0.15 
Memory 1% (1) - 2% (2) 0.52 
Mobility 3% (3) 7% (4) 3% (3) 0.32 
Mood 2% (2) - 5% (5) 0.15 
Mouth opening 7% (8) 2% (1) 10% (10) 0.17 
Mucus production 7% (7) 5% (3) 6% (6) 0.96 
Nausea 1% (1) - 1% (1) - 
Pain in head and neck 28% (30) 16% (9) 21% (21) 0.21 
Pain elsewhere 4% (4) 5% (3) 5% (5) 0.86 
PEG tube - 2% (1) 5% (5) 0.05 
Recreation 11% (12) 5% (3) 6% (6) 0.28 
Regret about treatment - - - - 
Regurgitation 8% (9) - - 0.001 
Relationships 2% (2) - 2% (2) 0.58 
Salivation 4% (4) 4% (2) 5% (5) 0.88 
Self-esteem 1% (1) - 1% (1) - 
Sexuality - - - - 
Shoulder 7% (8) 4% (2) 7% (7) 0.62 
Sleeping 4% (4) - 5% (5) 0.26 
Smell - - 1% (1) - 
Sore mouth 6% (6) 7% (4) 14% (14) 0.10 
Speech/voice/being understood 21% (22) 13% (7) 20% (20) 0.44 
Spiritual /religious aspects 1% (1) - 1% (1) - 
Support for my family - - - - 
Swallowing 24% (26) 15% (8) 27% (27) 0.20 
Swelling 10% (11) 7% (4) 9% (9) 0.82 
Taste 1% (1) 4% (2) 5% (5) 0.23 
Temperament and personality - - 2% (2) - 
Vomiting/sickness - - - - 
Weight 14% (15) 11% (6) 12% (12) 0.83 
Wound healing 12% (13) 7% (4) 7% (7) 0.38 
General well-being 82% (88) 87% (48) 90% (90) 0.26 
Anything else* 55% (59) 36% (20) 44% (44) 0.06 
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  *Anything else: 
 
Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
  
  blank 1 
Breast cancer diagnosis 
& treatment 
1 
Research/Clinical trial 1 
Dizziness 1 
Dysesthesia 1 
Eye tumour 1 
Gynae problems 1 
Housing 1 
Improvement in numb lip 1 
Infection 1 
Infection, Donor site 
problems, Job 
1 
Info, Speech valve, 
Medications 
1 
IxRes 6 
IxRes, Job 1 
IxRes, New diagnosis 2 
Job 6 
Job, Numb ear 1 
Leaking valve 1 
Limited tongue 
movement 
1 
Med, Job, TxCompl 1 
Medications 2 
Medications, 1 
Medications, IxRes 1 
  
Nasal secretion, Restless 
legs 
1 
Neck stiffness 1 
NO 2 
Recent dilatation 1 
Recent eye surgery, 
therabite 
1 
Recent surgery, Meds 1 
Reflux 1 
Research 1 
Sneezing 1 
Throat irritation 1 
TMJ problems 1 
Tongue stiffness, Job 1 
Tracheostomy tube 1 
Twitching, TxCompl, 
Job 
1 
TxCompl 4 
TxCompl & Meds 2 
TxCompl; Numb donor 
site 
1 
TxCompl; Numb lip 1 
TxCompl; Numb 
lip/tongue 
1 
Total 59 
 
 
  
 Bad odour, Nasal 
blockage 
1 
IxRes 5 
Pending 
investigations 
1 
Ear infection 1 
Job 1 
Medication 1 
Nasal congestion, 
Diplopia 
1 
Numb lip 1 
Numb tongue 1 
  
Recent fall 1 
Research 1 
Travel problems, 
Bipolar disorder 
1 
TxCompl 2 
Urinary problems 1 
Watery eyes 1 
Total 20 
 
 
 
  
 Alopecia 1 
Bereavement 1 
Crusty nose 1 
Diagnosis 2 
Watery eyes 1 
Further Treatment 1 
HPV virus infection 1 
IX results, Txcompl, 
Cancer risk 
1 
IxRes 2 
IxRes, TxCompl 1 
Jaw pain 1 
Job 1 
Leaking valve 1 
Leaking valve, New lump 
in spine 
1 
Liver issues, Stiff neck 1 
Medical prosthesis 1 
Medication, IxRes, Hair 
loss 
1 
Meds 1 
Metalwork exposed 1 
Neck stiff 1 
Numb donor site 1 
Numb lip 1 
Numb skin, Dizziness 1 
Osteoporosis 1 
Recent admission 2 
Recent heart surgery 1 
Recent infection, 
medication 
1 
Reflux 1 
Research, TxComp 1 
Skin irritation, Cataract 1 
Skin lesion 1 
Skin lesion, Job 1 
Stiff neck 1 
Stiff neck, Research 1 
Stroke 1 
Temperature regulation 1 
Testicle problems 1 
  TxCompl 2 
TxCompl, Acid reflux 1 
Valve 1 
Total 44 
 
 
Abbreviations: TxCompl, treatment complications; IxRes, investigation results; TMJ, 
temporomandibular joint  
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Table 7.18: Details of patient requests for professionals discussed during consultation 
 
 
Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
Chi-
squared 
test  
P value 
Chaplain - - - - 
Clinical nurse specialist 8% (9) 7% (4) 23% (23) 0.003 
Dental hygienist 2% (2) 2% (1) 1% (1) 0.86 
Dentist 6% (6) 13% (7) 4% (4) 0.10 
Dietician 2% (2) 4% (2) 3% (3) 0.78 
Nursing staff 3% (3) - 2% (2) 0.46 
Occupational therapist - - - - 
Oral rehabilitation team 13% (14) 2% (1) 1% (1) <0.001 
Physiotherapist 4% (4) 7% (4) 3% (3) 0.43 
Radiotherapist/oncologist 7% (7) 2% (1) - 0.02 
Speech and language therapist 6% (6) - 5% (5) 0.21 
Social worker - - - - 
Surgeon 1% (1) - - - 
Family doctor 13% (14) 13% (7) 12% (12) 0.97 
Clinical psychologist 2% (2) - 2% (2) 0.58 
Emotional support therapist 8% (9) - 4% (4) 0.05 
Anyone else** 12% (13) 16% (9) 13% (13) 0.76 
 
*Anyone else:  
 
Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
  
 
Camouflage nurse 1 
ENT surgeon 1 
Eye surgeon 1 
Gastroenterologist 1 
Hypnotherapy 1 
Lung oncology 1 
Neurosurgeon 1 
Pain team, TMJ 
surgeon 
1 
Thyroid oncology 4 
Thyroid oncology, 
Financial advisor 
1 
Total 13 
 
 
  
 
Colorectal surgeon 1 
ENT 1 
ENT, Ophthalmologist 1 
Gastroenterology, ENT 1 
Neurologist 1 
Radiologist 1 
Thyroid oncology 1 
Urologist 2 
Total 9 
 
 
 
  
 Audiology 1 
Audiology, 
Smoking cessation 
nurse 
1 
Chest physician 1 
Chest Physician, 
Neurosurgeon 
1 
Chest rehab 1 
Counselor 1 
Endocrinologist 1 
ENT 1 
HNC support 
group 
1 
Jaw specialist 1 
Neurologist 1 
Thyroid oncologist 1 
Thyroid oncologist, 
ENT, Cardiologist 
1 
Total 13 
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7.8.3.4. Clinical outputs of consultations 
 
The clinical outcomes (medical and non-medical) related to the consultation are shown 
in this section. All recruited patients attending outpatient clinics received medical 
attention irrespective of the HN-PCI intervention (Table 7.19). In Block 3, there was a 
greater proportion ≥ 3 medical actions (12%) compared with other blocks. Details of 
the medical actions undertaken in each block are shown in Table 7.20.  
 
Table 7.19. Medical actions resulting from the consultation 
 
 
Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
%YES 99% (106) 100% (55) 100% (100) 
1 action 67% (71) 76% (42) 57% (57) 
2 actions 26% (28) 22% (12) 31% (31) 
3 actions  7% (7) 2% (1) 10% (10) 
4 actions - - 2% (2) 
Kruskal-Wallis P=0.03, number of actions 
 
 
Table 7.20. What medical actions were undertaken 
 
Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
  
 Exam 67 
Exam, Investigation 11 
Exam, Investigation, 
Meds 
1 
Exam, Letter 6 
Exam, Medical device, 
Investigation 
1 
Exam, Medical device, 
Referral 
2 
Exam, Medication 4 
Exam, Medication, 
Referral 
1 
Exam, Perform 
procedure 
1 
Exam, Photo 1 
Exam, Referral 4 
Exam, WL surgery 4 
Exam, WL surgery, 
Letter 
1 
Exam, WL surgery, 
Referral 
1 
WL surgery 1 
Total 106 
 
 
  
 Exam 40 
Exam, Investigation 3 
Exam, Letter 3 
Exam, Letter, 
Investigation 
1 
Exam, Medication 1 
Exam, Photo 1 
Exam, Referral 3 
Exam, Wound 
inspection 
1 
Letter 2 
Total 55 
 
 
 
  
 Exam 58 
Exam, Investigation 5 
Exam, Investigation, Letter 1 
Exam, Investigation, Photo 1 
Exam, Investigation, WL 
surgery 
1 
Exam, Letter 3 
Exam, Medical device 1 
Exam, Medication 7 
Exam, Medication, Letter 2 
Exam, Organise MDT 1 
Exam, Organise MDT, WL 
cancer surgery, Letter 
1 
Exam, Photo, Medication 1 
Exam, Referral 10 
Exam, Referral, 
Investigation 
2 
Exam, Referral, Medication, 
Letter 
1 
Exam, WL non-cancer 2 
Exam, WL surgery 1 
Exam, Wound inspection, 
Letter 
1 
Referral, Investigation 1 
Total 100 
 
 
Abbreviation: WL, waiting list; MDT, multidisciplinary team 
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In regard to non-medical actions taken related to the consultation, similar results were 
obtained (Table 7.21), where all recruited patients received non-medical actions. 
Details of the non-medical actions undertaken are shown in Table 7.22.  
 
 
Table 7.21: Non-Medical actions resulting from the consultation 
 
 
Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
%YES 98% (106) 100% (55) 100% (100) 
1 action - - - 
2 actions 74% (78) 78% (43) 72% (72) 
3 actions  26% (27) 22% (12) 28% (28) 
4 actions 1% (1) - - 
 
Kruskal-Wallis P=0.70, number of actions 
 
 
 
Table 7.22. What non-medical action taken 
 
 
Abbreviation: Tx, treatment; FU, follow up; DC, discharge 
 
 
 
  
Block 1 
(N=107/136) 
Block 2 
(N=55/78) 
Block 3 
(n=100/111) 
  
 Bad news, Discuss Tx 
options, Reassure 
1 
Bad news, Explain Tx option, 
Reassure 
2 
Bad news, Explain Tx plan 1 
Educate, Reassure, DC 1 
Educate, Reassure, 
Encourage, FU 
1 
Educate, Reassure, FU 19 
Examination, Reassure, FU 1 
Explain Tx options, FU 1 
Reassure, DC 3 
Reassure, Educate, FU 1 
Reassure, FU 74 
Reassure, FU, education 1 
Total 106 
 
 
  
 
Educate, Reassure, 
FU 
2 
Reassure, DC 1 
Reassure, Educate, 
FU 
9 
Reassure, FU 43 
Total 55 
 
 
 
  
 Reassure, DC 6 
Reassure, Educate, 
FU 
21 
Reassure, FU 66 
Reassure, FU, 
education 
3 
Reassure, Tx Plan, 
FU 
4 
Total 100 
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7.8.4. Patient-reported outcomes of consultation (PROC) 
 
 
Patient distress levels and satisfaction with consultation were measured using the DT, 
PSQ-MD and post-consultation questionnaires, which were self-reported and returned 
to the researcher with a postage-paid reply envelope after their consultation. The 
proportion of PROC questionnaires received for each category is shown in Table 7.23. 
The clinical characteristics of patients who returned the PROC questionnaires were 
considered (Table 7.24). There were no significant differences seen between Blocks. 
 
Table 7.23: Self-reported outcomes of consultation received from patients 
 Block 1 
(n=136) 
Block 2 
(N=78) 
Block 3 
(n=111) 
P value* 
DT score 82% (111) 77% (60) 84% (93) 0.49 
Post consultation Q 82% (111) 80% (62) 83% (92) 0.84 
PSQ-MD  82% (111) 80% (62) 83% (92) 0.84 
        *chi-squared test 
 
The time lapse between completion of PROC questionnaires from the day of 
consultation is shown in Table 7.25. Evidence here to indicate the time between 
consultation and post consultation data completion increased over the course of the 
study.  
 
Post-consultation questionnaires were also considered from the surgeon seen at the 
consultation, and the results are shown in Table 7.26.   
 
Self-recorded level of distress at post-consultation using the DT is shown in Table 
7.27. There were no significant differences between the Blocks.  
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Table 7.24. Clinical characteristics of patients who returned PROC questionnaires 
  Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=94/111) 
P value* 
Sex Male 69% (76) 65% (40) 65% (61) 
0.74 
 Female 30% (33) 34% (21) 35% (33) 
 Not known 2% (2) 2% (1) -  
Age Mean (SD) 63.0 (13.3) 64.6 (10.1) 65.1 (11.2) 
0.71 
 Median (IQR) 65 (56-71) 64 (58-71) 65 (58-73) 
 <55 23% (26) 13% (8) 14% (13) 
0.49 
 55-64 28% (31) 37% (23) 35% (33) 
 65-74 32% (35) 34% (21) 32% (30) 
 75+ 15% (17) 13% (8) 17% (16) 
 Not known 2% (2) 3% (2) 2% (2)  
Specialty OMF 53% (59) 67% (41) 48% (45) 
0.06 
 ENT 47% (52) 33% (20) 52% (49) 
 Not known - 1% (1) -  
Tumour site Oral 37% (41) 47% (29) 34% (32) 
0.74 
 Oro-pharyngeal 21% (23) 16% (10) 19% (18) 
 Laryngeal 17% (19) 18% (11) 22% (21) 
 Others 25% (28) 19% (12) 24% (23) 
Histology SCC 85% (94) 84% (52) 83% (78) 
0.92 
 Not SCC 15% (17) 15% (9) 17% (16) 
 Not known - 2% (1) -  
Overall  1 30% (33) 31% (19) 31% (29) 
0.98 
P stage 2 18% (20) 19% (12) 20% (19) 
 3 11% (12) 6% (4) 9% (8) 
 4 27% (30) 27% (17) 30% (28) 
 Not known 14% (16) 16% (10) 11% (10)  
Primary Surgery only 46% (51) 55% (34) 44% (41) 
0.67 Treatment Surgery + RT/CRT 36% (40) 31% (19) 40% (38) 
 RT/CRT only 14% (16) 11% (7) 14% (13) 
 Not known 4% (4) 3% (2) 2% (2)  
Free-flap No surgery 14% (16) 11% (7) 14% (13) 
0.62  Surgery without FF 56% (62) 56% (35) 64% (60) 
 Surgery with FF 26% (29) 29% (18) 19% (18) 
 Not known 4% (4) 3% (2) 3% (3)  
Years from 
Primary 
diagnosis to 
consultation 
Median (IQR) 2.2 (0.8-3.6) 2.5 (1.2-3.8) 2.2 (1.2-3.8) 0.61 
< 1 year 30% (33) 21% (13) 18% (17) 
0.23 1.0-2.9 years 32% (36) 39% (24) 46% (43) 
≥ 3 years 36% (40) 39% (24) 35% (33) 
Not known 2% (2) 2% (1) 1% (1)  
 
*chi-squared comparing blocks for categorical data after excluding the not known 
category; Kruskal-Wallis test comparing blocks for age in years and for years from 
primary diagnosis to study consultation. 
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Table 7.25. Days questionnaire were completed from day of consultation 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=93/111) 
Number of days between 
consultation and completion 
of PROC data 
0 45% (50) 35% (22) 29% (27) 
1 41% (46) 40% (25) 41% (38) 
2 11% (12) 16% (10) 14% (13) 
3 1% (1) 2% (1) 5% (5) 
4 2% (2) 3% (2) 2% (2) 
5 - 3% (2) 2% (2) 
6 - - 2% (2) 
8 - - 2% (2) 
11 - - 1% (1) 
16 - - 1% (1) 
Median (IQR) 1 (0-1) 1 (0-1) 1 (0-2) 
Mean 0.73 1.06 1.63 
           *Kruskal-Wallis test comparing the 3 blocks: P=0.005 
 
 
Table 7.26. Post-consultation questionnaire completion based on surgeon  
Surgeon 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=94/111) 
1 36% (40) 40% (25) 23% (22) 
2 17% (19) 26% (16) 24% (23) 
3 23% (25) 8% (5) 23% (22) 
4 24% (27) 23% (14) 29% (27) 
SpR - 2% (1) - 
Not known - 2% (1) - 
    
 
 
Table 7.27. Levels of distress post-consultation 
 
DT score Block 1 
(n=111/136) 
Block 2 
(N=60/78) 
Block 3 
(n=93/111) 
0 No distress 41% (45) 48% (29) 48% (45) 
1 14% (15) 13% (8) 16% (15) 
2 17% (19) 5% (3) 10% (9) 
3 11% (12) 13% (8) 6% (6) 
4 2% (2) 5% (3) 8% (7) 
5 6% (7) 5% (3) 5% (5) 
6 5% (5) 2% (1) 3% (3) 
7 3% (3) 8% (5) - 
8 3% (3) - 3% (3) 
9 - - - 
10 Extreme distress - - - 
Mean 1.9 1.8 1.6 
Median (IQR) 1 (0-3) 1 (0-3) 1 (0-3) 
% 6-10 10% (11) 10% (6) 6% (6) 
 Kruskal-Wallis test of DT scores between blocks, P=0.52 
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7.8.4.1.  Non-validated post-consultation questionnaire 
 
Non-validated post-consultation questionnaires composed of 6 questions and the 
results are shown in Tables 7.28-.7.34. In question 1, (From your perspective, what 
were the items of your concern that you had wanted to discuss with your doctor during 
the most recent consultation?), the proportion of patients who replied ‘None’ was 
48/111 (43%), 20/59 (34%), and 16/88 (18%) in Blocks 1,2 and 3, respectively (Table 
7.28).  When the details of the self-reported items in question 1 were counted (Table 
7.29), the mean number of items indicated was 0.87 (Block 1), 1.34 (Block 2) and 1.42 
(Block 3), where the difference seen is statistically significant (p=0.002).   
 
In question 2 (How would you rate the extent with which these concerns were 
addressed?), the proportion who strongly agreed was higher in the intervention blocks 
though the differences across blocks were not statistically significant. (Table 7.30).  
 
In question 3 (Were you able to see or be referred to the healthcare professional or 
individual you had hoped to see during your most recent the consultation?), almost all 
patients replied ‘Yes’ i.e. Block 1 (100/102, 98%), Block 2 (55/57, 96%) and Block 3 
(85/86, 99%). (Table 7.31) 
 
In question 4 (To what degree would you agree with the statement: My expectations of 
the consultation were fulfilled in the most recent outpatient clinic visit), those who 
replied “Strongly agree” accounted for 40% (43/108), 59% (33/56) and 58% (53/92) in 
Blocks 1, 2 and 3 respectively. This difference seen across the blocks was not 
statistically significant (p=0.02). (Table 7.32) 
 
In question 5 (To what degree would you agree with the statement: I felt the HN-PCI 
was intrusive), those who replied “Strongly disagree” accounted for 40% (21/53) and 
46% (41/90) in Blocks 2 and 3, respectively. The difference was not statistically 
significant. Those who replied “Agree” and/or “Strongly agree” accounted for 24% 
(13/53) and 6/41 (14%) in Blocks 2 and 3, respectively. (Table 7.33) 
 
In question 6 (To what degree would you agree with the statement: I felt the HN-PCI 
was unhelpful), those who replied “Strongly disagree” accounted for 34% (17/50) and 
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54% (48/89) in Blocks 2 and 3, respectively. The difference was not statistically 
significant (p=0.03). (Table 7.34) 
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Table 7.28. Question 1: From your perspectives, what were the items of your concern 
that you had wanted to discuss with your doctor during the most recent consultation? 
 
BLOCK 1 (N=111/136) 
 N 
 Blood test results 1 
Breathing problems, mouth 
dryness 
1 
Candidal infection 1 
Cough, mucous secretions 1 
Dental pain, ulcer on cheek 1 
Dentures 1 
Drooling 1 
Dry mouth, chewing 1 
Follow up visit 1 
FOR 1 
Gum lesion, Implants 1 
Jaw pain, dental 1 
Life 1 
Medication 1 
Mouth ulcer 1 
Nasal discharge 1 
Neck lump 1 
Neck lump, neck pain 1 
Neck pain, mucus secretions 1 
New cancer 1 
None 48 
Pain in neck & jaw, sore 
throat 
1 
Pain neck & tongue 1 
Prognosis 1 
Progress 8 
Progress, FoR 1 
Progress, Prognosis 2 
Reassurance 1 
Reassurance FoR 1 
Recent chest infection 1 
Recent surgery, results 1 
Recurrence 1 
Recurrence, Rehabilitation 1 
Restorative dentistry 1 
Scan results 1 
SE treatment, after-care 1 
Self-care 1 
Shoulder, lip deformity 1 
Sore mouth, progress 1 
Sore throat, CT request 1 
Sore tongue, neck pain 1 
Speech valve leak 1 
Speech, oral disfigurement, 
abnormal sensations in mouth, 
mouth lesions 
1 
Speech, swallowing, loss of 
sensation to hand & mouth 
1 
Swallowing problem 1 
Swallowing, self-monitoring 1 
Teeth 1 
Thyroxine dosage 1 
Treatment 1 
Treatment outcome, progress 1 
Trismus, Further surgery 1 
Trismus, mouth pain, pain 
elsewhere 
1 
Upcoming breast cancer 
operation and potential 
difficulties with intubation 
1 
Update on condition 1 
Voice, eating 1 
Weight problems, 
medications, blood test 
1 
  
 
BLOCK 2 (n=62/78) 
 N 
  blank 3 
Abnormal lip sensation, leg 
scar itch 
1 
APPEARANCE, CHEWING, 
BREATHING, DENTAL, 
FATIGUE, SWELLING, 
WEIGHT, SWALLOWING 
1 
Blood test, teeth 1 
BREATHING, 
SWALLOWING 
1 
CHEW, TASTE, DENTIST, 
SORE MOUTH 
1 
DENTAL CARE, PROGRESS 1 
Eating, psysio for shoulder, 
cancer recurrence 
1 
FOR 3 
FOR, mood, swelling, 
swallowing, dry mouth 
1 
GWB, CANCER TX 1 
GWB, Check for recurrence 1 
Hearing, chewing 1 
mouth opening, dry mouth, 
chewing 
1 
mouth opening, prognosis 1 
MOUTH OPENING, 
PROGRESS 
1 
mucus, activity 1 
Neck tightness, drooling 1 
next surgery, wound healing 1 
None 20 
PAIN, FOR 1 
PEG, no oral intake for life 1 
Progress 1 
PROGRESS 5 
REASSURANCE 1 
RT side effects 1 
SORE MOUTH, CHEEK 
SWELLING 
1 
Sore mouth, pain 1 
SWELLING 2 
Swelling, pain 1 
teeth, recovery, GWB 1 
Test result 1 
WORK 1 
WOUND, TX REGRETS, 
SWELLING,EMOTIONAL 
1 
  
 
 
 
BLOCK 3 (N=92/111) 
  blank 4 
APPEARANCE, NUMB SKIN 1 
CHEWING, TEETH, MUCUS, 
FOR 
1 
COUGH, CHOKING, MUCUS 1 
DEPRESSION, FOR 1 
DRY MOUTH 2 
DRY MOUTH TEETH 1 
DRY MOUTH, BOWELS, 
EMOTIONAL 
1 
DRY MOUTH, DENTAL 
HEALTH 
1 
DRY MOUTH, SWALLOWING 1 
DRY MOUTH, SWALLOWING, 
APETITE 
1 
FATIGUE, MOUTH OPENING, 
JAW PAIN 
1 
FEELING LOW, ANXIETY, 
COPING 
1 
FOR 6 
FOR, PROGNOSIS 1 
FOR, SIDE-EFFECTS TX 1 
FOR. PROGRESS 1 
HEARING, MOUTH OPENING 1 
HEARING, MUCUS 1 
INDIGESTION 1 
JAW PAIN 2 
MEDICATION, THROAT 
TIGHTENING 
1 
MRI RESULT, FATIGUE, PAIN, 
REFERRALS, JOINT PAIN 
1 
NECK STIFFNESS/PAIN 2 
NEW CANCER 1 
None 16 
PAIN 1 
PAIN, FOR 1 
PAIN, MUCUS 1 
PAIN, SWALLOWING 1 
PEG 1 
PHYSICAL STATE OF TONGUE 1 
PHYSICAL STATE OF VOCAL 
CORDS 
1 
PROGNOSIS, FOR 1 
PROGRESS 2 
REASSURANCES 4 
SCAN RESULTS 1 
SHOULDER 1 
SIDE-EFFECTS OF RT 2 
SKIN ITCH 1 
SORE MOUTH, EATING 1 
SPEECH VALVE 1 
SPEECH, TIREDNESS 1 
SURGERY 1 
SWALLOWING 2 
TEETH 1 
TEETH, CHEWING, FOR 1 
TEETH, MOUTH OPENING 1 
TIREDNESS 1 
TIREDNESS, FEELING LOW, 
SWALLOWING 
1 
TIREDNESS, MEMORY, DRY 
MOUTH 
1 
VOICE 1 
VOICE, SIDE-EFFECTS TX 1 
WEIGHT, FOR, CHILDREN, 
DIET 
1 
WEIGHT, SLEEPING, 
TIREDNESS 
1 
WIFE UNWELL 1 
WOUND 6 
  
 
Abbreviation: GWB, general wellbeing; Tx, treatment; FOR/FoR, fear of recurrence  
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Table 7.29. Number of items of concerns that patient wanted discussing based on 
Question 1. 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=59/78) 
Block 3 
(n=88/111) 
 Number of items 0 43% (48) 34% (20) 18% (16) 
1 31% (34) 25% (15) 43% (38) 
2 23% (25) 29% (17) 24% (21) 
3 3% (3) 5% (3) 9% (8) 
4 1% (1) 3% (2) 5% (4) 
5 - 2% (1) 1% (1) 
8 - 2% (1) - 
Median (IQR) 1 (0-2) 1 (0-2) 1 (1-2) 
Mean 0.87 1.34 1.42 
 
Kruskal-Wallis test of number of items between blocks, P=0.002 
 
 
Table 7.30. Question 2. How would you rate the extent with which these concerns 
were addressed? 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
Strongly agree 31% (34) 42% (26) 48% (44) 
Agree 34% (38) 32% (20) 34% (31) 
Disagree 1% (1) 2% (1) - 
Strongly disagree - - - 
Does not apply 29% (32) 19% (12) 16% (15) 
Missing data 5% (6) 5% (3) 2% (2) 
 
%Strongly agree* 
 
47% (34/73) 
 
55% (26/47) 
 
59% (44/75) 
 
*Chi-squared test of % strongly agree: P=0.32, after excluding ‘Does not apply’ and 
‘missing data’. 
 
 
 
Table 7.31. Question 3. Were you able to see or be referred to the healthcare 
professional or individual you had hoped to see during your most recent the 
consultation? 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
Yes 90% (100) 89% (55) 92% (85) 
No  2% (2) 3% (2) 1% (1) 
Missing data 8% (9) 8% (5) 7% (6) 
 
%Yes* 
 
98% (100/102) 
 
96% (55/57) 
       
       99%(85/86) 
 
* after excluding ‘missing data’. 
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Table 7.32. Question 4. To what degree would you agree with the statement: My 
expectations of the consultation were fulfilled in the most recent outpatient clinic visit. 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
Strongly agree 39% (43) 53% (33) 58% (53) 
Agree 56% (62) 35% (22) 42% (39) 
Disagree 2% (2) 2% (1) - 
Strongly disagree 1% (1) - - 
Does not apply -  6% (4) - 
Missing data 3% (3) 3% (2) - 
 
%Strongly agree* 
 
40% (43/108) 
 
59% (33/56) 
 
58% (53/92) 
 
*Chi-squared test of % strongly agree: P=0.02, after excluding ‘Does not apply’ and 
‘missing data’. 
 
 
Table 7.33. Question 5. To what degree would you agree with the statement: I felt the 
HN-PCI was intrusive. 
 
 
 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
Strongly agree 11% (7) 2% (2) 
Agree 10% (6) 4% (4) 
Disagree 31% (19) 47% (43) 
Strongly disagree 34% (21) 45% (41) 
Does not apply 15% (9) 2% (2) 
Missing data - - 
 
  %Strongly disagree* 
  
40% (21/53) 
 
46% (41/90) 
*after excluding ‘Does not apply’ and ‘missing data’. Fishers exact test P=0.30 
 
Mann-Whitney  test of number of items between blocks, P=0.0.09, after excluding 
‘Does not apply’ and ‘missing data’. 
 
 
Table 7.34. Question 6. To what degree would you agree with the statement: I felt the 
HN-PCI was unhelpful. 
 
 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
Strongly agree 8% (5) 1% (1) 
Agree 3% (2) 2% (2) 
Disagree 42% (26) 41% (38) 
Strongly disagree 27% (17) 52% (48) 
Does not apply 16% (10) 3% (3) 
Missing data 3% (2) - 
    
  %Strongly disagree* 
 
34% (17/50) 
 
54% (48/89) 
 
*after excluding ‘Does not apply’ and ‘missing data’. Fishers exact test  P=0.02 
 
Mann-Whitney test of number of items between blocks, P=0.008, after excluding 
‘Does not apply’ and ‘missing data’. 
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7.8.4.2. Princess Margaret Hospital Satisfaction with Physician Questionnaire (PSQ-
MD) data  
 
PSQ-MD data is summarised in Tables 7.35-7.37. The 24 questions are mixed in 
terms of the direction of the wording, thus Strongly Agree could either be the best or 
worst response depending on the wording of the stem of the question. “Strongly 
Agree” is the best response for questions 1,3,10,11,13,14,15,19,20,21 and 22. 
“Strongly Disagree” is the best response for questions 2,4,5,6,7,8,9,12,16,17,18,23 and 
24.  
 
For scoring purposes, scores were allocated to the responses ‘Strongly Agree’, 
‘Agree’, ‘Disagree’, ‘Strongly Disagree’ so that the best response scores 4 and the 
worse scores 1. Any question with ‘Does not apply’ or ‘Missing data’ did not get 
scored. The average score for relevant questions was computed for each patient and 
then scaled from 0 to 100 where 100 is the best score and 0 the worst score.   
 
Table 7.35. Results of the PSQ-MD detailing individual question  
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM1. I will follow the 
doctor’s advice because I 
think s/he is absolutely 
right. 
1 Strongly Agree 48 31 36 
2 Agree 51 21 43 
3 Disagree 0 0 1 
5 Does Not Apply 10 10 12 
9 Missing data 2 0 0 
% Strongly Agree* 48% (48/99) 60% (31/52) 45% (36/80) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.23, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM2. The doctor did not 
take my problems very 
seriously. 
1 Strongly Agree 2 0 0 
2 Agree 2 2 1 
3 Disagree 43 13 40 
4 Strongly Disagree 45 41 45 
5 Does Not Apply 16 5 6 
9 Missing data 3 1 0 
% Strongly Disagree* 49% (45/92) 73% (41/56) 52% (45/86) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.02, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM3. The doctor 
considered my individual 
needs when treating my 
condition. 
1 Strongly Agree 41 28 34 
2 Agree 50 25 49 
3 Disagree 4 0 1 
5 Does Not Apply 14 8 7 
9 Missing data 2 1 1 
% Strongly Agree* 43% (41/95) 53% (28/53) 40% (34/84) 
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* after excluding ‘Does not Apply’ and ‘Missing data’Kruskal-Wallis test P=0.30, after excluding ‘Does not Apply’ 
and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM4 .The doctor did not 
give me all the information 
I thought I should have 
been given. 
1 Strongly Agree 2 1 1 
2 Agree 2 1 0 
3 Disagree 55 19 42 
4 Strongly Disagree 35 37 43 
5 Does Not Apply 13 4 4 
9 Missing data 4 0 2 
% Strongly Disagree* 37% (35/94) 64% (37/58) 50% (43/86) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.007, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM5. The doctor went 
straight to my medical 
problem without greeting 
me first. 
2 Agree 1 1 0 
3 Disagree 52 17 44 
4 Strongly Disagree 53 39 44 
5 Does Not Apply 3 5 3 
9 Missing data 2 0 1 
% Strongly Disagree* 50% (53/106) 68% (39/57) 50% (44/88) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.06, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM6. The doctor used 
words I did not 
understand. 
1 Strongly Agree 1 0 0 
2 Agree 7 1 2 
3 Disagree 52 14 50 
4 Strongly Disagree 44 42 38 
5 Does Not Apply 5 3 2 
9 Missing data 2 2 0 
% Strongly Disagree* 42% (44/104) 74% (42/57) 42% (38/90) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P<0.001, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM7. There was not 
enough time to tell the 
doctor everything I 
wanted. 
1 Strongly Agree 2 0 1 
2 Agree 3 0 0 
3 Disagree 56 20 42 
4 Strongly Disagree 42 38 47 
5 Does Not Apply 5 3 2 
9 Missing data 3 1 0 
% Strongly Disagree* 40% (42/103) 66% (38/58) 52% (47/90) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.005, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM8. I feel the doctor did 
not spend enough time with 
me. 
1 Strongly Agree 3 0 0 
2 Agree 5 2 0 
3 Disagree 55 20 52 
4 Strongly Disagree 44 39 39 
5 Does Not Apply 1 1 1 
9 Missing data 3 0 0 
% Strongly Disagree* 41% (44/107) 64% (39/61) 43% (39/91) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.01, after excluding ‘Does not Apply’ and ‘Missing data’ 
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Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM9. It seemed to me that 
the doctor was not really 
interested in my emotional 
well-being. 
1 Strongly Agree 2 0 0 
2 Agree 4 0 4 
3 Disagree 53 15 26 
4 Strongly Disagree 47 43 59 
5 Does Not Apply 4 3 3 
9 Missing data 1 1 0 
% Strongly Disagree* 44% (47/106) 74% (43/58) 66% (59/89) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P<0.001, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM10. I really felt 
understood by my doctor. 
1 Strongly Agree 43 29 47 
2 Agree 59 31 39 
3 Disagree 4 0 4 
4 Strongly Disagree 2 1 0 
5 Does Not Apply 2 1 2 
9 Missing data 1 0 0 
% Strongly Agree* 40% (43/108) 48% (29/61) 52% (47/90) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.20, after excluding ‘Does not Apply’ and ‘Missing data 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM11.  After my last visit 
with my doctor, I feel much 
better about my concerns. 
1 Strongly Agree 32 18 39 
2 Agree 57 40 42 
3 Disagree 8 0 8 
4 Strongly Disagree 1 1 1 
5 Does Not Apply 12 3 1 
9 Missing data 1 0 1 
% Strongly Agree* 33% (32/98) 31% (18/59) 43% (39/90) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.44, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM12 .The doctor was not 
friendly to me. 
1 Strongly Agree 1 0 0 
2 Agree 2 0 0 
3 Disagree 46 21 32 
4 Strongly Disagree 59 40 59 
5 Does Not Apply 1 0 1 
9 Missing data 2 1 0 
% Strongly Disagree* 55% (59/108) 66% (40/61) 65% (59/91) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.18, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM13. I understand my 
illness much better after 
seeing this doctor. 
1 Strongly Agree 30 18 22 
2 Agree 55 26 43 
3 Disagree 4 0 13 
5 Does Not Apply 21 17 14 
9 Missing data 1 1 0 
% Strongly Agree* 34% (30/89) 41% (18/44) 28% (22/78) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.04, after excluding ‘Does not Apply’ and ‘Missing data’ 
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Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM14. This doctor was 
interested in me as a 
person and not just my 
illness. 
1 Strongly Agree 29 24 41 
2 Agree 73 30 42 
3 Disagree 6 3 2 
4 Strongly Disagree 1 2 0 
5 Does Not Apply 1 2 7 
9 Missing data 1 1 0 
% Strongly Agree* 27% (29/109) 41% (24/59) 48% (41/85) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.007, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM15. I feel I understand 
pretty well the doctor’s plan 
for helping me. 
1 Strongly Agree 33 25 37 
2 Agree 65 26 39 
3 Disagree 2 0 0 
4 Strongly Disagree 0 1 0 
5 Does Not Apply 10 10 16 
9 Missing data 1 0 0 
% Strongly Agree* 33% (33/100) 48% (25/52) 49% (37/76) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.06, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM16. I would not 
recommend this doctor to a 
friend. 
2 Agree 1 1 1 
3 Disagree 39 12 25 
4 Strongly Disagree 66 45 63 
5 Does Not Apply 4 3 3 
9 Missing data 1 1 0 
% Strongly Disagree* 62% (66/106) 78% (45/58) 71% (63/89) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.13, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM17. The doctor seemed 
to brush off my questions. 
1 Strongly Agree 1 1 0 
2 Agree 0 1 0 
3 Disagree 45 15 43 
4 Strongly Disagree 59 43 45 
5 Does Not Apply 4 1 4 
9 Missing data 2 1 0 
% Strongly Disagree* 56% (59/105) 72% (43/60) 51% (45/88) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.07, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM18. The doctor should 
have told me more about 
how to care for my 
condition. 
2 Agree 8 2 0 
3 Disagree 52 17 48 
4 Strongly Disagree 39 33 35 
5 Does Not Apply 11 10 9 
9 Missing data 1 0 0 
% Strongly Disagree* 39% (39/99) 63% (33/52) 42% (35/83) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.02, after excluding ‘Does not Apply’ and ‘Missing data’ 
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Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM19. After talking with 
the doctor, I have a good 
idea of what changes to 
expect in my health over 
the next few weeks and 
months. 
1 Strongly Agree 25 22 31 
2 Agree 61 21 48 
3 Disagree 4 1 3 
4 Strongly Disagree 1 2 0 
5 Does Not Apply 19 16 10 
9 Missing data 1 0 0 
% Strongly Agree* 27% (25/91) 48% (22/46) 38% (31/82) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.10, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM20 .The doctor told me 
to call back if I had any 
questions or problems. 
1 Strongly Agree 32 25 47 
2 Agree 53 25 40 
3 Disagree 6 1 4 
5 Does Not Apply 17 8 1 
9 Missing data 3 3 0 
% Strongly Agree* 35% (32/91) 49% (25/51) 52% (47/91) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.06, after excluding ‘Does not Apply’ and ‘Missing data 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM21. I felt the doctor was 
being honest with me. 
1 Strongly Agree 41 29 53 
2 Agree 64 28 39 
3 Disagree 0 1 0 
4 Strongly Disagree 2 0 0 
5 Does Not Apply 3 4 0 
9 Missing data 1 0 0 
% Strongly Agree* (41/107) 50% (29/58) (53/92) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.02, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM22. The doctor 
explained the  reason why 
the treatment was 
recommended for me. 
1 Strongly Agree 29 20 31 
2 Agree 58 22 44 
4 Strongly Disagree 0 2 0 
5 Does Not Apply 23 18 17 
9 Missing data 1 0 0 
% Strongly Agree* (29/87) (20/44) (31/75) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.48, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM23. It seemed to me that 
the doctor was not really 
interested in my physical 
well-being. 
1 Strongly Agree 1 1 0 
2 Agree 1 0 1 
3 Disagree 46 16 30 
4 Strongly Disagree 58 41 55 
5 Does Not Apply 4 4 6 
9 Missing data 1 0 0 
% Strongly Disagree* (58/106) (41/58) (55/86) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.12, after excluding ‘Does not Apply’ and ‘Missing data’ 
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Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
PM24. The doctor 
should have shown more 
interest. 
2 Agree 2 1 0 
3 Disagree 46 14 29 
4 Strongly Disagree 61 39 61 
5 Does Not Apply 1 5 1 
9 Missing data 1 3 1 
% Strongly Disagree* (61/109) (39/54) (61/90) 
* after excluding ‘Does not Apply’ and ‘Missing data’ 
Kruskal-Wallis test P=0.07, after excluding ‘Does not Apply’ and ‘Missing data’ 
 
 
 
Table 7.36. Scoring system for PSQ-MD 
 
 
Block 1 
(n=111/136) 
Block 2 
(N=62/78) 
Block 3 
(n=92/111) 
P 
value
** 
Median (IQR) score 80 (67-91) 86 (74-96) 83 (74-93) 
0.02 
Mean 79.4 84.6 82.9 
Median (IQR) N of questions with scoreable* 
responses 
23 (21-24) 23 (21-24) 24 (22-24) 0.05 
Mean 21.8 21.4 22.5  
* ‘Strongly Agree’, ‘Agree’, ‘Disagree’, ‘Strongly Disagree’   
**Kruskal-Wallis test 
 
 
 
Table 7.37. Drop-plot showing PSQ-MD scores across Blocks 
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7.8.5. Relationship between HN-PCI and Distress 
 
In this section, analysis was restricted to one consultation per patient to reduce the bias 
introduced by repeated exposure to the HN-PCI. The consultation selected was the 
patient’s first attendance at clinics in study Blocks 2 and 3 during which they first used 
the PCI. Based on this criteria, one-hundred and seventy patients (n=170) were 
considered for analysis.  
 
The mean DT score overall was 2.9 and the median (IQR) was 2 (0-5).  The overall 
rate of significant distress (i.e. DT cut-off score of ≥4) was 36% (62/170). Thus, about 
two-thirds (64%, 108/170) of this cohort at clinic did not report significant distress.   
 
Overall, the number of HN-PCI items of concern selected ranged from 0-18, mean 
3.63, median 2 (IQR, 1-5). Patients with significant distress selected more items 
overall than patients without distress (Significant distress: mean, 5.4; median, 5; IQR, 
2-8 versus no distress: mean, 2.61; median, 2; IQR, 0-4) (Mann-Whitney test 
p<0.001).  More specifically, patients with significant distress had more concerns from 
within the Physical and Functional well-being domain (mean, 3.87 versus 1.96) and 
the Psychological and Emotional well-being domain (1.16 versus 0.46) than from the 
Social care/Social well-being domain (0.21 versus 0.10) and Treatment-related domain 
(0.16 versus 0.08). The association between HN-PCI items of concern and significant 
distress is summarised in Table 7.38.  
 
There were trends within each domain for the likelihood of significant distress to 
increase with the number of concerns selected and for this to be compounded within 
the total score. In stepwise logistic regression to predict significant distress using the 
category variables within Table 7.38, the total number of concerns was the only 
variable selected (at p<0.001) in regression modelling with p<0.01 inclusion criteria. 
Three distinct predictive groups were apparent:  20% of patients selecting zero items 
of concern - 9% (3/35) distressed, 47% selecting 1-4 items - 30% (24/80) distressed, 
and 32% selecting 5 or more items - 64% (35/55) distressed.  Possible cut-offs in the 
number of HN-PCI items of concern selected in relation to significant distress are 
explored in Table 7.39. Specific HN-PCI items of concern associated with significant 
distress are shown in Table 7.40. 
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Table 7.38. Number of HN-PCI items selected and significant distress (DT≥4) 
 
 
Significant distress 
(DT≥4) 
 
 % n P value* 
Physical & functional well-being    
0 20% 11/56  
1-2 32% 16/50  
3-4 42% 13/31 <0.001 
5-9 71% 17/24  
≥10 (range 10-15) 56% 5/9  
Treatment related     
0 35% 53/152 
0.30 
≥1 (range 1-2) 50% 9/18 
Social care & social well-being    
0 33% 50/150 
0.03 
≥1 (range 1-3) 60% 12/20 
Psychological, emotional & spiritual wellbeing  
0 28% 28/100  
1-2 42% 24/57 0.001 
≥3 (range 3-6) 77% 10/13  
Total number of items    
0 9% 3/35  
1-2 30% 17/56  
3-4 29% 7/24 <0.001 
5-9 61% 25/41  
≥10 (range 10-18) 71% 10/14  
Health professionals    
0 31% 37/121 
0.01 
≥1 (range 1-4) 51% 25/49 
*chi-square test (physical & functional, psychological emotional & spiritual well-being, total number), otherwise 
Fisher's exact test.  
 
 
Table 7.39.  Possible cut-offs in the number of HN-PCI items in relation to significant 
distress 
 
Number of 
total PCI items 
as cut-off 
Sensitivity Specificity 
Positive 
Predictive 
Value 
Negative 
Predictive 
Value 
≥1 95% (59/62) 30% (32/108) 44% (59/135) 91% (32/35) 
≥2 82% (51/62) 49% (53/108) 48% (51/106) 83% (53/64) 
≥3 68% (42/62) 66% (71/108) 53% (42/79) 78% (71/91) 
≥4 61% (38/62) 72% (78/108) 56% (38/68) 76% (78/102) 
≥5 56% (35/62) 81% (88/108) 64% (35/55) 77% (88/115) 
≥6 42% (26/62) 88% (95/108) 67% (26/39) 73% (95/131) 
≥7 34% (21/62) 90% (97/108) 66% (21/32) 70% (97/138) 
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Table 7.40. Specific HN-PCI items associated with significant DT distress  
 
 PCI item selected 
%DT score ≥4 
PCI item not selected 
%DT score ≥4 
P value* 
PCI item 
Anxiety 77 10/13 33 52/157 0.005 
Bowel 78 7/9 34 55/161 0.01 
Depression 88 7/8 34 55/162 0.004 
Fatigue 62 21/34 30 41/136 0.001 
Mood 78 7/9 34 55/161 0.01 
Pain in head/neck 65 17/26 31 45/144 0.002 
Sleeping 65 13/20 33 49/150 0.007 
Swallowing 67 20/30 30 42/140 <0.001 
*Fishers exact test 
 
Distress and patient concerns and length of consultation 
 
The median (IQR) number of concerns discussed in consultations was 3 (2-5) items, 
n=141.  When patients were distressed and ≤ 3 items of concern were discussed (19 
patients), the median (IQR) length of consultation was 4.2 (3.1-6.0) minutes; when ≥ 4 
items of concern were discussed (33 patients), the median (IQR) consultation length 
was 8.4 (5.5-12.1) minutes (Mann-Whitney test, p<0.001). In the absence of distress 
and ≤ 3 items were discussed (63 patients), the median (IQR) length of consultation 
was 3.3 (2.6-6.2) minutes; when ≥ 4 items were discussed (26 patients) the median 
(IQR) consultation length was 6.4 (4.3-8.9) minutes (Mann-Whitney test, p<0.001). 
 
Distress and perceived need for services 
 
Overall, the number of professionals selected ranged from 0-4, mean 0.38, median 
(IQR) 0 (0-1), n=170, with a mean 0.53 selected in those with significant distress and a 
mean 0.30 without significant distress.  No strong associations were found with type 
of professional selected, though it was noted that 52% (11/21) of those wanting to see 
the surgeon were distressed, 83% (5/6) of those wanting to see the physiotherapist, and 
all those wanting to see either a psychologist (2/2) or Emotional Support therapist 
(2/2).  
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The number of medical actions taken based on audiotaped consultations (n=141) 
ranged from 1 to 4, and the percentage when ≥ 2 actions was 52% (27/52) for those 
with significant distress and 29% (26/89) without distress (Fishers exact test, p=0.01). 
In regard to non-medical actions (range 2-4), the percentage when ≥ 3 actions was 
37% (19/52) for those with significant distress and 21% (19/89) without distress 
(Fishers exact test, p=0.18).  
 
7.8.6. Relationship between clinical variables in relation to consultations with 
HN-PCI intervention  
 
More detailed analysis was undertaken in Block 3. The clinical variables considered 
were gender, age, diagnosis, tumour site, overall stage, treatment, free flap 
reconstruction, years from diagnosis, surgeons/doctors, and specialty.  The outcomes 
of consultation considered include HN-PCI domains and items, the PROC and the 
PSQ-MD scores. Each clinical variable was analysed in turn against summarised 
outcomes. The most appropriate statistical test was undertaken during analysis across 
all categories and this is detailed in the table showing the results.  
 
Results of clinical significance (while showing either significant or borderline 
statistical significance) are summarised as follows: 
a. Gender (Table 7.41): Females were more likely to discuss items within the 
Psychological emotional or spiritual wellbeing, and were more likely to give 
favourable responses to the post-consultation question 2.  
 
b. Age-group (Table 7.42):   Patients <55 years had longer consultation length, had 
more discussions of Psychological/emotional or spiritual wellbeing, had more 
discussions about Pain in head and neck, and received more medical actions.  
 
c. Specialty (Table 7.43): Compared with OMF patients, ENT patients had fewer 
discussions in the Treatment-related domain and ‘Dental health/teeth’, more 
discussions of Psychological/emotional or spiritual wellbeing, and ‘Dry mouth’. ENT 
patients also had more discussion of referral to other health professionals. ENT 
patients were more likely to give favourable responses to the post-consultation 
question, and had better overall PSQ-MD scores. 
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d. Surgeons (Table 7.44):  There were notable inter-surgeon differences in 
consultation length, Treatment-related discussions, and in discussions of referral to 
other health professionals, and medical actions.  
 
e. Tumour site (Table 7.45):  Patients with primary larynx tumours were more 
likely to have more Social care and social well-being discussions, and have more 
discussions regarding ‘Speech/voice/understood’. Patients with oral cavity and 
oropharynx primary sites had more discussions regarding ‘Swallowing’, and ‘Dental 
health/teeth’. Patients with oropharynx primary had more discussions with ‘Dry 
mouth’.  
 
f. Overall p-stage (Table 7.46):  Consultation length increased with stage, as did 
discussions about Physical and functional wellbeing, and overall number of HN-PCI 
items discussed. 
 
g. Years from primary diagnosis (Table 7.47):  Consultation length fell with 
time, less discussion > 3 years about Physical and functional wellbeing, and in overall 
number of HN-PCI items discussed. 
 
h. Free flap reconstruction (Table 7.48): Patients who received free flap 
reconstruction had longer length of discussion, and had more discussions about 
‘Dental health/teeth’ compared with those who did not have surgery and/or those who 
underwent surgery without free flap reconstruction. 
 
g. Treatment (Table 7.49):  Those receiving RT had more discussions about ‘Dry 
mouth’ than those who did not receive RT.   
 
There were no notable associations seen in Diagnosis (Table 7.50).  
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Table 7.41. Gender 
 
  Male Female P value* 
Distress Mean (SE) 1.45 (0.28) 1.79 (0.36) 
0.25 
 %6-10 5% (3/60) 9% (3/33) 
Post consultation Q Mean (SE) 1.49 (0.14) 1.29 (0.22) 
0.24 # on Q1A % 2 or more 42% (24/57) 32% 
(10/31) 
Post consultation Q % Q2 SA 52% (27/52) 74% 
(17/23) 
0.08 
 % Q3 YES 98% (55/56) 100% 
(30/30) 
- 
 % Q4 SA 59% (35/59) 55% 
(18/33) 
0.66 
 % Q5 SD 46% (27/59) 45% 
(14/31) 
0.97 
 % Q6 SD 53% (30/57) 56% 
(18/32) 
0.74 
Princess Margaret Mean (SE) 83.1 (1.5) 82.7 (2.3) 
0.86 
Q score 0-100 Median (IQR) 83 (74-93) 84 (71-95) 
Consultation Mean (SE) 403 (39) 469 (74) 
0.28 Length (sec) Median (IQR) 302 (191-501) 393 207-
534) 
Audio taped 
# Items discussed 
D1 mean (SE),  %≥1 item 2.63 (0.34) 
84% (56/67) 
3.03 (0.51) 
76% 
(25/33) 
0.57 
D2 mean (SE),  %≥1 item 0.58 (0.07) 
54% (36/67) 
0.64 (0.11) 
58% 
(19/33) 
0.68 
 D3 mean (SE),  %≥1 item 0.48 (0.09) 
36% (24/67) 
0.55 (0.15) 
36% 
(12/33) 
0.81 
 D4 mean (SE),  %≥1 item 0.55 (0.12) 
36% (24/67) 
1.18 (0.31) 
52% 
(17/33) 
0.06 
 PCI mean (SE), %≥1 item 4.24 (0.43) 
94% (63/67) 
5.39 (0.80) 
97% 
(32/33) 
0.27 
 PCI-HP mean (SE), %≥1 
item 
0.63 (0.10) 
45% (30/67) 
0.55 (0.19) 
30% 
(10/33) 
0.24 
Discussion of % Cancer treatment 43% (29/67) 58% 
(19/33) 
0.21 
Common items % FOR 25% (17/67) 39% 
(13/33) 
0.17 
 % Swallowing 27% (18/67) 27% (9/33) >0.99 
 % Dental health/teeth 21% (14/67) 33% 
(11/33) 
0.22 
 % Dry mouth 25% (17/67) 21% (7/33) 0.80 
 % Pain in head/neck 19% (13/67) 24% (8/33) 0.61 
 % Speech/voice/understood 22% (15/67) 15% (5/33) 0.44 
 % Fatigue/tiredness 16% (11/67) 21% (7/33) 0.59 
Medical actions % 2 or more 46% (31/67) 36% 
(12/33) 
0.32 
Non-medical actions % 3 or more 28% (19/67) 27% (9/33) 0.91 
*Fishers exact test for Post consultation Q3, discussion of common items; otherwise Mann-Whitney test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.42. Age group 
 
  <55 55-64 65-74 75+ P 
value
* 
Distress Mean (SE) 2.85 (0.72) 1.38 (0.37) 1.13 (0.31) 1.50 (0.56) 
0.14 
 %6-10 15% (2/13) 6% (2/32) 0% (0/30) 13% (2/16) 
Post consultation Q Mean (SE) 2.08 (0.43) 1.34 (0.18) 1.25 (0.16) 1.37 (0.32) 
0.38 
# on Q1A % 2 or more 62% (8/13) 31% (9/29) 36% (10/28) 44% (7/16) 
Post consultation Q % Q2 SA 55% (6/11) 56% (15/27) 70% (16/23) 50% (6/12) 0.65 
 % Q3 YES 100% (13/13) 100% (29/29) 96% (26/27) 100% (15/15) - 
 % Q4 SA 54% (7/13) 55% (17/31) 57% (17/30) 69% (11/16) 0.81 
 % Q5 SD 62% (8/13) 40% (12/30) 45% (13/29) 44% (7/16) 0.55 
 % Q6 SD 62% (8/13) 45% (13/29) 70% (21/30) 40% (6/15) 0.08 
Princess Margaret Mean (SE) 85.6 (3.9) 80.3 (2.0) 84.7 (2.3) 81.5 (3.1) 
0.43 
Q score 0-100 Median (IQR) 89 (70-99) 80 (72-89) 86 (74-96) 80 (74-93) 
Consultation Mean (SE) 706 (154) 350 (48) 380 (40) 438 (83) 
0.02 length Median (IQR) 496 (327-792) 226 (154-484) 376 (205-
438) 
393 (174-511) 
Audio taped 
# Items discussed 
D1 mean (SE),  
%≥1 item 
3.20 (0.69) 
80% (12/15) 
2.38 (0.41) 
78% (29/37) 
2.81 (0.49) 
91% (29/32) 
3.33 (0.97) 
73% (11/15) 
0.66 
D2 mean (SE),  
%≥1 item 
0.47 (0.13) 
47% (7/15) 
0.65 (0.10) 
59% (22/37) 
0.59 (0.11) 
53% (17/32) 
0.67 (0.16) 
60% (9/16) 
0.77 
 D3 mean (SE),  
%≥1 item 
0.47 (0.26) 
20% (3/15) 
0.49 (0.11) 
41% (15/37) 
0.50 (0.13) 
38% (12/32) 
0.40 (0.16) 
33% (5/16) 
0.82 
 D4 mean (SE),  
%≥1 item 
2.13 (0.64) 
60% (9/15) 
0.49 (0.14) 
32% (12/37) 
0.63 (0.15) 
44% (14/32) 
0.40 (0.13) 
40% (6/15) 
0.06 
 PCI mean (SE), 
%≥1 item 
6.27 (1.46) 
93% (14/15) 
4.00 (0.51) 
97% (36/37) 
4.53 (0.61) 
97% (31/32) 
4.80 (1.22) 
87% (13/15) 
0.70 
 PCI-HP mean (SE), 
%≥1 item 
1.07 (0.38) 
53% (8/15) 
0.57 (0.13) 
41% (15/37) 
0.53 (0.14) 
38% (12/32) 
0.40 (0.16) 
33% (5/15) 
0.57 
Discussion of % Cancer treatment 33% (5/15) 49% (18/37) 50% (16/32) 60% (9/15) 0.53 
Common items % FOR 53% (8/15) 24% (9/37) 28% (9/32) 27% (4/15) 0.21 
 % Swallowing 33% (5/15) 30% (11/37) 22% (7/32) 27% (4/15) 0.83 
 % Dental 
health/teeth 
27% (4/15) 24% (9/37) 25% (8/32) 27% (4/15) 0.98 
 % Dry mouth 13% (2/15) 24% (9/37) 28% (9/32) 27% (4/15) 0.73 
 % Pain in 
head/neck 
33% (5/15) 19% (7/37) 9% (3/32) 40% (6/15) 0.06 
 % 
Speech/voice/under
stood 
7% (1/15) 19% (7/37) 25% (8/32) 20% (3/15) 0.53 
 % Fatigue/tiredness 27% (4/15) 19% (7/37) 9% (3/32) 27% (4/15) 0.37 
Medical actions % 2 or more 73% (11/15) 35% (13/37) 38% (12/32) 47% (7/15) 0.05 
Non-medical 
actions 
% 3 or more 33% (5/15) 30% (11/37) 28% (9/32) 20% (3/15) 0.87 
*Chi-squared test for Post consultation Q3, discussion of common items; otherwise Kruskal-Wallis test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.43. Specialty 
 
  OMF ENT P value* 
Distress Mean (SE) 1.53 (0.27) 1.60 (0.35) 
0.73 
 %6-10 2% (1/45) 10% (5/48) 
Post consultation Q Mean (SE) 1.18 (0.14) 1.66 (0.19) 
0.07 
# on Q1A % 2 or more 30% (13/44) 48% (21/44) 
Post consultation Q % Q2 SA 49% (18/37) 68% (26/38) 0.08 
 % Q3 YES 97% (38/39) 100% (47/47) - 
 % Q4 SA 44% (20/45) 70% (33/47) 0.01 
 % Q5 SD 44% (20/45) 47% (21/45) 0.96 
 % Q6 SD 50% (22/44) 58% (26/45) 0.42 
Princess Margaret Mean (SE) 80.4 (1.8) 85.2 (1.7) 
0.06 
Q score 0-100 Median (IQR) 82 (70-91) 88 (75-96) 
Consultation Mean (SE) 399 (41) 447 (56) 
0.87 Length (sec) Median (IQR) 333 (191-492) 332 (198-
547) 
Audio taped 
# Items discussed 
D1 mean (SE),  %≥1 item 2.45 (0.40) 
79% (37/47) 
3.04 (0.39) 
83% (44/53) 
0.24 
D2 mean (SE),  %≥1 item 0.81 (0.09) 
70% (33/47) 
0.42 (0.07) 
42% (22/53) 
0.001 
 D3 mean (SE),  %≥1 item 0.47 (0.11) 
32% (15/47) 
0.53 (0.11) 
40% (21/53) 
0.55 
 D4 mean (SE),  %≥1 item 0.49 (0.13) 
32% (15/47) 
1.00 (0.22) 
49% (26/53) 
0.06 
 PCI mean (SE), %≥1 item 4.21 (0.51) 
96% (45/47) 
4.98 (0.58) 
94% (50) 
0.41 
 PCI-HP mean (SE), %≥1 item 0.26 (0.09) 
19% (9/47) 
0.91 (0.14) 
58% (31/53) 
<0.001 
Discussion of % Cancer treatment 62% (29/47) 36% (19/53) 0.02 
Common items % FOR 23% (11/47) 36% (19/53) 0.20 
 % Swallowing 17% (8/47) 36% (19/53) 0.04 
 % Dental health/teeth 36% (17/47) 15% (8/53) 0.02 
 % Dry mouth 15% (7/47) 32% (17/53) 0.06 
 % Pain in head/neck 15% (7/47) 26% (14/53) 0.22 
 % Speech/voice/understood 11% (5/47) 28% (15/53) 0.04 
 % Fatigue/tiredness 13% (6/47) 23% (12/53) 0.30 
Medical actions % 2 or more 32% (15/47) 53% (28/53) 0.06 
Non-medical actions % 3 or more 23% (11/47) 32% (17/53) 0.34 
*Fishers exact test for Post consultation Q3, discussion of common items; otherwise Mann-Whitney test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.44. Surgeon 
 
  Surgeon 1 Surgeon 2 Surgeon 3 Surgeon 4 P value* 
Distress Mean (SE) 0.95 (0.30) 2.09 (0.42) 2.14 (0.58) 1.15 (0.40) 
0.09 
 %6-10 0% (0/22) 4% (1/23) 18% (4/22) 4% (1/26) 
Post consultation Q Mean (SE) 1.19 (0.18) 1.17 (0.21) 2.05 (0.30) 1.27 (0.20) 
0.06 # on Q1A % 2 or more 33% (7/21) 26% (6/23) 64% 
(14/22) 
32% (7/22) 
Post consultation Q % Q2 SA 56% (10/18) 42% (8/19) 68% 
(13/19) 
68% (13/19) 
0.30 
 % Q3 YES 100% (20/20) 95% 
(18/19) 
100% 
(22/22) 
100% (25/25) 
- 
 % Q4 SA 45% (10/22) 43% 
(10/23) 
59% 
(13/22) 
80% (20/25) 
0.04 
 % Q5 SD 45% (10/22) 43% 
(10/23) 
45% 
(10/22) 
48% (11/23) 
>0.99 
 % Q6 SD 50% (11/22) 50% 
(11/22) 
59% 
(13/22) 
57% (13/23) 
0.89 
Princess Margaret Mean (SE) 78.7 (2.6) 82.1 (2.6) 84.2 (2.7) 86.1 (2.2) 
0.22 
Q score 0-100 Median (IQR) 79 (68-85) 83 (71-92) 82 (73-98) 88 (75-95) 
Consultation Mean (SE) 285 (38) 509 (66) 561 (101) 353 (56) 
0.002 length Median (IQR) 214 (157-
386) 
454 (288-
674) 
400 (250-
684) 
241 (158-414) 
Audio taped 
# Items discussed 
D1 mean (SE),  
%≥1 item 
2.09 (0.50) 
78% (18/23) 
2.79 (0.63) 
79% 
(19/24) 
3.92 (0.66) 
88% 
(21/25) 
2.31 (0.43) 
79% (23/29) 0.15 
D2 mean (SE),  
%≥1 item 
0.87 (0.11) 
78% (18/23) 
0.75 (0.14) 
63% 
(15/24) 
0.21 (0.09) 
21% (5/24) 
0.59 (0.09) 
59% (17/29) 0.001 
 D3 mean (SE),  
%≥1 item 
0.48 (0.17) 
35% (8/23) 
0.46 (0.16) 
29% (7/24) 
0.58 (0.17) 
42% 
(10/24) 
0.48 (0.14) 
38% (11/29) 0.91 
 D4 mean (SE),  
%≥1 item 
0.30 (0.15) 
22% (5/23) 
0.67 (0.21) 
42% 
(10/24) 
1.46 (0.41) 
54% 
(13/24) 
0.62 (0.19) 
45% (13/29) 0.06 
 PCI mean (SE), 
%≥1 item 
3.74 (0.60) 
100% (23/23) 
1.67 (0.83) 
92% 
(22/24) 
6.17 (1.06) 
92% 
(22/24) 
4.00 (0.56) 
97% (28/29) 0.35 
 PCI-HP mean 
(SE), %≥1 item 
0.09 (0.06) 
9% (2/23) 
0.42 (0.16) 
29% (7/24) 
1.13 (0.26) 
63% 
(15/24) 
0.72 (0.15) 
55% (16/29) <0.001 
Discussion of % Cancer 
treatment 
70% (16/23) 54% 
(13/24) 
21% (5/24) 48% (14/29) 0.008 
Common items % FOR 13% (3/23) 33% (8/24) 38% (9/24) 35% (10/29) 0.24 
 % Swallowing 26% (6/23) 8% (2/24) 29% (7/24) 41% (12/29) 0.06 
 % Dental 
health/teeth 
17% (4/23) 54% 
(13/24) 
21% (5/24) 10% (3/29) 0.002 
 % Dry mouth 9% (2/23) 21% (5/24) 25% (6/24) 38% (11/29) 0.10 
 % Pain in 
head/neck 
13% (3/23) 17% (4/24) 29% (7/24) 24% (7/29) 0.52 
 % Speech/voice/ 
understood 
17% (4/23) 4% (1/24) 29% (7/24) 28% (8/29) 0.10 
 % 
Fatigue/tirednes
s 
9% (2/23) 17% (4/24) 33% (8/24) 14% (4/29) 0.14 
Medical actions % 2 or more 17% (4/23) 46% 
(11/24) 
79% 
(19/24) 
31% (9/29) <0.001 
Non-medical actions % 3 or more 26% (6/23) 21% (5/24) 38% (9/24) 28% (8/29) 0.63 
*Chi-squared test for Post consultation Q3, discussion of common items; otherwise Kruskal-Wallis test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.45. Tumour site 
 
  
Oral 
Oro-
pharyngeal 
Laryngeal Other 
P 
value* 
Distress Mean (SE) 1.78 (0.33) 0.94 (0.38) 1.19 (0.52) 2.14 (0.52) 
0.09 
 %6-10 3% (1/32) 0% (0/18) 10% (2/21) 14% (3/22) 
Post consultation Q Mean (SE) 1.19 (0.16) 1.89 (0.29) 1.28 (0.20) 1.48 (0.30) 
0.25 
# on Q1A % 2 or more 29% (9/31) 56% (10/18) 39% (7/18) 38% (8/21) 
Post consultation Q % Q2 SA 52% (14/27) 63% (10/16) 53% (8/15) 71% 
(12/17) 
0.62 
 % Q3 YES 96% (26/27) 100% 
(18/18) 
100% 
(20/20) 
100% 
(21/21) 
- 
 % Q4 SA 44% (14/32) 61% (11/18) 85% 
(17/20) 
50% 
(11/22) 
0.03 
 % Q5 SD 38% (12/32) 56% (10/18) 42% (8/19) 52% 
(11/21) 
0.59 
 % Q6 SD 42% (13/31) 72% (13/18) 44% (8/18) 64% 
(14/22) 
0.10 
Princess Margaret Mean (SE) 81.6 (2.1) 81.3 (3.3) 87.9 (2.4) 81.7 (2.4) 
0.23 
Q score 0-100 Median (IQR) 83 (70-91) 82 (68-94) 89 (76-99) 81 (71-93) 
Consultation Mean (SE) 384 (47) 498 (68) 323 (49) 524 (124) 
0.13 length Median (IQR) 305 (195-499) 434 (218-
685) 
232 (157-
385) 
340 (230-
504) 
Audio taped 
# Items discussed 
D1 mean (SE),  %≥1 
item 
2.19 (0.50) 
72% (23/32) 
3.79 (0.69) 
88% (21/24) 
2.17 (0.38) 
83% 
(20/24) 
3.15 (0.63) 
85% 
(17/20) 
0.11 
D2 mean (SE),  %≥1 
item 
0.75 (0.11) 
66% (21/32) 
0.75 (0.12) 
67% (16/24) 
0.46 (0.10) 
46% 
(11/24) 
0.35 (0.11) 
35% (7/20) 0.04 
 D3 mean (SE),  %≥1 
item 
0.66 (0.17) 
38% (12/32) 
0.17 (0.08) 
17% (4/24) 
0.75 (0.14) 
63% 
(15/24) 
0.35 (0.17) 
25% (5/20) 0.009 
 D4 mean (SE),  %≥1 
item 
0.47 (0.16) 
31% (10/32) 
0.83 (0.27) 
42% (10/24) 
0.50 (0.16) 
38% (9/24) 
1.45 (0.46) 
60% 
(12/20) 
0.13 
 PCI mean (SE), 
%≥1 item 
4.06 (0.66) 
94% (30/32) 
5.54 (0.89) 
88% (21/24) 
3.88 (0.49) 
100% 
(24/24) 
5.30 (1.12) 
100% 
(20/20) 
0.51 
 PCI-HP mean (SE), 
%≥1 item 
0.34 (0.13) 
22% (7/32) 
0.67 (0.16) 
54% (13/24) 
0.79 (0.20) 
50% 
(12/24) 
0.70 (0.27) 
40% (8/20) 0.11 
Discussion of % Cancer treatment 63% (20/32) 50% (12/24) 46% 
(11/24) 
25% (5/20) 0.07 
Common items % FOR 25% (8/32) 33% (8/24) 21% (5/24) 45% (9/20) 0.31 
 % Swallowing 9% (3/32) 50% (12/24) 29% (7/24) 25% (5/20) 0.009 
 % Dental 
health/teeth 
38% (12/32) 38% (9/24) 4% (1/24) 15% (3/20) 0.01 
 % Dry mouth 9% (3/32) 46% (11/24) 25% (6/24) 20% (4/20) 0.02 
 % Pain in head/neck 16% (5/32) 21% (5/24) 25% (6/24) 25% (5/20) 0.81 
 % Speech/voice/ 
understood 
9% (3/32) 8% (2/24) 50% 
(12/24) 
15% (3/20) <0.001 
 % Fatigue/tiredness 13% (4/32) 21% (5/24) 8% (2/24) 35% (7/20) 0.10 
Medical actions % 2 or more 34% (11/32) 54% (13/24) 29% (7/24) 60% 
(12/20) 
0.10 
Non-medical 
actions 
% 3 or more 22% (7/32) 33% (8/24) 21% (5/24) 40% (8/20) 0.40 
*Chi-squared test for Post consultation Q3, discussion of common items; otherwise Kruskal-Wallis test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.46. Overall P stage 
 
  1 2 3 4 P 
value* 
Distress Mean (SE) 0.86 (0.25) 1.63 (0.48) 2.75 (1.29) 1.96 (0.44) 
0.29 
 %6-10 0% (0/29) 11% (2/19) 25% (2/8) 7% (2/27) 
Post consultation Q Mean (SE) 1.07 (0.17) 1.50 (0.28) 1.17 (0.48) 1.67 (0.21) 
0.30 
# on Q1A % 2 or more 36% (10/28) 39% (7/18) 33% (2/6) 41% (11/27) 
Post consultation Q % Q2 SA 64% (14/22) 71% (10/14) 50% (2/4) 42% (11/26) 0.28 
 % Q3 YES 100% 
(26/26) 
100% 
(18/18) 
100% (6/6) 96% (25/26) 
- 
 % Q4 SA 55% (16/29) 63% (12/19) 86% (6/7) 48% (13/27) 0.32 
 % Q5 SD 36% (10/28) 42% (8/19) 50% (3/6) 56% (15/27) 0.53 
 % Q6 SD 52% (15/29) 56% (10/18) 60% (3/5) 59% (16/27) 0.96 
Princess Margaret Mean (SE) 85.0 (2.4) 82.9 (2.6) 85.4 (4.7) 80.5 (2.3) 
0.54 
Q score 0-100 Median (IQR) 87 (74-99) 82 (74-93) 83 (75-100) 81 (70-91) 
Consultation Mean (SE) 306 (33) 378 (67) 427 (97) 543 (69) 
0.04 length Median (IQR) 230 (170-
412) 
327 (189-
427) 
327 (142-
632) 
485 (237-
698) 
Audio taped 
# Items discussed 
D1 mean (SE),  
%≥1 item 
1.27 (0.21) 
70% (21/30) 
3.17 (0.76) 
72% (13/18) 
2.85 (0.90) 
85% (11/13) 
4.03 (0.56) 
97% (28/29) 
<0.00
1 
D2 mean (SE),  
%≥1 item 
0.53 (0.09) 
53% (16/30) 
0.56 (0.15) 
50% (9/18) 
0.69 (0.18) 
62% (8/13) 
0.76 (0.12) 
66% (19/29) 
0.53 
 D3 mean (SE),  
%≥1 item 
0.73 (0.16) 
50% (15/30) 
0.33 (0.14) 
28% (5/18) 
0.46 (0.14) 
46% (6/13) 
0.21 (0.10) 
14% (4/29) 
0.02 
 D4 mean (SE),  
%≥1 item 
0.60 (0.18) 
40% (12/30) 
1.22 (0.36) 
56% (10/18) 
0.15 (0.10) 
15% (2/13) 
0.72 (0.22) 
41% (12/29) 
0.09 
 PCI mean (SE), 
%≥1 item 
3.13 (0.45) 
90% (27/30) 
5.28 (1.05) 
94% (17/18) 
4.15 (1.03) 
92% (12/13) 
5.72 (0.71) 
100% (29/29) 
0.03 
 PCI-HP mean 
(SE), %≥1 item 
0.63 (0.18) 
37% (11/30) 
0.28 (0.11) 
28% (5/18) 
0.69 (0.31) 
38% (5/13) 
0.69 (0.13) 
55% (16/29) 
0.31 
Discussion of % Cancer 
treatment 
53% (16/30) 44% (8/18) 54% (7/13) 48% (14/29) 0.93 
Common items % FOR 30% (9/30) 33% (6/18) 8% (1/13) 34% (10/29) 0.32 
 % Swallowing 7% (2/30) 39% (7/18) 31% (4/13) 41% (12/29) 0.02 
 % Dental 
health/teeth 
13% (4/30) 28% (5/18) 31% (4/13) 34% (10/29) 0.28 
 % Dry mouth 10% (3/30) 33% (6/18) 23% (3/13) 34% (10/29) 0.12 
 % Pain in 
head/neck 
10% (3/30) 17% (3/18) 31% (4/13) 31% (9/29) 0.18 
 % 
Speech/voice/ 
understood 
27% (8/30) 22% (4/18) 15% (2/13) 7% (2/29) 0.23 
 % 
Fatigue/tirednes
s 
3% (1/30) 22% (4/18) 8% (1/13) 24% (7/29) 0.09 
Medical actions % 2 or more 37% (11/30) 33% (6/18) 38% (5/13) 52% (15/29) 0.40 
Non-medical actions % 3 or more 17% (5/30) 17% (3/18) 31% (4/13) 38% (11/29) 0.22 
*Chi-squared test for Post consultation Q3, discussion of common items; otherwise Kruskal-Wallis test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.47. Years from primary diagnosis to consultation 
 
  <1 year 1.0-2.9 years ≥3.0 years P value* 
Distress Mean (SE) 1.41 (0.38) 1.67 (0.36) 1.44 (0.37) 
0.80 
 %6-10 0% (0/17) 9% (4/43) 6% (2/32) 
Post consultation Q Mean (SE) 1.41 (0.23) 1.71 (0.19) 1.00 (0.16) 
0.04 
# on Q1A % 2 or more 47% (8/17) 48% (20/42) 21% (6/28) 
Post consultation Q % Q2 SA 57% (8/14) 62% (23/37) 52% (12/23) 0.75 
 % Q3 YES 100% (15/15) 100% (41/41) 97% (28/29) - 
 % Q4 SA 47% (8/17) 55%  (23/42) 66% (21/32) 0.42 
 % Q5 SD 59% (10/17) 48% (20/42) 33% (10/30) 0.22 
 % Q6 SD 71% (12/17) 60% (24/40) 39% (12/31) 0.10 
Princess Margaret Mean (SE) 83.9 (2.9) 84.1 (1.9) 80.5 (2.1) 
0.39 
Q score 0-100 Median (IQR) 83 (76-93) 85 (74-95) 77 (69-90) 
Consultation Mean (SE) 614 (101) 490 (64) 276 (22) 
0.001 
length Median (IQR) 543 (211-880) 377 (226-571) 226 (161-386) 
Audio taped 
# Items discussed 
D1 mean (SE),  %≥1 item 3.35 (0.92) 
82% (14/17) 
3.60 (0.45) 
88% (38/43) 
1.64 (0.25) 
74% (29/39) 
0.003 
D2 mean (SE),  %≥1 item 0.71 (0.19) 
53% (9/17) 
0.60 (0.09) 
56% (24/43) 
0.56 (0.08) 
56% (22/39) 
0.91 
 D3 mean (SE),  %≥1 item 0.76 (0.24) 
47% (8/17) 
0.47 (0.12) 
33% (14/43) 
0.36 (0.09) 
33% (13/39) 
0.35 
 D4 mean (SE),  %≥1 item 0.94 (0.36) 
47% (8/17) 
0.93 (0.23) 
47% (20/43) 
0.51 (0.16) 
33% (13/39) 
0.33 
 PCI mean (SE), %≥1 item 5.76 (1.26) 
88% (15/17) 
5.60 (0.64) 
95% (41/43) 
3.08 (0.35) 
97% (38/39) 
0.004 
 PCI-HP mean (SE), %≥1 
item 
0.88 (0.26) 
53% (9/17) 
0.72 (0.17) 
42% (18/43) 
0.36 (0.09) 
33% (13/39) 
0.18 
Discussion of % Cancer treatment 41% (7/17) 49% (21/43) 51% (20/39) 0.78 
Common items % FOR 41% (7/17) 33% (14/43) 23% (9/39) 0.36 
 % Swallowing 35% (6/17) 33% (14/43) 18% (7/39) 0.24 
 % Dental health/teeth 41% (7/17) 28% (12/43) 15% (6/39) 0.11 
 % Dry mouth 18% (3/17) 33% (14/43) 18% (7/39) 0.24 
 % Pain in head/neck 6% (1/17) 30% (13/43) 18% (7/39) 0.09 
 % Speech/voice/understood 18% (3/17) 21% (9/43) 18% (7/39) 0.93 
 % Fatigue/tiredness 18% (3/17) 28% (12/43) 8% (3/39) 0.06 
Medical actions % 2 or more 53% (9/17) 53% (23/43) 28% (11/39) 0.04 
Non-medical actions % 3 or more 53% (9/17) 23% (10/43) 23% (9/39) 0.05 
*Chi-squared test for Post consultation Q3, discussion of common items; otherwise Kruskal-Wallis test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.4. Free-Flap (FF) reconstruction 
 
  
No surgery 
Surgery  
without FF 
Surgery 
with FF 
P value* 
Distress Mean (SE) 0.85 (0.37) 1.63 (0.30) 1.89 (0.45) 
0.27 
 %6-10 0% (0/13) 8% (5/59) 6% (1/18) 
Post consultation Q Mean (SE) 1.92 (0.36) 1.25 (0.14) 1.44 (0.23) 
0.12 
# on Q1A % 2 or more 67% (8/12) 31% (17/55) 39% (7/18) 
Post consultation Q % Q2 SA 50% (5/10) 61% (28/46) 50% (8/16) 0.67 
 % Q3 YES 100% (13/13) 98% (52/53) 100% (17/17) - 
 % Q4 SA 69% (9/13) 57% (33/58) 50% (9/18) 0.57 
 % Q5 SD 25% (3/12) 45% (26/58) 56% (10/18) 0.08 
 % Q6 SD 36% (4/11) 55% (32/58) 59% (10/17) 0.58 
Princess Margaret Mean (SE) 87.8 (3.9) 82.5 (1.6) 80.1 (2.5) 
0.18 
Q score 0-100 Median (IQR) 93 (76-100) 82 (74-93) 82 (73-91) 
Consultation Mean (SE) 351 (51) 411 (51) 534 (80) 
0.08 
length Median (IQR) 377 (172-547) 310 (184-442) 475 (254-746) 
Audio taped 
# Items discussed 
D1 mean (SE),  %≥1 
item 
3.35 (0.82) 
82% (14/17) 
2.30 (0.31) 
80% (48/60) 
3.61 (0.76) 
89% (16/18) 
0.11 
D2 mean (SE),  %≥1 
item 
0.71 (0.14) 
65% (11/17) 
0.55 (0.07) 
52% (31/60) 
0.67 (0.14) 
61% (11/18) 
0.53 
 D3 mean (SE),  %≥1 
item 
0.53 (0.17) 
41% (7/17) 
0.43 (0.10) 
32% (19/60) 
0.56 (0.19) 
39% (7/18) 
0.68 
 D4 mean (SE),  %≥1 
item 
0.65 (0.23) 
41% (7/17) 
0.82 (0.19) 
42% (25/60) 
0.61 (0.24) 
39% (7/18) 
0.95 
 PCI mean (SE), %≥1 
item 
5.24 (0.97) 
94% (16/17) 
4.10 (0.49) 
95% (57/60) 
5.44 (1.01) 
94% (17/18) 
0.15 
 PCI-HP mean (SE), %≥1 
item 
0.59 (0.15) 
53% (9/17) 
0.58 (0.13) 
35% (21/60) 
0.44 (0.19) 
33% (6/18) 
0.58 
Discussion of % Cancer treatment 59% (10/17) 47% (28/60) 44% (8/18) 0.63 
Common items % FOR 35% (6/17) 27% (16/60) 33% (6/18) 0.73 
 % Swallowing 41% (7/17) 22% (13/60) 28% (5/18) 0.27 
 % Dental health/teeth 6% (1/17) 22% (13/60) 56% (10/18) 0.002 
 % Dry mouth 47% (8/17) 18% (11/60) 22% (4/18) 0.05 
 % Pain in head/neck 24% (4/17) 22% (13/60) 22% (4/18) 0.99 
 % 
Speech/voice/understood 
35% (6/17) 17% (10/60) 17% (3/18) 0.22 
 % Fatigue/tiredness 18% (3/17) 17% (10/60) 22% (4/18) 0.86 
Medical actions % 2 or more 41% (7/17) 42% (25/60) 44% (8/18) 0.92 
Non-medical actions % 3 or more 24% (4/17) 25% (15/60) 39% (7/18) 0.48 
*Chi-squared test for Post consultation Q3, discussion of common items; otherwise Kruskal-Wallis test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.49. Primary Treatment 
 
  
Surgery only 
Surgery + 
RT/CRT 
RT/CRT only P value* 
Distress Mean (SE) 1.54 (0.30) 1.84 (0.42) 0.85 (0.37) 
0.48 
 %6-10 5% (2/41) 11% (4/37) 0% (0/13) 
Post consultation Q Mean (SE) 1.20 (0.15) 1.50 (0.21) 1.92 (0.36) 
0.16 
# on Q1A % 2 or more 35% (14/40) 32% (11/34) 67% (8/12) 
Post consultation Q % Q2 SA 55% (17/31) 63% (20/32) 50% (5/10) 0.73 
 % Q3 YES 100% (35/35) 97% (35/36) 100% (13/13) - 
 % Q4 SA 51% (21/41) 58% (21/36) 69% (9/13) 0.51 
 % Q5 SD 41% (17/41) 54% (19/35) 25% (3/12) 0.07 
 % Q6 SD 56% (23/41) 57% (20/35) 36% (4/11) 0.55 
Princess Margaret Mean (SE) 82.6 (1.9) 80.8 (1.8) 87.8 (3.9) 
0.19 
Q score 0-100 Median (IQR) 82 (74-94) 82 (72-91) 93 (76-100) 
Consultation Mean (SE) 357 (40) 526 (73) 351 (51) 
0.22 length Median (IQR) 317 (181-
483) 
393 (226-727) 377 (172-547) 
Audio taped 
# Items discussed 
D1 mean (SE),  %≥1 item 2.26 (0.47) 
72% (28/39) 
3.00 (0.36) 
93% (38/41) 
3.35 (0.82) 
82% (14/17) 
0.08 
D2 mean (SE),  %≥1 item 0.59 (0.10) 
54% (21/39) 
0.59 (0.09) 
54% (22/41) 
0.71 (0.14) 
65% (11/17) 
0.73 
 D3 mean (SE),  %≥1 item 0.62 (0.13) 
44% (17/39) 
0.29 (0.10) 
22% (9/41) 
0.53 (0.17) 
41% (7/17) 
0.09 
 D4 mean (SE),  %≥1 item 0.82 (0.19) 
49% (19/39) 
0.80 (0.25) 
37% (15/41) 
0.65 (0.23) 
41% (7/17) 
0.65 
 PCI mean (SE), %≥1 item 4.28 (0.65) 
90% (35/39) 
4.68 (0.60) 
100% (41/41) 
5.24 (0.98) 
94% (16/17) 
0.46 
 PCI-HP mean (SE), %≥1 
item 
0.46 (0.15) 
26% (10/39) 
0.68 (0.15) 
46% (19/41) 
0.59 (0.15) 
53% (9/17) 
0.19 
Discussion of % Cancer treatment 54% (21/39) 39% (16/41) 59% (10/17) 0.27 
Common items % FOR 41% (16/39) 20% (8/41) 35% (6/17) 0.11 
 % Swallowing 18% (7/39) 29% (12/41) 41% (7/17) 0.18 
 % Dental health/teeth 28% (11/39) 32% (13/41) 6% (1/17) 0.11 
 % Dry mouth 8% (3/39) 29% (12/41) 47% (8/17) 0.003 
 % Pain in head/neck 23% (9/39) 20% (8/41) 24% (4/17) 0.91 
 % Speech/voice/understood 21% (8/39) 12% (5/41) 35% (6/17) 0.13 
 % Fatigue/tiredness 15% (6/39) 22% (9/41) 18% (3/17) 0.75 
Medical actions % 2 or more 38% (15/39) 49% (20/41) 41% (7/17) 0.44 
Non-medical actions % 3 or more 23% (9/39) 34% (14/41) 24% (4/17) 0.50 
*Chi-squared test for Post consultation Q3, discussion of common items; otherwise Kruskal-Wallis test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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Table 7.50. Diagnosis 
 
  SCC Other P value* 
Distress Mean (SE) 1.49 (0.24) 1.94 (0.55) 
0.33 
 %6-10 5% (4/77) 13% (2/16) 
Post consultation Q Mean (SE) 1.38 (0.13) 1.60 (0.27) 
0.45 
# on Q1A % 2 or more 38% (28/73) 40% (6/15) 
Post consultation Q % Q2 SA 54% (33/61) 79% (11/14) 0.10 
 % Q3 YES 99% (71/72) 100% (14/14) - 
 % Q4 SA 57% (43/76) 63% (10/16) 0.67 
 % Q5 SD 46% (34/74) 44% (7/16) 0.91 
 % Q6 SD 55% (40/73) 50% (8/16) 0.85 
Princess Margaret Mean (SE) 83.1 (1.4) 81.9 (2.8) 
0.67 
Q score 0-100 Median (IQR) 84 (74-9) 81 (72-88) 
Consultation Mean (SE) 404 (33) 519 (128) 
0.45 Length (sec) Median (IQR) 322 (189-518) 365 (231-
463) 
Audio taped 
# Items discussed 
D1 mean (SE),  %≥1 item 2.61 (0.31) 
78% (64/82) 
3.44 (0.62) 
94% (17/18) 
0.10 
D2 mean (SE),  %≥1 item 0.65 (0.06) 
60% (49/82) 
0.39 (0.14) 
33% (6/18) 
0.06 
 D3 mean (SE),  %≥1 item 0.52 (0.09) 
38% (31/82) 
0.39 (0.18) 
28% (5/18) 
0.40 
 D4 mean (SE),  %≥1 item 0.61 (0.11) 
38% (31/82) 
1.44 (0.51) 
56% (10/18) 
0.10 
 PCI mean (SE), %≥1 item 4.39 (0.40) 
94% (77/82) 
5.67 (1.12) 
100% (18/18) 
0.35 
 PCI-HP mean (SE), %≥1 
item 
0.60 (0.09) 
41% (34/82) 
0.61 (0.29) 
33% (6/18) 
0.57 
Discussion of % Cancer treatment 51% (42/82) 33% (6/18) 0.20 
Common items % FOR 28% (33/82) 39% (7/18) 0.40 
 % Swallowing 27% (22/82) 28% (5/18) >0.99 
 % Dental health/teeth 24% (20/82) 28% (5/18) 0.77 
 % Dry mouth 23% (19/82) 28% (5/18) 0.76 
 % Pain in head/neck 21% (17/82) 22% (4/18) >0.99 
 % Speech/voice/understood 21% (17/82) 17% (3/18) >0.99 
 % Fatigue/tiredness 15% (12/82) 33% (6/18) 0.09 
Medical actions % 2 or more 41% (34/82) 50% (9/18) 0.36 
Non-medical actions % 3 or more 28% (23/82) 28% (5/18) 0.98 
*Fishers exact test for Post consultation Q3, discussion of common items; otherwise Mann-Whitney test using numerical/ordinal 
values 
 
SE: Standard Error of mean. IQR: inter-quartile range 
 
SA: Strongly Agree, SD: Strongly Disagree.  
 
D1: Physical and functional wellbeing, D2: Treatment related, D3: Social care and social wellbeing, D4: Psychological emotional 
and spiritual wellbeing, PCI: total of PCI items, PCI-HP total of health professionals.  
 
Q1A: From your perspectives, what were the items of your concern that you had wanted to discuss with your doctor during the 
most recent consultation?  Q2: How would you rate the extent to which these concerns were addressed? Q3: Were you able to see 
or be referred to the healthcare professional or individual you had hoped to see during your most recent the consultation? Q4: To 
what degree would you agree to the statement: My expectations of the consultation were fulfilled in the most recent outpatient 
clinic visit? Q5: To what degree would you agree to the statement: I felt the PCI was intrusive?  Q6: To what degree would you 
agree to the statement: I felt the PCI was unhelpful?  
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7.8.7.  Pattern of consultations pre-intervention versus intervention 
 
 
Analysis was undertaken to determine the level of agreement between what patients 
selected on the HN-PCI and what was discussed at the consultation. Individual data 
were analysed from Blocks 2 and 3 separately. To facilitate analysis, the raw data was 
classified into 4 categories: YY: item selected on HN-PCI and discussed; YN: item 
selected on HN-PCI but not discussed; NY: item not selected on HN-PCI but 
discussed, and NN: item not selected on HN-PCI and was not discussed. Kappa 
coefficient of agreement and McNemar test for paired proportions were calculated.  
 
Generally, the kappa values for items of concern were low across both Blocks 2 and 3, 
indicating a weak level of agreement between items selected by patient on HN-PCI 
and those being discussed (Table 7.51).  When the HN-PCI items were summarised 
based on their domains, the overall agreement between selection of an item and 
discussion was only fair to moderate; there was some evidence of greater agreement in 
Block 3 than in Block 2 (Table 7.52).  
 
In Block 2, the median (IQR) of the 27 HN-PCI item kappa values was 0.25 (0.02-
0.48). For Block 3, the median (IQR) of 44 item kappa values was 0.42 (0.24-0.49), 
and when the same 27 items as Block 2 were considered, the median score was also 
0.42 (0.27-0.49).  Of these 27 items with kappa values in both Blocks 2 and 3, the 
kappa for block 3 was higher for 16 items, was the same for 1 and was lower for 10 
items, median (IQR) difference in kappa values between blocks was 0.05 (-0.07 to 
0.34) Wilcoxon related samples test p=0.05.    
 
Further evaluation was undertaken on the data where the largest disagreement had 
occurred between patient-selected data and the discussion data i.e. the NY and YN 
subgroups using the McNemar test for paired proportions within a two-by-two table. 
In general, analysis was difficult due to the gaps introduced by the less common HN-
PCI items within the tables particularly in Block 2 (Table 7.53).  
 
The relationship between the numbers of items selected grouped into domains with the 
items discussed was considered. The results are shown in Tables 7.54. When no items 
were selected, there was a greater likelihood of domain-related items being discussed 
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in Block 3 as compared with Block 2 for the following domains: Physical and 
Functional wellbeing (56%, 10/18 versus 67%, 22/33), Social care and social well-
being (27%, 14/51 versus 33%, 28/85) and Psychological/emotional and spiritual well-
being (10%, 4/39 versus 25%, 14/55), but less so for Treatment-related domain  (67%, 
35/52 versus 53%, 47/89). In regard to professionals selected, overall, there was a total 
lack of agreement between what was selected by patients and what was discussed 
(Table 7.54.). Details of the numbers selected and discussed are shown in Table 7.55. 
A similar trend for request for healthcare selected by patients and those discussed with 
that seen with items of concern detailed above.   
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Table 7.51. Agreement between items selected by patient on HN-PCI and those discussed (continued next page) 
 
 
 BLOCK 2 BLOCK 3 
 
NN YN NY YY Kappa 
McNemar 
P 
NN YN NY YY Kappa 
McNemar 
P 
ANY D1: Physical and functional well-
being 
8 7 10 30 0.27 0.63 11 8 22 59 0.24 0.02 
Activity  51 1 2 1 0.37 >0.99 82 - 15 3 0.25 <0.001 
Appetite 55 - - - - - 91 2 1 6 0.78 >0.99 
Breathing 52 2 1 - -0.03 >0.99 93 1 3 3 0.58 0.63 
Bowel habit (diarrhoea/constipation) 51 1 1 2 0.65 >0.99 93 2 1 4 0.71 >0.99 
Chewing/eating 39 6 5 5 0.53 >0.99 77 7 7 9 0.48 >0.99 
Coughing 54 - 1 - - - 83 8 6 3 0.22 0.79 
Dental health/teeth 37 3 8 7 0.44 0.23 70 5 17 8 0.30 0.02 
Dry mouth 45 5 - 5 0.62 0.06 66 10 7 17 0.55 0.63 
Energy levels 53 1 1 - -0.02 >0.99 86 4 5 5 0.48 >0.99 
Fatigue/tiredness 46 9 - - - - 73 9 5 13 0.56 0.42 
Hearing 46 5 1 3 0.45 0.22 89 5 1 5 0.60 0.22 
Indigestion 54 1 - - - - 95 4 - 1 0.33 0.13 
Mobility 49 2 4 - -0.05 0.69 92 5 2 1 0.19 0.45 
Mouth opening 46 8 1 - -0.03 0.04 85 5 3 7 0.59 0.73 
Mucus production 46 6 2 1 0.13 0.29 89 5 - 6 0.68 0.06 
Nausea 55 - - - - - 98 1 1 - -0.01 >0.99 
Pain in head and neck 43 3 7 2 0.19 0.34 73 6 10 11 0.48 0.45 
Pain elsewhere 49 3 2 1 0.24 >0.99 88 7 3 2 0.24 0.34 
Regurgitation 54 1 - - - - 98 2 - - - - 
Salivation 48 5 2 - -0.06 0.45 85 10 2 3 0.28 0.04 
Shoulder 49 4 1 1 0.25 0.38 85 8 4 3 0.27 0.39 
Sleeping 52 3 - - - - 82 13 2 3 0.23 0.007 
Smell 55 - - - - - 99 - - 1 - - 
Sore mouth 47 4 1 3 0.50 0.38 80 6 8 6 0.38 0.79 
Swallowing 43 4 5 3 0.31 >0.99 66 7 12 15 0.49 0.36 
Swelling 46 5 1 3 0.45 0.22 88 3 5 4 0.46 0.73 
Taste 52 1 1 1 0.48 >0.99 88 7 1 4 0.46 0.07 
Vomiting/sickness 55 - - - - - 100 - - - - - 
Weight 
 
46 3 5 1 0.12 0.73 84 4 6 6 0.49 0.75 
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 BLOCK 2 BLOCK 3 
 NN YN NY YY Kappa McNemar  NN YN NY YY Kappa 
ANY D2: Treatment related 17 1 35 2 0.00 <0.001 42 3 47 8 0.07 <0.001 
Cancer treatment 21 - 33 1 0.02 <0.001 50 2 43 5 0.07 <0.001 
Regret about treatment 55 - - - - - 100 - - - - - 
PEG tube 53 1 - 1 0.66 >0.99 94 1 4 1 0.27 0.38 
ANY D3: Social care and social well-
being 
37 - 14 4 0.28 <0.001 57 7 28 8 0.13 0.001 
Carer 54 - 1 - - - 96 - 4 - - - 
Dependants/children 55 - - - - - 96 - 4 - - - 
Financial / benefits 55 - - - - - 97 1 1 1 0.49 >0.99 
Home care/district nurse support 54 - 1 - - - 99 - 1 - - - 
Lifestyle issues (smoking/alcohol) 49 - 6 - - - 89 - 10 1 0.15 0.002 
Recreation 52 - 3 - - - 94 - 6 - - - 
Relationships 55 - - - - - 97 1 1 1 0.49 >0.99 
Speech/voice/being understood 46 2 5 2 0.30 0.45 75 5 16 4 0.17 0.03 
Support for my family 55 - - - - - 97 3 - - - - 
ANY D4:  Psychological emotional and 
spiritual well-being 
35 13 4 3 0.10 0.05 41 18 14 27 0.35 0.60 
Appearance 52 1 1 1 0.48 >0.99 90 3 5 2 0.29 0.73 
Angry 53 2 - - - - 96 1 2 1 0.39 - 
Anxiety  52 1 2 - -0.03 >0.99 84 4 7 5 0.42 0.55 
Coping 54 - 1 - - - 92 - 8 - - - 
Depression 54 1 - - - - 94 2 1 3 0.65 >0.99 
Fear of the cancer coming back 46 6 2 1 0.13 0.29 56 14 11 19 0.42 0.69 
Fear of adverse events 54 - 1 - - - 96 3 1 - -0.02 0.63 
Intimacy 53 2 - - - - 98 2 - - - - 
Memory 52 3 - - - - 92 6 - 2 0.38 0.03 
Mood 51 4 - - - - 93 2 3 2 0.42 >0.99 
Self-esteem 55 - - - - - 98 1 - 1 0.66 >0.99 
Sexuality 54 1 - - - - 99 1 - - - - 
Spiritual /religious aspects 55 - - - - - 98 1 1 - - - 
Temperament and personality 55 - - - - - 97 1 1 1 0.49 >0.99 
Anything else 33 2 18 2 0.05 <0.001 54 2 42 2 0.01 <0.001 
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Table 7.52. Summary of the level of agreement between items selected by patient on HN-PCI and those discussed based on HN-PCI domains 
 
 BLOCK 2 BLOCK 3 
 
NN YN NY YY Kappa 95% CI kappa NN YN NY YY Kappa 
95% CI 
kappa 
             
D1: Physical and functional 
well-being 
1418 86 52 39 0.32 0.21-0.43 2478 146 127 149 0.47 0.41-0.53 
D2: Treatment related 180 1 37 2 0.07 0-0.34 336 4 53 7 0.16 0-0.36 
D3: Social care and social 
well-being 
475 2 16 2 017 0-0.55 840 10 43 7 0.19 0-0.40 
D4:  Psychological emotional 
and spiritual well-being 
740 21 7 2 0.11 0-0.43 1283 41 40 36 0.44 0.32-0.56 
D1-D4 total # items 2813 110 112 45 0.25 0.16-0.35 4937 201 263 199 0.42 0.37-0.47 
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Table 7.53. Numbers of items selected by patients and the items discussed by domains 
 
 
Physical and functional well-being: Items discussed 
Total 0 1 2 3 4 5 6 7 8 9 11 14 
BLOCK 2:  
HN-PCI 
completed but 
retained by 
researcher and 
not seen by 
doctor 
Physical 
and 
functional 
well-
being: 
Items 
selected 
0 8 6 3 - - - 1 - - - - - 18 
1 1 2 3 - - - - - - - - - 6 
2 3 6 1 2 - - - - - - - - 12 
3 1 2 - 2 1 - - - - - - - 6 
4 1 1 2 - 2 1 - - - - - - 7 
6 - - - - 1 - - 1 - - - - 2 
7 1 - - - 1 - - - - - - - 2 
8 - - - - 1 - - - - - - - 1 
15 - - 1 - - - - - - - - - 1 
Total 15 17 10 4 6 1 1 1 - - - - 55 
BLOCK 3:   
HN-PCI 
completed and 
given to doctor 
before 
consultation 
Physical 
and 
functional 
well-
being: 
Items 
selected 
0 11 10 5 3 3 1 - - - - - - 33 
1 4 5 1 1 - - - - - - - - 11 
2 1 2 5 3 4 - - - - - - - 15 
3 2 1 2 4 1 - 1 1 - - - - 12 
4 - - 1 - - - - - - - 1 - 2 
5 - 1 - - 2 2 - - - 1 - - 6 
6 - 1 - - - - - - 1 - - - 2 
7 1 - 1 1 - 1 2 1 - 1 - - 8 
8 - 2 - - 1 1 - - - - - - 4 
10 - 1 - 1 - - - - - - - - 2 
11 - - - - - - - - - - 1 1 2 
12 - - - - - - 1 - - - 1 - 2 
14 - - - - 1 - - - - - - - 1 
Total 19 23 15 13 12 5 4 2 1 2 3 1 100 
 
 
 
Treatment related: Items discussed 
Total 0 1 2 
BLOCK 2: 
HN-PCI completed but 
retained by researcher and 
not seen by doctor 
 
Treatment related: Items 
selected 
0 17 34 1 52 
1 1 1 1 3 
Total 18 35 2 55 
BLOCK 3:  
HN-PCI completed and 
given to doctor before 
consultation 
 
Treatment related: Items 
selected 
0 42 45 2 89 
1 3 5 3 11 
Total 45 50 5 100 
 
 
 
Social care and social wellbeing: Items discussed 
Total 0 1 2 3 
BLOCK 2  
HN-PCI completed but 
retained by researcher 
and not seen by doctor 
 
Social care and social 
wellbeing: Items selected 
0 37 14 - - 51 
1 - 4 - - 4 
Total 37 18 
- - 
55 
BLOCK 3: 
HN-PCI completed 
and given to doctor 
before consultation 
 
 
Social care and social 
wellbeing: Items selected 
0 57 20 7 1 85 
1 6 5 1 1 13 
2 1 - - 1 2 
Total 64 25 8 3 100 
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Psychological emotional and spiritual wellbeing: Items discussed 
Total 0 1 2 3 4 5 8 
BLOCK 
2: 
HN-PCI 
completed but 
retained by 
researcher and 
not seen by 
doctor 
 
Psychological 
emotional and spiritual 
wellbeing: Items 
selected 
0 35 4 - - - - - 39 
1 8 1 - - - - - 9 
2 5 1 
- 
1 
- - - 
7 
Total 48 6 
- 
1 
- - - 
55 
BLOCK 3:   
HN-PCI 
completed and 
given to doctor 
before 
consultation 
 
 
 
 
 
Psychological 
emotional and spiritual 
wellbeing: Items 
selected 
0 41 11 3 - - -  55 
1 14 12 3 1 - 1 - 31 
2 1 2 1 - 1 - - 5 
3 1 - - 1 1 - 1 4 
4 1 - - 1 - - - 2 
5 - - 1 - - 1 - 2 
6 1 - - - - - - 1 
Total 59 25 8 3 2 2 1 100 
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Table 7.54. Agreement between professionals selected on HN-PCI by patients and what was discussed  
 
 BLOCK 2 BLOCK 3 
 
NN YN NY YY Kappa 
McNemar 
P 
NN YN NY YY Kappa 
McNemar 
P 
Chaplain 55 - - - - - 100 - - - - - 
Clinical nurse specialist 51 - 4 - - - 74 3 23 - -0.06 <0.001 
Dental hygienist 54 - 1 - - - 98 1 1 - - - 
Dentist 45 3 7 - -0.08 0.34 92 4 4 - -0.04 >0.99 
Dietician 53 - 2 - - - 95 2 3 - -0.03 >0.99 
Nursing staff 54 1 - - - - 98 - 2 - - - 
Occupational therapist 55 - - - - - 100 - - - - - 
Oral rehabilitation team 53 1 1 - - - 99 - 1 - - - 
Physiotherapist 50 1 4 - -0.03 0.38 94 3 3 - -0.03 >0.99 
Radiotherapist/oncologist 52 2 1 - -0.03 >0.99 98 2 - - - - 
Speech and language therapist 54 1 - - - - 94 1 5 - -0.02 0.22 
Social worker 55 - - - - - 100 - - - - - 
Surgeon 47 8 - - - - 86 14 - - - - 
Family doctor 46 2 7 - -0.06 0.18 84 4 10 2 0.16 0.18 
Clinical psychologist 54 1 - - - - 96 2 2 - -0.02 >0.99 
Emotional support therapist 55 - - - - - 96 - 3 1 0.39 0.25 
Anyone else 46 - 9 - - - 84 3 13 - -0.05 0.02 
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Table 7.55. Numbers of healthcare professionals selected by patients and the items 
discussed by domains 
 
 
Number of Health professionals: Items discussed  
Total 0 1 2 3 5 
BLOCK 2:  
HN-PCI completed 
but retained by 
researcher and not 
seen by doctor  
 
Number of Health 
professionals selected 
0 23 8 4 1 - 36 
1 10 8 - - - 18 
2 1 - - - - 1 
Total 34 16 4 1 
- 
55 
BLOCK 3:  
HN-PCI completed 
and given to doctor 
before consultation 
 
 
 
Number of Health 
professionals selected 
0 42 22 6 2 - 72 
1 13 3 2 2 1 21 
2 3 1 - - - 4 
3 1 1 - - - 2 
4 1 - - - - 1 
Total 60 27 8 4 1 100 
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7.9. Discussion  
 
7.9.1. Main findings of the study 
 
This study achieved its primary aim by demonstrating that the HN-PCI can be 
successfully introduced in a population of doctors and patients who were unfamiliar 
with the tool, its handling and the practical elements of its usage in routine 
outpatient clinics.  
 
The results showed that HN-PCI was able to help patients disclose their concerns 
during their visits, enable doctors to deliver a patient-centred consultation by 
addressing their specific concerns during clinic visits, while maintaining the usual 
medical and non-medical outputs expected during routine outpatient clinic 
consultations. In general, the introduction of the HN-PCI had generated a trend 
towards an increase in the number of concerns discussed in clinic when compared to 
control consultations. Furthermore, the types of concerns discussed had changed 
with the intervention. Higher numbers of items within the Psychological/ emotional 
and spiritual well-being domain were discussed in the HN-PCI intervention groups, 
suggesting that a broader range of expressed concerns were addressed in clinic as a 
result of this intervention. With the HN-PCI intervention, doctors were fair to 
moderately more likely to take on the patient’s agenda for discussion during 
consultation by addressing the items selected on the HN-PCI compared with non-
HN-PCI facilitated consultations. These findings were achieved with a trend 
towards longer consultations, and a higher usage of medical interventions. When 
HN-PCI driven consultations were analysed in more detail, it was observed that the 
characteristics of the consultations were significantly associated with certain clinical 
factors.  Following the consultation, patient having the HN-PCI intervention had 
higher scores of satisfaction with consultations than those without. Furthermore, the 
HN-PCI intervention group also reported higher levels of agreement with statements 
indicating that the consultation had fulfilled their expectations. There was good 
acceptance of the HN-PCI, where patients did not find the HN-PCI intrusive. 
 
This study also demonstrated that the HN-PCI was able to indirectly predict patients 
who experienced distress based on the number of items selected. However, this 
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study did not find any indications that the HN-PCI could reliably inform clinicians 
about the patient’s perceived need for supportive care services.  
 
Study limitations 
 
Before the specific study findings are discussed, the limitations of this study are 
presented. Firstly, the study design did not include randomisation at patient 
recruitment. While randomisation was considered initially, it was felt that this 
process could significantly disrupt the flow of busy outpatients clinics, which could 
impact negatively on study recruitment uptake (doctors and patients). Furthermore, 
recruitment difficulties were expected with randomization because many patients 
attend regularly and see a designated doctor, usually the surgeon who provided their 
cancer treatment. Furthermore, the study was undertaken across two different sites. 
Due to these restrictions, randomisation was abandoned. To provide a control 
population against the HN-PCI intervention, the study design included the ‘normal’ 
consultation group i.e. Block 1. This Block was done at the start of the study to 
avoid cross-contamination of patients in the successive intervention phase as they 
return for their repeat visits to the clinic.  
 
Secondly, the recruitment numbers to the study did not reach the target numbers 
indicated by sample size calculation, and is therefore under-powered. This is 
particularly evident in Block 2, where the recruited number (n, 78) was less than 
Blocks 1 (n, 136) and Block 3 (n, 111). The practical decision to stop recruitment 
and proceed into Block 3 from Block 2 was made due to time pressures to facilitate 
study completion. Furthermore, it was thought that shortening Block 2 would not 
impact significantly to the study as the purpose of this Block was to provide control 
in attention i.e. introduce the HN-PCI to patients, without it being exposed to the 
doctor in the actual consultation.  
 
Thirdly, there is a lack of data from eligible patients who were not recruited to the 
study. Thus, it is not possible to comment if these patients were significantly 
different from those recruited, and if this has introduced a bias to the overall results 
of this study. This data was not included in this current work due to incomplete data 
in some of the parameters. Fourthly, there was data loss of those recruited to the 
study due to failure to audiorecord the consultation. The main reason for this was 
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the ‘surgeon forgetting to record the consultation’. This was particularly significant 
in Block 1, where there was also the problem of seeing the wrong doctor i.e. one not 
involved in this study.  
 
Fourthly, assessor bias may have been introduced during the assessment of the 
recorded consultations. It was not possible to blind the assessors to the consultation 
in the respective blocks because of how the HN-PCI would have been used during 
the consultation i.e. the HN-PCI would have been referenced explicitly by the 
doctor during the consultations in Block 3. Therefore, a decision was made to 
undertake the evaluation of the recorded consultation in order of recruitment.  
 
Finally, the statistical analysis undertaken in this study involved large number of 
tests. There were also noticeable gaps in the HN-PCI data due to the inherent nature 
of some concerns being relatively less commonly expressed by patients.  While the 
accepted statistical level of significance was set to p<0.01, interpretations of 
statistical analysis also included results with borderline statistical significance i.e. 
0.01<p<0.10 when this allowed demonstration of trends of clinical significance. 
Thus, the results presented must not be over-estimated.  
 
Objectives of the study 
 
a. “What constitutes a normal HNC outpatient consultation?” 
 
This study describes aspects of a ‘normal’ consultation i.e. before HN-PCI 
intervention. Without the HN-PCI intervention, it is likely that this group represents 
the typical consultation that occurs in routine HNC FU clinics. This finding 
provides formative baseline data because this has never been previously explored, 
particularly in a large cohort (n, 111). The post-treatment survivors attending these 
clinics were at 2.2 years post-diagnosis (mean), had low levels of distress (mean DT 
score 2.7), and reported reasonably good HRQOL/UWQOL scores (mean, Physical 
function subscale, 76.3; Social/Emotional subscale 75.8; current HRQOL compared 
to pre-diagnosis, 56.1; HRQOL in the past 7 days, 61.3; QOL in the past 7 days, 
64.4). The median length of clinic consultation was 268 seconds (4.5 minutes), and 
the median (IQR) number of items of concern discussed during consultation was 3 
(2-5). The median (IQR) number of professionals requested per visit was 0 (0-1). 
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The Physical and functional well-being domain was the domain that had the types of 
concerns most frequently discussed. The five most common item of concern 
discussed was General wellbeing (82%), ‘Anything else’ (55%), Cancer treatment 
(53%), Pain in head and neck (28%) and Swallowing (24%). There was a range of 
professionals whom patients requested for referral/input, the most common being 
the oral rehabilitation specialist, family doctor and the CNS. All patients received 
medical and non-medical input during the visit. After the consultation, patients 
reported a lesser level of distress compared to pre-consultation level (mean DT 
score, 1.9) and on average, recalled discussing 1 item of concern (median, 1; IQR, 
0-2) that they wanted to discuss at consultation.  
 
A previous small, observational study of consultations in routine HNC FU clinics 
(n, 25) without the adjunctive use of HN-PCI [Ghazali et al, 2013B] provided 
valuable data for comparison. Interestingly, the results obtained from the two 
cohorts were not markedly different overall. The median length of control 
consultation in the observational study was 5.3 minutes (IQR, 3.2-8.1), which is 
comparable to 4.5 minutes (IQR, 3.2- 6.7) noted in this study. When mean lengths 
of consultations were considered, both the observational study (5.4 minutes) and the 
current study (5.9 minutes) were considerably shorter than that reported in 
Fagerlind et al [2008]’s study of consultations in routine gastrointestinal oncology 
clinics, where longer consultation times were noted i.e. mean length, 19 minutes 
(range, 9-36).  
 
Regarding the number of concerns discussed, the median (IQR) number identified 
during consultation in this current cohort was 3 (2-5), which was slightly higher 
than 2 (1-3) reported in the observational study [Ghazali et al, 2013B]. While both 
cohorts commonly requested referrals to the oral rehabilitations specialist, the 
observational study cohort also requested input by the dietitian, physiotherapist, 
speech therapist and radiotherapist as opposed to the current cohort who requested 
the family doctor and CNS. The difference may represent the slightly different 
supportive care needs between the two cohorts, where the current study includes a 
wider range of primary cancer sites, including larynx and thyroid, as compared with 
the pilot study, which is predominantly composed of oral cavity cancers.  
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In this current study, patients recalled having discussed much less concerns (mean, 
0.87; median, 1) compared with the numbers of concerns actually discussed (mean, 
3.64; median, 3). The difference may be accounted for by incomplete recall of 
conversations by patients, including misinformation due to memory lapses and/or 
may be distorted when sensitive issues were discussed, by the addition of items from 
the doctor’s agenda, and the inclusion of ‘General wellbeing’ as an item based on 
the thematic framework-based assessment of consultations [Ghazali et al, 2013A]. 
The presence of this theme during consultation was also recognised by Fagerlind et 
al [2008]’s study. Overall, doctors have interest in acquiring information about the 
patients’ general well-being and in non-medical areas of their lives and often spend 
time on this during clinic visits [Velikova et al, 2008].  ‘General wellbeing’ covers 
themes of general welfare or condition, which can represent common salutations 
that help initiate or begin conversations, facilitating the subsequent discussions 
during the visit. This theme also covers topics discussed based on pre-existing 
rapport already established between doctor and patient from previous visits i.e. 
‘catching up’ [Ghazali et al, 2013A]. Thus, it is unsurprisingly the most common 
item discussed during consultation (82%) in this study.  
 
‘Anything else’ (55%) and ‘Cancer treatment’ (53%) were the next two most 
common themes discussed. The finding of ‘Cancer treatment’ being the most 
common item for discussion in routine FU clinics was also reported previously in 
the observational study [Ghazali et al, 2013B]. Even after the HN-PCI was 
introduced to that cohort, ‘Cancer treatment’ was still discussed significantly during 
consultation despite the item not being selected by patients. This suggests that this 
topic of discussion may have been initiated by the doctor in keeping with their focus 
is on disease and treatment [Fagerlind et al, 2008; Rodriguez et al, 2010]. Such 
topics are known to form the largest proportion of consultation time [Fagerlind et 
al, 2008; Detmar et al, 2001]. The doctor’s agenda is composed of undertaking 
discussions on treatment response, its adverse effects and management, and also 
undertaking physical examination relating to cancer recurrence and wounds. This is 
sometimes pursued at the expense of psychosocial issues even when doctors have 
access to HRQOL-based PROs filled by patients prior to their consultations 
[Detmar et al, 2002]. This finding suggests that a typical routine oncology FU 
clinic consultation is generally doctor/physician-led rather than patient-centred.  
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The theme of ‘Anything else’, which was commonly discussed, reveals the potential 
limitless types of concerns that could be discussed during routine FU clinics that are 
not found on the HN-PCI checklist. This finding was not noted in the pilot 
observational study referenced previously [Ghazali et al, 2013A]. This was 
probably due to the difference of methodology where the previous study only used 
the items present on the HN-PCI checklist (n, 55) to evaluate the items discussed 
during consultation.  
 
b. “Has the HN-PCI intervention changed outcomes of clinic?” 
 
Clinic outputs:  One of the criticisms of routine adoption of PROs in 
routine clinical practice is the lack of data demonstrating that its usage has translated 
into a clinically meaningful outcome and it does not influence patient care 
[Greenhalgh et al, 2005; Luckett et al, 2009]. This study hypothesised that the 
HN-PCI intervention would cause an increase in clinical outputs. Study findings 
agree with the study hypothesis as the HN-PCI intervention had significantly 
increased the number of clinical outcomes (Table 7.19) and also showed a trend for 
lower distress levels post-consultation, and a significant increase in patient-reported 
satisfaction with consultations in HN-PCI intervention groups.  
 
The rationale for measuring clinical outputs in this study was based on the 
assumption that HN-PCI information can influence on clinical decision-making by 
measuring the clinical outcomes. The clinical outputs following HN-PCI 
intervention has to be taken in context of the usual temporal structure of clinic visit 
i.e. a routine oncology outpatient visit begins with identifying the reasons for the 
visit, updating patient’s medical history, undertaking a physical examination and 
conclusion of the visit with discussions about treatment, requirement for 
investigations, arranging FU and possible referrals to other healthcare professionals 
[Clayton & Dudley, 2009]. The data showed that all patients underwent physical 
examination as part of their consultation (Table 7.20), which is reassuring for 
patients because in some ways it addressed their concerns and FOR [Ghazali et al, 
2013C; Clayton & Dudley, 2009]. With this considered, there was still notably 
higher numbers of medical actions undertaken in the HN-PCI intervention groups 
when compared with control (p=0.03) (Table 7.19). The increased medical actions 
may be associated to higher numbers of referrals and investigation requests with 
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HN-PCI intervention, especially in Block 3 (Table 7.20). In a randomised 
controlled trial, Velikova et al [2004] investigated the influence of HRQOL data in 
routine oncology practice and reported that while doctors reported PRO data 
contributed to management decisions in only 11% while indicating this data to be 
useful in > 90% of intervention encounters. Greenhalgh et al [2005] notes that the 
impact of routine use of HRQOL data on clinical decision-making may be more 
prominent among cancer patients who are undergoing care with palliative rather 
than curative intent.  
 
On the other hand, there were no discernable changes relating to non-medical 
actions with HN-PCI intervention. The vast majority of patients had reassurances 
and their next FU arranged during their visit. Based on a content analysis study of 
routine oncology consultations, Clayton & Dudley [2009] suggested that 
“reassurances conversations”, which involved offering, giving and seeking 
reassurance, occurred regularly in consultations. Interestingly, they found that the 
more specificity of the patients plan for discussion with the doctor, the less likely 
the overall discussion time is spent in illness exploration and in reassurances. Time 
spent exploring and understanding the patient within the context of their life was a 
significant factor that enhances patient’s perception of patient-centredness approach 
to the visit. In a study of routine use of HRQOL in nurse-led chemotherapy 
outpatient clinics, Hilarius et al [2008] found that the intervention resulted in 
modest changes in patient management by nurses relating to counselling behavior.  
 
Evaluation of PROs in routine oncology clinical settings has largely focused on 
measuring HRQOL status as an outcome [Velikova et al, 2004; Rosenbloom et al, 
2008; Hilarius et al, 2008]. However, this health status was not chosen for this 
study because most HRQOL tools measure health status within the 7 days and 
because patients complete the UWQOL questionnaire on the day of consultation and 
the HN-PCI intervention was assessed as a single event rather than longitudinally, 
repeating the UWQOL post-consultation would not provide a meaningful 
assessment due to the overlap of timings. Instead, we evaluated patient distress as an 
outcome following the HN-PCI intervention as a tool to help disclose concerns. This 
is based on evidence indicating higher distress levels in cancer patients are related to 
unmet needs, which are often missed because they were not enquired about or 
disclosed. While the distress levels were generally low after consultations, there was 
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a trend towards lower distress levels being recorded in HN-PCI intervention group 
compared with the control group. The mean DT score (median; IQR) for the control 
group was 1.9 (1; 0-3), for Block 2 was 1.8 (1; 0-3) and in Block 3 was 1.6 (1; 0-3) 
(p=0.52). Furthermore, these scores were generally lower that the mean scores 
reported at baseline in all blocks i.e. control group was 2.7 (2; 0-5), Block 2 was 2.5 
(2; 0-5) and Block 3 was 3.0 (2; 0-5). It is possible that this observation may be 
influenced by the increasing length of time taken to complete the patient-reported 
outcomes consultation (PROC) from the date of consultation with successive 
blocks. The mean days between completion of PROC and day of consultation was 
0.73 days (median, 1; IQR, 0-1), in Block 2 was 1.06 (1; 0-1) and in Block 3 was 
1.63 (1; 0-2) (p=0.005).  
 
Patient satisfaction:   Patient satisfaction is the most recognised and 
widely used measure for gauging the effectiveness of patient-doctor communication 
[Ong et al, 2000; Takayama et al, 2001], particularly patient-centred interventions 
[Epstein et al, 2005; Fung & Hays, 2008]. The Princess Margaret Satisfaction with 
Physician questionnaire (PSQ-MD) was used in this study because the questionnaire 
was specifically developed for evaluating satisfaction with consultations in the 
oncology setting. An overall score was calculated from the responses ranging from 0 
(worse) to 100 (best). In addition, non-validated questionnaire was also used.  
 
This study hypothesised that patient satisfaction scores will improve with HN-PCI 
intervention. This study found that there was a trend for better patient satisfaction 
scores with HN-PCI intervention. The overall PSQ-MD scores (median; IQR) for 
HN-PCI intervention in Block 2 (86; 74-96) and Block 3 (83; 74-93) were higher 
than in control (80; 67-91) (p=0.02). Nine from 24 individual questions of the PSQ-
MD showed a statistically significant difference between HN-PCI intervention 
compared with the control group, where favourable responses were noted in the HN-
PCI intervention group. Interestingly, the overall PSQ-MD score and the responses 
for individual questions in the PSQ- MD were better in Block 2 compared with 
Block 3 in the HN-PCI intervention group. The significance of this is unclear. While 
the number of recruited patients in Block 2 is comparatively smaller, there were no 
statistically significant differences in clinicopathological features (Table 8.23), 
median length of consultation and in the median number of PCI items selected 
and/or discussed between the blocks. 
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Non-validated post-consultation questionnaires helped detail the overall satisfaction 
between blocks. Patients in HN-PCI intervention groups were able to recall more 
items of concern discussed during their recent consultation compared with control 
group. The mean number of items recalled for control block was 0.87 (median 1; 
IQR, 0-2), while for Block 2 was 1.34 (1; 0-2) and in Block 3 was 1.42 (1, 1-2) 
(p=0.002). In regard to the statement: My expectations of the consultation were 
fulfilled in the most recent outpatient clinic visit, the proportion of those responding 
‘Strongly Agree’ were statistically significantly higher in the HN-PCI intervention 
group i.e. Block 1: 34% versus Block 2: 59% versus Block 3: 58%  (p=0.02). To the 
statement: I felt the PCI was intrusive, the proportion of those responding ‘Strongly 
disagree’ in the HN-PCI intervention group was Block 2: 40% and Block 3: 46%, 
respectively. To the statement: I felt the PCI was unhelpful, the proportion of those 
responding ‘Strongly disagree’ in the HN-PCI intervention group was Block 2: 34% 
and Block 3: 54%, respectively. This finding suggests that there is reasonably good 
overall acceptance by patients of the HN-PCI. In the original HN-PCI study, when 
patients were asked: ‘How much difference has the HN-PCI made to their 
consultation?’,  50% (62/123) reported ‘Quite a bit’ (28, 23%) or ‘Very much’ (34, 
28%) compared with ‘A little’ (14, 11%,) or ‘No difference’ (34, 28%) (result not 
known: 13, 11%).  
 
A limitation of this study is the use of patient satisfaction as an outcome measure. 
While this outcome is established in evaluating patient-empowerment, patient 
satisfaction with the consultation can be influenced by other issues, including their 
preferences and expectations of the consultation, which were not assessed in in this 
study. There is also a lack of studies that can offer direct comparison with the level 
of patient satisfaction. This is related to the tool selected in this study, which is not 
widely used.  Only two studies that evaluated patient satisfaction with the 
intervention of HRQOL in routine oncology practice [Rosenbloom et al, 2008; 
Detmar et al, 2002]. The first study was a longitudinal study set in nurse-led clinics. 
The patient satisfaction used was the Medical Outcomes Study Patient Satisfaction 
Questionnaire-III, a validated questionnaire measuring domains of general 
satisfaction, technical quality, time spent with doctor, interpersonal aspects, 
access/availability/convenience, communication and financial aspects. This study did 
not find any change in the level of satisfaction in the HRQOL intervention group 
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compared with control. Authors cited the lack of impact on patient satisfaction was 
likely to be that the control care given had already reached the ‘ceiling effect’, 
whereby further interventions would not have made any difference. Another reason 
given was that this study involved nurses (rather than doctors), and as such, they 
were not able to make changes to the clinical care in the same way that doctors can.  
The second reason appears to suggest that patients require medical intervention to 
deal with symptoms, where ‘real’ improvements in symptom control would translate 
into improvements in HRQOL status rather than the traditional supportive roles 
given by nurses, who are more comfortable at addressing and discussing emotional 
and social issues than doctors [Morgan et al, 2010]. The other study measured the 
satisfaction relating to the supportive care received.  An increased level of patient 
satisfaction was reported in the HRQOL intervention group, where they recorded 
high satisfaction scores for support and care that they received [Detmar et al, 2002].  
 
c.  “How are self-reported HN-PCI data related to distress?” 
 
This study hypothesised that self-reported cocnerns were related to patient distress. 
The majority of patients examined in this cohort did not experience significant 
distress (64%, 108/170). However, patients with significant distress selected more 
concerns overall than patients without distress (mean, median (QR) of 5.40, 5 (2-8) 
versus 2.61, 2 (0-4); Mann-Whitney test, p<0.001). This finding corroborates other 
studies [Maguire, 2002; Chaturvedi et al, 1996], where patient concerns were 
related with the development of distress. The potential relationship between the 
number of concerns with the likelihood of experiencing significant distress was 
further evaluated, where it was possible to suggest a cut-off point indicating 
significant distress with a reasonable degree of sensitivity and specificity. On 
balance, cut-off points of either ≥4 or ≥5 items of concern selected on the HN-PCI 
demonstrated an acceptable level of sensitivity, specificity and predictive values 
(Table 7.38) for likelihood of experiencing significant distress.  From a clinical 
perspective, using either ≥4 or ≥5 cut-off score can help guide clinicians in risk 
assessing patients for significant distress, who may benefit from more in depth 
evaluation and intervention, at pre-consultation.  
 
Those experiencing significant distress were more likely to select items from the 
Physical and Functional well-being domain (p<0.001) and the Psychological and 
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Emotional well-being domain (p=0.001). This finding suggests that emotional 
distress may not be the only significant contributing factor in cancer-related distress 
in HNC population predominantly treated with surgery (84%, 142/170). Severe 
distress, in particular physical distress related to oral cavity dysfunction, has been 
reported in another HNC cohort treated by ablative surgery and immediate 
reconstruction [Chen et al, 2009]. Furthermore, the use of RT [Lewis et al, 2013] 
and chemoRT [Chen et al, 2013] were also strongly associated with significant 
distress in this population. HNC survivors struggling to cope with the after-effects of 
HNC treatment are likely to express significant distress and require physical support 
more than any other cancer types [Chen et al, 2009; Chen et al, 2016].  Addressing 
significant distress related to physical concerns can be initiated in clinic. This 
includes both non-medical (e.g. education, advice, reassurances) and medical actions 
(e.g. investigations, surgery, medications, referrals). Treatment-related domain was 
not associated with significant distress (p=0.3) although the trend was there as in all 
the domains. It is possible that disease-free, post-treatment HNC patients were less 
likely to be significantly distressed about these issues following the completion of 
treatment. Comparisons with other studies are not possible due to methodological 
differences in assessing concerns [Jacobsen et al, 2004; Grassi et al, 2013].  
 
When individual HN-PCI items of concern were evaluated, Anxiety (p=0.005), 
Depression (p=0.004), Mood (p=0.01), Pain in head/neck (p=0.002), Sleeping 
(p=0.007), Fatigue/tiredness (p=0.001), Swallowing (p<0.001) and Bowel habit 
(p=0.01) were related to significant distress. Apart from bowel habit, the other 
concerns associated with significant distress in this study have been consistently 
been reported by HNC patients previously [Rogers et al, 2009; Kanatas et al, 2012; 
Ghazali et al, 2013A]. It is recognised that Anxiety, Mood and Depression are 
essential components of, and possible overlapping elements of emotional distress in 
cancer [Holland & Bultz, 2007; Panday et al, 2006]. Post-treatment dysphagia is 
related to weight loss, progressive reduction in swallowing function, narrowing range 
of oral dietary intake and reliance on gastrostomy tube feeding [Oozeer et al, 2011], 
and these confer a global impact on the long-term day-to-day functioning and QOL 
[Cartmill et al, 2012]. Altered bowel function is related to distress in colorectal, 
urological and gynaecological cancer survivors but this has never been reported 
previously in HNC cohorts. This finding may be related to complications of opiate 
analgesia use, alterations to bowel function due to full reliance on enteral feeding and 
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also secondary to hormonal imbalances in a subgroup of thyroid cancers included 
within this study cohort. Pain is highly correlated to significant distress in HNC 
patients throughout the survivorship trajectory [Lewis et al, 2013; Maher et al, 
2013]
. 
 Cancer-related fatigue is a common problem in cancer survivors [Carlson et 
al, 2004; Brown & Kroenke, 2009] and is linked to emotional reactivity [Rissanen 
et al, 2014]. Like pain, sleep disturbances and insomnia can occur throughout the 
survivorship trajectory in HNC survivors [Scarpa et al, 2014; Zhou & Jolly, 2014]. 
While individual symptom/concern was related to significant distress in its own 
right, there is increasing interest in the prevalence of symptoms that frequently co-
occur in symptom clusters with distress. For example, sleep disturbances and 
insomnia occur commonly with other frequently reported side effects of cancer 
and/or its treatment, namely pain, fatigue, depression and distress [Butt et al, 
2008;Garland et al, 2014]. It is postulated that the clustering of co-occurring 
symptoms might be related to underlying inflammatory processes common to these 
concerns [Garland et al, 2014].  
 
Overall, the number of professionals selected ranged from 0-4, mean 0.38, median 
(IQR) 0 (0-1), n=170. From the patients’ perspectives, the attending doctor in clinic 
is often seen as the main clinician managing their cancer care. Thus, it is 
unsurprising that patients have indicated this professional as the one they would like 
to see or meet during their appointment, particularly those experiencing significant 
distress (52%, 11/21). Furthermore, those who were significantly distressed were 
more likely to select health professionals compared with those not experiencing 
significant distress (mean 0.53 versus 0.30). In this scenario, perhaps the attending 
doctor needs to be more proactive in suggesting onward referral or having direct 
access to the other professionals’ support in clinic. However, it remains unclear why 
so few additional HNC multidisciplinary personnel are ticked generally on the HN-
PCI and this is a subject for future research.  
 
Those significantly distressed with larger numbers of concerns were more likely to 
have had longer consultations compared with patients not reporting significant 
distress with fewer concerns.  Apart from increasing the length of consultation, 
significant distress impacts upon the individual management of these patients. 
Overall, those with significant distress were more likely to receive both medical and 
non-medical actions related to their consultation compared to those without distress. 
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While this finding is unsurprising, it places huge demand upon resources and 
outpatient clinic management. A different approach may be required to meet the 
concerns of significantly distressed patients in clinics where the HN-PCI is used. 
Suggestions include asking patients to prioritise their list of concerns for discussion 
during clinic, referral to the most appropriate professional who may be present at the 
clinic or at another appointment and self-referral through a web-based HN-PCI 
application. Future work should focus on the impact of HN-PCI-directed pathways in 
managing distress.  
 
d. “Is there an association between clinicopathological factors with outcomes of 
consultations with HN-PCI intervention?” 
 
An examination of the associations of multiple patient, doctor and contextual factors 
with the content and outcomes of consultations with HN-PCI intervention (Block 3 
only) was undertaken. These factors include gender, age, surgical specialty, surgeon, 
tumour primary site, overall cancer p-Stage, length of time from primary diagnosis, 
treatment rendered, and utilisation of free flaps.  The results of this study proved the 
study hypothesis wrong as the study results found that showed certain 
clinicopathological factors were significantly associated or showed a trend towards 
an association with concerns discussed during consultation.   
 
Overall, a larger number of concerns were discussed in consultations involving 
patients with a more advanced cancer stage, where more discussions were related to 
Physical and Functional wellbeing. These findings are unsurprising as patients with 
late stage tumours were more likely to receive multimodality treatment, experience 
complex side-effects and report poorer HRQOL [Hammerlid et al, 2001]. Due to 
the higher number of concerns, patients with higher overall cancer stage were also 
more likely to have longer consultations.  
 
A lesser number of concerns were discussed in those with > 3 years FU from 
diagnosis. Most concerning issues were typically experienced in the first year post-
diagnosis, particularly during the treatment period [Hammerlid et al, 2001], 
coinciding with the period when supportive care is most needed. Thereafter, only few 
significant improvements are seen between 1- and 3-year FU, during which issues of 
dry mouth, restricted mouth opening, sticky saliva and teeth problems persist 
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[Hammerlid et al, 2001]. Even though these could progress beyond 5 years post-
diagnosis [Abendstein et al, 2005], patient coping and adaptability to their 
dysfunction may explain why there is less discussion about concerns related to the 
Physical and functional well-being. This is corroborated by findings of a reduction in 
the need and request for supportive care at long-term FU [Oskam et al, 2013].  
 
There was a trend towards more discussions about concerns within the 
Psychological/emotional and spiritual well-being domain among females, younger (< 
55 years) patients and ENT patients. The reasons behind this finding are likely to be 
multifactorial, where multiple concerns are inter-related and clustered together. For 
example, in a previous study, the ‘Appearance’ concerns, being an item within the 
Psychological/emotional and spiritual wellbeing domain, was more frequently 
reported as a significant issue by females, those < 65 years and by patients with 
oropharyngeal primary site who are commonly under the care of ENT [Ghazali et al, 
2013A]. In addition, compared with those without appearance issues, patients with 
appearance concerns also wanted to discuss during consultations the following items 
i.e. anger, anxiety, depression, mood, sleeping and self-esteem. Interestingly, all of 
these items are clustered within the Psychological/emotional and spiritual well-being 
domain [Ghazali et al, 2013A].  
 
Survivors of primary larynx cancers were more likely to discuss concerns from the 
Social care and social wellbeing domain. This may be related to the 
‘Speech/Voice/Being understood’ concern, an item clustered within the Social care 
and social well-being domain, is significantly discussed more frequently in patients 
with laryngeal cancer. A similar finding has been reported previously [Kanatas et al, 
2013], where ‘Speech/voice/understood’ is one of the top two most common HN-PCI 
concerns selected by laryngeal cancer survivors. Significant voice changes occurring 
after cancer treatment [Rzepakowska et al, 2017], including complete loss of voice 
though laryngectomy can cause depression and social isolation which impacts upon 
their quality of life [Mertl et al, 2017] and their ability to return to work [Costa et 
al, 2017].  
 
In general, ENT patients showed a trend towards having a certain pattern of 
consultation that is different to non-ENT consultations. They had fewer discussions 
of concerns relating to Treatment-related domains. There was a trend towards more 
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discussions regarding ‘Dry mouth’ and also concerns within the 
Psychological/emotional and spiritual well-being domain.  On the other hand, 
‘Dental health/teeth’ were less likely to be discussed in ENT cohort even though the 
oral cavity including teeth, commonly demonstrate side-effects of RT due 
overlapping radiation fields for primary tumours that are usually managed by ENT 
i.e. nasopharynx, oropharynx, larynx, hypopharynx and cervical oesophagus. ENT 
patients also had notably more discussions about referral/requests for other 
professionals. A greater number of medical outcomes from the ENT consultations 
may be related with actual referrals made by the doctors as a result of the discussion.  
The ENT HNC clinics enrolled in this study are not always supported by the 
presence of speech and language therapist and/or dietitians in the same way that 
maxillofacial HNC clinics are set up. Furthermore, maxillofacial HNC surgeons who 
are also qualified dentists, may be able to address some of the more simple dental 
health/teeth related issues in clinic without resorting to referrals to dentists.  These 
factors may explain the significantly higher number of referrals/requests for other 
healthcare professionals in non-maxillofacial HNC clinics. ENT patients reported 
better patient satisfactions with consultations, where they scored favourable 
responses to the post-consultation questions and had better overall PSQ-MD scores. 
 
Longer consultation times were recorded in those < 55 years old, in those with late 
stage cancers, and in survivors with < 1 year FU since diagnosis. Longer 
consultations may be required in younger HNC patients to address their numerous 
and varied concerns. Younger HNC patients are known to report higher pain 
concerns [Rogers et al, 2012] which is also found in this study where they were 
more likely to discuss ‘Pain in head and neck’, experience chronic, significant FOR 
[Ghazali et al, 2013C], have a significant problem with anxiety and/or mood 
[Kanatas et al, 2012], have more appearance concerns [Flexen et al, 2012] and 
concerns about sexual health, particularly those with HPV-related cancers [Taberna 
et al, 2017]. Among cancer survivors in general, the younger aged subgroup also 
have specific concerns relating to parenting dependent children [Moore et al, 2015], 
returning to work [Stones et al, 2017], finances [Landwehr et al, 2016], concerns 
about fertility, relationships with others, spirituality and future outlook [Sodergren 
et al, 2017].  
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The relationship between more advanced cancer stage with longer consultations was 
due to the higher number of concerns reported by these patients. Longer 
consultations in those with < 1 year FU from diagnosis is also explained by the 
higher number of concerns discussed. In addition, physical recovery is still on going 
during this acute survivorship period, which is related to the higher recorded 
discussion relating to the Physical and functional wellbeing domain. While the 
difference was not statistically significant, those with < 1 year FU were more likely 
to have more discussions about referral/request for other healthcare professionals i.e. 
53% versus 33-42%. This fits in with the finding that younger patients were more 
likely to receive more medical actions that older patients at consultations. 
 
A trend towards longer consultations was seen in patients who received free flap 
reconstruction. As a group, free flap reconstruction may be a surrogate marker of 
extensive local disease, where the post-resection defect is likely to result in direct 
orocutaneous communication, or when direct closure would result in dysfunction of 
remaining tissues. Complications with free flaps are not uncommon due to the 
complexity of the procedure and patient characteristics [Al-Haydar et al, 2017], and 
this may cause a protracted period of wound healing, impacting significantly on 
quality of life [Momeni et al, 2013]. These issues require additional visits for 
continued outpatient management after in-patient care. Changes to the tongue, floor 
of mouth and cheek with the placement of soft tissue free flaps can change the way 
food is managed during eating and with wearing of dentures. Providing dental 
implant/prosthetic rehabilitation based on vascularized bone flaps is an inherently 
long process, and patients may continue to have issues with lack of teeth and 
chewing until its completion. Furthermore, the risk of vascularised tissues of 
developing osteoradionecrosis [Al-Haydar et al, 2017] may preclude some patients 
being offered dental implants indefinitely. These factors may explicate why free flap 
patients were more likely to discuss ‘Dental health/teeth’ concerns.  
 
Interestingly, this study found striking inter-surgeon differences impacting upon 
consultations. These differences were particularly evident in the consultation length, 
Treatment-related discussions, discussion of referral to other health professionals, 
and medical actions. In particular, Surgeon 1 had the shortest length of consultations, 
discussed predominantly Treatment-related issues, particularly the item ‘Cancer 
treatment’, and was least likely to discuss patient referrals/requests for other 
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healthcare professionals compared with other surgeons. On the other hand, Surgeon 
3 had the longest consultation time but discussed more number of concerns overall, 
also had more discussions about patient referral/requests for other healthcare 
professionals, and showed a higher number of medical outcomes.  
 
Studies of patient-doctor interactions indicate that consultations may be influenced 
by doctor-related factors which are related to individual surgeons’ perceptions of 
patients [Street et al, 2007], their belief regarding aspects of psychosocial care 
[Levinson & Roter, 1997], belief about their professional remit and preferences 
related to such consultations [Detmar et al, 2000], consultation style [Street et al, 
2007; Takayama et al, 2001], possession of advanced communication training/skill 
[Parker et al, 2005], and the patient-doctor relationship. Rodriguez et al [2011] 
showed that longer duration of discussions related to QOL during consultation was 
significantly related to the length of patient-doctor relationship measured by the 
number of previous visits, indicating that existing and continuing rapport helped 
facilitate this. It may be argued that the HN-PCI intervention should iron out striking 
differences introduced by individual surgeon variable, and this is investigated and 
discussed in depth in the next section.  
 
The findings of this study may be limited by the exclusion of other patient factors 
that have been shown to influence cancer communication behavior such as ethnicity, 
education, and income level [Siminoff et al, 2006]. Critically, this study did not 
enquire about patients’ preference regarding the style of consultation at baseline. 
Furthermore, multivariate analysis was not undertaken. There may be some value in 
undertaking this analysis because it is more likely to be influenced by a multitude of 
other competing factors during a dynamic process of the clinical encounter [Street et 
al, 2007]. 
 
e. “Does the HN-PCI intervention change the content of the consultation?” 
 
This study hypothesised that the HN-PCI intervention would raise more items and/or 
a broader range of expressed concerns during consultations. The findings of this 
study showed that the intervention had significantly changed the content of 
consultations, whereby concerns from the Psychological/emotional and Spiritual 
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well-being domains were more commonly discussed following the intervention  
(Table 7.16). 
 
The trend towards an increase in the number of concerns and a broader range of 
items discussed at consultation with HN-PCI PRO found in this study was also 
reported when HRQOL PROs were utilized in routine oncology practice settings in 
two randomised-controlled trials [Velikova et al, 2002; Detmar et al, 2002], a 
longitudinal, cross-sectional study of various cancer survivors [Takeuchi et al, 
2011], a controlled trial of paediatric haematological cancer survivors [Engelen et 
al, 2012] and a controlled trial of patients attending outpatient chemotherapy clinic 
run by nurses [Hilarius et al, 2008].  
 
The trend for more discussions of items was observed across the board even when 
patients do not select these items (Tables 7.51 and 7.52). These items may have 
been were brought up by one or several ways. The patient may have generated the 
items for discussion despite not selecting the item on the HN-PCI as a result of being 
primed to the HN-PCI checklist. This effect was observed in previous studies 
[Velikova et al, 2004; Takeuchi et al, 2011]. Alternatively, it may have been 
initiated by the doctor, or arisen from discussions surrounding other items as 
demonstrated in the pilot study [Ghazali et al, 2013A]. Overall, there were a higher 
number of items selected and discussed in Block 3 than in Block 2 in all domains 
(Table 7.53), where full HN-PCI implementation may have played a contributory 
role. However, there was more likelihood of lesser items being discussed as the 
number of items selected increased (Table 9.53). 
 
A previous study showed a tendency for some patients to select large numbers of 
concerns for discussion, particularly when filling in the HN-PCI for the first time 
[Ghazali et al, 2015]. It is probable that patients may have felt ‘spoilt for choice’ 
where the novelty of the opportunity to express their concern was met with an excess 
number of selected items, because this tendency is not repeated as the numbers 
selected reduced with succeeding visits. The reduction in the number of symptom 
with succeeding visits was also observed in a longitudinal study of using HRQOL 
PRO in routine oncology setting [Takeuchi et al, 2011]. As indicated in the pilot 
study discussion, when patients select too many items to be addressed in single visit, 
this may sign post the patient for an additional visit with the doctor or with the CNS 
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to help address any remaining concerns [Ghazali et al, 2013A]. Nevertheless, in this 
situation, it may not be practically possible for the doctor to address all of the items 
selected in a single visit due to clinic appointment constraints. This may account for 
why fewer numbers of items were discussed with increasing number selected by 
patients (Table 7.53). However, it is still unclear why from a collection of items 
selected, some items were chosen for discussion, while others were disregarded.  
 
To determine if the HN-PCI helped to bring the patient’s agenda up for discussion, 
the level of agreement between self-reported HN-PCI data and consultation-assessed 
data was evaluated. The overall agreement between patient selection of an item and 
discussion with doctor with HN-PCI intervention was only fair to moderate. There 
was improvement in the levels of agreement when the HN-PCI was fully 
implemented (Block 3) then with partial implementation (Block 2). In Block 2, 
where self-reported data were not available to the doctor during discussion, the 
median (IQR) level of agreement for 27 items of concerns was recorded as fair i.e. 
0.25 (0.02-0.48). In Block 3, where self-reported data were available to the doctor 
during discussion, the median levels of agreement for both 27- and 44 items of 
concerns were recorded as moderate i.e. 0.42 (0.27-0.49) and 0.42 (0.24-0.49), 
respectively. When the level of agreement was compared by domain across Blocks 2 
and 3, better levels of agreement were seen in all domains in Block 3. 
 
A closer look at the level of disagreement between the proportions of items selected 
and those discussed (i.e. YN: ‘patient selected but not discussed’ and NY: ‘not 
selected by patient but discussed’) in relation to the proportion where there was 
agreement (i.e. NN: ‘item not selected and not discussed’, and YY: ‘item selected 
and was discussed’) may provide a window into how items of concerns may have 
been handled during consultations in Block 3.  With items in the Treatment-related 
domain, a vast gap was observed when the proportion of disagreement (i.e. NY=47 
and YN=3) was considered alongside the proportion of agreement (i.e. NN=42 and 
YY=8), thereby, producing a kappa value that was barely above zero.  Thus, the 
dominating feature here was that treatment-related items were not being selected by 
patients, but treatment-related items were discussed. For the Social care and social 
wellbeing domain, there is tendency to discuss one or more items from this domain 
even when none has been selected than vice versa. But because the dominant feature 
here is for none to be raised or discussed (NN=57), the level of agreement is 
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somewhat raised. On the other hand, the items in the Psychological/emotional and 
Spiritual wellbeing domain showed a near balance between NY (14) and YN (18), 
but when this is considered in relation to the proportion of agreed items (NN=41 and 
YY=27), the dominant feature overall is of agreement, producing a better kappa level 
of agreement.  
 
There are 4 items in the Treatment-related domain. ‘Cancer treatment’ was most 
likely to be discussed during consultations even when patients did not select this. 
‘Cancer treatment’ is often a doctor-directed item during discussion as this enables 
doctors to familiarise themselves with where patients are in terms of their post-
treatment progress [Fagerlind et al, 2008; Detmar et al, 2001; Takeuchi et al, 
2011]. While this may help open further discussions relating to treatment-related 
concerns that patients may have, there is a danger that the proportion of discussion 
time will be spent here rather than other areas more important to patients. Although 
there was no definitive evidence to validate this in the current study, the discussions 
about other items in the Treatment-related domain that were not selected by patients 
(NY items) such as ‘Wound healing’ and ‘PEG tubes’ may suggest that this could 
have occurred. The remaining item in this domain i.e. ‘Regret about treatment’ is 
considered an important concern to both patient and clinicians. While post-treatment 
regret is not unusual among cancer patients [Connoly & Reb, 2005], the prevalence 
of post-treatment regret among HNC patients and their carers is reportedly low [Gill 
et al, 2011], which may to some extent explain why this concern was not highlighted 
by this study cohort or discussed in clinics. 
 
There is further evidence suggesting that doctor-directed discussions may have also 
occurred in items within the Social care and social wellbeing domain. There were 
more discussions relating to some items in this domain even though there was a 
general trend for patients choosing not to select items within this domain. Kappa 
values were obtained only in 4/9 items in this domain. ‘Financial /benefits’ and 
‘Relationships’ showed moderate level of agreement (κ =0.49), indicating that these 
concerns were likely to be discussed if they were initiated by selection on the HN-
PCI. ‘Speech/Voice/Being understood’ and ‘Lifestyle issues (smoking/alcohol)’ 
showed less than fair kappa values (κ <0.20). In both items, the kappa value was the 
result of the gap seen when the proportion of disagreement (Speech/Voice/Being 
understood: NY=16 and YN=5; Lifestyle issues: NY=10 and YN=0) was considered 
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alongside the proportion of agreement (Speech/Voice/Being understood: NN=75 and 
YY=4; Lifestyle issues: NN=89 and NN=1) in both concerns, respectively. This 
finding indicates that discussions of these two concerns were more likely to occur 
even if they were not selected for discussion by patients. It is reported that doctors 
felt more comfortable discussing social concerns when these were related to 
dysfunction and its impact on performance status, as many social activities are reliant 
upon on physical functioning [Taylor et al, 2011]. This may account for the 
increased likelihood of discussion related to ‘Speech/Voice/being understood’ and 
‘Recreation’.  It is highly probable that doctors had also initiated ‘Lifestyle issues 
(smoking/alcohol)’ discussions because doctors are trained to undertake secondary 
prevention of HNC [Detmar et al, 2001; Fagerlind et al, 2008; Rodriguez et al, 
2010]. On the other hand, the overall trend of patients choosing not to select items 
within this domain perhaps reflects this cohort’s preference for not wanting to 
discuss social concerns in clinic. Taylor et al [2011] reported that only 44% of their 
cancer patients expressed a willingness to discuss social concerns in clinic while 
39% would only do so at the doctors’ prompting, and 11% would not rather not 
discuss these concerns in clinic. Despite a lowered trend for patients selecting items 
in the Social care and social wellbeing domain in Block 3, 8/9 items (89%) in this 
domain (except ‘Support for my family’) were discussed in clinic. This may suggest 
that doctors’ willingness to broach social concerns may have helped bring NY social 
concerns into discussion, even if the initiating factor to discussion may have been 
related to treatment side-effect.  
 
In regard to the Psychological/emotional and Spiritual wellbeing domain, 9/14 items 
showed fair to moderate level of agreement, while kappa value was not obtained 4/14 
items and a negative kappa value was obtained in 1 item. Items showing fair to 
moderate kappa values include those related to psychological distress (i.e. ‘FOR’, 
‘Anxiety’, ‘Anger’, ‘Depression’ and ‘Mood’) and those related to the individual’s 
character/quality (i.e. ‘Self-esteem’ and ‘Temperament/Personality’). This finding 
indicates that both patients and doctors were willing to discuss these issues when 
patients choose to disclose them in clinic on the HN-PCI. Kappa values were 
unobtainable with ‘Spirituality/religious aspects’, ‘Sexuality’, ‘Intimacy’ and 
‘Coping’. In general, the vast majority of patients did not choose to discuss any of 
the items without kappa values.  When these weren’t chosen, these items were 
unlikely to be discussed other than ‘Coping’ (NY=8 versus NN=92). Coping may be 
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discussed when addressing other ‘stressful’ concerns that patients may have.   
 
Sexual dysfunction is a significant problem in people with cancer, but discussions 
about sexual dysfunction and sexual health remain taboo subjects [Barbera et al, 
2017].  The items, ‘Intimacy’ and ‘Sexuality’ are difficult subjects to discuss in 
clinic, and these concerns are believed to be under-reported in HNC [Low et al, 
2009; Rogers et al, 2015]. In Block 3 of this study, ‘Intimacy’ was highlighted in 
2% (2/100) while ‘Sexuality’ was highlighted in 1% (1/100), which was smaller 
when compared with a previous HN-PCI study, where the proportions were 5% 
(9/177) and 2% (4/177), respectively [Rogers et al, 2015]. This finding supports the 
notion that having a prompt like the HN-PCI, patients can take the initiative and 
highlight their interest in having open discussions about them in clinic. However, 
there were three instances in Block 3 where both concerns were highlighted, but 
these were not discussed (YN=3), indicating that these concerns remained 
unaddressed. Blocking these concerns from open discussion means that the unmet 
need persists. Rogers et al [2015] suggests that doctors may not be willing and/or 
express lack of confidence in dealing with these concerns. Training is paramount in 
overcoming these issues, and this is essential as doctors increasingly confront more 
cases of HPV-related cancers, a sexually-transmitted disease, in their practice [Chu 
et al, 2013].  HPV screening in HNC is becoming a standard of care, and a patient-
centered approach is warranted in dealing with the aftermaths of HPV screening, 
which may bring up a unique set of anxieties and stresses on patients and their 
interpersonal relationships [Chu et a, 2013]. Awareness of and access to specific 
services that can support sexual health needs with may help facilitate its open 
discussion in routine oncology clinic.  Addressing these concerns in routine HNC 
clinics has led to referrals to other professionals [Rogers et al, 2015] with 
psychosexual training, who may be better equipped in dealing with these issues with 
patients and their carers [Manne & Badr, 2010; Hoole et al, 2015].  
 
The recognition of the importance of ‘Spirituality/Religious aspects’ in oncology and 
survivorship is increasing [Pereet & Balboni , 2013], particularly in terms of its 
central role in helping cancer patients cope, providing comfort, hope and meaning 
with the existential crises at diagnosis, during treatment [Becker et al, 2006], and 
also in the palliative care setting [Williams, 2006].  Patients describe having 
‘spiritual pain’ as a major factor that influences their sense of religiosity and their 
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spiritual wellbeing [Delgado-Guay et al, 2011]. Maintaining good spiritual 
wellbeing is critical because of its impact on QOL, not only at the concluding stages 
of their journey [Kandasamy et al, 2011] but also in long-term cancer survivorship. 
‘Spirituality/Religious aspects’ are linked with post-traumatic growth where benefit-
finding and making meanings are ways that can help patients create a more positive 
revised worldview after a significant adverse event i.e. cancer diagnosis, 
[Kandasamy et al, 2011; Pereet & Balboni, 2013]. Pereet & Balboni [2013] 
broadly indicates spiritual needs to include ‘distressing spiritual struggles (e.g. 
feeling abandoned by God) and spiritual seeking (e.g. seeking forgiveness, thinking 
about what gives meaning to life)’ [page 281] and unmet spiritual needs may include 
negative religious coping (e.g. anger at God). Traditionally, the clergy (i.e. chaplains, 
priests, imams, rabbi, monks or other religious ministers) have been responsible for 
the spiritual care of patients [Best et al, 2014]. However, irrespective of their 
religious background, the majority of cancer patients wanted their doctor to ask 
about their source of spiritual support and facilitate access to it, even though doctors 
felt that they would not broach this subject without patient initiating it [Best et al, 
2014]. This study also specified that cancer patients did not want spiritual guidance 
from their doctors, but discussions about spirituality by doctors were perceived as 
fulfilling their expectations to be treated holistically, and as the basis of a good 
patient-doctor relationship, which enabled them to discuss their fears [Best et al, 
2011].  
 
In Block 3, this concerns was identified in 2/100 consultations (2%), where there 
were one case each of YN and NY. The rarity of this concern being highlighted may 
represent either the lack of need, or patient preference not to discuss the issue in 
clinic. Studies have shown that spirituality concerns are infrequently discussed in 
clinics, and while patients welcome the idea of doctors discussing spirituality in 
clinics, there maybe a mismatch between patients and doctors regarding what 
constitutes this discussion [Best et al, 2016]. Multiple issues underlie this, which 
includes the lack of universal definition of spirituality and/or religion; ethnocultural 
differences; individual personality; doctors’ beliefs regarding who should best 
address these concerns; some doctors’ preference for not discussing this concern 
even when broached by patients; the lack of knowledge/training in dealing with this 
concern; doctors’ belief that they lack capacity to help with such concerns; doctors’ 
belief that discussing this concern can exceed professional boundaries and/or cause a 
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negative impact on patient outcomes; doctors’ discomfort discussing concerns that 
‘did not have a scientific basis’; discordance between the doctors’ and patients’ 
personal religious beliefs; the strength of patient-doctor relationship;  and practical 
considerations i.e. lack of time [Best et al, 2016]. It is unclear how the discussion 
relating to this concern was broached in the single case of NY seen in Block 3.     
 
In Block 3, most items in the Physical and Functional wellbeing domain (24/29, 
83%) showed at least fair kappa values (κ ≥ 0.20). This finding indicates that patients 
want to discuss concerns relating to their function, and there was a fair chance that 
these concerns were addressed during their visit. These items were issues brought 
about as a consequence of their treatment, which are of interest to both parties. This 
has been reported previously in other studies, where patients and doctors express 
preference for discussing physical concerns during clinic visits [Detmar et al, 2000; 
Fagerlind et al, 2008]. In this subset, some items showed better kappa values than 
others, e.g. ‘Appetite’ κ= 0.78 and ‘Bowel habit (diarrhoea/constipation)’ κ= 0.71 
while ‘Sleeping’ κ= 0.23 and ‘Activity’ κ=0.25. The imbalance seen in Sleeping i.e. 
YN=13 and NY=2; and with Activity i.e. YN=0 and NY=15 may account for the 
kappa agreement value of being only fair. ‘Mobility’ showed less than fair kappa 
value, where a reasonable gap is seen between the proportion showing agreement 
(NN=92 and NN=1) in comparison to the proportion of disagreement (YN=5 and 
NY=2). This indicates that this concern is infrequently discussed and was 
particularly less likely to be discussed even if selected by patients. Kappa value was 
not available from 3 items i.e. ‘Vomiting/Sickness’, ‘Regurgitation’, and ‘Smell’, 
where these were hardly selected and/or discussed at all in Block 3. 
‘Vomiting/sickness’ and ‘Nausea’ are more common concerns in HNC patients who 
are undergoing active treatment, particularly with chemotherapy, in comparison to 
those who have completed their treatment, and this may explain why these concerns 
were hardly an issue in this post-treatment cohort. 
 
It is not possible to determine definitively how discussions regarding concerns were 
initiated with the HN-PCI in place, as this study was not designed to explore the 
specific dynamics of the discussion. Without qualitative analysis, it is impossible to 
examine thoroughly how patients and doctors use the HN-PCI in eliciting patient 
concerns and how discussions about these concerns were initiated or otherwise 
during the visit. This is a subject for future work.  
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Therefore, the following observations are tentative based on existing data. For items 
not addressed, it may be speculated that patients may not have taken the initiative to 
broach these subjects during consultation having completed the prompt sheet, and/or 
doctors had blocked discussion of patient-selected topics, or there was simply no 
time to address all of the concerns selected. Even with the HN-PCI intervention, 
there was a trend indicating that consultations continue to focus on medical/technical 
issues despite an increase in psychosocial discussions. Some of these issues were 
related to the patient selecting these items on the HN-PCI but some were discussed 
irrespective of patient selection. Perhaps, these discussed items were due to its 
relatedness to medical/technical issues (e.g. ‘Speech/Voice/Being understood as an 
issue related to treatment), and these are concerns that doctors are more familiar 
with. Doctors may also preferentially address symptoms they are able to alleviate or 
manage. Clinicians using PROs in cancer clinics have expressed their reservations 
about initiating discussions about issues that they would not personally be able to 
deal with or could not do anything about [Velikova et al, 2008; Takeuchi et al, 
2011]. In addition, with concerns of complex and multifactorial nature, doctors may 
not directly address those concerns but rather approach this by discussing other 
symptoms/concerns that are often clustered together. Take the example of ‘Sleeping’, 
a concern is not commonly discussed in Block 3 (NN=82; YN=13 versus NY=2; 
YY=3; κ=0.23). Other concerns that are often clustered with ‘Sleeping’ were 
discussed more commonly in Block 3 with moderate levels of agreement: 
‘Fatigue/tiredness’ (κ=0.56);  ‘Energy levels’ (κ=0.48); ‘Dry mouth’ (κ=0.55); and 
‘Breathing’ (κ= 0.58). This method of discussion may not easily or necessarily 
translate into the method of assessment used in this study.  
 
Perhaps, the crux of the problem i.e. the mismatch seen between what the patient 
selects and what is discussed lies in the doctor’s willingness to take on the 
discussion. This is succinctly summarised by Greenhalgh et al [2005, page 840]: 
‘Even if patients raise their concerns within the consultation, this must be taken on 
board by clinicians if it is to have any influence on their decision making’. The fair 
to moderate level of agreement may suggest the possibility that some surgeons in this 
study have not consistently utilised the HN-PCI prompt sheet when it was available 
to them. This finding was recorded in another study [Greenhalgh et al, 2013; Hatta 
et al, 2014]. These are several issues that may account for this: (1) time and resource 
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constraints; (2) unfamiliarity with instrument; (3) belief that doctors’ subjective 
assessment is better; (4) belief that PROs can interfere with the patient-doctor 
relationship; and (5) the belief that PROs do not contribute towards clinical decisions 
due to the lack of clear guidance or pathways that can guide doctors in dealing with 
types of concerns raised [Hayland & Ferrans, 2008; Velikova et al, 2008; Luckett 
et al, 2009; Takeuchi et al, 2011; Greenhalgh et al, 2013]. 
 
Clinicians are still uncertain on how to use HRQOL PROs in routine clinical practice 
despite increasing enthusiasm to do so [Greenhalgh et al, 2005; Hayland & 
Ferrans, 2008; Luckett et al, 2009]. Greenhalgh et al [2013] undertook a detailed 
qualitative study of how clinicians used HRQOL as prompt sheets in routine 
oncology clinics. They found that by simply making explicit reference to the prompt 
sheet at the start of the consultation, clinicians have strengthened patients by 
allowing them the opportunity to clarify and explain the disclosed concerns on the 
prompt sheet. This ‘permission-giving’ effect by referencing to the PRO data at 
consultation was also noted during the development of thematic framework of this 
study [Ghazali et al, 2013A]. Interestingly, Greenhalgh et al, [2013] notes that 
doctors may not always know how to do this even when the PRO is accessible to 
them.  
 
Greenhalgh et al [2013] observed that initial references to the prompt sheet during 
consultations tend to be general, mainly as recognition of its completion, and to 
acknowledge the patient’s self-reported responses. When direct references are made 
to a particular concern selected, patients usually attempt to explain their experience 
of the concern. In response, the doctor often tries to explain away the concern, 
particularly if the concern was a symptom. The explanations given i.e. the reasons 
and purported cause for why those concerns may have been experienced i.e. 
‘candidate cause’ are usually based on the disease or treatment. On the occasion that 
the patient concern did not seem to fit in with the understanding of the disease or 
treatment, it is deemed ‘not cancer-related’. Consequently, the doctor terminates 
further discussion relating to that concern, and the next concern on the list is 
approached. For some symptom-type concerns where the candidate cause is 
determined, doctors often resort to medical symptomatic treatment by way of 
addressing them. Doctors have a tendency to close down further discussions 
regarding a concern once the candidate caused is provided, even if their explanation 
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sometimes contradicts the patient experience. At this point, when patients attempt to 
continue the discussion, the doctor may block or change discussions to another topic. 
The only time a candidate cause is abandoned is when there is objective evidence 
e.g. blood investigation, etc. is available. Therefore, further exploration of the 
psychosocial impact of the concern is blocked. This finding suggests that while 
PROs may be able to help disclose a concern and initiate its discussion, the quality of 
that discussion may still be influenced by other factors.  
 
An interesting observation in the MD Pilot study [Ghazali et al, 2013] was how the 
inter-relatedness of individual concerns can influence the way patients select items 
on PROs and how they are discussed. Some clustering of items of concern are 
intuitive, for example, clustering of the following concerns: ‘Teeth/Dental health’, 
‘Chewing/eating’, ‘Appearance’, ‘Speech/Voice/being understood’ and request for 
‘Dentist’ and ‘Oral rehabilitation’ support may relate to issues surrounding loss of 
teeth. These types of clusters are often based on the understanding of anatomy, 
function and the impact of treatment. Initiating discussions about these concerns are 
relatively easier because it is immediately clear to both patients and doctors.  
 
In an exploration of symptoms, function and supportive care needs, Synder et al 
[2008] showed that some concerns e.g. sleeping problems have greater unmet needs 
than others. Greenhalgh et al [2013] provides the example of how doctors dealt with 
the concern ‘Fatigue’, a complex item with multifactorial causes. Doctors tend to 
approach this concern with their medical/technical understanding, including 
enquiring about the problem with closed ended questions, offering a candidate cause 
(e.g. chemotherapy), probes other candidate cause related issues (e.g. pain, breathing 
problems, appetite), suggest medical interventions based on their candidate causes 
(e.g. high-energy drinks for perceived loss of appetite) while blocking patients 
explanation of the concern (e.g. changes topic of discussion to other related/known 
causes of tiredness) with consequential impact on access to supportive care (e.g. 
‘tiredness is an inevitable chemotherapy side-effect, therefore nothing can be done’) 
and preferring to rely on objective medical evidence before changing management 
(e.g. only intervene when blood results indicate deficiency). Doctors failed to explore 
possible psychosocial reasons or impact of fatigue, for example, psychological 
distress, social isolation, inability to return to work, and in doing so may 
inadvertently block access to supportive care. 
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The data regarding discussions on patient request for referrals to healthcare 
professionals was not forthcoming. There was hardly any discernable level of 
agreement seen across both blocks, mainly because of the relatively few requests 
selected by patients in the first place. When patients did indicate a request, there was 
very little acknowledgement of that during discussions. Interestingly, there were 
significantly more discussions about the CNS input despite patients not selecting that 
in Block 3. With the trend of discussing more items, particularly in the 
Psychological/Emotional and Spiritual wellbeing in this block, discussion 
surrounding the CNS may be a way by which the doctor enlists additional help to 
deal these types of concerns. Overall, these results did not provide any strong 
evidence for the potential role of the HN-PCI as a prompt for access to supportive or 
additional care. It is unclear if this is because there is lack of need for additional 
supportive help, or if patients preference is to self-manage their concerns/issues. 
There are several limitations to this section of the study. The main limitation relates 
to the statistical analysis. Multiple statistical analyses were undertaken on 
underpowered data, and on HN-PCI where there were large gaps were seen in items 
that were less commonly selected. Interpretation of the statistical analyses also 
included borderline statistical significant findings, which allowed the formulation of 
trends that are clinically relevant. Existing data was obtained from a single clinic 
encounter only. The coding data were not adequate to allow in depth content and 
conversational analysis of discussions to elucidate how the HN-PCI may have 
changed the discussions during consultation. While this is not an objective of this 
current study, an opportunity for future qualitative evaluation is possible as the 
consultations were audiorecorded.  
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CHAPTER 8 
8.0. MD STUDY CONCLUSIONS 
 
8. 1.  Implications for clinical practice and future research 
 
In this study, normal consultations that occur in routine HNC clinics without the HN-
PCI intervention were found to retain the traditional, doctor-centric approach, where 
medical/technical-based discussions predominate within the expected temporal and 
structure of the visit.  This falls short of the overall concept of patient-centred care in 
cancer, which is unlikely to occur without a good understanding of patient needs and 
factors that influence them [Richardson et al, 2007]. Without engaging the patient in 
the process of disclosing their concerns, needs and problems and the discussions that 
can help explore and address these issues, it would be impossible to personalise their 
care.  
 
This study provided evidence for the introduction of HN-PCI as a PRO in routine 
multispecialty HNC practices. The intervention of HN-PCI as a prompt sheet helped 
patients to disclose their concerns by demonstrating a trend towards a higher number of 
concerns discussed compared to control. Furthermore, a broader range of concern was 
discussed, particularly concerns relating to the psychological-emotional domain. These 
resulted in a trend towards slightly longer consultations. As a prompt for requesting 
referrals for other health care professionals to support their care, the impact of HN-PCI 
intervention was less clear. There was no increase in the request for referrals or access 
to supportive care seen at both the self-completed data and the discussion stages. While 
primarily used as a prompt sheet for discussions in clinic, the HN-PCI was also able to 
indirectly screen for those with significant levels of distress based on a cut–off point of 
the numbers of concerns selected. This finding suggests that the HN-PCI may also be 
deployed as a quick screening tool not only for identifying significant distress, but it 
may also simultaneously identifying the concerns that may be associated with this.  
 
This study showed that patients did not reject the HN-PCI, where trends suggested 
favourable acceptance by patients who used the HN-PCI. Favourable responses by 
patients who used the HN-PCI were also recorded in studies by Rogers et al [2009], 
Hatta et al, [2014] and Jungerman et al [2017]. First time users of the HN-PCI in 
Brazil comment on the impact of the HN-PCI in acknowledging their often 
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unrecognised concerns, enables them to indicate their complete list of concerns, 
preempts the dialogue they will have with the doctors, empowers patients by giving 
them an outlet to voice their concerns, and how it provides reassurances that their 
concerns mattered [Jungerman et al, 2017].   In a detailed review of patient’s 
perspectives as users of the HN-PCI tool, Rogers & Lowe [2016] reported that almost 
two-thirds of patients surveyed felt that the HN-PCI was helpful in enabling all or most 
of their concerns to be discussed, and in their communication with the doctor. 
Favourable responses regarding the HN-PCI as a communication prompt includes 
reminding patients the items for discussion, opens door for discussion of items not 
normally discussed in clinic, assist patients to mentally prepare for the discussion, 
inform doctors of patients concerns, help doctors to initiate items for discussion, focus 
the discussion, and enable patients to speak with different people for help. In addition, 
patients also report on the positive effect of filling the HN-PCI as providing an 
opportunity for them to concentrate on thinking about what concerns they may have and 
to determine if any of the concerns on the list constitutes a problem that requires 
addressing, and for some, the process enables them to make a mental note about their 
health. Some patients indicate a sense of relief after consultations, and this seems to 
relate to having their worries addressed and talked about through discussions.  
 
Rogers & Lowe [2016] reports that a small percentage (11%) did not feel the HN-PCI 
made a difference to their communication during consultation, and based on the 
verbatim comments made, these patients could be categorized into (1) those who did not 
have any concerns; (2) those who are self-aware and feel able to initiate the discussions 
with doctors without help; (3) those who have their concerns unacknowledged or 
blocked from discussion; (4) those who have a preference to discuss non-
medical/technical concerns with nurses rather than doctors; and (5) those who are 
unfamiliar or uncomfortable with self-directed questionnaires/tools.  
 
For the HN-PCI to become a useful tool in assisting patient-centred consultations, both 
patients and doctors have to buy into the idea, and be willing participants in the process. 
This is a prerequisite before HN-PCI data can be of any value in decision-making of 
patient care. This study offered a broad perspective of how patient-reported concerns 
highlighted by the HN-PCI are managed by the patient and doctor during consultations. 
The HN-PCI intervention improved the level of agreement between patient-reported 
concerns and concerns discussed slightly from fair to moderate. Any mismatch seen 
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between patient-reported concerns and concerns discussed reflects multiple reasons 
influenced by patient-, doctor-, and contextual-related factors.  
      
For the HN-PCI to be accepted more widely, there remain several barriers to be 
overcome. With the potential for HN-PCI to increase consultation times, time 
constraints expected from a busy HNC clinic are a major consideration. This is 
particularly relevant in situations where longer consultation times than normal may be 
expected, such as those identified in this study i.e. when large number of items of 
concern are selected, in younger patients, those with late stage cancers, patients who 
received free flaps, and in survivors with < 1 year FU from diagnosis. Continued 
commitment of the HN-PCI usage in routine clinical practice is largely driven by patient 
acceptance. This study, as well as previous studies [Rogers et al, 2009; Hatta et al, 
2014; Jungerman et al, 2017] have shown that there is favourable acceptance of the 
HN-PCI, but these are based on a one-off assessment of the HN-PCI, and longitudinal 
reception of the HN-PCI by patients remains unproven. This may be influenced by the 
extent of respondent burden per visit, the relevance of the HN-PCI at long-term FU with 
decreasing needs, and the patient perception of its efficacy in addressing their concerns. 
The question of whether having completed the HN-PCI before the consultation may 
have raised expectations of the imminent consultation was explored by Rogers & Lowe 
[2016].  While almost half (45%) thought that the HN-PCI may, or had definitely raised 
expectations of the consultation, only a minority (12%) felt that raised expectations had 
possibly or definitely led to disappointment because their needs had not been met. Thus, 
it was unsurprising that a similar proportion (47%) thought that the HN-PCI had made a 
positive difference to their appointment. More than half (58%) felt that they would 
definitely like to continue using the HN-PCI compared with 17% who thought they 
might, and 5% who thought they definitely would not.  
 
Doctor acceptance of the HN-PCI is also a pre-requisite for the regular and long-term 
commitment towards the HN-PCI implementation. In regard to this, it can be argued 
that doctor-related barriers are far more critical than those presented by patients 
[Mitchell, 2013]. The barriers for PROs use in routine clinical practice noted in other 
studies [Synder et al, 2010; Takeuchi et al, 2011] and these are also applicable to the 
HN-PCI, and include (1) doctors’ preferences; (2) doctors’ ability to discuss 
psychosocial issues; (3) doctors’ tendency to minimise or ignore psychosocial concerns 
based on their belief that these are unavoidable consequences of cancer diagnosis; (4) 
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doctors’ belief that they are unable to provide appropriate management i.e. advice 
and/or solutions; and (5) doctors’ unfamiliarity with PROs and how to use them. It is 
also suggested that having a structured questionnaire/form to guide communication 
between patients and doctors may reduce the value of the conversational approach, 
particularly when there is already a long established patient-doctor relationship 
[Takeuchi et al, 2011].  
 
In regard to the HN-PCI, doctors’ views have not been explored in detail. This current 
study failed to evaluate the views of the doctors who participated in this study.  In the 
UK, there were only two verbatim comments made by doctors who have used the HN-
PCI, where comments were positive and supportive of the tool, indicating that the tool 
helped to focus discussions and also facilitated discussion of items that were never 
talked about before [Rogers & Lowe, 2016]. Malaysian doctors who used the HN-PCI 
were surveyed at the end of the study [Hatta et al, 2014]. All the surgeons in that study 
had referred to the HN-PCI before the consultation. All surgeons were of the opinion 
that referring to the HN-PCI checklist helped prompt patients to recall the issues that 
they had selected for discussion. Nine out of 10 surgeons felt that the HN-PCI helped to 
focus the consultations, and most (70%, 7/10) did not think that using the HN-PCI 
lengthened the consultation. Overall, the vast majority (90%) indicated that they would 
agree to use the HN-PCI in future consultations. Specialist HNC nurses, who are often 
keyworkers of HNC patients, expressed positive feedback regarding the use of HN-PCI 
relating to its ability screen more holistically, and its empowering effect on patients as 
they take ownership of their condition. There were some reservations regarding 
potential duplication of work as nurses are expected to undertake a more formal holistic 
needs assessment during separate visits for patients [Rogers & Lowe, 2016].  
 
Nurses have also highlighted logistical issues with implementing the HN-PCI in busy 
HNC clinics, due to the lack of suitable space for patients to complete the HN-PCI, and 
the sheer volume of patients attending those clinics [Rogers & Lowe, 2016]. Despite 
some disruption at the registration area where Malaysian patients complete the 
questionnaire, more than half of the clinic registration staff felt that it was suitable to 
give patients the questionnaire at the registration area [Hatta et al, 2014], indicating 
that these were simply early, teething problems. From the patients’ perspectives, the 
appointment was time-efficient due to the focused consultation [Rogers & Lowe, 2016] 
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and the process of filling in the HN-PCI did not amount to additional difficulties, 
although a small number of some patients had trouble with the TST [Hatta et al, 2014].   
 
A major problem that may hinder the implementation of the HN-PCI is the way the 
health care system is currently structured, as it is not geared up to meet with some of the 
concerns on the HN-PCI checklist. Individual HNC services need to have a strategy, 
structure and care pathways in place to cater for the concerns that are being potentially 
screened with the checklist. Failure to plan for and organise pathways of care based on 
the HN-PCI prompt list can result in doctors feeling out of depth to deal with unfamiliar 
problems, and frustrations on the part of doctors and patients with the lack of services 
that can support the concerns highlighted.  
 
In the UK, the endorsement of the Macmillan Recovery package [Macmillan, 2013] 
within the national strategy for cancer [NHS England, 2014; NHS England, 2017] 
may help address the fundamental issue with a health care system that is currently not 
organised to achieve the full implementation of personalised care through holistic 
assessment. Being one of the four interventions of the Macmillan Recovery package, all 
cancer services services will need to adopt a suitable holistic assessment process, and 
develop a local/regional strategy and structure to to support its implementation. This 
MD study demonstrates that the HN-PCI could be used as a holistic assessment tool in 
routine HNC clinic setting. In considering this finding, the MD study discussion has 
highlighted some of the practical issues that could occur with its implementation, 
especially when it is implemented in isolation i.e. without the accompanying paradigm 
change in cancer strategy, health care system and structure. Longer consultation times, 
higher clinic outputs and an increased range of patients’ concerns they want to discuss 
during consultation can put extra demands on health care providers and the cancer 
services.   
 
Rolling out holistic needs assessment also requires careful consideration of practicalities 
i.e. who undertakes holistic assessments, how and when is it best done. While this MD 
study cannot definitively comment on the role of doctors in enabling a patient-centred 
consultation with the help of a holistic prompt sheet (HN-PCI), there is a suggestion 
from this work that this is an area that needs addressing e.g. work in educating and 
changing the minds of doctors, if the model of holistic assessment described in this MD 
study is to adopted more widely.  
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Other than the problem strategy and health care systems, another fundamental question 
regarding the routine use PROs relates to a skepticism as to whether the theory of 
routine PRO use can be translated clinically [Greenhalgh et al, 2005]. Several authors 
have questioned if PROs could be a meaningful tool that plays a valuable role in 
shaping a shared decision regarding treatment, and in personalising care [Greenhalgh 
et al, 2005; Luckett et al, 2009]. From only a handful of studies, there is only one 
oncology-based study on the routine use of PROs, which had a positive impact on 
clinical outcomes [Velikova et al, 2004]. This lack of consistent evidence does little to 
allay the skepticism. In this context, the finding in this current study that HN-PCI 
intervention resulted in an increase in medical actions without compromising the normal 
temporal structure of the FU visit provides new evidence supporting the value of PROs 
in reaching shared-decisions about patient care. Furthermore, patients in the HN-PCI 
intervention group reported lower levels of distress and better satisfaction with the 
consultations in compared with the control group.  
 
Steps to overcome known barriers should be considered to improve the efficacy of HN-
PCI. Longer appointment slots can be built-in to the clinical template to accommodate 
patients who require longer consultation times, which can be predicted by their 
demographic and clinical factors. Also, preempting the concerns profile prior to clinic 
visit can help screen out patients who will require the additional time for discussions, 
and this may be achieved using a web-based questionnaire that patients fill well ahead 
of their visit [Rogers & Lowe, 2016]. Having this ability can preclude the need for 
additional room/space for patients to fill in their questionnaire, and reduce the 
likelihood of disrupting the clinic on the day of their visit. This information may also 
help determine if certain healthcare professionals could be present during the 
appointment to help address their concerns there and then. This may be a consideration 
in oncology clinics that are not set up to have multiple professionals in attendance. The 
increased referrals as part of the increased medical actions in the ENT subgroup, may 
have been related to this scenario.   
 
A CNS-led clinic to address some of the specific concerns identified during doctor-led 
clinics [de Leeuw et al, 2013] is one service delivery model that could improve the 
efficacy of HN-PCI. A randomised controlled trial of nurse-led psychosocial 
interventions in HNC patients showed good HRQOL outcomes overall, particularly 
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emotional functioning and fatigue, which persisted at 24 months FU [van der Muellen 
et al, 2014]. Another service delivery model that may help to address patients 
psychosocial concerns during cancer survivorship is a shared care model between the 
oncology doctor and the general practitioner, where both play roles in initiating and 
coordinating discussions about patients’ psychological concerns. MacKenzie et al 
[2015] reports that the majority of cancer patients undergoing RT were willing to 
discuss emotional concerns with their oncology doctor and/or their general practitioners. 
On the other hand, Mosher et al [2014] notes that most lung cancer patients (75%) 
prefer to talk about their distress and emotional concerns with their general practitioners 
rather than the oncology doctor. Those who did not want to discuss their emotional 
concerns with the cancer doctor indicated that there were ‘more important things to 
discuss about during their oncology visit’ [Mackenzie et al, 2015]. Furthermore, there 
is evidence that patients and general practitioners would support such a model. Adam et 
al [2011] report that patients and primary care teams believe primary care has an 
important role to play in cancer care, where an active approach through specific review 
appointments would legitimise the raising of concerns. Indeed, this is an area that could 
be explored with the HN-PCI because patients surveyed about their views if the 
information on the HN-PCI would be useful to their general practitioners (after 
excluding not known, n=11 from 123), 59% reported that ‘quite a bit’ (27/109) or ‘very 
much’ (37/109) [Rogers et al, 2009]. In this current study, other than the surgeon and 
dentist, patients selected the family doctor (4-6%) on the HN-PCI among other 
professionals they would like to gain access/referred on to.  
 
Education and training of oncology doctors may change their perception and approach 
towards a more holistic and patient-centred approach during post-treatment survivorship 
could break down some of the barriers towards routine use of PROs rather than the 
narrowed mindset where PROs are only in specific situations i.e. research/clinical trials 
in the oncology settings. Additional generic training in communication skills can help 
towards changing doctors’ perception and beliefs while acquiring new skills. Specific 
training in HN-PCI should include how the tool is handled, how to manage situations 
when patients select large number of items, and how to manage certain types of concern 
e.g. FOR, regret of treatment, spirituality etc. Additionally, training in understanding 
the UWQOL measures and its interpretations could provide additional information to 
that furnished by HN-PCI data. Development of rehabilitative/supportive care pathways 
for managing various problems in the HN-PCI checklist based on existing local/regional 
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services could help information-giving and strategies for active management. Auditing 
the HN-PCI usage should include patient feedback about their experience using the tool 
with specific questions relating to responder burden particularly with long-term use of 
the tool, relevance of the tool in general and/or the items on the checklist, satisfaction 
with the consultation, and also the efficacy of any HN-PCI-specified 
rehabilitation/clinical pathways received.  
 
The feasibility of using the HN-PCI as a holistic assessment tool in routine clinical 
practice is suggested by the results obtained in this study and augmented by other HN-
PCI studies. In the current format, HN-PCI can be completed regularly in routine FU 
clinics. It maintains a multidimensional, holistic content while retaining the HNC-
specific items, ensuring that HNC patients are able to assess all aspects of the lives in 
context of their HNC. The HN-PCI also has the ability to screen for significant distress, 
while simultaneously indicating which unmet concerns are likely to be associated with 
this. The HN-PCI is simple in its structure, where there is only one question associated 
with a checklist, thereby, easy for patients to read and understand. The HN-PCI can be 
filled in using TST or the paper version, which may cater for a wider user-base with 
different levels of education and socioeconomic backgrounds. Overall, there is 
favourable acceptance by patients. All these fulfill the National Cancer Action Team 
[2011] criteria set out for PRO tools that are suitable for use during holistic assessments 
i.e. self-directed, thereby easy for patients to read and understand, considers all of the 
domains of assessment, and able to stimulate the assessment conversation. This current 
study has shown that having HN-PCI assisted discussions have resulted in formulation 
of an action plan to address concerns, which was measured by the increased number of 
medical actions compared to conventional consultations. Based on this, it may be 
concluded that the HN-PCI has the ability to personalise the care of HNC received 
through the engagement of both the patient and their doctor.  
 
Future studies of the HN-PCI should include a qualitative investigation into how the 
HN-PCI is used by doctors and patients during the consultations, particularly on how it 
mediates the decision-making process that results in a shared action plan that is 
personalised to the patient. This may help future training of doctors in handling the HN-
PCI in clinics. Future studies should also evaluate the longitudinal impact of HN-PCI to 
augment the positive results reported in the early stages. This may inform the long-term 
service planning and delivery. Other areas of research interest include exploring ways 
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that the HN-PCI can help patients disclose their concerns ahead of their appointments 
and developing the HN-PCI further as a platform for self-management that they can 
access at anytime.  
 
8.2. Closure 
 
A patient-centred approach is key in personalising HNC survivorship. The HN-PCI is a 
PRO that can help personalise HNC patient survivorship by promoting patient-
centredness during routine HNC visits. As a prompt sheet, the tool enables patients to 
disclose their concerns, and encourage discussions about a wider range of concerns, 
particularly in psychological/emotional areas. Critically, the HN-PCI intervention also 
resulted in higher number of medical outcomes, suggesting an influencing role in shared 
decision–making in patient care. There is good acceptance of the tool by patients, who 
report lower levels of distress and better satisfaction scores after HN-PCI mediated 
consultations. While the HN-PCI was able to indirectly identify patients with significant 
distress in clinic, its role in understanding the perceived need for additional 
help/supportive care through requests for referrals was not clearly defined in this study. 
Wider adoption of the HN-PCI will depend on reducing the barriers that impact upon 
the efficacy of its implementation. Future work should focus on deeper understanding of 
how the tool is used to influence clinical decision-making during routine visits, and 
obtaining longitudinal data that demonstrates its impact on shared clinical decision-
making in the long-term.  
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Appendix 1: Literature review of HRQOL-themed publications 
 
 
Method 
 
The methodology presented is based on the method previously described by Rogers et 
al [2007; 20]. A single author (NG) searched and scrutinized the literature. The ISI 
search engine with cross-referenced PubMed and OVID was searched using the search 
terms ‘Quality of life’, ‘Head and neck cancer’ and ‘Questionnaires’ for the period 2013 
to present (20 July 2017). This time scale was chosen as the two previous detailed 
reviews have dealt with the period from 200-2005 [Rogers et al, 2007] and 2006-2013 
[Rogers et al, 2016]. Further cross-referencing used the keyword ‘HRQOL’. Only 
studies published in the English language were selected.  
 
The abstracts were searched for evidence of patient self-reported questionnaires/ 
patient-reported outcome measures and HRQOL outcome. Full text article was obtained 
to clear any ambiguous methodology in the abstract. During the abstract/literature 
review, the following HNC subsites were included: oral cavity, oropharynx, 
nasopharynx, parotid and larynx. The sites excluded from this review were oesophageal, 
gastric, thyroid, skin and base of skull.  Other exclusion criteria were non-human 
subjects, repeat citation/study findings, studies that were not patient-reported and 
studies unrelated to QOL. A proforma was used to record key findings. 
 
The type of article was classified into 5 categories by the researcher (NG) based on 
Rogers et al [2007]: (1) Predictors of HRQOL i.e. reported on factors influencing 
HRQOL outcomes; (2) “Functional” outcome i.e. reported physical functional outcomes 
e.g. swallowing, mouth opening, mucositis, and emotional functioning e.g. distress; (3) 
Questionnaire development/validation i.e. reports of psychometric testing, translation of 
questionnaire, comparative study of different types of questionnaire; (4) Clinical trials 
i.e. reports of HRQOL outcomes related to clinical trials; (4) Review/Editorial i.e. 
published literature reviews, systematic reviews, meta-analysis and reports of meeting.  
 
Results 
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The search identified 538 articles. Based on the exclusion criteria, 239 abstract/papers 
were excluded. Thus, a total of 299 articles were reviewed. The results are summarised 
in Table A1-1. The papers included in this review are shown in Table A1-2. 
 
 
Table A1-1: Summary of search findings and articles reviewed 
  
TOTAL SEARCH OUTPUT 538 papers 
  
EXCLUDED 239 
Reasons for papers excluded  
Not head and neck cohort only 4 
Not head and neck cancer 122 
Thyroid/Skull base 27 
Not PRO 50 
Not QOL studies 20 
Not English language 14 
Repeat citation 1 
Not human subjects 1 
  
TOTAL PAPERS REVIEWED 299 
  
Year published  
2017 59 
2016 94 
2015 75 
2014 70 
2013 1 
  
Cohort  
Head and neck 204 
Larynx 31 
Oropharynx only 19 
Oral cavity only 17 
Oral cavity/oropharynx 7 
Nasopharynx/ Nose 13 
Others/ other combinations 8 
  
Design  
Cross-sectional 236 
Longitudinal 46 
Reviews 17 
  
Types of paper  
Predictor for HRQOL 161 
Functional outcomes 61 
Clinical trial 21 
Questionnaire development 39 
Review/Editorial 17 
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Discussion 
 
The aim of this review was to provide the most recent evidence as a foundation for 
exploring the experience of patients and their carers of HNC based on self-reported 
HRQOL measures. This is to complement the narrative accounts of their living with 
HNC based on qualitative assessments [Lang et al, 2013]. Table A1-2 provides an 
overview of the areas evaluated by self-reported HRQOL measures, and demonstrates 
the holistic and global nature of (head and neck) cancer survivorship.  
 
The limitation of this review lies in the methodology, which has been detailed 
previously [Rogers et al, 2007]. A potential problem relates to missing articles, which 
may be the result of an inadequate search strategy, and the exclusion of some articles, 
including non-English language articles. Rejection of some articles based only on the 
abstracts presented may result in potential loss of evidence if the abstract did not 
contain the pertinent information required. In addition, this review was carried out by 
only a single researcher, which can introduce selection bias. A single researchers’ 
interpretation of the abstract is not tested against an expert opinion provided by other 
researchers.  
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Table A1-2: showing the papers selected from the literature search (Des: Study design; L: longitudinal; C: cross-sectional) (PRO: 
patient-reported outcome; abbreviations for PRO at the end of table) 
       
 Year Author Cohort Des Type  PRO Purpose Outcome 
1 2017 Si NPC C Predictor of 
HRQOL 
FACT-H&N 
EORTC QLQ-H&N35 
Evaluate outcomes of 
surgery (endoscopic sinus 
surgery approach) vs CRT 
 
Pain and dry mouth scores better in 
surgery group 
2 2017 Hsin Glottic L Functional outcome 
‘Speech/Voice’ 
 
EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
Evaluate impact of transoral 
laser microsurgery (TOLM) 
on speech outcomes 
 
QLQ-H&N35 speech subscale 
improvement with time 
3 2017 Dogan 
 
HNC L Clinical trial UWQOL 
CTCAE v4 
 
Randomised trial comparing 
mulberry molasses 
intervention to prevent RT-
induced mucositis 
 
No difference in HRQOL status 
4 2017 Maguire 
 
HNC C Predictor of 
HRQOL 
‘Carers’ FOR’ 
FACT-G 
Worry of Cancer Scale to 
measure FOR 
To establish the role of care-
related stressors-as distinct 
from survivor 
characteristics-in predicting 
FOR in HNC caregivers 
Caregivers who reported more 
loneliness, spent more time caring, and 
had greater financial stress from caring 
had higher scores on Worry of Cancer. 
Female caregivers, those caring for 
younger survivors, and those with 
survivors who had undergone less 
extensive forms of surgery also reported 
higher FOR. 
 
5 2017 Spinato OPC C Predictor of 
HRQOL 
EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
Evaluate QOL outcomes in 
long-term survivors of HPV 
(+ ) vs HPV (– ) treated with 
multimodality Tx 
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6 2017 Li HNC C Functional outcome 
‘Sleep’ 
Pittsburgh Sleep Quality 
Index  
Epworth Sleepiness 
Scale 
OHIP-14  
SF-36 
To evaluate sleep quality in 
post-treatment HNC 
Poor sleep quality associated with 
extensive ND, a lower SF-36 mental 
component score, and a higher OHIP-14 
psychological disability score  
 
7 2017 Harrington HNC L Clinical trial EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
EQ-5D 
Phase 3 RCT. Nivolumab 
versus standard, single-
agent therapy of 
investigator's choice in 
recurrent or metastatic HN 
SCC (CheckMate141) 
 
The intervention stabilised symptoms 
and functioning from baseline to 15 
weeks compared with other therapy. 
QOL outcomes support its use in this 
subpopulation. 
8 2017 Terkawi HNC C Functional outcome 
‘Symptom burden: 
Chronic Pain’ 
Brief Pain Inventory-
Short Form  
Neuropathic 
Pain Questionnaire-Short 
Form  
Pain Catastrophizing 
Scale questionnaires 
 
Evaluate prevalence of 
chronic pain and determine 
factors associated with it 
There is high burden of chronic pain in 
posttreatment. Chronic pain related to 
poor HRQOL status manifested by its 
interference with general activity, mood, 
walking ability, normal work, and 
sleeping. 
 
9 2017 Jungerman HNC C Development of 
questionnaire/ 
Validation 
 
HN-PCI 
UWQOL 
Translate and validate in 
Portuguese language for 
Brazilians 
FOR was the most common item of 
concern. Positive acceptance by 
patients. 
 
10 2017 Majid HNC L Predictor of 
HRQOL 
 
EORTC QLQ-C30 
 
Evaluate outcomes of 
treatment 
 
No difference in HRQOL status 
between pre and post treatment. 
Worsening of diarrhoea,constipation, 
nausea/vomiting, and financial difficulty 
in posttreatment period. 
 
11 2017 Nemeth OC C Predictor of 
HRQOL 
UW-QOL 
FACT-H&N 
 
Evaluate outcomes of 
neoadjuvant chemo with 
surgery and immediate 
reconstruction  
 
Most frequent complaints: Chewing 
difficulties, decreased salivary function, 
and swallowing dysfunction 
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12 2017 Engelen HNC C Development of 
questionnaire/ 
validation 
 
 
Liverpool Oral 
Rehabilitation 
Questionnaire (LORQ 
Translate into Dutch 
language and validate 
 
13 2017 Huyett 
 
HNC C Functional outcome 
‘Breathing/Sleeping 
problems’ 
 
Epworth sleepiness scale 
UWQOL 
Functional Outcomes of 
Sleep Questionnaire 
 
Evaluate prevalence of 
sleeping apnoea related to 
RT 
Suggestion that prevalence of sleep 
apnoea is increased in HNC patients  
14 2017 Memtsa HNC 
 
L Predictor of 
HRQOL; 
Functional 
outcomes 
‘xerostomia’ 
EORTC QLQ-C30 
QLQ-H&N35 
XQ (Greek) 
 
Evaluate outcomes of RT  Subjective symptom of xerostomia 
parallelled salivary flow and QOL. 
15 2017 Lechien Larynx 
 
C Functional 
outcomes ‘Voice’ 
 
VHI 
EORTC QLQ-H&N35 
Evaluate outcomes of CRT 
in supra- versus infrahyoid 
tumours 
Patients with infrahyoid tumour had 
presented more severe VHI values, 
dysphonia, breathiness, asthenia, and 
some acoustic cues than suprahyoid 
tumour.   
The EORTC QLQ-H&N35 
communication item was better in the 
suprahyoid patient group. 
 
16 2017 Becker Nasal 
 
C Predictor of 
HRQOL 
UWQOL 
Patient satisfaction 
survey 
 
Evaluate patient  satisfaction 
with nasal prosthesis. 
'Satisfaction with function' had the most 
influence on UWQOL domains. 
17 2017 Pan NPC 
 
C Predictor of 
HRQOL 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluate treatment 
outcomes in IMRT versus 
other RT delivery system 
with/without chemotherapy 
IMRT with or without concurrent 
chemotherapy had better outcomes in 
head and neck related symptoms and 
general aspects of QoL than those 
receiving 2D-CRT with or without 
concurrent chemotherapy 
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18 2017 Norquist 
 
HNC C Questionnaire 
development / 
validation 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
To qualitatively assess the 
comparability of paper 
and electronic versions of 
the EORTC QLQ-H&N35 
 
Electronic and paper verrsions were 
comparable 
19 2017 Heydarirad HNC 
 
C Clinical trial  EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
RCT testing two natural 
products against artificial 
saliva (control) in reducing 
RT-induced xerostomia 
 
Test intervention had better xerostomia 
scores than control. May be useful 
adjunct in management of xerostomia 
20 2017 Dzebo 
 
OC C Predictor of 
HRQOL 
UWQOL To evaluate outcomes of 
treatment , and determine 
cut off points for ‘success’ 
 
 
21 2017 Xiao 
 
NPC C Functional 
outcomes 
‘Symptom burden’ 
FACT- H&N 
MDADI (chinese) 
 
To identify symptom 
clusters following RT 
Four system clusters identified, may 
guide intervention to manage ide effects 
of treatment 
 
22 2017 Thor HNC 
 
C Functional 
outcomes ‘Trismus’ 
GTQ 
EORTC QLQ-H&N35 
 
To identify trismus-related 
domains, its impact on QOL 
Eating/Jaw/Pain/QoL were significant 
domains in trismus-related QOL 
 
23 2017 Hoxbroe 
 
OPC - Review/Editorial  Review and meta-analysis 
of 1366 patients relating to 
HRQOL outcomes  
 
OPC survivors face clinically important 
deteriorations in QOL that most 
markedly centre on xerostomia, 
dysphagia and chewing. 
 
24 2017 Algtewi 
 
HNC C Predictors of 
HRQOL  
‘Support group’ 
 Investigate the association 
between using online 
support groups (OSGs) and 
HRQOL 
 
OSG participation is associated to better 
HRQoL either directly or indirectly 
through decreasing depression, anxiety 
and the negative adjustment behaviours 
and increasing self-efficacy and 
empowerment of the users. 
 
 
  
 328 
 
25 2017 Yuce Sari HNC C Predictor of 
HRQOL 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
QLQ-OES18 
Evaluate outcomes in case-
control intervention with 
glutamine and arginine-
enriched solution (GAES) 
during RT 
Control group showed poorer scores of 
social functions, and for individual 
items: Pain, appetite, dry mouth, sticky 
saliva.  Control group also had trouble 
with taste, trouble with social eating 
and swallowing problems 
 
26 2017 Terro HNC L Predictor of 
HRQOL 
UW-QOL 
3 other PRO 
Evaluate patient and carers 
HRQOL during survivorship 
Patients reported serious deterioration 
in psychosocial and physical domains 
Carers showed deterioration of anxiety 
and depression 
 
27 2017 Franco HNC L Functional outcome 
‘Mucositis’ 
 
OMWQ-HN 
FACT-H&N 
 
Evaluate the impact of oral 
mucositis during RT on 
QOL 
Progressive increase in OM during 
treatment and a partial recovery  after 
RT were correlated to PROs and QOL. 
 
28 2017 Loh 
 
HNC - Review/Editorial  Systematic review literature 
on trismus measurements 
 
 
29 2017 Loth OPC C Functional outcome 
‘Sleep’ 
Epworth Sleepiness Scale 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Identify post-treatment OPC 
with sleep apnoea and 
evaluate impact on QOL 
Global Health Status Scale and fatigue 
score was poorer in those with sleep 
apnoea 
30 2017 
 
He NPC C Predictor of 
HRQOL 
EORTC QLQ-H&N35 
 
 
Evaluate nutritional status 
and HRQOL outcomes 
during IMRT  
Nutritional status and QLQ-H&N35 
scores in NPC patients decreased 
during IMRT 
 
31 2017 Andrade OC, 
OPC, 
HPC, 
Larynx 
 
C Functional outcome 
‘Dysphagia’ 
MDADI Correlate PRO with 
objective measure in relation 
to post-treatment dysphagia 
MDADI correlates with objective 
measure 
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32 2017 Charalambou
s 
HNC C Clinical trial XeQOL Testing feasibility of a trial 
evaluating the effectiveness 
of thyme honey for the 
management of treatment-
induced xerostomia  
 
 
33 2017 Hajdu HNC 
 
C Questionnaire 
development/ 
validation 
MDADI Translate into Danish 
language and validate 
 
34 2017 Palma 
 
HNC C Predictor of 
HRQOL; 
Functional 
outcomes 
‘xerostomia’ 
 
UWQOL Evaluate low-level laser 
therapy intervention to 
reduce RT-induced 
xerostomia 
Low-level laser therapy mitigates 
salivary  hypofunction and increase 
salivary pH, with HRQOL 
improvement 
 
35 2017 Ghazali 
 
HNC C Predictor of 
HRQOL 
‘Distress’ 
UWQOL 
DT 
 
Identify correlation between 
DT and HRQOL outcomes  
DT screening identifies emotional 
distress which correlates with poorer 
HRQOL functioning/status 
 
36 2017 Pan 
 
NPC C Predictor of 
HRQOL 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluate outcomes with 
different treatment 
modalities 
RT had better outcomes than CCRT for 
global QoL, functional scales, 
symptom scales of fatigue and 
insomnia, financial problems, and 
weight gain. 
 
37 2017 Axelsson 
 
HNC L Functional 
outcomes  
‘Swallowing’ 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluated the long-term 
swallowing function with 
prophylactic PEG tube 
placement 
 
No long-term deterioration in 
swallowing outcomes with PEG tubes 
38 2017 Hartford HNC L Clinical trial FACT-H&N 
PSS-H&N 
Explore the feasibility of 
hyperbaric oxygen (HBO) 
treatments immediately 
before IMRT in conjunction 
with cisplatin 
 
HRQOL in intervention group 
comparable to control group 
 330 
39 2017 Montavlo 
 
HNC C Functional 
outcomes ‘Trismus’ 
 
   
40 2017 De Oliveira 
 
HNC L Predictive for 
HRQOL 
 
UWQOL Evaluate HRQOL status 
post-treatment 
HRQOL status changes at different 
time points after treatment completion 
41 2017  Tian Larynx C Predictive for 
HRQOL 
 Evaluate different types of 
communication model on 
dysphagia 
QOL scores based on dysphagia 
questionnaires were significantly 
higher in the patient communication 
and physician communication groups 
than in the routine communication 
group. 
 
42 2017 Christopher 
 
HNC L Predictive of 
HRQOL 
 
EORTC QLQ-H&N35 
 
Evaluate outcomes of CRT  HNC survivors exhibit different QOL 
related symptoms depending on 
combined treatment modalities, and 
time post-treatment 
 
43 2017 Daugaard HNC L Functional outcome EORTC QLQ-C30 
EORTC QLQ-H&N35 
Compare patient-reported 
and clinician assessed 
problem related to late 
effects of treatment 
 
Dysphagia: patients and clinicans 
correlated well. 
Fibrosis and xerostomia not as well 
correlated. 
44 2016 Dholam OC C Predictor of 
HRQOL 
OHIP 
LORQ 
Evaluate long-term 
outcomes of prosthetic 
rehabilitation 
Improvement in all domains of 
LORQv3 and OHIP-14 with 
rehabilitation 
 
45 2017 Lastrucci NPC C Predictor of 
HRQOL 
FACT-G  
FACT-NP 
PSS-H&N 
XeQOLS 
EQ-5D-3L 
 
Evaluate outcomes of NPC 
treated by RT and IMRT 
FACT-G and PSS-H&N scores better 
in < 55 years; PS-H&N and XeQOL 
scores better in IMRT 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
46 2017 Ullgren HNC C Predictor of 
HRQOL 
(Issue: Information) 
QLQ C-30 
INFO25 
Evaluate outcomes and 
informational needs of 
palliative HNC managed by 
early referral to palliative 
care  
Global health was the lowest reported 
functional scale; Fatigue was the 
highest reported symptom. Better 
satisfaction when given written care 
plan. Higher use of ED in those les 
satisfied with information given. 
 
47 2017 Martín HNC C Functional outcome 
‘xerostomia’ 
XeQOLS 
VAS 
Evaluate the intervention of 
topical agents in the 
management of RT-induced 
xerostomia 
 
Improved xerostomia-related QOL 
scores with intervention; 7/8 topical 
agents had good HRQOL scores. 
 
48 2017 Pugh 
 
HNC C Questionnaire 
development / 
validation 
UWQOL-Radiation 
Therapy Oncology Group 
(RTOG) modification 
(UW-QOL-RTOG 
Modification) 
 
Psychometric testing  
49 2016 Cohen HNC L Predictor of 
HRQOL 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
Evaluate outcomes of 
surgical resection in 
different HNC subsites 
 
Differences in HRQOL scores shown 
by different subsites 
 
50 2017 Singh 
 
OPC L Predictor of 
HRQOL 
UWQOL Evaluate HPV status in 
newly diagnosed HPV+ 
OPC 
 
No differences seen in  HRQOL in 
relation to HPV status 
51 2017 Memtsa 
 
HNC C Questionnaire 
development/ 
validation 
 
XeQ Translate into Greek, and 
validation 
 
52 2016 Valls-Mateus Larynx L Predictor of 
HRQOL 
UWQOL 
SF-12 
Evaluate outcomes of 
laryngeal ca treates with 
transoral laser surgery 
(TOLR) 
Very good long-term HRQOL 
outcomes, global QOL score equal at 
1- and 5 years postTOLR. Reduction in 
activity scores at long-term. 
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53 2017 Spalthoff HNC C Predictor of 
HRQOL 
 Evaluate outcomes of types 
of ND 
 
Significant differences seen in HRQOL 
between non-ND versus ND group, and 
also within ND subgroups. The 
problems  include impairments in 
speech intelligibility, ingestion & 
swallowing, tongue mobility, mouth 
opening, lower jaw mobility, neck 
mobility, and shoulder / arm movement 
 
54 2017 Dholam 
 
OC L Predictor of 
HRQOL 
OHIP 
LORQ 
 
Evaluate outcomes of 
prosthetic rehabilitation 
Oral rehab improved HRQOL in areas 
of oral function, orofacial apprearance, 
and patient satisfaction with prosthesis 
 
55 2017 Beck-
Broichsitter 
 
OC C Functional 
outcomes 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
Evaluate/compare 
professionals and patient 
assessment of physical 
dysfunction 
 
Speech: professionals scored better 
than self-assessment 
Swallowing better in local flaps as 
reported by patients 
56 2017 Xiao HNC C Clinical trial PSS-H&N 
HNRQ 
SQLI 
 
Evaluate outcomes between 
2 different RT regime with 
chemotherapy 
No HRQOL differences reported 
between arms  
57 2017 Kisser HNC C Questionnaire 
development 
ICF  Development of ICF-based 
clinical guideline & 
screening tool 
 
 
58 2017 Yeh 
 
OC C Predictor of 
HRQOL 
‘Pain’ 
 
EORTC QLQ-H&N35 
VAS for pain 
Evaluate pretreatment 
parameters in predicting PNI 
PNI predicted by higher VAS scores 
59 2017 Drost HNC C Functional outcome 
‘Facial appearance’ 
Utrecht Questionnaire for 
Outcome Assessment in 
Aesthetic Rhinoplasty 
Patient Scar Assessment 
Questionnaire 
Evaluate facial medical 
tattooing intervention in the 
management of facial 
disfigurement 
Improved scores with intervention  
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60 2016 Bozec HNC C Predictor of 
HRQOL 
(Issue: information) 
 
EORTC QLQ-C30 
EORTC QLQ-INFO25 
Evaluate outcomes of 
treatment and of 
informational provision 
 
Low correlation between HRQOL and 
informational provision 
 
61 2016 Lin HNC C Predictor of 
HRQOL 
(Issue: FOR) 
FOR Inventory (Caregiver) 
MOSHS 
Evaluate the experience of 
carers of HNC undergoing 
RT 
Higher FOR scores in patients 
undergoing shortened vs longer RT 
courses 
 
 
62 2016 Sapir HNC C Functional outcome 
‘Taste’ 
UWQOL 
HNQOL 
XeQOL 
 
Evaluate the outcomes of 
CRT 
Dysguesis correlated with mean RT to 
OC. Patient-reported xerostomia 
correlated with severe dysgeusia. 
 
         
65 2016 Morand OPC C Functional outcome 
‘xerostomia’ 
 
EORTC QLQ-H&N35 Evaluate outcomes of 
salivary gland transfer 
before CRT 
 
Low xerostomia scores after salivary 
gland transfer 
66 2016 Martins HNC C Clinical trial FACT-HN 
EORTC-HN35 
EORTC-Q30 
 
Phase 2 RCT evaluating the 
‘guarana’ intervention in the 
management of fatigue 
Guarana is not beneficial. No 
difference in terms of HRQOL scores.  
67 2016 Keillmann HNC C Questionnaire 
development/ 
Validation 
 
Articulation handicap 
index (AHI) 
  
68 2016 Richardson  HNC C Predictor of 
HRQOL 
(Issue: relationship; 
carers) 
 
PSS-H&N 
Brief IPQ 
Evaluating illness perception 
and relationship changes in 
HNC patients and their 
carers 
 
Perceptions of emotional impact and 
illness concern reduced over time in 
patients and carers.  
69 2016 Wang OPC C Predictor of 
HRQOL 
 
EORTC QLQ-C30 
EORTC H&N-35  
EAT-10 (swallowing) 
NDII 
Evaluating outcomes of 
preplanned CRT followed 
by superselective ND 
Intervention did not prevent recovery 
of most QOL metrics to near baseline. 
Early reduction in ND scores, more 
pronounced with more nodes dissected. 
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70 2016 Gunn HNC C Questionnaire 
development/ 
validation 
 
MDADI Translation into Turkish and 
validation 
 
71 2017 Schweyen 
 
HNC C Predictor of 
HRQOL 
 
 
OHIP-G14 Evaluate impact of oral 
rehabilitation  
Prosthetic treatment in HNC patients 
do not lead to the same improvement in 
OHRQoL as found in the normal 
population 
 
72 2015 Chen 
 
NPC L Predictor of 
HRQOL 
SF-36 
EORTC H&N-35  
 
Evaluate outcomes of 
different types of RT regime 
Any RT regime reduces HRQOL  
73 2016 Kannan OPC, 
Larynx 
HPX 
 
L Predictor of 
HRQOL 
EORTC-H&N35 
EORTC-Q30 
Evaluate outcomes of RT 
with concomitant boost 
radiotherapy by Volumetric 
Intensity Modulated Arc 
Therapy (VMAT) technique 
 
Comparable results  
74 2016 Wijbenga HNC - Review  Reviews impact of  
oral rehabilitation with or 
without dental implants 
following reconstruction of 
such segmental maxillofacial 
defects with fibula flap. 
 
 
75 2017 Zhang 
 
HNC C Questionnaire 
development/ 
validation 
MDADI Translate into chinese 
language and validate 
 
76 2016 Reeve 
 
HNC C Predictor of 
HRQOL 
FACT-H&N Evaluate clinical and 
sociodemographic factors 
influencing outcomes  
 
 
77 2016 Ringash 
 
OPC C Clinical trial FACT-H&N Phase 3 RCT 
(HEADSTART) 
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78 2016 Kucharska HNC C Questionnaire 
development/ 
validation 
 
QLQ-C30 
EORTC QLQ-H&N35 
 
 
 
Development of the Polish 
version 
 
79 2016 Hanly 
 
HNC C Predictor of 
HRQOL 
 
 
SCNS-P&C 
CarerQol (assesses burden 
and happiness) 
 
Evaluate carers experience 
and unmet needs 
Different aspects of carer 
characteristics 
and unmet needs are associated with 
carer burden and happiness, impact on 
HRQOL 
 
80 2016 Flach OC L Predictor of 
HRQOL 
 
QLQ-C30 
QLQ-H&N35 
HADS  
IES 
SDQ 
Evaluates outcomes of 
sentinel node biopsy (SNB) 
Comparable outcomes for SNB-
negative and SNB-positive patients in 
terms of HRQOL, psychological 
distress and shoulder function.  
 
81 2016 Kumar OC L Predictor of 
HRQOL 
‘Dental/teeth’ 
EORTC-QLQ c30,  
EORTC-QLQ H&N35 
OHIP 
DSI 
Evaluate outcomes of dental 
rehabilitation using implant-
supported overdentures in 
segmental mandibulectomy 
defect reconstruction with 
fibula free flap 
 
Implant-based reconstruction with 
fibula flap improves QOL outcomes. 
82 2016 Kjaer HNC L Predictor of 
HRQOL 
‘symptom burden’ 
 
EORTC QLQ C-30,  
EORTC QLQ H&N35 
HADS 
Evaluated impact of regular 
patient-reported feedback of 
side-effects of treatment to 
clinicians 
 
Regular feedback of Patient-reported 
symptoms improves clinicians 
identification of late effects of 
treatment  
83 2016 Wu 
 
HNC C Predictor of 
HRQOL 
‘Psychological 
distress’ 
 
EORTC QLQ-H&N35 Evaluated the prevalence of 
psychological distress and 
HRQOL 
Anxiety prevalent at early in journey; 
depression occurs later. Loss of sense, 
loss of speech, low libido, dry mouth, 
and weight loss were related to 
depression over time. Depressed 
patients were more likely to use more 
analgesia and nutritional supplements. 
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84 2016 Janssens Larynx L Clinical trial  
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
Phase 3 RCT comparing 
accelerated radiotherapy 
with carbogen and 
nicotinamide (ARCON) 
against accelerated 
radiotherapy alone (AR). 
 
85 2016 Su NPC C Questionnaire 
development/ 
validation 
 
FACT-G 
FACT-H&N 
Development/validation of 
the QOL-NPC 
 
86 2016 Brandao 
 
HNC C Predictor of 
HRQOL 
OHIP-14 
 
 
Evaluate outcomes of using 
surgical guides in fibula flap 
reconstruction of the 
mandible 
  
Good QOL scores obtained with use of 
guides which helps guide mandible and 
implant placement. 
87 2016 Rigoni HNC C Predictor of 
HRQOL 
 
EORTC QLQ-C30 
EORTC QLQ H&N35  
Coop/Wonca 
CSI 
 
Evaluate outcomes in 
patients and their carers 
QOL impairment is similar between 
patients and their carers. 
88 2016 Rylands 
 
HNC C Predictor of 
HRQOL 
 
UWQOL Evaluate the association 
between deprivation and 
HRQOL outcomes 
 
Deprivation is associated with overall 
QOL, particularly socioemotional 
function 
89 2016 Yuan HNC L Predictor of 
HRQOL 
 
EORTC QLQ- H&N35 
UWQOL 
OHIP 
Evaluated outcomes of 
postresection thigh and 
radial flap reconstruction 
 
Both flaps showed good HRQOL score 
posttreatment 
90 2016 Janssen 
 
HNC C Questionnaire 
development/ 
validation 
 
EORTC QLQ-H&N35 
UWQOL 
Evaluated relationship 
between 2 questionnaires 
and determine cut-off points 
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91 2017 Batıoğlu-
Karaaltın 
Larynx C Predictor of HRQOL 
‘sexual function & 
self confidence’ 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
ASEX 
BDI,BAI 
RSES) 
 
Evaluated outcomes of total 
laryngectomy (TL) versus 
partial laryngectomy (PL) 
TL patients had more problems 
regarding 
depression, anxiety, self-esteem and 
sexual functions 
92 2016 Tuomi 
 
Larynx L Functional outcomes S-SECEL 
EORTC QLQ-H&N35 
 
 
Evaluated outcomes of voice 
therapy in postRT 
HRQL and self-perceived 
communication function showed 
improvement in study group and trends 
of impairment in control group 
 
93 2016 Rogers OPC C Predictor of HRQOL 
 
UWQOL Evaluated outcomes of 
TOLM 
76% reported overall QOL as being 
good, very good or outstanding, and by 
domain 95% reported none or only 
minor problems, most notably for 
swallowing, chewing and speech. 
 
94 2016 Kraaijenga 
 
OPC C Functional outcome Subjective Functional 
Oral Intake Scale scores 
Swallowing Quality of 
Life Questionnaire 
 
Evaluate outcomes of 
lipofiller injections in 
posttreatment OPC  
 
95 2016 Nightingale  
 
HNC L Predictors of HRQOL 
‘Carers burden’ 
 
 Evaluate burden and QOL in 
HNC carers during and after 
RT 
Carers experience psychosocial  
impairments during and shortly after 
patient RT 
 
96 2016 Karlsson 
 
Larynx L Predictors of HRQOL S-SECEL 
EORTC QLQ-H&N35 
 
Longitudinal descriptive 
study of HRQOL postRT 
Comparable results with other similar 
studies  
97 2016 Elliot HNC C Predictor of HRQOL 
 
 Evaluated outcomes of 
medical marijuana (MM) 
use in HNC treated with RT  
MM provided benefit in altered sense, 
weight maintenance, depression, pain, 
appetite, dysphagia, xerostomia, 
muscle spasm, and sticky saliva. 
 
         
 338 
 Year Author Cohort Des Type  PRO Purpose Outcome 
98 2015 Parkar HNC - Review/Editorial EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Review HNC papers using the 
EORTC questionnaire 
 
99 2016 Bajwa OC L Predictor of HRQOL 
 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluated outcomes of 
brachytherapy 
Pain, swallowing, sensory, speech, 
social contact, social eating worsened 
at 3mths but improved over 2ys. 
Sexuality & financial status showed 
delayed improvement. Dry mouth and 
sticky saliva were significant 
determinants of QOL with delayed 
improvement 
 
100 2016 Liu 
 
Salivar
y gland 
 
L Clinical trial EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluate protocol in 
management of inoperable 
salivary gland malignancy 
 
 
101 2016 Yadav 
 
HNC C Predictor of HRQOL PSS-H&N Evaluate physical morbidity 
post surgery 
 
Type of resection and reconstruction 
impacted on physical morbidity 
102 2016 Rogers HNC - Review/editorial  Evaluated HRQOL-related 
papers from 2006 to 2013 
 
 
103 2016 Holtmaart 
 
HNC C Predictor of HRQOL PTGI 
HADS 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluate prevalence of 
Posttraumatic growth in HNC, 
and its impact on HRQOL 
Prevalence of PTG is low, occurred in 
relationship domain. 
104 2016 
 
Sanchez HNC C Questionnaire 
development/ 
validation 
 
MDASI-HN 
 
Psychometric testing and 
validation 
 
105 2016 Gabbo HNC C Predictor of HRQOL 
 
UWQOL Evaluated the degree of 
HRQOL improvement in 
patients treated by surgery 
over a time period 
Significant HRQOL improvement in 
was at 6mths. More invasive treatment 
and bigger tumours had biggest QOL 
improvement between time-points 
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106 2016 Pauli 
 
HNC C Functional outcome 
‘Trismus’ 
GTQ 
EORTC-QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluated long-term outcome 
of jaw opening exercises 
intervention 
Positive persistent effect of exercises in 
objective and HRQOL-related 
outcomes 
107 2016 Kraaijenga HNC C Functional outcome 
‘Voice/articulation’ 
VHI  
SHI 
Evaluated outcomes of 
advanced HNC treated by 
chemoRT 
Patient-reported voice problems 
(VHI>15) and speech (SHI>6) in daily 
life were present in 68% and 77% of 
patients, respectively 
108 2016 Kobayashi 
 
HNC C Clinical trail UWQOL Evaluated different chemoRT 
regimes 
 
 
109 2016 Chotigavanic
h 
Glottic C Functional outcome 
‘Voice/articulation’ 
V-RQOL survey Evaluated outcomes of 
narrow-margin endoscopic PL 
intervention 
 
Better voice-related QOL in subgroup 
who underwent superficial surgery 
 
110 2016 Boughartz 
 
HNC C Predictor of HRQOL EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluated outcomes of new 
surgical technique of 
submandibular gland 
preservation in RT 
 
 
111 2016 Li 
 
HNC C Predictor of HRQOL UWQOL Evaluated outcomes following 
free flap reconstruction 
 
Chewing, swallowing and speech 
outcomes favourable. PORT impacts 
negatively on function. 
 
112 2016 Capozzi HNC L Predictor of HRQOL 
 
 Evaluated the timings to 
initiate a lifestyle and 
progressive resistance exercise 
training intervention i.e. 
during or after RT 
 
Improvements in HRQOL scores with 
exercise 
113 2016 Petrosyan 
 
OC - Review/Editorial  Systematic review of 
outcomes of oral rehabilitaton 
and impact on HRQOL 
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114 2016 Ninu HNC C Functional outcomes 
‘Distress’ 
DT 
EORTC QLQ-C30 
EORTC QLQ-H&N35 
 
 
Evaluated outcomes at 1 year 
post treatment 
Distress higher in those with 
tracheostomy. Higher levels of 
suffering related to sensory problems, 
social eating, and dry mouth among 
patients treated with combined therapy 
 
115 2016 Samuels OPC C Predictor of HRQOL 
‘Dysphagia’ 
HNQOL 
UWQOL 
Evaluated RT versus CRT in 
HPV(+) patients  
QOL Summary and domain scores for 
eating were good pretreatment, worse 
at 3mths, and then improved to near 
baseline at 12mths 
without differences between the groups 
in any QOL domains 
 
116 2016 Florie 
 
HNC C Functional outcome MDADI Evaluated MDADI and FEES 
outcomes 
 
 
117 2016 Krebber HNC C Functional outcome 
‘Distress’ 
HADS 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
Evaluated use of touch-screen 
computer system OncoQuest  
in screening for distress in 
routine follow up care 
 
OncoQuest distress screening is 
beneficial as 82% were identified with 
an increased level of distress. Higher 
HADS score was related to a worse 
emotional functioning, worse fatigue 
score, and problems with sexuality, 
oral pain and speech.  
 
118 2016 Lee OC C Predictor of HRQOL 
‘Unmet needs’ 
SUNS Evaluated the unmet support 
care needs of OC patients  
Substantial unmet needs reported 
across all domains, with many 
of top unmet needs within the 
emotional domain. Poorer mental and 
physical health were associated with 
greater unmet needs. 
 
119 2016 Wells HNC C Predictor of HRQOL 
 
QLACS Evaluated predictors of 
HRQOL status in first 5 years 
posttreatment survivorship 
 
Socio-economic factors and 
comorbidity are important predictors of 
QoL in HNC survivors. 
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120 2016 Van der 
Linden 
 
HNC C Predictors of HRQOL EQ5D Evaluated economic impact of 
treatment approaches to neck  
 
121 2016 Alvarez-
Camacho 
HNC L Functional outcome 
‘Taste & smell’ 
CCS 
UWQOLv3 
 
Evaluated taste and smell 
outcomes in tube-fed versus 
oral fed patients  
CCS was a significant predictor of 
overall QoL,  social-emotional, 
physical and overall functions.  
 
122 2016 Rylands 
 
HNC C Predictors of HRQOL UWQOL Evaluated deprivation and its 
association with mortality and 
HRQOL 
 
Patients residing in  more deprived 
areas had worse QOL outcomes in 
regard to 
social-emotional functioning and 
overall QOL but not in regard to 
physical oral function. 
 
123 2016 Licitra HNC - Review/editorial  Reviewed HRQOL studies to 
evaluate the use of HRQOL in 
clinical care  
 
 
124 2016 Pedersen HNC C Functional outcome 
‘Dysphagia’ 
 
PSS: Normalcy of Diet  
MDADI 
 
Evaluated the swallowing 
outcomes in posttreatment 
HNC patients and to assess 
relationship between clinical 
assessment and PRO-
dysphagia 
Clinical dysphagia, associated with 
significant morbidity, and patient 
reported 
dysphagia related to quality of life are 
not interchangeable and must be 
measured 
separately. 
 
125 2016 Duman-
Lubberding 
HNC C Predictor of HRQOL 
‘Self-management’ 
Patient satisfaction was 
measured with the Net 
Promotor Scale (NPS) 
 
Evaluated the feasibility of 
using a web-based self-
management application 
(OncoKompas) 
 
OncoKompas was feasible with an 
adoption grade of 64%, an 
implementation grade of 75-91%, a 
mean satisfaction score of 7.3, and a 
positive NPS (1.9). 
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126 2015 Pottel HNC C Predictor of HRQOL 
 
Euroqol-5 dimensions 
(EQ-5D) 
Evaluated the feasibility of 
using the Geriatric-8 (G-8) 
questionnaire and a 
comprehensive geriatric 
assessment (CGA) in 
ChemoRT treatment decision  
 
G-8 is indicative of quality-adjusted 
survival 
127 2015 Agrawal Larynx C Functional outcome 
‘Voice/articulation’ 
VHI 
V-RQOL  
Evaluated the outcomes of TL Comparatively better voice-related 
QOL scores due to cross-cultural 
differences. 
 
128 2016 Dinescu Larynx C Predictor of HRQOL 
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
Evaluated outcomes of TL 
versus PL 
TL group had low scores regarding 
functional scales: role, emotional  
and social; and high scores on 
insomnia and financial difficulties. PL 
group had a high score on functional 
scales: role, emotional and social. 
 
129 2016 Ouattassi HNC C Questionnaire 
development/ 
Validation 
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
Translation into Moroccoan 
Arabic language 
 
 
130 2015 Cote HNC C Clinical trial EORTC QLQ-C30  
EORTC QLQ-H&N35 
Pain VAS 
questionnaire 
 
Randomised trial in placebo-
controlled of nabilone 
intervention in management of 
RT-related side effects 
 
At the dosage used, nabilone was not 
potent enough to improve patients' 
QOL over placebo 
 
131 2015 Ehrrson  HNC C Predictor of HRQOL 
‘Tube feeding’ 
Schedule for the 
Evaluation of 
Individual Quality of 
Life (SEIQoL) 
 
Evaluated which HRQOL 
areas are influenced by having 
a nasogastric feeding tube or a 
percutaneous endoscopic 
gastrostomy tube 
 
Neither showed any advantage over the 
other  
132 2016 Brandao 
 
HNC - Review/Editorial  Systematic review of 
maxillary rehabilitation 
following surgery 
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133 2015 Barosso HNC C Questionnaire 
development/ 
validation 
VHNSS 2.0 Translation of questionnaire 
into Brazilian Portuguese 
language 
 
 
134 2015 Pollum HNC C Predictor of HRQOL 
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluated outcomes and the 
feasibility of using electronic 
data capture 
QOL assessment using tablet devices in 
HNC patients is feasible, but may be 
more challenging in elderly patients. 
 
135 2015 Shavi 
 
HNC C Predictor of HRQOL EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate outcomes following 
treatment in Indian population 
Main factors affecting QOL were loss 
of weight, use of painkillers, sticky 
saliva, reduced mouth opening and 
problems in social eating. Type of 
treatment impacted on specific areas of 
QOL. 
 
136 2015 Barrios OC / 
OPC 
C Predictor of HRQOL 
‘oral health’ 
SF-12  
OHIP-14 
OIDP 
 
Evaluated the relationship 
between oral-related QOL to 
overall HRQOL 
Long-term oral-related QOL influenced 
HRQoL 
137 2015 Barosso 
 
HNC C Questionnaire 
development / 
validation 
 
VHNSS 2.0 Validation study  
138 2015 
 
Mucke HNC C Predictor of HRQOL UWQOL Evaluated outcomes, 
comparison between different 
treatment modality 
 
RT  triggers functional limitations and 
emotional distress, impacts on HRQOL 
 
139 2015 Kovac OC/ 
OPC 
C Predictor of HRQOL 
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluated outcomes of 
multitreatment modalities 
Complex reconstruction and adjuvant 
(chemo)RT were main reasons for 
significant QOL impairment  
 
 
140 2015 Noronha HNC C Clinical trial  EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Randomized trial metronomic 
(methotrexate and celecoxib) 
versus cisplatin 
 
QOL not significantly different 
between 2 groups. Metronomic arm 
showed better pain improvement scores 
between time points. 
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141 2015 Barber HNC L Predictor of HRQOL 
 
QIDS 
FACT-H&N 
 
Evaluated the relationship 
between preoperative 
depressive symptoms (PDS) 
and postoperative functional 
performance status (PFPS) 
  
PDS affected PFPS and survival 
outcomes 
142 2016 Kim HNC C Predictor of HRQOL 
 
BDI 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluated the the presence of 
Pretreatment depression 
(PDS) and pretreatment  
QOL, nutritional status, and 
survival outcomes 
 
PDS was predictive of 3-year Disease-
Free Survival. Differences seen in 
HRQOL scores seen in PDS and non-
PDS. 
 
143 2015 Van Nuffelen HNC L Clinical trial 
 
 Evaluate 3 different tongue 
strengthening exercise 
intervention 
 
 
144 2015 Garzaro HNC 
 
C Functional outcome 
‘Shoulder dysfunction’ 
 
UWQOL Evaluate shoulder function 
after ND and cervical root 
preservation 
Nerve preservation grouphad  
significantly less pain, fewer shoulder 
complaints, and fewer limitations on 
activities and recreation, as well as 
significantly better health-related and 
overall QoL 
 
145 2016 Adnane HNC C Questionnaire 
development/ 
Validation 
 
UWQOL  Translation into Moroccan 
Arabic language 
 
 
146 2015 Rogers HNC C Predictor of HRQOL 
‘Osteoradionecrosis 
UWQOL Evaluate outcomes related to 
osteoradionecrosis (ORN) 
diagnosis/management  
UWQOL scores for grade III ORN 
were particularly poor, even after 
mandibular resection/reconstruction. 
147 2016 Cnossen Larynx C Predictor of HRQOL 
‘Self-management’ 
Net Promoter Score 
(NPS) 
Evaluate the feasibility of 
using online self-care 
education programme 
supporting early rehabilitation 
of TL 
 
The online self-care programme was 
feasible with high patient satisfaction 
and acceptance. 
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148 2015 Kumar 
 
HNC L Clinical trial  Randomised palliative RT 
regime in unresectable HNC 
 
149 2016 Hagen HNC C Functional outcome  
‘xerostomia’ 
EORTC QLQ-H&N35 
 
Evaluated the outcomes of 
submandibular gland 
autotransfer before and after 
RT 
 
xerostomia was markedly reduced due 
to improved saliva production of the 
reimplanted gland 
 
150 2015 Bussu Larynx C Functional outcome 
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluated the recovery of 
swallowing after supracricoid 
partial laryngectomy (SCL) 
 
 
151 2016 Miyoshi Larynx C Functional outcome  
‘Speech/voice’ 
SF-8 
VHI-10 
V-RQOL 
Evaluate the outcomes using 
the transoeophageal voice 
prosthesis after laryngectomy 
 
Voice intensity correlated with 
comprehensive QOL, including 
physical and mental health. 
 
152 2015 Galli Parotid 
 
C Predictor of HRQOL 
 
 Evaluate outcomes of 
parotidectomy and nerve 
preservation 
 
Sacrifice of the great auricular nerve 
has only a small impact on QOL 
 
153 2015 Rogers HNC C Questionnaire 
development/ 
validation 
UWQOL Describes the development of 
patient information sheet 
based on HRQOL scores 
 
 
154 2015 Wells HNC C Predictor of HRQOL 
‘Unmet needs’ 
 
DT 
HN- PCI  
Evaluated the unmet needs 
and distress in posttreatment 
HNC 
One-third of the survivors had 
moderate or severe  
Distress. 74% had at least one unmet 
need.  
 
 
155 2016 Kjaer HNC C Predictor of HRQOL 
‘Symptom burden’ 
EORTC QLQ C-30  
EORTC QLQ 
H&N35 HADS 
Evaluated the outcomes of 
treatment, and the feasibility of 
computerised data acquisition.  
 
Late symptoms are common in HNC 
survivors 
 
156 2015 Sun HNC C Functional outcome  
‘Shoulder function’ 
UWQOL Evaluated should outcomes in 
neck dissection and/or RT 
RT does not increase shoulder 
dysfunction in surgically treated necks. 
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157 2015 Ciocca 
 
HNC C Predictor of HRQOL Head and Neck 
(H&N30) 
 
Evaluated the outcomes of 
implant-retained or removable 
prosthesis after mandibular 
reconstruction 
 
Comparable QOL outcomes  
158 2016 Aro HNC C Predictor of HRQOL 
 
15D HRQoL Evaluated outcomes within 1 
year following diagnosis 
 
Comparable results with similar studies 
159 2015 Noel HNC C Predictor of HRQOL 
 
SG 
TTO 
VAS exercises  
EQ-5D  
HUI3  
 
Evaluated health utilities (HU) 
and HRQOL  
Indirect HU measures may be more 
reflective of the health status of 
patients with head and neck cancer 
than direct measures 
160 2016 Govers OC C Functional outcomes 
‘Shoulder dysfunction’ 
EuroQol-5D-3L Evaluated shoulder function 
outcomes and HU in various 
management options 
 
More invasive procedures appear to 
result in lower health utility 
 
161 2016 Trivic 
 
Larynx C Questionnaire 
development / 
validation 
 
EORTC-QLQ-
H&N43 
Translate into Serbian language 
and validate 
 
162 2016 Yang HNC L Predictor of HRQOL 
 
EORTC QLQ C-30  
EORTC QLQ 
H&N35 
Evaluated pretreatment HRQOL 
status with treatment outcomes 
 
Significant relationships between 
certain pretreatment QOL measures 
and survival or functional outcomes 
 
 
163 2016 Ichikura HNC C Functional outcome 
‘distress’ 
FACT-H&N 
HADS 
Evaluate persistence of 
psychological distress  
during hospitalization and 
physical outcomes 
 
Impaired physical and emotional 
function is associated with persistent 
psychological distress 
 
164 2016 Viscari  
 
HNC C Predictor of HRQOL UWQOL Evaluate HRQOL outcomes in 
CRT 
 
QOL scores reduced with start of 
treatment, then improves esp after 2
nd
 
chemo cycle and after 6 week RT.  The 
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abilities to taste, swallow, salivate, and 
participate in activities and recreation 
were affected significantly. 
 
165 2016 Rinkel HNC C Functional outcome 
‘Speech and 
swallowing’ 
SWAL-QOL 
SHI 
Evaluate swallowing and speech 
outcomes after 
ChemoRT 
Swallowing -related QOL scores worse 
in those taking soft diet or using tube 
feeding. Less swallowing problems in 
larynx/hypopharynx compared to 
OC/OPC. IMRT related to less 
psychosocial speech problems. CRT 
related to higher daily swallowing and 
speech problems.  
 
166 2015 
 
Landstom HNC C Predictor of HRQOL EORTC QLQ 
H&N35 
 
Evaluate outcomes using 
electrochemotherapy (ECT) 
 
QOL outcome 1 year post-ECT showed 
a significant increase in problems with 
senses (taste, smell), speech, mouth 
opening and xerostomia. 
 
167 2015 Kanatas HNC C Functional outcome 
‘Emotional problems’ 
UWQOL 
HN-PCI 
Evaluate emotional problems 
reported by disease-free 
posttreatment patients attending 
routine clinics 
 
 
168 2015 Taberna HNC C Predictor of HRQOL  
 
RTOG toxicity 
questionnaire  
Evaluate the prevalence of 
toxicity following CRT 
 
 
169 2016 Huang 
 
HNC C Predictors of HRQOL EORTC QLQ C-30  
EORTC QLQH&N35 
Evaluate long-term outcomes of 
C-IMRT 
IMRT technique was associated with 
the improvement of QOL 
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170 2015 Hoole HNC - Review/Editorial  Identification of validated 
questionnaire for assessment 
of intimacy in HNC 
 
 
171 2015 Visacri 
 
HNC L Predictors of HRQOL UWQOL Evaluate outcomes of 
cisplatin-RT regime 
 
 
172 2015 Kraaijenga HNC C Functional outcome 
‘Dysphagia and 
trismus’ 
 
FOIS 
SWAL-QOL 
Evaluate swallowing and 
mouth opening outcomes 
following CRT 
Swallowing and mouth opening 
problems are substantial in 
Long-term survivors after 
organ-preservation CRT. 
 
173 2016 Passchier HNC C Predictor of HRQOL  
‘Distress’ 
 
EORTC QLQ C-30  
EORTC QLQ H&N35 
DT 
Evaluate feasibility and 
outcomes of a dedicated 
multidisciplinary 
(MDT)rehabilitation program 
 
Dedicated MDT HNR program 
is feasible and has a positive 
impact on HRQoL 
174 2016 Bozek HNC C Predictor of HRQOL 
‘Information’ 
 
 Evaluates the information 
given to HNC patients treated 
by surgery 
Satisfaction with information 
given, correlates with HRQOL 
 
175 2015 Richardson HNC C Predictor of HRQOL  Evaluated HRQOL status in 
carers and patients 
 
 
176 2014 Silviera 
 
HNC C Functional outcome 
‘Swallowing’ 
SWAL-QOL Evaluated swallowing 
outcomes CRT versus RT 
only 
 
Relationship between OC 
primary site and the fatigue 
domain; and also between 
advanced cancer stage and the 
impact of food 
selection,communication, and 
social function domains. CRT, 
feeding tubes and trachesotomy 
impacted negatively on QOL. 
 
177 2017 Bacorro 
 
HNC C Questionnaire 
development/ 
validation 
MDASI-HN Translation into Filipino 
language and validation 
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178 2015 van Gemert HNC C Predictor of HRQOL EORTC QLQ C-30  
EORTC QLQ H&N35 
 
Evaluate outcomes between 
reconstruction plate and fibula 
flap in segmental defects 
mandible 
 
comparable HRQoL 
179 2015 Kanatas HNC C Questionnaire 
development/ 
validation 
UWQOL Evaluate large database of 
UWQOL data to present 
patient information sheet 
about likely HRQOL 
outcomes with treatment 
 
 
180 2015 McNeely HNC L Clinical trial; 
Functional outcome 
‘Shoulder 
dysfunction’ 
 
 Evaluate shoulder resistance 
exercise outcomes in 
randomised, cross-over trials 
 
181 2015 Ganzer HNC C Functional outcome 
‘Swallowing’ 
VHNSS 2.0 Evaluate the eating experience 
of posttretament patients 
Psychological, functional, and 
social losses associated with 
eating were identified. Patients 
modify or avoid foods that are 
challenging yet report 
enjoyment with eating. 
Challenges with eating were 
downplayed. 
 
182 2014 Agrawal OC C Predictor of HRQOL 
 
UWQOL Evaluate treatment outcomes  Early stage had better HRQOL 
outcomes 
 
183 2015 Choby OPC C Predictor of HRQOL UWQOL Evaluate outcomes of 
transoral robotic surgery 
(TORS)  
Very good short- and long-term 
HRQOL outcomes 
184 2015 Vainshtein OPC C Predictor of HRQOL 
 
HNQOL 
UWQOL  
XQ 
Evaluated outcomes of 
swallowing and salivary-
sparing C-IMRT protocols in 
HPV(+) OPC 
Stable or improved HRQOL in 
nearly all domains compared 
with pretreatment and 2y FU. 
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185 2015 Mecedante 
 
HNC C Predictor of HRQOL Karnofsky  Evaluated the prevalence and 
impact of oral symptoms in 
those with advanced cancer 
 
A wide range of symptoms are 
experienced, early detection 
helpful esp in palliative setting 
186 2016 Li OC, OPC C Questionnaire 
development/ 
Validation 
 
SHI 
UWQOL 
 
Validation of translation into 
chinese language 
 
187 2015 Greco HNC C Questionnaire 
development/ 
Validation 
 
MDADI Validation of translation into 
Italian language 
 
 
188 2015 Dale OPC C Functional outcomes  
‘Dysphagia’ 
 
MDADI Evaluated long-term 
swallowing outcomes in OPC 
Comparable results obtained 
with other published studies. 
189 2016 Rogers OC/ OPC C Functional outcome 
‘FOR’ 
FOR questionnaire 
UWQOL 
Evaluated the prevalence of 
FOR and impact on HRQOL 
status 
 
FOR is prevalent and impact 
significantly on HRQOL 
190 2015 Tribius HNC C Predictor of HRQOL 
 
EORTC QLQ C-30  
EORTC QLQ H&N35 
 
Evaluate the outcomes of 
IMRT  
Patients experience long-term 
dry mouth 
and sticky saliva, esp post-
definitive IMRT. 
 
191 2015 Ghazali HNC C Predictor of HRQOL 
‘Unmet needs’ 
 
UWQOL 
HN-PCI 
Evaluate the prevalence of 
unmet needs/concerns of 
disease-free posttreatment 
patient attending routine 
clinics 
 
Patients reporting poor HRQoL 
outcomes were significantly 
more likely to indicate more 
items of concern. 
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192 2015 Perry Larynx C Predictor of HRQOL 
 
 Evaluate outcomes of TL TL survivors demonstrated 
reduced physical health QOL 
and social relationship QOL 
and higher levels of depression 
and anxiety when compared 
with normative samples. 
Psychological well-being had a 
stronger association than 
functioning (speech, 
swallowing) for their 
psychological QOL. 
 
193 2014 Mazzeo 
 
HNC C Functional outcome Xerostomia-related Q Evaluate outcomes of IMRT 
with boost schedule with 
concurrent chemo and 
neoadjuvant platinum-based 
regime 
 
 
194 2015 Li HNC C Predictor of HRQOL 
 
UWQOL Evaluated the outcomes of 
radial flap reconstruction 
 
Good long-term HRQOL status 
with flap. 
195 2015 Yang HNC C Functional outcome 
 
MDADI Evaluated the relationship 
between objective measure, 
PRO and survival outcomes  
 
PRO was able to pretreatment 
MDADI predicted survival  
196 2016 Cavell  HNC C Predictor of HRQOL 
‘Benefit finding’ 
 
 Evaluated unmet needs, 
coping and benefit finding in 
posttreatement cohort 
 
Patients reported at least 
moderate 
benefit finding in the majority 
of areas. More benefit finding 
was predicted by 
the presence of more advanced 
disease, Maori/Pacific Island 
ethnicity, lower 
baseline QOL, and the use of 
active coping strategies. 
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197 2015 Offerman 
 
Larynx C Predictor of HRQOL 
 
 Evaluate patient and carer 
experience following TL 
 
 
198 2014 Żmijewska-
Tomczak 
 
HNC C Predictor of HRQOL 
 
EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
 
Evaluate outcomes of CRT  
199 2015 
 
Rinkel OC / 
OPC 
C Questionnaire 
development/ 
validation 
SWAL-QOL 
SHI 
FROG 
 
Validate SWAL-QOL  
200 2016 Yamashita HNC C Questionnaire 
development/ 
validation 
 
Head and Neck Cancer 
Inventory (HNCI) 
 
Validation of translation into 
Japanese language 
 
201 2015 Pereira da Silva Larynx C Predictor of HRQOL 
 
EORTC-QLQ-C30 
HADS 
Self-Evaluation of 
Communication 
Experiences after 
Laryngeal Cancer 
Questionnaire 
 
Evaluated treatment outcomes 
with TL 
 
202 2015 Barrios 
 
OC/ OPC C Predictor of HRQOL 
 
SF-12 
OHIP 
OIDP 
  
Evaluate oral health related 
HRQOL compared with 
normal control population 
At least 6 months after 
treatment, oral cancer patients 
had worse 
OHRQoL, worse physical 
HRQoL and similar 
psychological HRQoL than the 
general population. 
 
203 2016 Veldhuis OPC 
Larynx 
 
C 
 
Predictor of HRQOL 
 
EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
 
Evaluated treatment outcomes 
in two different HNC subsites 
OPC patients described more 
problems with fatigue and oral 
health. 
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204 2016 Almståhl HNC L Functional outcome  
‘xerostomia’ 
 
EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
HADS 
 
Evaluated objective and 
patient-reported experience 
with salivary flow after RT 
Poor salivary flow related to 
poor emotional functioning, 
sticky saliva, and dyspnea. 
Distress levels were higher with 
this group. 
 
205 2016 Dwivedi OC/OPC C Functional outcomes 
‘Speech’ 
SHI  
London Speech Evaluation 
scale 
 
Evaluated speech acoustic 
outcomes after treatment 
 
206 2016 Tuomi Larynx C Questionnaire 
development/ 
Validation 
 
S-SECEL 
 
Evaluated cut-off points for 
questionnaire use 
 
207 2015 Lee HNC C Functional outcome  
‘mouth opening 
/trismus’ 
HADS 
EORTC-QLQ-H&N35 
Evaluated outcomes i.e. 
objective measure and 
HRQOL in HNC with mouth 
opening problems  
  
Moderate chewing dysfunction 
with regard to different types of 
food were noted. Patients with 
objective trismus had problems 
with social contact, sexuality, 
teeth, mouth opening, dry 
mouth, feeling ill, nutritional 
supplement, and weight loss.  
 
208 2014 Roe HNC C Predictor of HRQOL; 
functional outcome 
‘swallowing’ 
 
MDADI 
UWQOL 
Evaluate the outcomes of 
parotid-sparing protocol with 
RT 
 
Swallowing dysfunction 
occurred with protocol, lasts 
beyond treatment completion 
but results suggest patients able 
to cope and overcome 
dysfunction 
 
209 2014 Tsai NPC C Predictor of HRQOL EORTC QLC-C30 
CTCAE v4 
Evaluate the outcomes of 
treatment in NPC 
survivors with more severe 
neuropathy, hearing loss or 
xerostomia had a worse 
outcome on global QoL, all five 
functional scales, and a variety 
of symptomatic scales. 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
210 2015 Moubayed  
 
HNC C Predictor of HRQOL HADS 
EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
 
Evaluate clinical factors that 
can predict posttreatment 
depression 
 
Pretreatment predictors of 
depression were smoking at 
diagnosis, >14 alcoholic drinks 
per week, T3  
or T4 status, and >3 
medications. 
 
211 2015 
 
Kraaijenga HNC C Predictor of HRQOL FOIS 
VHI 
SWAL-QOL 
 
Evaluate outcomes of 
preventative and posttreatment 
swallowing rehabilitation 
programme 
 
 
212 2015 Meyer Larynx C Functional outcome HADS Evaluated psychological 
distress of spouses of total 
laryngectomised 
 
57% reported a high level 
distress and 33% reported 
restlessness. 21% spouses 
reported wanting to learn 
relaxation methods and 5%) had 
received psychological 
treatment. 
 
213 2015 Trachootham HNC C Clinical trial  
 
 Evaluate Nutri-gel 
intervention to improve eating 
difficulties induced by RT 
 
 
214 2015 Peker HNC C Questionnaire 
development/ 
validation 
 
LORQv3 Validation of Turkish 
translation of questionnaire 
 
215 2015 Yekaninejad 
 
HNC C Questionnaire 
development / 
validation 
European Organization for 
Research and Treatment of 
Cancer Oral Health 
Questionnaire (QLQ-
OH17) 
 
Translation into Persian 
language and validation 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
216 2015 Egestad 
 
HNC C Predictor of HRQOL EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
CTCAE 
 
Evaluate impact of BMI on 
RT outcomes  
BMI influences HRQOL and 
toxicity. Overweight patients 
experienced more dyspnea, and 
dry mouth postRT. Overweight 
patients also received less 
information about food/drink 
during treatment. 
 
217 2015 van 
Nieuwenhuizen 
HNC - Review/editorial  Review of the relationship 
between HRQOL and survival 
 
Strong evidence for a positive 
association between pre-
treatment physical functioning 
and survival and between 
change in global QoL from pre-
treatment to 6mths after 
treatment and survival. 
 
218 2015 Pellegrino HNC C Questionnaire 
development/ 
validation 
 
XeQOL Validation of Italian 
translation of questionnaire 
 
219 2015 Bian HNC - Review EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
 
Review of papers using the 
outcomes of IMRT using the 
questionnaire  
 
maximal deterioration of most 
QoL scales including 
global health status developed 
intra-treatment or at the end of 
treatment 
and then followed by a gradual 
recovery to 1 year, 1-2 years 
post-IMRT, compared with 
baseline level. 
 
220 2014 Bilal HNC C Questionnaire 
development/ 
validation 
 
FACT-H&N Validation of Urdu translation 
for Pakistani patients 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
221 2016 Canis OC L Predictor of HRQOL EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
 
Evaluate outcomes of 
reconstruction of T3 tongue 
defects 
After reconstruction, there were 
fewer problems with 
swallowing, speech, and social 
eating. 
 
222 2016 Stuiver HNC C Questionnaire 
development/ 
validation 
Shoulder Disability 
Questionnaire (SDQ), 
Neck Dissection 
Impairment Index (NDII), 
and the Shoulder Pain and 
Disability Index 
(SPADI) 
 
Evaluation of psychometric 
properties of questionnaires 
 
 Year Author Cohort Des Type  PRO Purpose Outcome 
223 2016 Stenner Parotid C Predictor of HRQOL EORTC-QLQ-C30 
EORTC-QLQ-H&N35 
 
Evaluate long-term HRQOL 
status in patients treated by 
parotid surgery 
 
 
224 2014 Jung-Chun NPC C Predictor of HRQOL SF-36 
EORTC-QLQ-H&N35 
 
Evaluate the HRQOL in 
patients treated by different 
RT modalities  
Different RT modalities used 
was significantly associated 
with speech difficulties,  
Chewing problems and 
dysphagia, and dry throat 
sensation.  
 
225 2014 Gandhi 
 
HNC C Predictor of HRQOL 
‘Symptom burden’ 
EORTC QLQ-C15-PAL Evaluate symptom burden and 
HRQOL 
 
Advanced HNC has a 
significant burden of symptoms. 
226 2014 Pierre OPC C Predictor of HRQOL 
 
DOSS 
VHI-10 
EORTC-QLQ-C30 
EORTC QLQ-H&N35 
 
Evaluate long-term functional 
outcomes and HRQOL 
Speech outcomes influenced by 
BOT involvement and T-size; 
swallowing outcomes 
influenced by age, gender and 
RT. 
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227 2014 Zheng Larynx C Functional outcome 
‘swallowing’ 
 
EORTC-QLQ-C30 
EORTC QLQ-H&N35 
SWAL-QOL 
Evaluated patient-to-patient 
model and swallowing 
problems in patients with  
supraglottic laryngeal cancer 
 
 
228 2015 
 
Rogers HNC C Predictor for HRQOL 
 
UWQOL Evaluated outcomes in a large 
database, and developed 
tabulated view 
 
 
229 2014 Chera HNC - Review  Review of patient-reported 
core set of symptoms to 
measure clinical trials  
  
 
230 2015 Cardoso HNC C Predictor for HRQOL 
‘Symptom burden: 
myofacial pain’ 
UWQOL Evaluated the prevalence of 
myofascial pain and impact on 
HRQOL status 
 
Prevalence is 1/9 patients and 
they have poorer HRQOL status 
231 2015 Loimu Larynx, 
pharynx 
or nasal 
cavity 
 
L Predictor for HRQOL 15D-HRQOL Evaluated outcomes of 
treatment  
 
Comparable findings to similar 
studies 
 
232 2015 Pauli HNC L Predictor for 
HRQOL; 
Functional outcome 
‘Mouth opening’ 
 
EORTC-QLQ-C30 
EORTC QLQ-H&N35 
GTQ 
 
Evaluated exercise 
intervention to improve mouth 
opening 
Exercise improved mouth 
opening  
233 2015 Johnson HNC C Functional outcome  
‘Mouth opening’ 
GTQ 
SF-36 
HADS 
 
Evaluated impact of trismus 
on HRQOL 
Trismus is associated with a 
significant 
impact on HRQOL, and is seen 
in those with depression 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
234 2014 Rinkel Larynx C Predictor for 
HRQOL; Functional 
outcome 
‘Swallowing, Speech, 
Voice’ 
VHI  
SHI 
SWAL-QOL  
EORTC QLQ-C30, 
EORTC QLQ-HN35 
HADS 
 
Evaluate the prevalence of 
dysfunction and its impact on 
HRQOL  
Prevalence of voice, speech, 
and 
swallowing problems is high, 
and clearly related to quality of 
life and distress 
235 2014 Erkal HNC C Functional outcome 
‘Dysphagia’ 
EORTC QLQ-C30, 
EORTC QLQ-HN35 
 
Evaluated the relationship 
between multiple outcomes 
(PRO and objective) with 
radiation doses 
 
Evaluation of multiple outcome 
measures compliment each 
other and help identify late 
effects of RT 
 
236 2014 Mahmood 
 
HNC C Predictor of HRQOL 
‘Oral health’ 
 
UWQOL 
HN-PCI 
Evaluated patient concerns 
regarding oral health and 
impact on HRQOL 
 
3 groups of patients are 
identified: patients with 
significant chewing problems, 
patients without significant 
chewing problems who wanted 
to discuss dental-related 
concerns and patients without 
significant chewing problems 
who did not want to discuss 
such concerns.  
 
237 2015 Tuomi Larynx C Predictor for HRQOL  Evaluated outcomes of RT in 
subgroups supraglottic and 
glottis 
 
 
238 2014 Eickmeyer HNC C Predictor for 
HRQOL; Functional 
outcomes ‘shoulder 
dysfunction’ 
UWQOL 
FACT-H&N 
PSS-H&N 
 
Evaluating outcomes of 
treatment in particular 
shoulder dysfunction with 
neck dissection 
QOL measures demonstrated 
the highest level of function in 
no dissection group, an 
intermediate level of 
functioning with nerve sparing, 
and 
poorest function when the nerve 
is sacrificed. 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
239 2014 Rana 
 
HNC C Predictor of HRQOL 
‘Coping’ 
Freiburg Personality 
Inventory   
Freiburg Questionnaire of 
Coping with Illness 
 
Evaluated the influence of 
personality on coping 
Personality affects coping 
behaviour 
240 2014 Barrios HNC C Predictor for HRQOL 
‘Oral health’ 
 
OHIP Evaluated the impact of 
malnutrition on oral-HRQOL 
Malnourished status is related 
to poorer oral HRQOL status 
241 2014 So HNC C Predictor for HRQOL 
‘unmet needs’ 
 
SCNS-SF34 (Chinese) 
FACT-H&N 
 
Evaluate the possible 
mediating effects of unmet 
need to HRQOL 
Unmet needs accounted for 
majority of the variance seen in 
total HRQOL score.  
Optimism, educational level, 
comorbidity, number of somatic 
symptoms, household income, 
eating ability, support from 
others, whether the cancer is 
under control or not and 
travelling time from home to 
hospital have direct or indirect 
effects, or both, on the QOL of 
HNC survivors.  
 
242 2015 Singer HNC C Questionnaire 
development/ 
validation 
EORTC-QLC-H&N60 Pilot testing the updated 
version of questionnaire  
After pilot, refinement of 
questionnaire resulted in the 
production of the EORTC 
QLQ-H&N43 
 
 Year Author Cohort Des Type  PRO Purpose Outcome 
243 2015 Kucuk Larynx C Predictor of HRQOL 
 
BDI 
EORTC QLQ-C30, 
EORTC QLQ-HN35 
 
 Advanced stage had poorer 
Emotional, cognitive, and social 
functions. Sense and speech 
problems were also 
significantly higher in this 
group.  
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 Year Author Cohort Des Type  PRO Purpose Outcome 
244 2014 Shiraz 
 
HNC C Predictor for HRQOL HADS 
ASD  
WHOQoL-BREF 
 
Evaluate psychological 
distress, measure impact of 
QOL, explore preference for  
psychological support. 
 
High HADS scores on reported 
poorer QOL. Some with 
distress declined help 
245 2014 
 
Zavalishina HNC C Predictor for HRQOL  Evaluated outcomes of 
mandibular reconstruction 
 
 
246 2014 Zhao NPC C Predictor for HRQOL EORTC QLQ-C30 
EORTC QLQ-HN35 
 
Evaluated the intervention of  
non-invasive extracorporeal 
radiofrequency (ERF) with 
CRT 
 
Combination CRT and ERF had 
better QOL scores 
247 2014 Lai HNC C Predictor for HRQOL EORTC QLQ-C30 
EORTC QLQ-HN35 
 
Evaluate QALY in IMRT 
intervention in NPC 
QALY for NPC were lower 
than reference population 
 
248 2014 Thomas HNC C Predictor for HRQOL FACT-H&N Evaluated the impact of place 
of residence (rural versus 
urban) on outcomes 
 
There are significant 
differences in life experiences 
of cancers survivors in urban 
and rural settings. Patient in 
rural residences had better 
physical, emotional and H&N 
specific QOL than those living 
in urban areas. 
 
249 2014 Chen HNC C Questionnaire 
development / 
validation 
QOL-RTI/H&N Translate and validate the 
Chinese version of 
questionnaire  
 
 
250 2014 Vilaseca Larynx C Predictors for 
HRQOL 
SF-36 
UWQOL 
 
Evaluate outcomes of TOLM  RT and ND negatively impact 
QOL. Elderly patients cope 
better with their disabilities. 
Worse speech in larger 
tumours. Swallowing problems 
seen with age and PORT. 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
251 2014 Ryzek OPC C Predictors of HRQOL EORTC QLQ-C30, 
EORTC QLQ-HN35 
 
Evaluate treatment outcomes 
in early versus late stage OPC  
Better QOL outcomes in early 
OPC treated by syurgery 
252 2014 Stachler HNC C Questionnaire 
development / 
validation 
PROMIS 
VHI 
EORTC QLQ-C30, 
EORTC QLQ-HN35 
 
Evaluate the correlations 
between different PROs 
Significant correlations between 
the PROMIS instruments and 
EORTC 
functional scales were 
observed. The fatigue PROMIS 
scale correlated with VHI. 
 
253 2014 Binenbaum HNC C Questionnaire 
development/ 
validation  
UWQOL 
EORTC QLQ-C30, 
EORTC QLQ-HN35 
 
 
Determine the minimal 
important differences in the 
respective questionnaires 
 
254 2014 Zhang HNC C Predictors of HRQOL 
 
UWQOL Evaluate outcomes of 
reconstruction using pectoralis 
major versus thigh flap 
 
Patients reconstructed with 
thigh had better shoulder but 
worse speech functions 
compared with pectoralis major. 
 
255 2014 Bornbaum Larynx C Questionnaire 
development/ 
validation 
V-RQOL Testing content validity of 
questionnaire in patients who 
underwent TL 
 
Some V-RQOL questions do 
not align with their proposed 
domains. An alternative scoring 
algorithm may be 
warranted for alaryngeal 
populations 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
256 2014 Koch 
 
HNC C Predictors of HRQOL 
‘Need for 
psychological 
support’ 
FACT;  
Miller Behavioral Style 
Scale 
General Perceived 
Self-Efficacy Scale 
Patient Health 
Questionnaire-9 (PHQ-9) 
Hornheider-Fragebogen 
short version (HFB) 
 
Explored the issues of need 
for psychological support and 
employment in HNC 
survivorship 
Many patients do not return to 
employment posttreatment. 
Current unemployment was 
associated with harder physical 
work before cancer 
diagnosis, surgical treatment, 
and current risky alcohol 
consumption.  
Unemployed  survivors 
reported decreased FACT 
functional and social well-being 
and higher PHQ 
depression scores. 
 
257 2014 Eadie HNC C Questionnaire 
development/ 
validation 
Communicative 
Participation 
Item Bank (CPIB), 
Determine how a new self-
report 
outcome measure of 
communicative participation 
related to validated HRQOL  
 
A stronger correlation was 
found between the CPIB and 
the VHI-10 compared with the 
correlation with UWQOL. 
258 2015 Rogers HNC C Predictors for 
HRQOL;  
Functional outcome 
‘Intimacy’ 
UWQOL 
HN-PCI 
Determine the prevalence of 
intimacy related 
concern/unmet need in 
disease-free posttreatment 
patients attending routine 
clinics 
 
15% reported problems of 
considerable /some concern or 
selected intimacy/sexuality on 
the PCI 
259 2014 Fang 
 
HNC C Predictors of HRQOL 
‘Appearance’ 
 
UWQOL (appearance) Evaluated outcomes of a local 
flap technique 
 
260 2015 Van Loon OPC C Predictors of HRQOL 
 
  Patients who needed PORT had 
a worse outcome and patients 
treated with 
TORS only  
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 Year Author Cohort Des Type  PRO Purpose Outcome 
261 2014 Lazarus HNC C Predictors of HRQOL EAT-10 
MDADI 
SHI 
EORTC H&N35 
Evaluate outcomes of CRT  Comparable results obtained 
with similar studies. 
 
262 2014 Yang HNC C Predictors of HRQOL UWQOL 
OHIP-14 
 
Evaluate outcomes of using 
fibula flap in mandibular 
reconstruction 
 
With UWQOL, the best-scoring 
domain was mood, whereas the 
lowest 
scores were for chewing and 
saliva. With OHIP-14, the 
lowest-scoring domain was  
social disability, followed by 
handicap, and psychological 
disability. 
 
263 2014 Verdonck-de 
Leeuw 
HNC L Predictors of HRQOL 
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate HRQOL status from 
diagnosis to 2 years follow-up 
in those treated with CRT 
 
HRQOL of HNSCC patients 
during the first 2 years after 
CRT is different for survivors 
compared to control group.  
264 2014 Klein HNC - Review/Editorial  Review papers reporting 
HRQOL in those receiving 
CRT 
 
HRQoL declines after treatment 
but recovers to baseline levels, 
generally within 12mths. 
Xerostomia-related HRQoL 
deficits may remain long-term. 
Combined CRT showed a trend 
toward worse HRQoL 
compared with RT alone. IMRT 
had better HRQOL compared 
with other RT modalities. 
 
265 2014 Hoffman HNC L Clinical trial  Randomized, 
placebo-controlled trial 
evaluating the efficacy of GM-
CSF in reducing mucosal 
injury and symptom burden 
from curative RT 
Concurrent GM-CSF 
administration during HN RT 
does not significantly improve 
patient-reported QoL symptom 
burden 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
266 2014 Pottel HNC C Predictors of HRQOL Vulnerable Elders Survey-
13 (VES-13), G8 and the  
Combined Screening Tool 
 
Evaluate screening tools for 
elderly in treatment planning 
and correlation with HRQOL 
The G8 remains the best 
screening tool, which correlates 
with HRQOL 
 
267 2014 Oliveira HNC C Functional outcome 
‘Pain’ 
BPI 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate the severity of pain 
and its impact on HRQOL in 
untreated HNC patients 
 
Severity of pain is statistically 
related to the advanced stages 
of cancer and directly affects 
HRQOL 
 Year Author Cohort Des Type  PRO Purpose Outcome 
268 2014 Bottomley 
 
Larynx 
HPX 
 
L Clinical trial  RCT 2 arm of different CRT 
regimes 
 
 
269 2015 Arias Larynx C Predictors of HRQOL EORTC QLQ-C30  
EORTC QLQ-H&N35 
VHI 
Evaluate outcomes by 
comparing surgery versus RT 
for early glottis cancer  
Voice quality, emotional 
functioning, and social contact 
were better in the RT group 
 
270 2014 Maxwell OPC C Predictors of HRQOL UWQOL Evaluate outcomes of OPC 
(HPV + versus HPV-) treated 
by surgery versus RT 
 
HPV+ patients had better 
baseline and posttreatment 
overall QOL. The overall and 
category specific QOL scores 
for HPV+ patients were not 
affected by primary treatment 
modality. 
 
271 2014 Lango HNC C Functional outcome 
 
SWAL-QOL 
EuroQOL-5D-3L 
 
Evaluate baseline dysphagia 
and its impact on HRQOL, 
and survival 
Baseline dysphagia affects 
multiple domains of QOL and 
predictive of disease recurrence 
and disease-related death. 
 
272 2014 Chen HNC C Predictors of HRQOL UWQOL Evaluate the long-term 
outcomes treated with IMRT 
 
84% reported HRQOL was 
"much better" or"somewhat 
better" than at the time of 
cancer diagnosis. 82% rated 
their overall QOL as 
"outstanding" or "very good." 
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273 2014 Fang Parotid C Predictors of HRQOL UWQOL Evaluate outcomes of surgery  Parotidectomy had limited 
impact on  HRQOL 
 
274 2014 Lazarus OC C Predictors of HRQOL Head and Neck Cancer 
Inventory 
Evaluate outcomes of tongue 
exercise intervention in 
postCRT in tongue cancers 
 
The experimental group 
demonstrated greater 
QOL impairment in the social 
disruption domain following 
treatment, whereas the control 
group demonstrated a slight 
improvement in functioning 
 
 Year Author Cohort Des Type  PRO Purpose Outcome 
275 2014 Ma NPC C Predictors of HRQOL 
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate the correlation 
between comprehensive 
nutritional status and HRQOL 
in patients receiving  IMRT  
 
A positive correlation seen 
between comprehensive 
nutritional status with QoL 
scores of functional and global 
QoL scales.  
Patients with different 
nutritional status had different 
QoL. 
 
276 2015 Ringash HNC - Review/Editorial  Reports outcome of National 
Cancer Institute committee 
meeting regarding set of 
instruments suitable for 
widespread application in the 
conduct of clinical 
trials for HNC 
 
 
277 2014 Heutte HNC - Review/Editorial  Review articles using Quality 
of life tools in head and neck 
oncology 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
278 2014 Linardoutsos HNC C Questionnaire 
development/ 
Validation 
 
UWQOL Translate and validate Greek 
version of UWQOL 
 
279 2014 Elfring HNC C Predictor for HRQOL EORTC QLQ-H&N35 
 
Evaluate the impact of nerve 
transection on HRQOL  
No significant differences 
between patient 
nerve status and HRQOL 
outcomes for speech, sticky 
saliva and use of feeding tubes 
 
280 2014 van der Meulen HNC L Clinical trial CES-D 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate the nurse-led 
psychosocial intervention 
 
Intervention improved several 
domains of HRQOL and 
depressive symptoms in HNC 
patients 
 
281 2014 Aarstad HNC C Predictors of HRQOL GHQ 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
 The GHQ sum scores predicted 
survival, and even when 
adjusted for HRQOL status.  
 
282 2014 
 
Pauli HNC C Functional outcome EORTC QLQ-C30  
GTQ 
 
Evaluated trismus 
posttreatment 
 
283 2014 Metcalfe HNC C Predictors of HRQOL 
 
UWQOL 
 
Evaluate domains selected as 
‘Most important’ by patients 
according to stage and subsite  
Swallowing, chewing, speech 
and saliva were selected more 
often by late stage OC. 
Swallowing and saliva were 
more important in OPC, and 
taste in late stage OPC.  
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 Year Author Cohort Des Type  PRO Purpose Outcome 
284 2013 Zhang OC C Predictors of HRQOL UWQOL 
SF-36 
Evaluate outcome of 
immediate mandibular 
reconstruction with free fibula 
flap 
 
With SF-36, the lowest-scoring 
domain was vitality, whereas 
the highest scores occurred in 
physical role. 
In UWQOL, the key domains 
affected by surgery are 
chewing, speech, and 
appearance. Pain scores were 
better. 
 
285 2014 Henry HNC C Predictors of HRQOL 
 
SCNS-SF34 
FACT-G 
FACT-H&N 
HADS 
 
Evaluate the prevalence of 
unmet needs, and determine 
predictors of unmet needs 
There is an overwhelming 
presence of unmet 
psychological needs. Patients 
who are divorced and present 
low levels of 
physical well-being were more 
likely to have more unmet 
needs. 
 
286 2014 Crombie HNC C Predictors of HRQOL  UWQOL 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate outcomes of OC 
treated vy CRT versus surgery 
with/out adjuvant tretment 
With UWQOL, surgical group 
recorded higher scores than the 
CRT only group in all domains 
except shoulder and 
Anxiety. 
With EORTC, surgical group 
recorded lower scores in all 
scales and items.  
 
287 2013 Shinn HNC C Functional outcomes 
‘dysphagia’ 
 
MDADI To evaluate adherence to 
swallowing exercises 
Adherence was associated 
with the Physical MDADI 
Subscale score. However, 
majority of HNC patients are 
non-adherent to swallowing 
exercise regime. 
 
 368 
 Year Author Cohort Des Type  PRO Purpose Outcome 
288 2014 Laoufi Larynx C Functional outcomes  
‘Speech/ Voice’ 
 
VHI-30 
EORTC QLQ-H&N35 
 
To evaluate outcomes 
following treatment by RT 
versus transoral laser surgery 
(LS) 
 
Long-term subjective voice-
related quality of life was worse 
after LS, but no difference in 
other domains. 
289 2014 Stier-Jarmer 
 
HNC - Review/Editorial  Review literature regarding 
outcomes measured by clinical 
trials based on the ICF-HNC 
 
 
290 2014 Risberg-Berlin 
 
Larynx L Functional outcome 
‘Smell function’ 
 
EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate the Nasal Airflow-
Inducing Manoeuvre (NAIM) 
intervention for improving 
smell function 
 
Itervention has potential to 
improve smell function to 
baseline values after treatment. 
291 2014 Goldstein HNC - Review/Editorial   Review papers relating to self-
reported ‘Shoulder 
dysfunction’ 
 
Seven questionnaires available.  
292 2014 Singer Larynx C Predictors of HRQOL EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate HRQOL status at 1y 
post TL 
QOL decreases initially after 
laryngectomy; some QOL areas 
recover 
slowly over the year after 
surgery, and some remain 
significantly worse than at 
baseline. Areas that did not 
recover to baseline were 
physical functioning, role 
functioning, social functioning, 
fatigue, dyspnea, appetite loss, 
financial  difficulties, senses, 
speech, and social contact, 
whereas global health status, 
coughing, and weight 
improved.  
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293 2014 Kendall OPC C Predictor of HRQOL; 
Functional outcome 
‘dysphagia’ 
 
UWQOL 
MDADI 
Evaluate outcome at 1 year 
following CRT treatment 
Patient perception of the impact 
of swallowing function on 
quality 
of life does not correlate well 
with actual physiologic 
functioning. 
 
294 2014 Oates 
 
OPC C Predictor of HRQOL EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate outcomes  Comparable results to similar 
studies 
295 2014 Pierre HNC C Predictor of HRQOL EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate long-term outcomes 
of microvascular 
reconstruction in OC/OPC 
 
Dysphagia scores were 
predicted by RT, age and 
gender. Speech scores were 
predicted by BOT and T stage.  
296 2014 Nagy HNC C Predictor of HRQOL EORTC QLQ-C30  
EORTC QLQ-H&N35 
UWQOL 
Evaluate the impact of post-
treatment intraoral and 
extraoral rehabilitation  
HRQOL after rehabilitation was 
significantly enhanced as 
compared to the post-treatment 
status, in all domains of both 
questionnaires 
 
297 2014 Ch’ng HNC C Predictor of HRQOL EORTC QLQ-C30  
EORTC QLQ-H&N35 
 
Evaluate the effect of PORT-
associated morbidity 
 
PORT is associated with 
reduced global health status, 
increased xerostomia, and 
marginally increased levels of 
fatigue at 6 months 
posttreatment for oral cavity 
cancer 
 
 Year Author Cohort Des Type  PRO Purpose Outcome 
298 2014 de Almeida OPC C Functional outcomes MDADI 
modified Velopharyngeal 
Insufficiency 
Quality of Life (VPIQL) 
 
 adjuvant radiotherapy was a 
predictor of poor swallowing 
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 Year Author Cohort Des Type  PRO Purpose Outcome 
299 2014 Qui HNC C Predictor of HRQOL UWQOL Evaluate outcomes in 
advanced stage HNC treated 
by surgery + reconstruction 
versus radical RT 
 
 
 
Abbreviations for PRO: 
ASEX: Arizona Sexual Experiences Scale; Acute Stress Disorder (ASD) Scale); Beck's Depression Inventory (BDI); Beck's Anxiety Inventory (BAI); Brief IQP: Brief Illness 
Perception Questionnaire; Brief ICF Core Set for head and neck cancer (ICF-HNC)Chemosensory Complaint Score (CCS); Caregiver Strain Index (CSI); Common Terminology 
Criteria for Adverse Events (CTCAE); Distress  Thermometer (DT); Dysphagia Outcome and Severity Scale (DOSS); Euroqol-5 dimensions (EQ-5D); Eating assessment tool (EAT-
10); Functional Assessment of Cancer Therapy-Head and Neck Cancer; (FACT-H&N; )Functional Oral Intake Scale (FOIS); Functional Rehabilitation Outcomes Grade(FROG); 
Gothenburg Trismus Questionnaire (GTQ); General health questionnaire (GHQ); Hospital Anxiety and Depression Scale (HADS); Head Neck Cancer Inventory (HNCI); Head and 
Neck Radiotherapy Questionnaire (HNRQ); Head and Neck QOL instrument (HNQOL); Health Utilities Index Mark 3 (HUI3); Liverpool Oral Rehabilitation Questionnaire 
(LORQ) 
M. D. Anderson Dysphagia Inventory (MDADI); Medical Outcomes Short-Form Health Survey (MOSHS); M. D. Anderson Symptom Inventory-Head and Neck Module (MDASI-
HN); Neck Dissection Impairment Index (NDII); Oral Health Impact Profile (OHIP); Oral Mucositis Weekly; Oral Impacts on Daily Performances (OIDP) ; Performance Status 
Scale (PSS): Normalcy of Diet; Performance Status Scale-Head and Neck Cancer (PSS-H&N); Posttraumatic Growth Inventory (PTGI) ; Patient-Reported Outcomes Measure 
Information System (PROMIS); Quality of Life in Adult Cancer Survivors (QLACS); Quick Inventory of Depressive Symptoms (QIDS); Quality OF Life Questionnaire-Head and 
Neck Cancer  (QOL-H&S); Quality of life (WHOQoL-BREF); Radiation Therapy Instrument and the Head & Neck Module (QOL-RTI/H&N); Rosenberg Self-Esteem Scale 
(RSES); Speech Handicap Index (SHI); Survivors Unmet Needs Survey (SUNS); Short-Form Health Survey (SF-8); Short-Form Supportive Care Needs Questionnaire (SCNS-
SF34); Spitzer Quality of Life Index (SQLI); Swedish Self-Evaluation of Communication Experiences after Laryngeal Cancer (S-SECEL)V-RQOL:; Voice-related quality of life; 
VHI:  Voice Handicap Index; VHNSS 2.0: Vanderbilt Head and Neck Symptom Survey version 2.0; Voice Handicap Index-10 (VHI-10); Swallowing; Quality of Life Questionnaire 
(SWAL-QOL); Xerostomia Questionnaire (XQ) 
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Appendix 2. The Patient Concerns Inventory (version 1)  
 
 
THE HEAD AND NECK PATIENT CONCERNS INVENTORY 
 
Please choose from the list of issues you would specifically like to talk about in the  
consultation/whilst at clinic today. You can choose more than one option: (Tick the box ) 
 
 Activity  Nausea 
 Anger  Pain in head and neck 
 Anxiety  Pain elsewhere 
 Appearance  PEG tube 
 Appetite  Recreation 
 Bowel habit (diarrhoea or constipation)  Regret about treatment 
 Breathing  Relationships 
 Carer  Salivation 
 Chewing/eating  Sex 
 Dental health/teeth  Shoulder 
 Depression  Sleeping 
 Energy levels  Smell 
 Fatigue/tiredness  Speech/voice/being understood 
 Fear of the cancer coming back  Spiritual /religious aspects 
 Financial / benefits  Support for my family 
 Hearing  Swallowing 
 Home care/district nurse support  Swelling 
 Intimacy  Taste 
 Lifestyle issues (smoking/alcohol)  Temperament and personality 
 Memory  Vomiting/sickness 
 Mobility  Weight 
 Mood  Wound healing 
 Mouth opening  Anything else 
 
 
 
Please indicate the people you would specifically like to talk with either in clinic or by referral.  
You can indicate more than one person. (Tick the box ) 
 
     Chaplain      Family doctor      Radiotherapist/oncologist 
     Clinical nurse specialist      Nursing staff      Social worker 
     Dental hygienist      Occupational therapist      Speech and language therapist 
     Dentist      Oral rehabilitation team      Surgeon 
     Dietician      Physiotherapist      Anyone else 
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Appendix 3. The Patient Concerns Inventory (version 2). Newly added items are in 
CAPITALS. 
 
 
 
THE HEAD AND NECK PATIENT CONCERNS INVENTORY 
 
Please choose from the list of issues you would specifically like to talk about in the  
consultation/whilst at clinic today. You can choose more than one option: (Tick the box ) 
 
 Activity  Mouth opening 
 Angry  MUCUS PRODUCTION 
 Anxiety  Nausea 
 Appearance  Pain in head and neck 
 Appetite  Pain elsewhere 
 Bowel habit (diarrhoea or constipation)  PEG tube 
 Breathing  Recreation 
 Carer  Regret about treatment 
 CANCER TREATMENT  REGURGITATION 
 Chewing/eating  Relationships 
 Dental health/teeth  Salivation 
 COPING  Sexuality 
 COUGHING  SELF-ESTEEM 
 Depression  Shoulder 
 DEPENDANTS / CHILDREN  Sleeping 
 Energy levels  Smell 
 Fatigue/tiredness  Speech/voice/being understood 
 FEAR OF ADVERSE EVENTS  Spiritual /religious aspects 
 Fear of the cancer coming back  Support for my family 
 Financial / benefits  Swallowing 
 Hearing  Swelling 
 Home care/district nurse support  Taste 
 INDIGESTION  Temperament and personality 
 Intimacy  Vomiting/sickness 
 Lifestyle issues (smoking/alcohol)  Weight 
 Memory  Wound healing 
 Mobility  Anything else / Others 
 Mood   
 
 
Please indicate the people you would specifically like to talk with either in clinic or by referral.  
You can indicate more than one person. (Tick the box ) 
 
     Chaplain      Family doctor      Radiotherapist/oncologist 
     Clinical nurse specialist      Nursing staff      Social worker 
     Dental hygienist      Occupational therapist      Speech and language therapist 
     Dentist      Oral rehabilitation team      Surgeon 
     Dietician      Physiotherapist      Anyone else 
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Appendix 4. The Patient Concerns Inventory (version 3). Newly added items are in 
CAPITALS. 
 
 
THE HEAD AND NECK PATIENT CONCERNS INVENTORY 
 
Please choose from the list of issues you would specifically like to talk about in the  
consultation/whilst at clinic today. You can choose more than one option: (Tick the box ) 
 
 Activity  Mouth opening 
 Angry  Mucus production  
 Anxiety  Nausea 
 Appearance  Pain in head and neck 
 Appetite  Pain elsewhere 
 Bowel habit (diarrhoea or constipation)  PEG tube 
 Breathing  Recreation 
 Carer  Regret about treatment 
 Cancer treatment   Regurgitation 
 Chewing/eating  Relationships 
 Dental health/teeth  Salivation 
 DIZZINESS  Sexuality 
 Coping  Self-esteem  
 Coughing  Shoulder 
 Depression  SKIN RASH 
 Dependents / Children  Sleeping 
 Energy levels  Smell 
 Fatigue/tiredness  Speech/voice/being understood 
 Fear of adverse events  Spiritual /religious aspects 
 Fear of the cancer coming back  Support for my family 
 Financial / benefits  Swallowing 
 Hearing  Swelling 
 Home care/district nurse support  Taste 
 Indigestion  Temperament and personality 
 Intimacy  Vomiting/sickness 
 Lifestyle issues (smoking/alcohol)  Weight 
 Memory  Wound healing 
 Mobility  Anything else / Others 
 Mood   
 
Please indicate the people you would specifically like to talk with either in clinic or by referral.  
You can indicate more than one person. (Tick the box ) 
 
     Chaplain      Family doctor      Radiotherapist/oncologist 
     Clinical nurse specialist      Nursing staff      Social worker 
     Dental hygienist      Occupational therapist      Speech and language therapist 
     Dentist      Oral rehabilitation team      Surgeon 
     Dietician      Physiotherapist      Anyone else 
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Appendix 5. Research Ethics Approval  
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Appendix 6. Patient information sheet 
 
Patient Concerns Inventory for Head & Neck Cancer Patients in Outpatients Clinics 
Aintree University Hospitals NHS Foundation Trust 
WELCOME 
 
This ‘Information Leaflet’ has been designed to 
tell you about the Patients Concerns Inventory 
(PCI) and the study that we are conducting 
related to this. 
 
What is the Patient Concerns Inventory? 
The Patients Concerns Inventory (PCI) is used in 
the cancer (oncology) out-patients clinics. It is a 
list of 55 issues that patients and their carers 
might wish to mention in their consultation and a 
list of 15 team members they might specifically 
wish to see or be referred on to. 
 
The PCI has been developed in partnership with 
patients in our regional unit and has been 
successfully trialled in head and neck cancer 
patients in the Maxillofacial Surgery unit. 
 
Why do we need a PCI? 
We have found out from patients and carers that 
there are many issues that they would like to 
bring up in their consultation. However during the 
consultation they may forget. The PCI acts as a 
prompt.  
 
During a trial of the PCI patients have made the 
following comments: 
 
- ‘it made it a bit more personal’  
- ‘reminds me of the points I want discuss’ 
- ‘allows consultation to get straight to the point’ 
- ‘encourages me to talk about things I would 
otherwise not discuss’ 
- ‘if it helps you its fine by me’  
 
Which patients use the PCI?  
All patients treated for head and neck cancer 
attending the outpatient clinic during their follow-
up at the Regional Cancer Centre are 
encouraged to use the PCI.  
 
What does this study aim to do? 
We would like to evaluate the application and 
usefulness of the PCI in head and neck cancer 
patients managed through the ENT and 
maxillofacial units.  
 
When is the PCI completed?  
The PCI is filled in before your consultation. 
 
What is involved? 
1.  First you need to register in the normal way 
at the clinic reception desk.  
 
2.  At this point, you may be invited to complete 
the PCI by a researcher. This is voluntary; you 
do not have to do it. If you don’t take part this 
will not affect the quality of care you receive. 
 
3. Upon the invitation to participate, you will be 
taken by the researcher to a separate room in 
the clinic to do the PCI, which is completed in a 
paper form. It takes approximately 10 minutes to 
complete along with other questionnaires. The 
researcher is usually present to assist if 
required.   
 
4. Depending on the study design, information 
from the PCI may or not be made available to 
your doctor. However, you may discuss the 
concerns that you have highlighted through the 
PCI as part of a routine clinic visit. 
 
5. Your consultation will be sound recorded. 
Only one copy of the audiotaped consultation is 
made and is used only for the purpose of this 
study.  
 
6. You will NOT lose your place in the clinic 
order. Once you have completed the PCI you 
will be seated back in the waiting area ready for 
your consultation.  
 
7. Once you have completed your consultation, 
you will be asked to recall the items discussed 
during the consultation in a short checklist.  
 
8. You will be given a satisfaction questionnaire 
with self-addressed envelope for you to complete 
and post back within 1 week of your consultation.  
 
9. All information is confidential. No individuals 
name or other details are used. Identification is 
by NHS number only. Access to the information 
is password-protected and limited separate room 
in the clinic to do the PCI.  
 
Ethical approval and your consent would be 
sought to use this information for educational 
purposes.  
 
THANK YOU FOR YOUR INTEREST AND SUPPORT 
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Appendix 7. Patient consent form 
 
 
 
 
Regional Maxillofacial Unit 
Aintree University Hospitals NHS Foundation Trust  
 
Appointment date: NHS 
number: 
 
 
CONSENT FORM 
 
PATIENTS CONCERNS INVENTORY (PCI)  
FOR HEAD AND NECK CANCER STUDY 
 
Please read each statement carefully and complete the option that represents your choice. 
 
I have read the information sheet on the use of PCI. 
 
YES NO 
I understand that participation in this study is voluntary. 
 
YES NO 
I confirm that I understand the purpose of this study. 
 
YES NO 
I agree to use the PCI.  
I understand that the PCI information may or may not be passed on to my 
consultant on the day. 
 
YES NO 
I agree to have my consultation audiotaped.  
I understand that any identifiable information in the recorded consultation will 
be erased to maintain patient-doctor confidentiality. The recorded consultation 
will be transcribed in written form for the purpose of this study. Only one 
recorded copy is retained and this will be stored in a secure facility for duration 
of 5 years to allow collaborative members of the research team to listen to the 
audiotaped consultation in the future.  
  
YES NO 
I give permission for the researcher to contact me after the appointment for the 
purpose of conducting a satisfaction survey. 
 
YES NO 
I give permission for my medical and related records to be examined and 
information taken for confidential use in this study. 
 
YES NO 
 
 
 
  
Name of patient Date Signature 
 
 
  
Consented by Date Signature 
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Appendix 8. University of Washington Quality of Life, version 4 
 
 
Date:  _____/_____/_____  Study Number:   |__|__|__|__|__|__|__|__| 
 
 
University of Washington Quality of Life Questionnaire (UW-QOL v4) 
 
This questionnaire asks about your health and quality of life over the past seven days.  
Please answer all of the questions by ticking one box for each question. 
 
1. Pain.  (Tick one box:  ) 
  I have no pain. (100)             
  There is mild pain not needing medication. (75)                  
  I have moderate pain - requires regular medication (e.g. paracetamol). (50)                         
  I have severe pain controlled only by prescription medicine (e.g. morphine). (25) 
  I have severe pain, not controlled by medication. (0) 
 
 
2. Appearance.  (Tick one box:  ) 
  There is no change in my appearance. (100)                
  The change in my appearance is minor. (75) 
  My appearance bothers me but I remain active. (50) 
  I feel significantly disfigured and limit my activities due to my appearance. (25) 
  I cannot be with people due to my appearance. (0) 
 
 
3. Activity.  (Tick one box:  ) 
  I am as active as I have ever been. (100) 
  There are times when I can't keep up my old pace, but not often.  (75) 
  I am often tired and have slowed down my activities although I still get out. (50) 
  I don't go out because I don't have the strength. (25) 
  I am usually in bed or chair and don't leave home. (0)   
 
 
4. Recreation.  (Tick one box:  ) 
  There are no limitations to recreation at home or away from home.  (100) 
  There are a few things I can't do but I still get out and enjoy life. (75) 
  There are many times when I wish I could get out more, but I'm not up to it. (50) 
  There are severe limitations to what I can do, mostly I stay at home and watch TV. 
(25) 
  I can't do anything enjoyable. (0) 
 
 
5. Swallowing.  (Tick one box:  ) 
  I can swallow as well as ever. (100) 
  I cannot swallow certain solid foods. (70) 
  I can only swallow liquid food. (30) 
  I cannot swallow because it "goes down the wrong way" and chokes me. (0) 
   
 
6. Chewing.  (Tick one box:  ) 
  I can chew as well as ever. (100) 
  I can eat soft solids but cannot chew some foods. (50) 
  I cannot even chew soft solids. (0) 
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7.  Speech.  (Tick one box:  ) 
  My speech is the same as always. (100) 
  I have difficulty saying some words but I can be understood over the phone. (70) 
  Only my family and friends can understand me.  (30) 
  I cannot be understood.  (0) 
 
 
8. Shoulder.  (Tick one box:  ) 
  I have no problem with my shoulder. (100) 
  My shoulder is stiff but it has not affected my activity or strength.  (70) 
  Pain or weakness in my shoulder has caused me to change my work / hobbies. (30) 
  I cannot work or do my hobbies due to problems with my shoulder. (0) 
 
 
9. Taste.  (Tick one box:  )  
  I can taste food normally. (100) 
  I can taste most foods normally.  (70) 
  I can taste some foods. (30) 
  I cannot taste any foods. (0) 
 
 
10. Saliva.  (Tick one box:  ) 
  My saliva is of normal consistency. (100) 
  I have less saliva than normal, but it is enough. (70) 
  I have too little saliva. (30) 
  I have no saliva. (0) 
 
 
11. Mood.  (Tick one box:  ) 
  My mood is excellent and unaffected by my cancer. (100) 
  My mood is generally good and only occasionally affected by my cancer. (75) 
  I am neither in a good mood nor depressed about my cancer. (50) 
  I am somewhat depressed about my cancer. (25) 
  I am extremely depressed about my cancer. (0) 
 
 
12. Anxiety.  (Tick one box:  ) 
  I am not anxious about my cancer. (100) 
  I am a little anxious about my cancer. (70) 
  I am anxious about my cancer. (30) 
  I am very anxious about my cancer. (0) 
 
 
 
 
Which issues have been the most important to you during the past 7 days?   
Tick  up to 3 boxes. 
   Pain  Swallowing  Taste 
   Appearance  Chewing  Saliva 
   Activity  Speech  Mood 
   Recreation  Shoulder  Anxiety 
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GENERAL QUESTIONS 
 
Compared to the month before you developed cancer, how would you rate your health-
related quality of life? (Tick one box:  ) 
  Much better        (100) 
  Somewhat better        (75) 
  About the same          (50) 
  Somewhat worse          (25) 
  Much worse          (0) 
 
 
In general, would you say your health-related quality of life during the past 7 days has 
been:  (Tick one box:  ) 
  Outstanding        (100) 
  Very good         (80) 
  Good            (60) 
  Fair            (40) 
  Poor          (20) 
  Very poor          (0) 
 
 
Overall quality of life includes not only physical and mental health, but also many other 
factors, such as family, friends, spirituality, or personal leisure activities that are important to 
your enjoyment of life.  Considering everything in your life that contributes to your personal 
well-being, rate your overall quality of life during the past 7 days.  (Tick one box:  ) 
 
  Outstanding       (100) 
  Very good        (80) 
  Good           (60) 
  Fair           (40) 
  Poor         (20) 
  Very poor         (0) 
 
 
Please describe any other issues (medical or nonmedical) that are important to 
your quality of life and have not been adequately addressed by our questions 
(you may attach additional sheets if needed). 
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Appendix 9. Distress thermometer 
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Appendix 10. Princess Margaret Princess Margaret Hospital Patient Satisfaction 
with Physician Questionnaire (PSQ-MD) 
 
 
NHS number                 
 
Princess Margaret Hospital Patient Satisfaction 
with Physician Questionnaire (PSQ-MD) 
 
This form contains a list of questions about your views on the last visit you made to the doctor.  Please 
answer all of them.  Your answers are anonymous and are kept entirely confidential, so feel free to say 
whatever you wish.  For each question please circle the answer that is nearest your opinion.  
 
For example: 
 
1 This doctor listened carefully. 
 Strongly agree / Agree / Disagree / Strongly disagree / Does not apply  
 
 
1 I will follow the doctor’s advice because I think s/he is absolutely right. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
2 The doctor did not take my problems very seriously. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
3 The doctor considered my individual needs when treating my condition. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
4 The doctor did not give me all the information I thought I should have been given. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
5 The doctor went straight to my medical problem without greeting me first. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
6 The doctor used words I did not understand. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
7 There was not enough time to tell the doctor everything I wanted. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
8 I feel the doctor did not spend enough time with me. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
9 It seemed to me that the doctor was not really interested in my emotional well-being. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
10 I really felt understood by my doctor. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
11 After my last visit with my doctor, I feel much better about my concerns. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
12 The doctor was not friendly to me. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
13 I understand my illness much better after seeing this doctor. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
14 This doctor was interested in me as a person and not just my illness. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
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15 I feel I understand pretty well the doctor’s plan for helping me. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
16 I would not recommend this doctor to a friend. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
17 The doctor seemed to brush off my questions. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
18 The doctor should have told me more about how to care for my condition. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
19 After talking with the doctor, I have a good idea of what changes to expect in my health 
over the next few weeks and months. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
20 The doctor told me to call back if I had any questions or problems. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
21 I felt the doctor was being honest with me. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
22 The doctor explained the  reason why the treatment was recommended for me. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
23 It seemed to me that the doctor was not really interested in my physical well-being. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
      
24 The doctor should have shown more interest. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
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Appendix 11.  Non-validated patient-reported outcomes of consultation 
 
 
Date  NHS number   
 
POST-CONSULTATION QUESTIONNAIRE 
 
Thank you for taking part in this short follow up survey regarding your most recent 
outpatient clinic consultation. This questionnaire is aimed at understanding your 
perspectives on your perceived views of the consultation. Please read carefully and answer 
the most representative response for the relevant question. Thank you for your participation. 
 
1.  From your perspectives, what were the items of your concern that you had wanted to 
discuss with your doctor during the most recent consultation? Please write in the space 
allocated below: 
 
2. How would you rate the extent to which these concerns were addressed? 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
  
3. Were you able to see or be referred to the healthcare professional or individual you had 
hoped to see during your most recent the consultation?  
 YES NO 
  
4. To what degree would you agree to the statement: My expectations of the consultation 
were fulfilled in the most recent outpatient clinic visit. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
  
5 To what degree would you agree to the statement: I felt the PCI was intrusive. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
  
6 To what degree would you agree to the statement: I felt the PCI was unhelpful. 
 Strongly agree Agree Disagree Strongly disagree Does not apply 
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 Appendix 12. Study design 
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Appendix 13: Published pilot study 
 
Ghazali N, Roe B, Lowe D, Rogers SN. Uncovering patients' concerns in routine head and neck 
oncology follow up clinics: an exploratory study. Br J Oral Maxillofac Surg. 2013 
Jun;51(4):294-300. doi: 10.1016/j.bjoms.2012.08.002.  
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bstract
he Patient Concerns Inventory (PCI) is a tool that enables patients to highlight issues they wish to discuss, and helps to uncover concerns that
ight otherwise be missed. Previous PCI studies have involved direct observation of a consultation by one assessor using a coding method
ased rigidly on items listed on the inventory. This pilot study explores the feasibility of developing a standardised method of scoring which
an be used to evaluate it. We prospectively recruited 40 disease-free patients attending 42 routine outpatient consultations after treatment for
ead and neck cancer. Before the consultation they completed the University of Washington quality of life questionnaire and the PCI. Nineteen
onsultations were audio-recorded and transcribed, and 2 assessors used a thematic framework to analyse the content of the consultation to
nd the number and types of concerns, the professionals involved, and the clinical outcomes. The assessors were in agreement about 80%
65/81) of the audio-recordings. The mean number of items of concern highlighted on the PCI before consultation was 5.95, median (IQR)
(3–8) in contrast to 6.47, median (IQR) 6(4–9) for those discussed; for involvement of professionals it was 0.74, median (IQR) 0(0–1)
n contrast to 2.63, median (IQR) 3(1–4), respectively. We identified 4 new themes for the working thematic framework, which provided a
ynamic, standardised, and comprehensive approach based on the observation and responses of those studied. This approach gave an insight
nto the way the PCI mediates consultations, and how patients do not always understand the support that specific professionals can provide.
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n making decisions about their care,1 but it requires them
o communicate their needs, concerns, and perspectives
ffectively,2 and the process can be improved. The Patient
oncerns Inventory (PCI) is a self-reported tool that focuses
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Early PCI studies conducted in a single practitioner’s
linical practice have suggested that the inventory helps to
ncover concerns that might otherwise be missed.3–8 How-
ver, data were analysed from direct observation of the
onsultation by one assessor using an itemised checklist
hat focused on specific words that corresponded directly
o items on the PCI. They did not consider items not on
he list and may have missed some that were included
f the patients or doctors used different words than those
isted.
The primary aim of this study was to pilot a thematic
ramework to score items discussed in a PCI-mediated con-
ultation for agreement and standardisation, and to evaluate
ts suitability for use in a multiclinic, rollout study. Other
econdary aims were to compare the number and category
f items highlighted on the PCI with those discussed, and
o report the clinical outcomes and satisfaction reported by
atients.
ethod
ubjects
e prospectively recruited disease-free patients who had
een treated for head and neck cancer and were attending
outine clinics of one maxillofacial surgeon from February
o May 2011. Those awaiting treatment, having palliative
reatment, or who were attending the clinic for reasons
ther than routine follow up, were excluded. Informa-
ion sheets about the study were posted to all eligible
atients 2 weeks before their appointments. On the day
f appointment while they were waiting, the researcher
sked them whether they were willing to participate. For-
al informed consent was subsequently obtained from those
ecruited.
ata  collection
atients completed the University of Washington quality of
ife questionnaire10 (UW-QoL) then the PCI. The UW-QoL is
 health-related quality of life (HRQoL) questionnaire spe-
ific to head and neck cancer that consists of 12 domains
caled from 0 (worst) to 100 (best) according to the hier-
rchy of response. Other questions relate to the previous
eek and ask patients to choose up to three domains most
mportant to them, to rate their HRQoL, and to rate their
verall quality of life. The PCI questionnaire lists 55 issues
including “Anything else”) and 15 professionals (including
Anyone else”) for patients to choose.3 Both questionnaires
ere written as Microsoft Access-based software application
ackages and were filled in using a touch-screen computer
inked to the hospital mainframe. After completion, the clin-
cian retrieved a summarised report.9 On one occasion when
he touch-screen computer had broken down, 6 paper versions
f the questionnaires were used.
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udio-recording  equipment
o ensure uniformity, audio-recordings were made only in
onsultations that involved one maxillofacial surgeon, as
ther clinicians were not familiar with the PCI. A Tascam
R-100 (TEAC UK Ltd., Watford, UK) recorder was used to
ecord the whole of the consultation, and it was saved in MP3
ormat. All identifiable information was removed to maintain
onfidentiality. Only recordings of complete consultations
ere used and transcribed.
ata  analysis
valuation of the consultation involved identifying the num-
er and type of concerns, involvement by healthcare or
upportive professionals, and the clinical actions that resulted
rom the consultation. The framework, which involves 5
teps, was used to analyse the transcribed recordings.11,12
he proposed framework (Table 1) is based on themes derived
rom previous knowledge (the PCI, which was distilled from
arious HRQoL questionnaires specific to head and neck can-
er, and involvement by the Merseyside head and neck cancer
ocus group).3 The themes were then coded into discrete
ategories that related to the items of concern, healthcare
rofessionals, and type of clinical action or decision made
uring the consultation – for example, words or phrases
uch as “lethargy”, “exhausted”, or “run down” were cate-
orised under the theme of “Fatigue or tiredness”. Outcomes
ere classified as medical or non-medical actions. Medical
ctions comprised being placed on the waiting list for opera-
ions to aid rehabilitation, symptomatic or supportive medical
reatment, investigations, and referrals. Non-medical actions
ncluded provision of information, advice on lifestyle, strate-
ies for coping, and reassurance. The system was developed
o standardise the classification of spoken phrases or terms
sed by patients and clinicians for the purpose of evaluation.
igour
o improve the reliability of qualitative data analysis (rigour),
 second independent skilled qualitative researcher assessed
he transcripts, and their decisions were compared.14 Both
ssessors evaluated every one of 4 transcripts selected
andomly. This also enabled formation of the thematic frame-
ork, which was used by one assessor to evaluate the
emaining transcripts. When an item was identified by one
nd missed by the other it was discussed until resolved. This
nvolved building a holistic picture of the patient or clini-
ian, or both, on which to base analysis of the words used,
nd to identify key ideas and themes that were ultimately
greed by both assessors. This was particularly relevant when
tems were missed because they were not in the framework
s they were carefully considered as potential new codings.
owever, for the purpose of this pilot study, they were consid-
red under “Others”. The overall level of agreement for each
onsultation assessed was derived as a percentage from the
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Table 1
The framework approach.11
Step Definition Process
1 Familiarisation The process through which the researcher
becomes familiarised with the data
Listened to audio-recordings
Read through transcripts
2 Identification of
thematic framework
Identification of issues, themes and concepts
from the data. They can also be based on
previous knowledge
At this stage the framework can be tentative and
open to further changes for refinement based on
logical and intuitive thinking
Previous knowledge of the themes was gained from the PCIa (items
of concern and professionals), and through the conventional
approach to clinical management (for clinic outcomes)
Themes were structured according to a collection of words, terms,
and expressions considered to be of the same type (thematic
coding).13 This provided a standardised list for reference during
evaluation
3 Indexing Identification of portions or sections of data that
correspond to a particular theme
Transcripts were analysed by 2 assessors using thematic coding
Portions of data that represented a theme were highlighted in the
text, and the corresponding theme annotated in the margin for the
purpose of indexing
4 Charting Organisation of indexed data into charts
(portions of highlighted text were organised
systematically to identify the best way to report
the findings).
Both assessors met to agree the codes.
For each transcript assessed by both, the items were considered as
“item agreed” or “missed”. Those missed were discussed and
ultimately resolved.
Some items were missed because they had been overlooked,
misclassified, or the theme was not included on the thematic
framework. They were carefully considered to potentially create
new themes to refine the existing framework for future studies
5 Mapping and
interpretation
Analysis of key characteristics as set out in the
tables
The indexed themes from the transcript were tabled according to
type
This was contrasted against another table consisting of the items
identified by patients on the PCI before consultation
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ormula: number of items agreed/total number of items iden-
ified.
valuation  by  patients  after  consultation
atients were given 2 questionnaires to complete after the
onsultation: the Princess Margaret Hospital patient satisfac-
ion with doctor questionnaire15 (PSQ-MD), which includes
4 items, and is validated and specific to visits in an oncol-
gy setting; and a non-validated questionnaire consisting of
 questions to gauge patients’ perceptions of their concerns
free text response), the extent to which their concerns were
ddressed (Likert-type scale), whether they were able to see
r be referred to the professional they had wanted to see
yes/no), and their views about the PCI (Likert-type scale).
The study was done with approval from the North West –
iverpool East Research Ethics Committee (11/H1002/7).
esults
 total of 63 consultations (56 patients) from 6 clinics were
ligible for inclusion in the study; 67% (42 consultations)
ere included and 33% (21) were missed. The losses resultedrom a lack of opportunity to recruit during a busy clinic
14/21) and refusal to participate (7/21). Those enrolled were
n average 5 years younger (mean 61.6 compared with 66.4
ears) at clinic than those missed, and in regard to primary
3
p
w
siagnosis, had more advanced T-stage (T3-4) tumours (38%
ompared with 15%), but fewer operations that involved flaps
29% compared with 61%); otherwise there were no notable
ifferences in the demographic and clinicopathological data
results not shown).
Of the 42 enrolled consultations (40 patients), 69% (29)
f the patients were men, mean (SD) age 61.6 (11.3) years.
n 37 the primary diagnosis was squamous cell carcinoma.
ites of primary tumours were the oral cavity (n = 28), phar-
nx (n  = 11), salivary glands (n  = 2), and skin (n  = 1). Fourteen
ere pathological stage 1, 12 were stage 2, 8 were stage 3,
nd 8 were stage 4. Primary treatment was operation (n  = 34),
rimary radiation or chemoradiotherapy, or both (n = 7), flap
urgery (n  = 12), and adjuvant postoperative radiotherapy
n = 14). The median (IQR) time from first diagnosis to study
onsultation was 22 (10–53) months.
tems  reported  by  patients  on  the  PCI
CI data were available from 42 consultations (touch-screen
6; paper 6). The mean number of items of concern high-
ighted was 5.52, median (IQR) 4(2–8), and of professionals
as 0.50, median (IQR) 0(0–1). On almost all the question-
aires, patients had selected at least one item on the PCI (88%,
7/42) and on a minority (38%, 16/42) at least one healthcare
rofessional had been selected. Items chosen by at least 20%
ere fear of recurrence (33%, 14), dental health (31%, 13),
wallowing (29%, 12), chewing (26%, 11), speech (21%, 9),
N. Ghazali et al. / British Journal of Oral and M
Table 2
Content analysis and level of agreement between the 2 assessors. Data are
number.
Consultations Total
1 2 3 4 5
Total number of items 17 15 14 15 20 81
Items missed 2 4 2 4 1 13
Definition of coding changed 1 1 1 0 0 3
Number of items agreed 14 10 11 11 19 65
Percentage agreement 82 67 79 73 95 80
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analysis, more items were discussed than had been high-
lighted originally. This was because new themes had beenain in the head and neck (21%, 9), and pain elsewhere (21%,
). Dentists were the only healthcare professionals selected
y at least 10% (21%, 9).
udio-recordings
here were 19 complete audio-recordings. The reasons for a
ecording being incomplete or for it not being done at all were
ack of consent (n  = 12), seeing a different surgeon (n  = 5),
orgetting to record (n  = 3), and failure of the equipment
n = 3). Patients with audio-recordings were 5 years younger
n average (mean 59 compared with 64 years) and were
loser to the time of treatment (median 16 months compared
ith 45 months), also fewer had had adjuvant postoperative
adiotherapy or radical neck dissection (16% compared with
2%). There were no notable differences in the number of
tems selected on the PCI before consultation (median (IQR)
(3–8) compared with 4(1–8)) or in the number of healthcare
rofessionals selected.
ontent  analysis
he main assessor reviewed all 19 transcripts. From these
 were randomly selected for evaluation by both assessors
Table 2). Potential new themes for coding identified by con-
ent analysis included “wellbeing”, “dizziness”, “skin rash”,
nd “further surveillance”.
The 19 consultations that were recorded lasted for a
edian (IQR) duration of 8.4 (5.6–10.3) min. For these the
ean number of items of concern highlighted on the inven-
ory was 5.95, median (IQR) 4(3–8), and the mean number
f professionals highlighted was 0.74, median (IQR) 0(0–1).
n contrast, content analysis of the audio-recordings gave a
ean of 6.47, median (IQR) 6(4–9) for items of concern, and
.63, median 3(1–4) for professionals.
The contrast between the items selected on the PCI and
he content of the discussions is shown in Table 3. More
tems were discussed than were raised on the PCI particularly
n regard to healthcare professionals. Of the items on the
CI, fear of recurrence stands out as it was selected on the
nventory by 8/19 patients and was discussed by 9/19.
i
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linical  outcomes
he median number of clinical decisions or actions taken
uring consultations was 2.8 (range 2–5). The predominant
ecision made was for no intervention and the most common
ctions were appointments for further surveillance, provision
f information, and giving reassurance. Two consultations
esulted in onward referrals.
utcomes  reported  by  patients  after  consultation
uring the latter part of this pilot, questionnaires were dis-
ributed after 22 consultations (15 patients), of which 11 had
een audio-recorded. Questionnaire response was therefore
8% (15/22), and returns were completed within a median of
 day (range 0–12) from the consultation. Fourteen patients
elt that they had been able to see the person they had hoped
o see on that day. Most responses described satisfactory
xperiences (Table 4).
iscussion
his study explored the feasibility of introducing a thematic
ramework approach to content analysis for future use in eval-
ating outcomes of PCI-mediated consultations. We found
hat the approach enabled us to explore the personal and
ynamic nature of patients’ needs in the period after they
ad completed treatment because it is based on the observa-
ion of the subjects involved. Other valuable features include
ts dynamic approach (allows the framework to be amended
uring analysis), the system used (standardises the approach
o handling data), and its comprehensive nature (allows a full
eview of the data). The study also showed the feasibility of
rospective recruitment in a busy clinic, and the varied atti-
udes of patients to having consultations audio-recorded. It
lso gave an insight into the use of a visit-specific question-
aire about patients’ satisfaction, which has never been used
efore in head and neck cancer.
The study also highlighted the potential problem of loss
f recruitment. Lack of familiarity with the study by patients,
taff, and researchers, and the nature of a dynamic, busy clinic
ay account for the logistical reasons for losses. Another
roblem is the multilayered process of obtaining consent
here patients give consent (or otherwise) to individual sec-
ions of the study. Many patients were happy to provide PCI,
W-QoL, and clinical data, but about half were not happy
bout the consultations being audio-recorded. This may have
 greater potential for systematic error than losses for logisti-
al reasons. However, these problems could be overcome in
uture prospective studies.
When the thematic framework was used for contentntroduced, which may or may not have been related to some
f the items highlighted. The new themes identified as items
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Table 3
Number of items of concern or health professionals selected by 19 patients on the Patient Concerns Inventory (PCI) and noted from the audio-recordings of
their consultations. Items of concern were selected by 4 or more of the 19 patients, whereas the health professionals selected are all those noted on the PCI or
mentioned in the consultation.
On PCI Discussed On PCI and not
discussed
On PCI and
discussed
Not on PCI but
discussed
Items of concern
Fear of recurrence 8 9 2 6 3
Othera 0 12 0 0 12
Chewing 5 7 1 4 3
Dental health 4 6 1 3 3
Swallowing 6 5 1 5 0
Saliva 4 6 1 3 3
Pain in head and neck 4 5 4 0 5
Anxiety 4 6 1 3 3
PEG 3 5 0 3 2
Speech 4 5 1 3 2
Activity 3 4 1 2 2
Sleeping 4 3 1 3 0
Mood 5 2 4 1 1
Swelling 2 4 1 1 3
Appearance 2 4 0 2 2
Depression 5 1 4 1 0
Weight 1 4 1 0 4
Lifestyle 1 5 0 1 4
Mucus 4 1 3 1 0
Mobility 4 1 4 0 1
Total of these 20 items 73 95 31 42 53
Total of other 35 items 40 28 28 12 16
Total of all 55 items 113 123 59 54 69
Health professionals
General practitioner 2 11 0 2 9
Dentist 5 7 3 2 5
Otherb 1 8 1 0 8
Oncologist 2 6 1 1 5
Speech and language therapist 0 5 0 0 5
Emotional support therapist 0 4 0 0 4
Oral rehabilitation 0 3 0 0 3
Social worker 2 1 1 1 0
Dietician 0 2 0 0 2
Psychologist 0 2 0 0 2
Physiotherapist 1 0 1 0 0
Clinical nurse specialist 0 1 0 0 1
Surgeon 1 0 1 0 0
Total of all the health professionals 14 50 8 6 44
a Wellbeing (7), wellbeing and dizziness (1), new cancer (1), deformed jaw (1), altered sensation (1), skin rash (1).
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mb Psychiatrist (1), dermatologist (1), financial advisor (2), alcohol nurse 
f concern include “Dizziness” and “Skin rash”. “Dizzi-
ess” includes terms such as “light-headedness”, “giddy”,
woozy”, and “vertigo”. “Skin rash” includes descriptions
f skin symptoms such as “rash”, “eczema”, and “dry, flaky
kin”. These, along with the theme “Further surveillance” in
elation to clinical outcome, have been incorporated into the
xisting theoretical framework for use in further studies.
Another new theme identified was “Wellbeing”, which
as most commonly discussed during the consultations. We
ecognise that the linguistic implications of the term are com-
lex, and we considered it as a fluid social construct that
s subject to primary cultural judgement.16 As an opera-
ional definition to form the basis for coding, we considered
r
i
wT consultant (1), medical specialty doctor (1), respiratory consultant (1).
wellbeing” to be the subjective notion of how well a person’s
ife is going, and it includes descriptions such as “doing well”,
feeling great in myself”, and “super”. The frequency with
hich the theme was discussed may be a reflection that some
atients feel they have coped well and do not have any con-
erns, but in others, it could simply be an automatic response
o enquiries about their condition because further exploratory
CI-led discussions have identified various concerns.
Thematic mapping of individual transcripts showed that
ore items were discussed than were highlighted, and it mayelate to the way the PCI is used in a consultation. One of these
s by the association of themes – for example, the clinician
as able to discuss fear of recurrence when “anxiety” had
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Table 4
Results of questionnaires filled in after consultation by 15 patients, comprising the Princess Margaret Hospital patient satisfaction with doctor questionnaire
(PSQ-MD)14 and non-validated questionnaires specific to the study.
Strongly
agree
Agree Disagree Strongly
disagree
Does not
apply
Positive
responsea
Princess Margaret Hospital patient satisfaction with doctor questionnaire (PSQ-MD)
I will follow the doctor’s advice because I think s/he is
absolutely right
11 3 – – 1 14/14
The doctor did not take my problems very seriously – – 4 10 1 14/14
The doctor considered my individual needs when treating my
condition
10 3 – 1 1 13/14
The doctor did not give me all the information I thought I
should have been given
– – 4 10 1 14/14
The doctor went straight to my medical problem without
greeting me first
– – 3 12 – 15/15
The doctor used words I did not understand 1 – 5 9 – 14/15
There was not enough time to tell the doctor everything I wanted 1 – 5 8 1 13/14
I feel the doctor did not spend enough time with me – – 3 12 – 15/15
It seemed to me that the doctor was not really interested in my
emotional wellbeing
– – 3 12 – 15/15
I really felt understood by my doctor 11 4 – – – 15/15
After my last visit with my doctor, I feel much better about my
concerns
5 8 1 – 1 13/14
The doctor was not friendly to me – – 2 13 – 15/15
I understand my illness much better after seeing this doctor 5 6 1 – 3 11/12
This doctor was interested in me as a person and not just my
illness
10 4 – 1 – 14/15
I feel I understand pretty well the doctor’s plan for helping me 8 4 – 2 1 12/14
I would not recommend this doctor to a friend 1 – – 14 – 14/15
The doctor seemed to brush off my questions – – 1 14 – 15/15
The doctor should have told me more about how to care for my
condition
2 – 2 10 1 12/14
After talking with the doctor, I have a good idea of what changes
to expect in my health over the next few weeks and months
6 6 – – 3 12/12
The doctor told me to call back if I had any questions or
problems
9 4 1 – 1 13/14
I felt the doctor was being honest with me 11 4 – – – 15/15
The doctor explained the reason why the treatment was
recommended for me
7 5 – – 3 12/12
It seemed to me that the doctor was not really interested in my
physical wellbeing
– – 1 14 – 15/15
The doctor should have shown more interest – – 2 13 – 15/15
Non-validated questions specific to this study
How would you rate the extent to which these concerns were
addressed?
8 7 – – – 15/15
To what degree would you agree to the statement: my
expectations of the consultation were fulfilled in the most
recent outpatient visit?
10 4 – 1 – 14/15
To what degree would you agree to this statement: I felt the PCI
was intrusive?
2 – 8 5 – 13/15
To what degree would you agree to the statement: I felt the PCI – 1 8 6 – 14/15
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a Strongly agree/agree, or strongly disagree/disagree, as appropriate and
een selected on the PCI because of the known association
etween them,6,7 which gave the patient an opportunity to
isclose concerns if he or she so wished (Supplementary
igure). Other known thematic associations are between
wallowing and use of a percutaneous endoscopic gastros-
omy tube; saliva, chewing, and swallowing; and fear of
ecurrence and depression. Another way is based on the
ermission-giving impact of the PCI – for example, a patient
id not indicate fear of recurrence on the PCI during the
t
t
sble.
urrent visit but had done so in the past, which allowed it to
e brought up again for discussion during the current visit.
Some items that were rarely indicated on the PCI were
ften touched upon during consultations – for example, rela-
ionships, but others indicated on the PCI were not discussed.
his was because there was not enough time in the consulta-ion to discuss all the items chosen. The PCI could be used
o indicate patients who need more time, and clinical nurse
pecialists could provide this after the consultation with the
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octor. We also found that more professionals were discussed
uring the consultation than were indicated on the PCI. In
ome instances this reflects some patients’ lack of under-
tanding about the role of each professional, and about the
ervices that are available. Another reason why more pro-
essionals were discussed during consultations is because of
he multidisciplinary team approach and also the importance
f the general practitioner (GP) in the community, and was
vident by the frequency with which the GP and oncologist
ere mentioned. However, it has not resulted in an increase
n the number of referrals (2/19 patients) compared with a
revious study (21/100 patients).5
Results obtained from a small subgroup of patients sug-
est that most were satisfied with their consultations. While
urveys on the satisfaction of patients are thought to favour
he clinician, scales that are specific to a visit are thought
o measure different aspects than those that cover the dura-
ion of the relationship between the patient and physician.17
owever, the PSQ-MD questionnaire has never been used in
ead and neck oncology and precludes any potential compar-
sons with other groups. Our early data provide a measure of
ts feasibility and an understanding of how it could translate
nto a true measure of satisfaction.
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bstract
urrently, the head and neck cancer Patients’ Concerns Inventory (HNC-PCI), a holistic, self-reported tool to help patients disclose needs
nd concerns during consultations, is not organised into domains. We used a Delphi approach to generate domains and applied them to an
xisting HNC-PCI database to assess association with health-related quality of life (HRQoL). The expert panel comprised 10 experts in head
nd neck cancer who were selected ad hoc. The HNC-PCI checklist was analysed and fed back to the panel for 3 rounds until consensus was
chieved. Five domains were generated (A = Physical and functional; B = Psychological and emotional or spiritual well-being; C = Social care
nd well-being; D = Treatment-related; and E = Other) and were applied to a database compiled from 674 patients who had completed the PCI
n 1276 occasions. On first completing the inventory (median 32 months after treatment) 81% selected items under domain A and 58% under
omain B. Fewer items were selected/domain thereafter. Younger patients were more likely to select from domains B and C. Those treated by
adiotherapy and adjuvant radiotherapy were more likely to select from domains A and C, respectively. Patients with laryngeal cancer tended
o select from domain C, and those with poor HRQoL outcomes were significantly more likely to indicate more items of concern. The items
elected under the HNC-PCI domains showed that certain clinical, pathological, and HRQoL factors were associated with specific patterns
f needs or concerns.
 2015 Published by Elsevier Ltd. on behalf of The British Association of Oral and Maxillofacial Surgeons.
eywords: Patients Concerns Inventory; Head neck cancer; Holistic assessments; Unmet needs; Health-related quality of life
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antroduction
olistic assessment in cancer1 involves an evaluation of a
atient’s perceived needs in various areas of health so that
ealthcare providers can understand and address them, and
rovide care that is tailored and supportive. The Patients’
oncerns Inventory (PCI), a holistic, patient-reported tool
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266-4356/© 2015 Published by Elsevier Ltd. on behalf of The British Associationhat helps to disclose items of concern,2 has already been
uccessfully rolled out across a head and neck cancer (HNC)
etwork.3 HNC-PCI data are included in the national dataset
udit for head and neck cancer (DAHNO) and efforts are con-
inuing to incorporate them into the electronic holistic needs
ssessment of the National Cancer Survivorship Initiative.
The HNC-PCI checklist covers a spectrum of issues that
ffect patients2,4–8 and comprises 57 items9 that are not
rganised into domains. Grouping them into domains has
ractical advantages as it can ease completion by patients,
uide discussion during holistic assessment,1 and help to
dentify the services required.1,2
 of Oral and Maxillofacial Surgeons.
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Table 1
Categories suggested by participants and researcher.
Thematic
category and
items
Frequency
(n = 10)
Suggested categories after
collation by researcher
A
Fitness 2 Physical and functional
well-beingRehabilitation 2
Physical 7
B
Social care/support 4 Social care and well-being
Practical 1
Lifestyle 1
Support 6
Social life 3
C
Spiritual 5 Psychological and emotional
well-being/spiritualityEmotional 8
Feelings 6
D
Treatment 4 Treatment-related
Treatment-related 4
Side-effects 8
E
Body image 1 Others
Personal 2
Symptoms 1
Illness 1
Others 7
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Previously, reports of patients’ expressed needs and con-
erns through a HNC-PCI were summarised as an extensive
ar chart or a list of the topmost ranked items.3,5–9 Fear
f recurrence, dental health and teeth, and chewing, eat-
ng, and swallowing, were most commonly highlighted.3,5–9
onversely, religious aspects, regret about treatment, and
ependents and children, were rarely chosen.2,9 Grouping
y domain can enable findings to be summarised more sys-
ematically and allows comparative evaluation.
We aimed to generate domains for the HNC-PCI using
 systematic methodology and to apply them to a growing
NC-PCI database for the purpose of describing emerging
rends.
ethod
election  of  domains
he Delphi technique, an established tool used to reach
onsensus in a group of experts, involves a series of sequen-
ial questionnaires or “rounds” interspersed by controlled
eedback in which individual judgements are tapped and
ombined to address a lack of agreement or incomplete
nowledge.10 We used it to generate the HNC-PCI domains
s it is a recognised method of solving problems in healthcare
ettings,10,11 and can help to structure and organise commu-
ication in a group.
We selected on an ad hoc basis a panel of 10 healthcare
xperts with a wide range of expertise in head and neck can-
er. This fulfilled the requirement of the Delphi method that
he panel is representative and is measured by the qualities of
hose involved rather than by their number, as there is little
mpirical evidence that the number has an impact on the reli-
bility or validity of the stages used to reach consensus.10
iverse viewpoints that span respectable controversy can
elp to generate interest and involvement, particularly when
xperts reflect current knowledge and perceptions.10
We used a 3-step approach (Fig. 1). To establish consensus
n each item, 70% of panelists had to agree in rounds 2 and
. When they did not, the checklist with the related items was
istributed again until the expected level was achieved.
pplication  of  HNC-PCI  domains
thics approval was not required as the study met the local
linical governance department criteria for service evalua-
ion. HNC-PCI data were collected from 2 main groups:
17 patients with head and neck cancer who attended 829
linics between 1 August 2007 and 31 December 2011, and
47 patients treated for primary squamous cell carcinoma
SCC) of the head and neck between 1998 and 2009 (sur-
eyed in March 2011).12 A total of 90 patients were included
n both groups, and once this was accounted for, 674 patients
ompleted the inventory on 1276 occasions.
S
o
n
aAlthough it can be used as a stand-alone questionnaire,
e use the HNC-PCI with the University of Washington
uality of Life questionnaire, version 4 (UWQoL),13 which
s a validated HNC-specific health-related QoL (HRQoL)
ool that contains 12 domains scaled from 0 (worst) to 100
best) according to the hierarchy of response. There are 2
ubscale composite scores14: Physical function and Social-
motional function, and a single 6-point overall measure
f QoL. Physical function is the simple mean score of the
wallowing, chewing, speech, saliva, taste, and appearance
omains. Social-emotional function is the simple mean of
he activity, recreation, pain, mood, anxiety, and shoulder
omains. For the single-item overall QoL scale, patients are
sked to consider not only their physical and mental health,
ut also other factors such as family, friends, spirituality, or
ersonal leisure activities that help them to enjoy life.
The HNC-PCI and UWQoL were self-administered using
 touch-screen computer2 and paper versions,15 which were
sed in the surveys and in some outpatient clinics when the
ouch-screen computer was not available.
We investigated associations between the domains
elected on the HNC-PCI and the characteristics of 674
atients who had completed the inventory for the first time.
tatistical significance was assessed using Fisher’s exact test
r the chi square test as appropriate. Because of the large
umber of tests, probabilities of less than 0.01 were regarded
s significant.
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esults
election  of  domains
he panel consisted of 2 doctors, 2 clinical nurse special-
sts, one speech and language therapist, 3 outpatient clinic
urses, one research nurse, and one PCI hospital volunteer.
able 1 shows the headings they suggested in Round 1. They
ere analysed and distilled into 5 groups based on thematic
onsiderations: (A) Physical and functional well-being; (B)
ocial care and well-being; (C) Psychological and emotional
ell-being, and spirituality; (D) Treatment-related; and (E)
thers, and were subsequently used as the domain headings
n the inventory.
In Round 2 there was agreement of 70% and over onost items (89%, 51/57) (not shown). The 6 that remained
appearance; dependents and children; PEG tube; speech,
oice, and being understood; and sexuality and relationships)
1
a
(
i to generate domains.
ere eventually resolved at the second stage of Round 2.
t the first stage of Round 3, 100% agreement was achieved
n almost all the items (93%, 53/57); in the second stage
0% or more was achieved in those that remained. The final
onsensus is shown in Table 2.
pplication  of  domains
he 674 patients analysed had a mean (SD) age of 64 (11)
ears; 67% (449/674) were male. Primary diagnosis was
ade between 1 August 2007 and 31 December 2011,
edian (IQR) May 2007 (October 2004 to December
008). In 616 (91%) it was SCC. Tumour site was the
ral cavity in 340 (50%), pharynx in 170 (25%), larynx in
15 (17%), other sites in the head and neck in 40 (6%),
nd was unknown in 9 (1%). Tumour stage was advanced
T3-4) in 164/647 (25%) and in 180/652 (28%) nodes were
nvaded. Primary treatment was operation alone (n  = 335,
374 N. Ghazali et al. / British Journal of Oral and M
Table 2
Suggested groupings and consensus.
Item on patient concerns inventory
A: Physical and functional well-being
1 Activity
5 Appetite
6 Bowel habit
7 Breathing
10 Chewing/eating
12 Coughing
13 Dental health/teeth
16 Dry mouth
17 Energy levels
18 Fatigue/tiredness
22 Hearing
24 Indigestion
28 Mobility
30 Mouth opening
31 Mucus
32 Nausea
33 Pain in head and neck
34 Pain elsewhere
39 Regurgitation
40 Salivation
43 Shoulder
44 Sleeping
45 Smell
46 Sore mouth
50 Swallowing
51 Swelling
52 Taste
54 Vomiting/sickness
55 Weight
B: Social care and well-being
9 Carer
14 Dependents/children
21 Financial/benefits
23 Home care/district nurse
26 Lifestyle issues
36 Recreation
38 Relationships
47 Speech/voice/being understood
49 Support for my family
C: Psychological/emotional/spiritual well-being
4 Appearance
2 Angry
3 Anxiety
11 Coping
15 Depression
19 Fear of the cancer coming back
20 Fear of adverse events
25 Intimacy
27 Memory
29 Mood
41 Self-esteem
42 Sexuality
48 Spiritual/religious aspects
53 Temperament and personality
D: Treatment-related
8 Cancer treatment
37 Regret about treatment
35 PEG tube
56 Wound healing
E: Others
57 Anything else
5
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0%), operation with adjuvant radiotherapy (n = 225, 33%),
hemoradiotherapy alone (n  = 96, 14%), and in 18 (3%)
as unknown. Of those operated on, 237/560 (42%) had
ree-flaps (179 soft tissue, 58 composite). The median (IQR)
ime from primary operation (or from primary diagnosis if
o operation) to first completion of the inventory was 32
14–58) months (n  = 660). Most (n  = 472, 70%) completed
t only once at a median of 39 months (range 20–69). Just
nder one-third (n  = 202, 30%) completed it more than once.
Of those who completed it for the first time (n  = 674),
1% selected items in the physical and functional well-being
omain, 30% in the social care and well-being domain, 58%
n the psychological and emotional well-being and spiri-
uality domain, and 15% in the treatment-related domain
Table 3). “Other” items were rarely chosen (4%). Fewer
tems were selected on subsequent forms; on the first inven-
ory 11% selected none, and on later forms this had doubled
o 23%.
We investigated associations between the selection of
omains and the clinical characteristics of the patients who
ompleted the inventory for the first time (Table 4). Younger
atients (under 65 years) were more likely to select items from
he psychological and emotional well-being and spirituality
omain (66% compared with 48% for those 65 and over), and
tems in the social care and well-being domain (36% com-
ared with 24% for those 65 and over). More women than men
64% compared with 55%) chose items in the psychological
nd emotional well-being and spirituality domain. Patients
ho had operation alone as the primary treatment were less
ikely to select from the physical and functional well-being
omain (74%) than those who had operation and radiothe-
apy (89%) or chemoradiotherapy alone (86%). Those who
ad operation and radiotherapy were also more likely (39%)
o select from the social care and well-being domain than
ther patients. More patients with laryngeal tumours chose
tems in the social care and well-being domain. There were
o notable patterns of association between the domains and
ther clinicopathological variables.
We found clear associations between the domains selected
nd subscale scores on the UWQoL, and also with the single
tem UWQoL. Regarding overall QoL, patients with a serious
ondition were more likely to select items from each domain
n the inventory. Those with particular problems16 (see foot-
ote to Table 4) were generally more likely to select from
ach domain than those not identified as having a problem.
iscussion
he domains generated from this exercise fulfilled the
ational recommendations for holistic assessment tools1 as
hey included items that assessed physical, social and occu-
ational, and psychological and spiritual well-being.
Physical and functional well-being consisted of items cov-
ring activities of daily living, physical symptoms (including
ain), and functional impairment. Social care and well-being
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Table 3
Items chosen on head and neck cancer Patient Concerns Inventory (PNC-PCI) by domain. Data are number (%).
Domain and items chosen First PCI (674 patients) Subsequent PCI (602 PCI from 202 patients)
Domain A: Physical and functional well-being
0 128 (19) 181 (30)
1 122 (18) 104 (17)
2 92 (14) 88 (15)
3-4 139 (21) 105 (17)
5-9 153 (23) 106 (18)
10 or more 40 (6) 18 (3)
Domain B: Social care/social well-being
0 470 (70) 480 (80)
1 156 (23) 92 (15)
2 or more 48 (7) 30 (5)
Domain C: Psychological/emotional/spiritual well-being
0 286 (42) 343 (57)
1 197 (29) 133 (22)
2-3 132 (20) 81 (13)
4 or more 59 (9) 45 (7)
Domain D: Treatment-related
0 573 (85) 557 (93)
1 85 (13) 40 (7)
2 or more 16 (2) 5 (<1)
Number of domains selected
0 76 (11) 140 (23)
1 177 (26) 191 (32)
2 236 (35) 170 (28)
3 150 (22) 88 (15)
All 4 35 (5) 13 (2)
Main combinations of domains selected
None 76 (11) 140 (23)
A only 137 (20) 155 (26)
A & C only 172 (26) 125 (21)
A, B, & C only 115 (17) 68 (11)
Other combinations 174 (26) 114 (19)
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bnvolved areas in which practical support may be needed,
ccess to medical support and care, financial security (includ-
ng occupation), involvement of family and friends, lifestyle
hoices, and interactions in social settings (recreational or
ocial groups). The psychological and emotional well-being
nd spirituality domain assessed issues relating to psycholog-
cal adjustments, feelings toward diagnosis and treatment,
heir effects on personality and sexual relationships, and
eligious and spiritual fulfilment. We created 2 additional
omains to account for items that were treatment-related, and
 single item domain of “Others” to account for any that had
ot been considered, such as the need for information.
The domains may reflect the experts’ opinion on how the
oncerns of individual patients can be addressed using avail-
ble services. The panel found it difficult to achieve consensus
n disease and treatment-related changes as they are often
ultidimensional in nature – for example, “appearance” can
elate to physical and functional concerns and to psycho-
ogical distress, and could also have an impact on social
ell-being or reflect a patient’s interest in further treatment.
Several studies have been done on the need for support-
ve care12 in patients with cancer of the head and neck17–23
ut direct comparisons with our findings were impossible
u
recause there were fundamental differences in the popula-
ions studied. In our study, most patients chose items from
he physical and functional well-being (81%), psychologi-
al, emotional and spiritual well-being (53%), and social care
nd well-being (30%) domains. Longitudinally, there was an
verall reduction in the number of items selected across all
omains.
The method of treatment is associated with concerns from
he physical and functional domain. Recognised complica-
ions of radiotherapy may account for the reason why patients
ho had operation only were less likely to highlight con-
erns in this area. The fact that younger patients (under 65
ears) are more likely to voice concerns in the psychologi-
al, emotional, and spiritual well-being, and social care and
ell-being domains, may have important implications for
he planning of supportive care when the rising incidence
f oropharngeal cancer in younger populations is taken into
onsideration.24 The direct impact of laryngeal disease and
reatment on verbal communication, and swallowing and
reathing may explain why more concerns were expressed
nder the social care and well-being domain.
The association between need, HRQoL, and quality of care
emains unclear.25 We found a clear association between poor
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Table 4
Domains selected on first use of head and neck cancer Patient Concerns Inventory (HNC-PCI) by patients’ characteristics (n = 674). Data are number (%).
Patients Domain A: Physical
and functional
well-being
p  value Domain B:
Social care
and well-being
p  value Domain C: Psychologi-
cal/emotional/spiritual
well-being
p  value Domain D:
Treatment-
related
p value
Total no. of patients 674 546 (81) 204 (30) 388 (58) 101 (15)
Sex
Male 449 370 (82) 0.21 139 (31) 0.60 245 (55) 0.03 71 (16) 0.43
Female 225 176 (78) 65 (29) 143 (64) 30 (13)
Age (years)
<55 129 106 (82) 0.40 45 (35) 0.007 78 (60) <0.001 23 (18) 0.06
55–64 242 203 (84) 87 (36) 166 (69) 45 (19)
65–74 209 163(78) 46(22) 103(49) 22(11)
75+ 94 74(79) 26(28) 41(44) 11(12)
Primary treatment
Operation & radiotherapy 225 201(89) <0.001 87(39) 0.005 130(58) 0.83 34(15) 0.52
Operation alone 335 249(74) 87 (26) 188(56) 47(14)
Chemotherapy and radiotherapy alone 96 83(86) 27(28) 57(59) 18(19)
Free-flap
None 312 245(79) 0.27 94(30) 0.65 183(593) 0.69 44(14) 0.60
Soft 179 151(84 57(32) 98(55) 30(17)
Composite 58 48(83) 21(36) 34(59) 7(12)
Months from operation (or diagnosis if no operation)
Within 12 149 121(81) 0.83 48(32) 0.57 88(59) 0.02 31(21) 0.13
12–23 124 103(83) 42(34) 85(69) 19(15)
24–59 230 182(79) 68(30) 124(54) 29(13)
60+ 157 128(82) 42(27) 80(51) 20(13)
Diagnosis
SCC 616 502(81) 0.35 190(31) 0.53 351(57) 0.55 97(16) 0.22
Other 50 38(76) 13(26) 31(62) 4(8)
T stage
Tis, T1 256 200(78) 0.06 77(30) 0.35 147(57) 0.20 39(15) 0.97
T2 227 183(81) 62(27) 122(54) 34(15)
T3, T4 164 143(87) 56(34) 103(63) 26(16)
N stage
N0 472 375(79) 0.19 145(31) 0.67 269(57) 0.97 65(14) 0.04
N1 70 59(84) 21(30) 40(57) 8(11)
N2-3 110 95(86) 29(26) 64(58) 25(23)
Tumour site
Oral 340 268(79) 0.20 109(32) 0.002 187(55) 0.43 47(14) 0.73
Pharyngeal 170 147(86) 36(21) 101(59) 30(18)
Laryngeal 115 91(79) 48(42) 66(57) 17(15)
Other head and neck 40 33(83) 10(25) 27(68) 6(15)
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Table 4 (Continued)
Patients Domain A: Physical
and functional
well-being
p value Domain B:
Social care
and well-being
p  value Domain C: Psychologi-
cal/emotional/spiritual
well-being
p value Domain D:
Treatment-
related
p value
UWQoL physical function subscale score
<50 78 74(95) <0.001 35(45) <0.001 52(67) 0.006 25(32) <0.001
50–74 230 205(89) 81(35) 143(62) 31(13)
75–89 141 121(86) 38(27) 84(60) 18(13)
90–100 204 132(65) 43(21) 98(48) 23(11)
UWQoL social-emotional subscale score
<50 68 66(97) <0.001 34(50) <0.001 55(81) <0.001 20(29) 0.001
50–74 205 190(93) 79(39) 137(67) 35(17)
75–89 199 165(83) 52(26) 114(57) 25(13)
90–100 182 112(62) 32(18) 71(39) 17(9)
UWQoL overall score
Outstanding/very good 243 173(71) <0.001 52(21) <0.001 107(44) <0.001 28(12) 0.001
Good 224 186(83 65(29) 133(59) 33(15)
Fair 131 124(95) 52(40) 95(73) 19(15)
Poor/very poor 47 45(96) 24(51) 36(77) 16(34)
UWQoL’ problem as identified from UWQoL algorithm*
Pain 115 111(97) <0.001 45(39) 0.03 86(75) <0.001 27(23) 0.006
Appearance 65 60(92) 0.02 31(48) 0.002 55(85) <0.001 18(28) 0.005
Activity 87 81(93) 0.003 41(47) <0.001 56(64) 0.20 25(29) <0.001
Recreation 49 46(94) 0.02 24(49) 0.005 37(76) 0.01 12(24) 0.06
Swallowing 88 81(92) 0.005 36(41) 0.02 51(58) 0.99 25(28) <0.001
Chewing 55 50(91) 0.07 22(40) 0.13 34(62) 0.57 22(40) <0.001
Speech 41 39(95) 0.02 26(63) <0.001 30(73) 0.05 13(32) 0.005
Shoulder 65 63(97) <0.001 26(40) 0.09 45(69) 0.05 18(28) 0.005
Taste 74 69(93) 0.004 25(34) 0.50 46(62) 0.45 19(26) 0.009
Saliva 138 129(93) <0.001 36(26) 0.34 89(64) 0.07 28(20) 0.06
Mood 87 84(97) <0.001 46(53) <0.001 76(87) <0.001 17(20) 0.20
Anxiety 88 82(93) 0.002 39(44) 0.003 71(81) <0.001 19(22) 0.07
∗ Significant problem trigger criteria10:- pain, appearance, activity, recreation, mood: (scores of 0 or 25 or 50 & important); swallowing, speech, anxiety: (scores of 0 or 30); shoulder, taste, saliva: (scores or
0 or 30 & important); chewing: (score of 0)
Results for those not triggered by the algorithm are not shown in the table.
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20. Chen SC, Lai YH, Liao CT, et al. Unmet information needs and preferen-78 N. Ghazali et al. / British Journal of Ora
utcomes for HRQoL and perceived needs of long-term sur-
ivors of head and neck cancer whose disease is in remission.
hen we related HRQoL outcomes to HNC-PCI data, we
ound that those who reported poor overall QoL (including
hose with poor outcomes for physical and socioemotional
unction, and those who were shown to have serious prob-
ems on the UWQoL) were more likely to select items for
iscussion. The clustering pattern of certain needs and their
ssociation with HRQoL can help healthcare professionals to
dentify patients at risk who would benefit in the long term
rom tailored and supportive care.
There are limitations in this study. We did not measure
greement between patients and professionals on the ter-
inology used for the items. This is a subject for future
ork on the provision of additional information to help
atients understand what each item refers to, and may over-
ome any potential individual variation in interpretation or
eaning. Without a standard definition for guidance patients
ay find some items ambiguous. However, any vagueness
ould be cleared up during the consultation as the inventory
tself can facilitate communication between the patient and
octor.
Although all our patients had cancer of the head and
eck, the design was cross-sectional and restricted to patients
ho had been treated. A baseline level of perceived need
t diagnosis or immediately after treatment was unavailable
or comparison, and although we had a glimpse of a possi-
le change in needs over time, most (70%) completed the
nventory only once. Future prospective studies may con-
ider other reported factors that can influence need, including
omorbidity, psychological state, level of education, and
ocioeconomic status.
onclusion
he categorisation of items into domains helps to show trends
f perceived need and will potentially aid in the planning of
upportive care. Emergent trends suggest that certain clin-
copathological factors are associated with specific needs
r concerns, and further work may help to clarify some of
hem. There were close associations between domains on the
nventory and outcomes for HRQoL.
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the HNC population. The DT cut-off score ≥4 was effec-
tive in identifying those with significant distress. Signifi-
cant distress is associated in survivors with poor health-
related quality of life, those who received radiotherapy and 
patients who have longer consultation times in clinic.
Keywords Distress · Head and neck cancer · University 
of Washington Quality of Life · Distress thermometer · 
Screening
Background
Cancer-related distress is ‘a multifactorial, unpleasant 
experience of a psychological, social or spiritual nature that 
interferes with the ability to cope with cancer treatment, 
its physical symptoms and its treatment. Distress extends 
along a continuum from common normal feelings of vul-
nerability, sadness and fear, to disabling problems, such as 
true depression, anxiety, panic and feeling isolated or in 
a spiritual crisis’ [1]. Cancer-related distress is common 
[2]. It is reported that 35–70% of cancer patients experi-
ence distress at some time during their cancer journey [2]. 
Between 20 and 44% head and neck cancer (HNC) survi-
vors will experience clinically significant depressive or 
anxiety symptoms at least once during the course of their 
illness [3, 4].
Longitudinal studies report cancer survivors may 
experience the trajectory of distress differently, and dif-
ferent factors, including demographic, clinical and social 
parameters, can influence the severity and consequen-
tial effects of distress [5]. Head and neck cancer (HNC) 
patients are prone to psychological problems because 
social interactions and emotional expression depends 
largely upon the structural and functional integrity of 
Abstract The primary aim was to determine the efficacy 
of the Distress Thermometer (DT) in screening for anxiety 
and mood problems against the University of Washington 
Quality of Life, version 4 (UWQOL). Secondary aims were 
to evaluate the association between demographic, clinical 
and health-related QOL variables with significant distress. 
Two hundred and sixty one disease-free HNC ambulatory 
patients attending routine follow-up clinics were prospec-
tively recruited. Both DT and UWQOL were completed 
pre-consultation. Receiver operating characteristic (ROC) 
curve analyses of DT score for anxiety dysfunction yielded 
an area under the curve (AUC) of 0.877, with a sensitivity 
of 84% (43/51) and specificity of 76% (159/210) for a DT 
cut-off of ≥4; with a corresponding AUC of 0.825 for mood 
with sensitivity 78% (28/36) and specificity 71% (159/225). 
Treatment with radiotherapy and a longer consultation time 
were associated with significant distress (DT ≥4). Signifi-
cant distress was also reported in two third of those report-
ing less than “Good” overall QOL. Distress levels were 
particularly associated with poor Social–Emotional func-
tion, more so than the association seen with poor physical 
function. DT is a reasonable screening tool for distress in 
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the HN region [6]. Those with preexisting psychologi-
cal morbidity, serious comorbidity, or social isolation, 
are particularly at risk of psychological distress [6]. 
This population demonstrates a high incidence of anxi-
ety immediately post-diagnosis while depression peaks 
approximately 3 months post-completion of treatment, 
and levels for both constructs tend to return to pre-treat-
ment levels by 12 months post-treatment completion [7, 
8]. In addition, fear of cancer recurrence (FoR) is the 
most common concern of disease-free HNC survivors [9, 
10] and can cause severe psychological morbidity [11]. 
Longitudinal follow-up suggests that screening for mood 
and anxiety may help identify those with persistent sig-
nificant FoR due to its close association [12].
Distress impacts negatively on cancer care and out-
comes, namely, quality of life (QOL) [13, 14], treatment 
adherence [15], satisfaction with care [16], and survival 
[17]. Distress levels in HNC patients have also been 
shown to relate negatively with QOL [18] and predicts 
survival in HNC patients [19]. Screening for distress is 
the first vital step in identifying patients who may be vul-
nerable to the damaging impact of chronic and/or signifi-
cant distress [2, 5]. This sign-posting exercise may also 
aid professionals in developing with HNC survivors an 
individualized supportive care plan, incorporating vari-
ous services including physical rehabilitation [20] social 
support [6] and psychosocial interventions [21], because 
cancer-related distress is explicitly tied to a number of 
common practical, physical, and psychological problems/
concerns [5].
The Distress thermometer (DT) was introduced in 
1998 as a rapid screening instrument for cancer-related 
distress [22] and has been validated for various cancer 
types worldwide [23] including the United Kingdom 
[24]. However, the DT has never been used to determine 
distress in a HNC cohort. Screening for psychologi-
cal distress in HNC has been carried out using various 
tools, include the General Health Questionnaire [18, 19] 
and in particular, the Hospital Anxiety Depression Scale 
(HADS) [7, 8, 25–28]. Mood and Anxiety constructs 
were incorporated into the University of Washington 
Quality of Life (UWQOL), a widely used HNC-specific, 
validated health-related QOL measure [29]. The UWQOL 
is highly correlated with HADS [27] and thus, UWQOL 
has been used in routine clinical practice as a tool to help 
screen for a significant problem in these two areas [30].
The primary objective of this study was to screen for 
distress in post-treatment HNC patients using the DT and 
to determine an effective DT cut off score for this cohort. 
The secondary aims were to examine the relationship 
between significant distress with clinicopathological fac-
tors and quality of life.
Materials and methods
This work is part of a wider prospective roll out study on 
the Patients Concerns Inventory [31] and obtained research 
ethics approval from the North West Research ethics com-
mittee (study reference: 11/H1002/7).
Subjects and recruitment
Potential patients were derived from the outpatient clinic 
patient list of four participating HNC surgery consultants. 
These were two oral and maxillofacial/HNC surgeons (RJ, 
JB) and two otolaryngology/HNC surgeons (ST, TJ). The 
inclusion criteria for patient recruitment were disease-free 
HNC survivors who had completed primary treatment 
of at least 6 weeks. The exclusion criteria included HNC 
patients who had active/recurrent disease, those at the pre-
treatment or palliative stage of survivorship, and those una-
ble to speak or read English.
All eligible patients were sent the study patient infor-
mation sheet together with their clinic appointment let-
ter 6 weeks before their appointment date. On the day of 
appointment, eligible patients were approached in the 
waiting area for recruitment. Informed consent was sought 
and formalised. Recruitment opened on 15 June 2011 and 
patients were prospectively recruited consecutively accord-
ing to the date and time of their clinic attendance. Recruit-
ment closed on 9 January 2013.
Study design
Recruited patients completed the DT and UWQOL before 
their consultation. The consultation was audio-recorded 
as part of the wider Patient Concerns Inventory study. The 
digital audio-recording encompassed the entire consulta-
tion [31].
Measures
University of Washington Quality of Life, version 4 
(UWQOL)
The UWQOL comprises 12 domains, scaled from 0 (worst) 
to 100 (best) according to the hierarchy of response [29]. 
The UWQOL has two subscale composite scores, i.e. 
‘Physical function’ and ‘Social–Emotional function’ and 
a single six-point ‘overall’ QOL measure. ‘Physical func-
tion’ is the simple average of the swallowing, chewing, 
speech, saliva, taste and appearance domain scores whilst 
‘Social–Emotional function’ is the simple average of the 
activity, recreation, pain, mood, anxiety and shoulder 
domains. In regard to the single item overall QOL scale, 
respondents were asked to consider not only physical 
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and mental health, but also other factors, such as family, 
friends, spirituality or personal leisure activities important 
to their enjoyment of life.
To allow incorporation of UWQOL into routine clini-
cal practice, i.e screening for dysfunction, a ‘significant 
problem’ was considered present in a particular UWQOL 
domain when it fulfilled one of the following criteria: (1) 
scores beyond a cut-off point specified in a domain, (2) 
(for some domains only) a score adjacent to the cut-off 
and respondents indicating the particular domain as being 
important during the previous week [30]. For example, 
a significant problem with Mood is triggered when the 
UWQOL Mood score was 0 or 25; or selection of Mood 
as being important in the past 7 days with a Mood score of 
50. Furthermore, a significant problem with Anxiety is trig-
gered when UWQOL Anxiety score was 0 or 30.
Distress thermometer (DT)
The DT is a single item self-report measure of distress. 
This instrument has been used to screen for distress in vari-
ous types of cancer diagnoses [22–24, 32, 33]. It is scaled 
from 0 (no distress) to 10 (severe distress) in a thermometer 
layout to rate the level of distress experienced. A DT score 
of ≥ 5 was originally recommended as denoting significant 
distress necessitating psychosocial referral [34]. However, 
a DT score of ≥ 4 has been shown to correlate with optimal 
sensitivity and specificity to the HADS in various cross-
cultural studies [13, 14, 23, 32].
Data analysis
To examine the relationship between distress and other 
variables, the Fisher’s exact test, Pearson’s chi-squared test 
or Kruskal–Wallis analysis were applied as appropriate. 
Statistical significance was regarded as p < 0.01. Receiver 
operating characteristic (ROC) curve analyses were per-
formed to identify a DT cut-off score that effectively detects 
cases of significant distress defined by the UWQOL screen-
ing for dysfunction in anxiety and mood from the UWQOL 
[30]. All statistical analysis was performed using the SPSS 
version 19.0 (SPSS Inc.).
Results
There were 261 patients recruited at 325 clinics and data 
were analysed for the first clinic. Clinicopathological char-
acteristics of the patients recruited to this study are shown 
in Table 1. Overall, the median (IQR) time from primary 
surgery (or from primary diagnosis if no surgery) to clinic 
attendance was 2.2 (0.9–3.8) years, n = 256. The median 
Table 1  Clinicopathological characteristics of 261 patients at first 
study clinic
All 
patients 
(n = 261)
Sex
 Male 68% 
(175)
 Female 32% (83)
 Not known 1% (3)
Age
 Mean (SD) 63.0 
(12.4)
 Median (IQR) 63 
(57–71)
 <55 20% (53)
 55–64 34% (89)
 65–74 30% (77)
 75+ 14% (37)
 Not known 2% (5)
Specialty
 MFU 52% 
(136)
 ENT 48% 
(124)
 Not known 0.4% (1)
Tumour site
 Oral 34% (90)
 Oro-pharyngeal 21% (55)
 Laryngeal 20% (52)
 Other 25% (64)
Histology
 SCC 83% 
(217)
 Not SCC 16% (43)
 Not known 0.4% (1)
Overall pTNM stage
 1 28% (73)
 2 25% (66)
 3 11% (29)
 4 20% (52)
 Not known 16% (41)
Primary treatment
 Surgery only 44% 
(114)
 Surgery + RT/CRT 38% 
(100)
 RT/CRT only 15% (39)
 Not known 3% (8)
Free-flap (214 surgery)
 Surgery without FF 70% 
(149)
 Surgery with FF 29% (63)
 Not known 1% (2)
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(IQR) length of consultation was 4.9 (3.2–7.4) minutes, 
n = 213.
Distress levels and identification of the DT cutoff
The mean DT score overall was 2.9 and the median (IQR) 
was 2 (0–5) (Table 2). The overall rate of significant dis-
tress (defined by a DT cut-off score of ≥4) was 36% 
(94/261). Thus, by this definition about two third of this 
cohort at clinic did not report significant distress.
ROCS analysis was performed to identify suitable DT 
cut-off points for emotional distress as defined as a ‘sig-
nificant problem’ in the UWQOL mood (14%, 36/261) 
and anxiety (20%, 51/261) domains. Areas under the ROC 
curve (AUC) estimate the discriminative accuracy of cut-
off scores in relation to a binary criterion, with a range from 
1 (perfect discriminative accuracy) to 0.5 (poor discrimina-
tive accuracy) [13]. The ROC analyses showing the AUC 
using the DT as a predictor of UWQOL dysfunction are 
summarised in Table 3 and higher areas under the curve are 
Table 2  Level of reported distress at first study clinic prior to con-
sultation
DT score All clinics (n = 261)
0 No distress 32% (84)
1 10% (27)
2 12% (31)
3 10% (25)
4 5% (14)
5 9% (23)
6 5% (14)
7 8% (20)
8 5% (12)
9 1% (2)
10 Extreme distress 3% (9)
Mean 2.9
Median (IQR) 2 (0–5)
Table 3  Area under the 
Receiver Operative Curve 
(AUC) for DT score predicting 
a significant problem 
(dysfunction) in UWQOL 
domains
The AUC can be used as a summary measure of how well the DT predicts a binary outcome, i.e. having a 
significant problem as derived from the UWQOL algorithm
Domains in the physical func-
tion subscale of the UWQOL
Area under curve Domains in the Social-Emo-
tional subscale of the UWQOL
Area under curve
Appearance 0.628 Pain 0.763
Swallowing 0.668 Activity 0.755
Chewing 0.618 Recreation 0.795
Speech 0.691 Shoulder 0.674
Taste 0.626 Mood 0.825
Saliva 0.662 Anxiety 0.877
Fig. 1  ROC comparing DT score with UWQOL anxiety and mood dysfunction
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apparent towards dysfunction in domains within the Social-
Emotional subscale of the UWQOL than for domains 
within the physical functioning subscale. The highest areas 
were for anxiety and mood dysfunction (Fig.  1), and for 
these Table  4 shows sensitivity and specificity values for 
binary cut-offs within the distribution of DT scores.
The ROC analyses offered support for cut-offs at ≥ 4 or 
≥ 5. DT score yielded an AUC of 0.877 for anxiety dys-
function with a cut-off of ≥ 4 giving a sensitivity of 84% 
(43/51), specificity of 76% (159/210), positive predictive 
value of 46% (43/94) and negative predictive value of 95% 
(159/167); with a corresponding AUC of 0.825 for mood 
with sensitivity 78% (28/36), specificity 71% (159/225) 
positive predictive value of 30% (28/94) and negative pre-
dictive value of 95% (159/167).
Defining significant distress by a DT score cut-off of 
≥5 gave a distress rate slightly lower at 31% (80/261). In 
predicting anxiety dysfunction it gave a sensitivity of 78% 
(40/51), specificity of 81% (170/210), positive predictive 
value of 50% (40/80) and negative predictive value of 94% 
(170/181); whilst in predicting mood dysfunction gave a 
sensitivity of 78% (28/36), specificity 77% (173/225), posi-
tive predictive value of 35% (28/80) and negative predictive 
value of 96% (173/181).
From a purely practical screening perspective of wanting 
to be inclusive and confident of capturing cases of dysfunc-
tion, the clinical choice would be to use ≥4 rather than ≥5, 
and further analysis continued using ≥4 to signify signifi-
cant distress.
Relationship between DT score and clinicopathological 
variables
The relationship between significant distress (DT score ≥ 4) 
and age at consultation, gender, surgical specialty, his-
tology, primary site, tumour stage, treatment, length of 
consultation and length of follow-up were evaluated. Only 
two variables showed a statistically significant associa-
tion with significant distress, namely, length of consulta-
tion (Mann–Whitney test, p < 0.001) and treatment (Chi 
square, p = 0.01). For consultations lasting under 4  min 
the distress rate was 26% (22/85), between 4 and 8  min 
it was 34% (27/79) and for more than 8  min it was 57% 
(28/49). For patients having had primary surgery alone the 
rate was 30% (34/114), for surgery with adjuvant RT it was 
37% (37/100), and for RT/CT without surgery it was 56% 
(22/39).
Other variables failed to demonstrate a statistically sig-
nificant association with significant distress at p < 0.01, 
but age (p = 0.04, Mann–Whitney) and overall P-stage 
(p = 0.04, Chi-squared) were borderline associations, with 
higher distress rates noted for those aged under 55  years 
(51%, 27/53) and for those with advanced P-stage 4 
tumours (48%, 33/77).
Distress and quality of life
The DT scores correlated moderately (rs  =  −0.44) to 
UWQOL Physical subscale scores but more strongly 
(rs  =  −0.65) with the Social–Emotional subscale score. 
Those scoring under 50 on the Social–Emotional scale 
were notably distressed (85% 22/26), with the rate decreas-
ing as the score increased—61% (37/61) for 50–69 scores, 
38% (20/52) for 70–79 scores and 12% (15/122) for 80–100 
scores. For physical subscale scores under 50 the distress 
rate was 57% (13/23), with 47% (34/73) for scores 50–69, 
53% (21/40) for scores 70–79 and 21% (26/125) for scores 
80–100. Spearman correlation was rs = −0.52 with overall 
QOL and 95% (20/21) of those with ‘very poor’ or ‘poor’ 
QOL had significant DT distress, 60% (27/45) of those 
with ‘fair’ QOL, 34% (33/96) of those with ‘good’ QOL 
and 14% (14/99) of those with ‘very good’ or ‘outstanding’ 
QOL.
Using the UWQOL dysfunction algorithm, significant 
dysfunction in anxiety OR mood was reported in 24%, 
63/261. In addition, patients with significant problems in 
areas of pain, activity, recreation, mood and anxiety were 
more likely to report significant distress (Fisher’s exact test, 
p ≤ 0.001 in all). The reported importance of pain, mood 
and anxiety in the past week was also associated with sig-
nificant distress (p ≤ 0.001).
Discussion
This study evaluated the efficaciousness of DT in screening 
for significant distress in disease-free, post-treatment HNC 
survivors attending a routine outpatient clinic. According 
to NCCN guidelines [34], those with a score of ≥5 would 
Table 4  Sensitivity and specificity values for binary cut-offs within 
the distribution of DT scores in regard to UWQOL anxiety and mood 
dysfunction
Cut-off 
DT score
Anxiety Mood
%Sensitivity %Specificity %Sensitivity %Specificity
≥1 100 40 97 37
≥2 96 52 92 48
≥3 88 65 86 61
≥4 84 76 78 71
≥5 78 81 78 77
≥6 65 89 64 85
≥7 53 92 50 89
≥8 35 98 33 95
≥9 18 99 14 97
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require a referral for psychosocial care team, based on the 
recommendation that this cut off represents the threshold 
for those who will benefit from psychiatric referral [32]. 
Our study uses the UWQOL algorithm attempts to provide 
empirical evidence for this type of clinical judgment in 
relation to the HNC cohort.
Receiver operating characteristic analysis revealed that 
both DT cut-off scores ≥4 and ≥5 yielded AUC estimates 
indicating good overall accuracy relative to UWQOL dys-
function scores for Mood and Anxiety. However, the DT 
cut-off score ≥4 was found to be more effective in discrimi-
nating those with significant emotional distress compared 
with a ≥5 cut off score. In terms of predicting anxiety dys-
function, in choosing the ≥4 over ≥5 cut-off score, there is 
a trade off, i.e. there is better sensitivity with ≥4 (84 ver-
sus 78%) but worse specificity (76 versus 81%). In terms of 
predicting mood dysfunction, the ≥5 is only slightly more 
effective as the sensitivity rate is equal to the ≥4 cut off (i.e. 
78%) but shows better specificity (77 versus 71%). Table 4 
suggests that having a cut-off other than ≥4 or ≥5 reduces 
sensitivity or specificity quite considerably, and hence, the 
most optimal cut-off probably lies between 4 and 5. From 
a purely practical screening perspective of wanting to be 
inclusive and confident of capturing cases of dysfunction, 
the clinical choice would be to use ≥4 rather than ≥5. This 
may be the reason why both cut-offs have been suggested in 
the literature. While HADS was not used in this study, our 
results echo the findings of other studies that have evalu-
ated a DT cut-off score ≥4 relative to HADS in cohorts at 
a similar plane on the cancer trajectory, i.e. post-treatment 
cancer patients attending outpatient clinics [23, 32]. Our 
finding may be related to the strong correlation between 
UWQOL with HADS [27–30].
Significant distress as determined by DT (cut-off 
score ≥4) was 36% in this cohort. When using the UWQOL 
algorithm, the significant mood and/or anxiety dysfunction 
rate was 24% (63/261), which is similar to that seen in our 
previous work in a different group of post-treatment dis-
ease-free HNC, where the reported rate was 26% (116/454) 
[4]. When UWQOL was combined with the Patients Con-
cerns Inventory, a patient-reported tool that aids patients 
in highlighting their concerns, the proportion of patients 
with significant mood and anxiety problems/concerns was 
higher, i.e. 44% (89/204). In addition, those with signifi-
cant mood and anxiety problems identified by UWQOL 
alone and the UWQOL-PCI combination showed a higher 
onward referral rate for psychological support [4]. The pick 
up rate using the UWQOL-PCI combination is nearer to 
the rate reported with DT with cut-off score ≥4. Based on 
this observation, we extrapolate that the DT cut-off score 
≥4 may be able to identify most of HNC patients with sig-
nificant distress.
In this study, only two clinical-pathological variables, 
namely, treatment received and length of consultation, were 
associated with significant distress. In this cohort, RT as 
a single modality or within a multimodality approach is 
associated with significant distress. It is known that HNC 
patients experience increasing symptoms of depression 
during RT [27]. Depressive symptoms persist post-radia-
tion [3, 8] and while there is slight improvement with time, 
depression levels remain worse than at pre-treatment [35]. 
This is also reported by those irradiated post-surgery [3, 
36]. In contrast, anxiety is less pronounced in HNC patients 
during RT, which improves after completion of RT [8]. RT-
related distress is purportedly related to symptoms burden 
from side-effects of RT [8] particularly pain and fatigue in 
the acute stage, and xerostomia, trismus and osteoradione-
crosis in the long-term. This could account for the higher 
referral rates for psychological support in irradiated HNC 
patients compared with other cancer types receiving RT 
[37]. It is surprising that overall advanced tumour stage 
4 did not demonstrate more than borderline significance 
association with distress as tumours with larger dimensions 
tend to cause more dysfunction due to the extent and com-
bination of treatment rendered. Perhaps this may be attrib-
uted to the influence of coping, although this was not evalu-
ated in this study.
A longer consultation time was associated with sig-
nificant distress in this study. Consultation comprises 
proportional time dedicated to HN examination, inspec-
tion of surgical wounds/dressing and patient–doctor dis-
cussions on a range of topics that may be related or oth-
erwise to HNC. Any concerning issue(s) could result in 
an increase in the overall consultation time, e.g. through 
having extensive physical examinations and/or longer 
discussions. This may be relevant as the number and 
severity of cancer patients’ concerns are associated with 
the development of distress [38]. Distress during routine 
oncology consultations is frequently associated with FoR 
[11], which is the most common concern in HNC clinic 
visits [9, 10, 12]. Patients find physical examination and 
direct reference to issues surrounding cancer recurrence 
during clinic appointment discussions reassuring [39] 
and this may account for longer consultations. Our pre-
vious work did not reveal any relationship between the 
number and type of patient concerns/issues with signif-
icant mood and/or anxiety problems [4], but this is the 
subject of further data analysis in this current cohort (in 
press). In a study of adjuncts in facilitating oncology con-
sultations, e.g. prompt sheet for patients, higher levels of 
distress were related to longer consultation times and this 
was attributed to the contents of the prompt sheet, which 
include prompts to difficult questions, e.g. prognosis [40]. 
Associations between younger age, gender, performance 
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status, and tumour characteristics with significant distress 
in HNC patients evident elsewhere [7, 25, 26] were not 
noted in our study.
The association between health-related quality of life 
(HRQOL) with significant distress was evaluated. In 
our cohort, significant distress was experienced in two 
third reporting less than “Good” overall QOL, suggest-
ing an association between significant distress and poorer 
HRQOL, which is not unexpected, and in accordance to 
previous work [7, 8, 25]. Distress levels were particularly 
associated with poor Social–Emotional function, more 
so than the association seen with poor physical function. 
This may be related to the additional finding of patients 
with significant problems in the individual areas of pain, 
activity, recreation, mood and anxiety (i.e. components 
of the Social–Emotional function subscale) were more 
likely to report significant distress. Physical functioning 
showed moderate correlation to significant distress. There 
is an existing body of literature that supports the notion 
that both psychosocial and physical correlates contribute 
towards psychological distress and impacts upon HRQOL 
[20].
This study may be limited by not including a validated 
screening tool for anxiety and depression, such as the 
HADS. The addition of a psychological screening tool 
may speculatively enhance the overall accuracy, includ-
ing the sensitivity and specificity of the DT cut-off score 
identified for a HNC cohort. Another limitation relates to 
the sample lacking diversity, where patients outside the 
defined cancer trajectory were excluded, i.e. pre-treat-
ment, active treatment and palliative stages, and this may 
influence generalizability of the DT cut-off score iden-
tified. Furthermore, the DT cut off score of ≥4 was not 
cross-validated in a second sample, which may provide 
additional assurances particularly as a validated psy-
chological screening tool was not used. This study did 
not evaluate other recognised factors related to distress, 
including performance status, comorbidity and other 
sociodemographic data, e.g. education and employment. 
This current paper is unable to comment on the benefi-
cial outcomes of distress screening, which is a subject of 
another publication (in press).
Conclusions
DT is a reasonable screening tool for distress in the HNC 
population. The DT cut-off score ≥ 4 was effective in iden-
tifying those with significant distress. Significant distress 
is associated in survivors with poor HRQOL, those who 
received radiotherapy and patients who have longer consul-
tation times in clinic.
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Purpose: Cancer patients can experience signiﬁcant distress during their cancer trajectory, which im-
pacts upon clinical outcomes and quality of life. Screening for distress using holistic assessments can help
identify and address unmet concerns/needs. The purpose of this study was to evaluate the relationship
between concerns and distress, and the impact of distress on clinic outcomes in post-treatment head and
neck cancer patients.
Methods: 170 patients attending routine follow-up clinics were prospectively recruited. All patients
completed the Patient Concerns Inventory (PCI) and the Distress thermometer (DT) at preconsultation.
Results: The rate of signiﬁcant distress (i.e. DT cut-off score 4) was 36% (62/170). Signiﬁcantly distressed
patients selected more items overall than patients without distress (mean, median (QR) of 5.40, 5 (2e8)
vs 2.61, 2 (0e4), p < 0.001). Signiﬁcant distress was most strongly associated with Physical and Func-
tional well-being (p < 0.001) and Psychological and Emotional well-being domains (p ¼ 0.001). On
balance, very little difference was noted between cut-off points of either 4 or 5 PCI items of concern
selected. Both cut-off points demonstrated an acceptable level of sensitivity, speciﬁcity and predictive
values for signiﬁcant distress. Consultations were longer with increasing numbers of concerns.
Conclusions: Just over one-third of patients are signiﬁcantly distressed. They were more likely to express
a higher number of concerns. A cutoff score 4 or 5 PCI items selected can identify those at risk of
signiﬁcant distress. Concerns causing signiﬁcant distress were related to emotional/psychological issues
and physical function.
© 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights
reserved.1. Introduction
Distress is commonly experienced during the cancer trajectory
and signiﬁcantly impacts upon cancer care and its outcomes,
justifying calls for its screening (Carlson et al., 2012). Screening for
distress is regarded as the primary step in managing cancer-related
distress. This process involves identifying contributing causes,
ranging from common practical, physical, and psychological prob-
lems/concerns by way of holistic assessments (Carlson et al., 2012;, University Hospital Aintree,
5288.
. Ghazali).
axillo-Facial Surgery. Published byRichardson et al., 2007), and developing individualized supportive
care plan to meet these issues. It is suggested that the number and
severity of cancer patients' concerns is associated with develop-
ment of distress (Maguire, 2002; Chaturvedi et al., 1996).
There is an accumulating body of work surrounding patient's
concerns in the head and neck cancer (HNC) population based on
the Patients Concerns Inventory (PCI). The PCI is a holistic tool that
helps HNC patients disclose items of concern during routine clinical
consultations, and also assists patients in indicating professionals
with whom they wish to see or be referred to (Rogers et al., 2009)
The PCI has been successfully rolled out as a sign-posting tool for
supportive care across a regional HNC network in the United
Kingdom.Elsevier Ltd. All rights reserved.
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et al., 2010). Preliminary analysis of this dataset identiﬁed the most
common patient concerns were fear of recurrence (FoR, 37%),
dental health/teeth (27%), chewing (24%), pain in head/neck (20%),
fatigue/tiredness (19%), saliva (18%) and swallowing (18%) (Rogers
et al., 2009). When the PCI is used in conjunction with other
measures, it is possible to identify individuals with signiﬁcant
problems i.e. requiring attention/support in speciﬁc areas. For
example, those with signiﬁcant problems from FoR can be identi-
ﬁed when the PCI is used in conjunctionwith the FoR questionnaire
(Rogers et al., 2010; Ghazali et al., 2013). Also, patients with sig-
niﬁcant problems in areas of mood and anxiety (Kanatas et al.,
2012), pain (Rogers et al., 2012), appearance (Flexen et al., 2012),
and speech and swallowing (Ghazali et al., 2012a) can be identiﬁed
when the PCI is used in conjunction with the University of Wash-
ington Quality of Life version 4 (UWQOL).
Different factors have been related to the expression of speciﬁc
concerns. For example, predictors of those experiencing signiﬁcant
FoR concerns over time (35%) were related to patient-related
characteristics (i.e. female gender, those experiencing anxiety and
mood disorders) rather than clinicopathological characteristics
(Ghazali et al., 2013). On the other hand, clinicopathological factors
were important predictors for those citing pain concerns with
signiﬁcant problems (i.e. received radiotherapy (RT), age < 65
years) (Rogers et al., 2012) and in those citing appearance concerns
with signiﬁcant appearance issues (i.e. oropharyngeal tumours,
large primary tumours, and age <65 years) (Flexen et al., 2012).
However, the relationship between patient concerns and distress in
HNC has not been explored.
The Distress thermometer (DT) is a rapid, validated screening
instrument for cancer-related distress for patients with various
cancer types in America (National Comprehensive Cancer Network,
2005) and the United Kingdom (Gessler et al., 2008). However,
there was paucity in the literature regarding patient concerns
related to distress and the use of DT in distress screening in HNC
population. A DT score of 5 was originally recommended as
denoting signiﬁcant distress necessitating psychosocial referral
(National Comprehensive Cancer Network, 2005) but a DT score of
4 has been shown to correlate with optimal sensitivity and
speciﬁcity to the Hospital Anxiety Depression Scale (HADS) in
various cross cultural studies in identifying signiﬁcant distress
(Jacobsen et al., 2005; Ozalp et al., 2007; Shim et al., 2006; Grassi
et al., 2013). Recently, we found that a DT cut-off score of 4 was
effective in screening for signiﬁcant anxiety and mood problems
against the UWQOL in disease-free, post-treatment HNC survivors
attending out-patient clinics (Ghazali et al., 2017), where just over
one-third of HNC patients (36%, 94/261) reported signiﬁcant
distress.
The primary objective of this study was to determine the rela-
tionship between distress and patient concerns in a cohort of
disease-free, post-treatment HNC patients attending routine
follow-up. A speciﬁc objective was to evaluate the relationship
between the numbers of concerns with signiﬁcant distress, so as to
identify suitable cut-off point based on the number of items
selected on the PCI that could be used as a simple indicator for
clinicians in risk assessing signiﬁcant distress in clinic. The sec-
ondary aims were to determine the signiﬁcance of distress on
outcomes of clinic consultations in relation to patient's concerns.
2. Methods
This study obtained research ethics approval from the North
West Research ethics committee (study reference: 11/H1002/7).
The study was conducted in two HNC outpatient clinics within the
Merseyside region.2.1. Subjects
Study participants comprised surgeons and patients. Four
consultant surgeons comprising two Oral &Maxillofacial surgeons
and two Otolaryngology, Head and Neck surgeons, without prior
experience of using the PCI were invited to participate in this study
and formed a convenience sample. The inclusion criteria for patient
recruitment were disease-free HNC survivors who had completed
primary treatment of at least 6 weeks and had not used the PCI
before. The exclusion criteria included HNC patients who were at
pre-treatment or palliative stage of survivorship. In addition, pa-
tients who were unable to speak or read English were excluded.
2.2. Measures
2.2.1. Distress thermometer (DT)
The DT is a single item self-report measure of distress. This in-
strument is scaled from 0 (no distress) to 10 (severe distress) in a
thermometer layout to rate the level of distress experienced. A DT
cut-off score of 4 correlates with optimal sensitivity and speci-
ﬁcity to the HADS in various cross cultural studies (Jacobsen et al.,
2005; Ozalp et al., 2007; Shim et al., 2006; Grassi et al., 2013), and is
effective in identifying signiﬁcant anxiety andmood problems with
good sensitivity and speciﬁcity to the UWQOL in HNC (Ghazali et al.,
2017).
2.2.2. Patient Concerns Inventory (PCI)
The PCI is a checklist comprising 57 items of patient concern and
18 professionals tiled alphabetically (Ghazali et al., 2015). These
items have been grouped into 5 domains: (A) Physical and Func-
tional well-being (29 items); (B) Psychological and Emotional well-
being/Spiritual (14 items); (C) Social care/Social well-being (9
items); (D) Treatment-related (4 items) and (E) Other (1 items). The
PCI asks respondents to indicate items from the checklist they were
concerned about andwanted to discuss with the doctor during their
consultation. Patients were also asked to indicate professionals from
the checklist they would like to speak or be referred to.
2.3. Study design
This work is part of a wider prospective project evaluating the
PCI intervention set up into three study blocks organized sequen-
tially. In Block 1, patients did not complete the PCI before their
consultation, representing usual practice and the control group. In
Block 2, patients completed the PCI at the pre-consultation stage
but the PCI was withheld from clinicians during consultation,
representing the ‘control in attention’ group. In Block 3, patients
completed the PCI at the pre-consultation stage; the completed PCI
was passed on to the clinicians and was available for use during the
consultation, representing the intervention group. For the purpose
of this study only patients from Blocks 2 and 3 were selected, and
the PCI data acquired was derived from the clinic they had ﬁrst
experienced using the PCI.
All recruited patients also completed the DT at pre-consultation.
Questionnaires were administered in a paper format. The length of
consultation was determined from the start to the end of consul-
tation, which was audio-recorded and subsequently transcribed.
Thematic content analyses of the audio-recorded transcriptions
were carried out by two assessors (NG, BR) based on a thematic
framework approach (Ghazali et al., 2012b). Clinic outcomes were
classiﬁed as medical (e.g. placement on surgical waiting list to aid
rehabilitation, institution of symptomatic or supportive medical
treatment, request for investigations, and onward referrals) or non-
medical actions (e.g. provide information, advice on lifestyle, stra-
tegies for coping, and reassurance).
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To examine the relationship between distress and other vari-
ables, Fishers Exact test, Pearson's chi-squared test or Man-
neWhitney analysis were applied as appropriate. Statistical
signiﬁcance was regarded as p  0.01. All statistical analysis was
performed using SPSS version 19.0 (SPSS Inc.).
3. Results
One hundred and seventy patients (n ¼ 170) were recruited at
ﬁrst attendance at clinics within study Blocks 2 and 3 during which
they ﬁrst used the PCI. Clinicopathological characteristics of these
patients are shown in Table 1. Overall the median (IQR) time from
primary surgery (or from primary diagnosis if no surgery) to clinic
attendance was 2.2 (1.2e3.9) years, n ¼ 167. The median (IQR)
length of consultation was 5.2 (3.2e7.9) minutes, n ¼ 141.
3.1. Distress and patient concerns
The mean DT score overall was 2.9 and the median (IQR) was 2
(0e5). The overall rate of signiﬁcant distress (i.e. DT cut-off score of
4) was 36% (62/170). Thus, about two-thirds (64%, 108/170) of this
cohort at clinic did not report signiﬁcant distress.
Overall, the number of PCI items selected ranged from 0 to 18,
mean 3.63, median (IQR) 2 (1e5). Patients with signiﬁcant distress
selected more items overall than patients without distress (mean,
median (QR) of 5.40, 5 (2e8) versus 2.61, 2 (0e4), ManneWhitney
test p < 0.001). More speciﬁcally, they selected more items from
within the Physical and Functional well-being domain (mean 3.87
versus 1.96) and the Psychological and Emotional well-being
domain (1.16 versus 0.46) than from the Social care/Social well-Table 1
Clinicopathological characteristics of the study sample.
All patients (n ¼ 170)
Gender Male 66% (113)
Female 33% (56)
Not known 0.6% (1)
Age Mean (SD) 64.2 (11.4)
Median (IQR) 64 (58e73)
<55 16% (27)
55e64 36% (62)
65e74 30% (51)
75þ 15% (26)
Not known 2% (4)
Specialty MFU 53% (90)
ENT 46% (79)
Not known 0.6% (1)
Tumour site Oral 37% (63)
Oro-pharyngeal 21% (35)
Laryngeal 21% (36)
Other 21% (36)
Histology SCC 84% (143)
Not SCC 15% (26)
Not known 0.6% (1)
Overall P stage 1 29% (50)
2 18% (31)
3 11% (18)
4 29% (50)
Not known 12% (21)
Primary treatment Surgery only 46% (78)
Surgery þ RT/CRT 38% (64)
RT/CRT only 14% (23)
Not known 3% (5)
Free-ﬂap (142 with surgery) Surgery without FF 72% (102)
Surgery with FF 27% (38)
Not known 1% (2)
MFU, maxillofacial unit; ENT, otorhinolaryngology; SCC, squamous cell carcinoma;
RT, radiotherapy; CRT, chemoradiotherapy; FF, free ﬂap.being domain (0.21 versus 0.10) and Treatment-related domain
(0.16 versus 0.08). The association between PCI items and signiﬁcant
distress is also summarised in Table 2. There were trends within
each domain for the likelihood of signiﬁcant distress to increase
with the number of items selected and for this to be compounded
within the total score. In stepwise logistic regression to predict
signiﬁcant distress using the category variables within Table 2, the
total number of itemswas the only variable selected (at p < 0.001) in
regression modelling with p < 0.01 inclusion criteria. Three distinct
predictive groups were apparent: 21% of patients selecting zero
items e 9% (3/35) distressed, 47% selecting 1e4 items e 30% (24/80)
distressed, and 32% selecting 5 or more items e 64% (35/55) dis-
tressed. Possible cut-offs in the number of PCI items selected in
relation to signiﬁcant distress are explored in Table 3. Speciﬁc PCI
items associated with signiﬁcant distress are shown in Table 4.
3.2. Distress and patient concerns and length of consultation
Themedian (IQR)numberof itemsactuallydiscussed in theaudio
recorded consultations was 3 (2e5) items, n ¼ 141. When patients
were distressed and three or fewer items were discussed (19 pa-
tients), the median (IQR) length of consultation was 4.2 (3.1e6.0)
minutes; when four ormore itemswere discussed (33 patients), the
median (IQR) consultation length was 8.4 (5.5e12.1) minutes
(ManneWhitney test, p<0.001). In the absence of distress and three
or fewer itemswerediscussed (63patients), themedian (IQR) length
of consultationwas 3.3 (2.6e6.2)minutes; when four ormore items
were discussed (26 patients) the median (IQR) consultation length
was 6.4 (4.3e8.9) minutes (ManneWhitney test, p < 0.001).
3.3. Distress and perceived need for services
Overall, the number of professionals selected ranged from 0 to 4,
mean 0.38, median (IQR) 0 (0e1), n ¼ 170, with a mean 0.53
selected in those with signiﬁcant distress and a mean 0.30 without
signiﬁcant distress. No strong associations were found with type of
professional selected, though it was noted that 52% (11/21) of thoseTable 2
Number of PCI items selected and signiﬁcant distress (DT  4).
Signiﬁcant distress (DT  4)
% n p valuea
Physical & functional well-being
0 20% 11/56
1e2 32% 16/50
3e4 42% 13/31 <0.001
5e9 71% 17/24
10 (range 10e15) 56% 5/9
Treatment related
0 35% 53/152 0.30
1 (range 1e2) 50% 9/18
Social care & social well-being
0 33% 50/150 0.03
1 (range 1e3) 60% 12/20
Psychological, emotional & spiritual wellbeing
0 28% 28/100
1e2 42% 24/57 0.001
3 (range 3e6) 77% 10/13
Total number of items
0 9% 3/35
1e2 30% 17/56
3e4 29% 7/24 <0.001
5e9 61% 25/41
10 (range 10e18) 71% 10/14
Health professionals
0 31% 37/121 0.01
1 (range 1e4) 51% 25/49
a Chi-square test (physical& functional, psychological emotional& spiritual well-
being, total number), otherwise Fisher's exact test.
Table 3
Possible cut-offs in the number of PCI items in relation to signiﬁcant distress.
Number of total
PCI items as
cut-off
Sensitivity Speciﬁcity Positive
predictive
value
Negative
predictive
value
1 95% (59/62) 30% (32/108) 44% (59/135) 91% (32/35)
2 82% (51/62) 49% (53/108) 48% (51/106) 83% (53/64)
3 68% (42/62) 66% (71/108) 53% (42/79) 78% (71/91)
4 61% (38/62) 72% (78/108) 56% (38/68) 76% (78/102)
5 56% (35/62) 81% (88/108) 64% (35/55) 77% (88/115)
6 42% (26/62) 88% (95/108) 67% (26/39) 73% (95/131)
7 34% (21/62) 90% (97/108) 66% (21/32) 70% (97/138)
Table 4
Speciﬁc PCI items associated with signiﬁcant DT distress (DT score  4).
PCI item If PCI item
selected, what % had a
DT score  4
If PCI item NOT selected,
what % had a DT score  4
p valuea
Anxiety 77 10/13 33 52/157 0.005
Bowel 78 7/9 34 55/161 0.01
Depression 88 7/8 34 55/162 0.004
Fatigue 62 21/34 30 41/136 0.001
Mood 78 7/9 34 55/161 0.01
Pain in
head/neck
65 17/26 31 45/144 0.002
Sleeping 65 13/20 33 49/150 0.007
Swallowing 67 20/30 30 42/140 <0.001
a Fishers exact test.
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wanting to see the physiotherapist, and all those wanting to see
either a psychologist (2/2) or Emotional Support therapist (2/2).
The number of medical actions taken based on audiotaped
consultations (n¼ 141) ranged from 1 to 4, and the percentagewith
2 or more actions was 52% (27/52) for those with signiﬁcant
distress and 29% (26/89) without distress (Fishers exact test,
p ¼ 0.01). In regard to non-medical actions (range 2e4), the per-
centage with 3 or more actions was 37% (19/52) for those with
signiﬁcant distress and 21% (19/89) without distress (Fishers exact
test, p ¼ 0.18).
4. Discussion
This seminal work evaluated the relationship between patient
concerns and distress inpost-treatmentHNC survivors using PCI.We
found avery strong association between level of distress and number
of reported concerns. Distress levelswas associatedwith the number
of items of concerns selected, suggesting that the number of PCI
items selected could potentially be a surrogate marker of signiﬁcant
distress. Concerns relating to the Psychological and Emotional well-
being and the Physical and Functional well-being domains were
related to signiﬁcant distress. The study also demonstrated that
experiencing signiﬁcant distress and having numerous concerns
impacts upon the length of consultations and the outcomes of these
consultations. Furthermore, the study ﬁndings also suggest that
when the PCI is used as a single tool, it can potentially undertake
multiple tasks simultaneously i.e. enable patients to voice their
concerns, identify those at risk of signiﬁcant distress, sign-post
supportive services required by patients and may facilitate the
running of outpatient clinics by indicating which patients may
require longer appointments based on their proﬁle of concerns.
The study design allowed a prospective, multicenter recruit-
ment of a cohort representing the breadth of HNC subsites
attending routine follow-up clinics run by multiple clinicians of
different specialities. The data acquired was cross-sectional and
this must be considered in relation to the nature of distress, whichcan be experienced at anytime during the cancer journey.
Furthermore, patient concerns also vary at different time-points
along the cancer journey (Richardson et al., 2007). The degree of
concern expressed may ﬂuctuate and could contribute differently
toward the overall experience of cancer-related distress. We have
not speciﬁcally attempted to quantify the degree of concern per
item selected other than establishing the presence of a signiﬁcant
problem for the item of concern as described previously (Rogers
et al., 2009, 2010; Ghazali et al., 2013; Kanatas et al., 2012; Rogers
et al., 2012; Flexen et al., 2012; Ghazali et al., 2012a).
The majority of patients in this cohort did not experience sig-
niﬁcant distress (64%, 108/170). Patients with signiﬁcant distress
selected more items overall than patients without distress (mean,
median (QR) of 5.40, 5 (2e8) versus 2.61, 2 (0e4); ManneWhitney
test, p < 0.001). This corresponds to other studies (Maguire, 2002;
Chaturvedi et al., 1996) where patient concerns were related with
the development of distress. The potential relationship between
the numbers of concerns with the likelihood of experiencing sig-
niﬁcant distress was further evaluated, where it was possible to
suggest a cut-off point indicating signiﬁcant distress with a
reasonable degree of sensitivity and speciﬁcity. On balance, cut-off
points of either 4 or 5 items of concern selected on the PCI
demonstrated an acceptable level of sensitivity, speciﬁcity and
predictive values (Table 3) for likelihood of experiencing signiﬁcant
distress. From a clinical perspective, using either 4 or 5 cut-off
score can help guide clinicians in risk assessing patients for sig-
niﬁcant distress, who may beneﬁt from more in depth evaluation
and intervention, at pre-consultation.
Those experiencing signiﬁcant distress were more likely to
select items from the Physical and Functional well-being domain
(p < 0.001) and the Psychological and Emotional well-being
domain (p ¼ 0.001). This ﬁnding demonstrates that emotional
distress is not the only signiﬁcant contributing factor in cancer-
related distress in a HNC population predominantly treated with
surgery (84%, 142/170). Severe distress, in particular physical
distress related to oral cavity dysfunction, has been reported in
another HNC cohort treated by ablative surgery and immediate
reconstruction (Chen et al., 2009). Furthermore, the use of RT
(Ghazali et al., 2017; Lewis et al., 2013) and chemoRT (Chen et al.,
2013) are also strongly associated with signiﬁcant distress in this
population. HNC survivors struggling to cope with the after-effects
of HNC treatment are likely to express signiﬁcant distress and
require physical support more than any other cancer types (Chen
et al., 2009, 2013). Addressing signiﬁcant distress related to phys-
ical concerns can be initiated in clinic. This includes both non-
medical (e.g. education, advice, reassurances) and medical actions
(e.g. investigations, surgery, medications, referrals). Treatment-
related domain was not associated with signiﬁcant distress
(p ¼ 0.3). It is possible that disease-free, post-treatment HNC pa-
tients were less likely to be signiﬁcantly distressed about these
issues following treatment completion. Comparisons with other
studies are not possible due to methodological differences in
assessing concerns (Jacobsen et al., 2005; Grassi et al., 2013).
When individual PCI items of concern were evaluated, Anxiety
(p ¼ 0.005), Depression (p ¼ 0.004), Mood (p ¼ 0.01), Pain in head/
neck (p ¼ 0.002), Sleeping (p ¼ 0.007), Fatigue (p ¼ 0.001), Swal-
lowing (p < 0.001) and Bowel habit (p ¼ 0.01) were related to sig-
niﬁcant distress. Apart from bowel habit, the other concerns
associated with signiﬁcant distress in this study have been consis-
tently been reported by HNC patients previously (Rogers et al., 2009;
Kanatas et al., 2012; Ghazali et al., 2012a). It is recognised that
Anxiety, Mood and Depression are essential components of, and
possible overlapping elements of emotional distress in cancer
(Holland and Bultz, 2007; Pandey et al., 2006). Post-treatment
dysphagia is related to weight loss, progressive reduction in
N. Ghazali et al. / Journal of Cranio-Maxillo-Facial Surgery 45 (2017) 1743e1748 1747swallowing function, narrowing range of oral dietary intake and
reliance on gastrostomy tube feeding (Oozeer et al., 2011), and these
confer a global impact on the long-term day-to-day functioning and
QOL (Cartmill et al., 2012). Altered bowel function is related to
distress in colorectal, urological and gynaecological cancer survivors
but this has never been reported previously in HNC cohorts. This
ﬁnding may be related to complications of opiate analgesia use, al-
terations to bowel function due to full reliance on enteral feeding and
also secondary to hormonal imbalances in a subgroup of thyroid
cancers includedwithin this study cohort. Pain is highly correlated to
signiﬁcant distress in HNC patients throughout the survivorship
trajectory (Lewis et al., 2013; Maher et al., 2013). Cancer-related fa-
tigue is a common problem in cancer survivors (Carlson et al., 2004;
Brown and Kroenke, 2009) and is linked to emotional reactivity
(Rissanen et al., 2014; Bower, 2014). Like pain, sleep disturbances and
insomnia can occur throughout the survivorship trajectory in HNC
survivors (Scarpa et al., 2014; Zhou and Jolly, 2014).While individual
symptom/concernwas related to signiﬁcant distress in its own right,
there is increasing interest in the prevalence of symptoms that
frequently co-occur in symptom clusters with distress. For example,
sleep disturbances and insomnia occur commonly with other
frequently reported side effects of cancer and/or its treatment,
namely pain, fatigue, depression and distress (Butt et al., 2008;
Garland et al., 2014). It is postulated that the clustering of co-
occurring symptoms might be related to underlying inﬂammatory
processes common to these concerns (Garland et al., 2014).
Overall, the number of professionals selected ranged from 0 to 4,
mean 0.38, median (IQR) 0 (0e1), n ¼ 170. From the patent's per-
spectives, the attending doctor in clinic is often seen as the main
clinician managing their cancer care. Thus, it is unsurprising that
patients have indicated this professional as the one they would like
to see or meet during their appointment, particularly those expe-
riencing signiﬁcant distress (52%, 11/21). Furthermore, those who
were signiﬁcantly distressed were more likely to select other pro-
fessionals compared with those not experiencing signiﬁcant
distress (mean 0.53 vs. 0.30). In this scenario, perhaps the attending
clinician needs to be more proactive in suggesting onward referral
or having direct access to the other professionals' support in clinic.
However, it remains unclear why so few additional HNC multidis-
ciplinary personnel are ticked generally on the PCI and this is a
subject of future research.
Those signiﬁcantly distressed with larger numbers of concerns
were more likely to have had longer consultations compared with
patients not reporting signiﬁcant distress with fewer concerns.
Apart from increasing the length of consultation, signiﬁcant
distress impacts upon the individual management of these pa-
tients. Overall, those with signiﬁcant distress were more likely to
receive both medical and non-medical actions related to their
consultation compared to thosewithout distress. While this ﬁnding
is unsurprising, it places huge demand upon resources and
outpatient clinic management. A different approach may be
required to meet the concerns of signiﬁcantly distressed patients in
clinics where the PCI is used. Suggestions include asking patients to
prioritize their list of concerns for discussion during clinic, referral
to the most appropriate professional who may be present at the
clinic or at another appointment and self-referral through a web-
based PCI application. Future work should focus on the impact of
PCI-directed pathways in managing distress.
5. Conclusions
Signiﬁcant distress is experienced in just over one-third of post-
treatment HNC patients attending clinic. The PCI has the potential to
be a risk assessment tool for signiﬁcant distress. Using the PCI with a
cut-off point 4 or 5 of items selected, it was possible to identifythose at risk of signiﬁcant distress. The concerns of patients with
signiﬁcant distress were related to Psychological and Emotional/
Spiritual well-being, and to Physical and Functional well-being.
Treatment that maximizes functional outcomes without compro-
mising cure should be considered at the outset to address this
upfront. A shift of emphasis toward supportive rehabilitation is
paramount in the post-treatment period, where managing physical
and psychological concerns with close involvement of other
personnel within a multidisciplinary team is required. Addressing
concerns and distress can result in longer consultations and a higher
number of both medical and non-medical actions. Further work is
required in understanding the impact of distress screening and PCI-
directed pathways in the management of patient concerns.Acknowledgement
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Abstract Head and neck cancer (HNC) patients suffer
substantial emotional problems. This study aimed to
explore how utterance-level variables (source, type and
timing of emotional cues) and patient-level variables (e.g.
age, gender and emotional well-being) relate to consul-
tants’ responses (i.e. reducing or providing space) to
patient expressions of emotional distress. Forty-three HNC
outpatient follow-up consultations were audio recorded and
coded, for patients’ expressions of emotional distress and
consultants’ responses, using the Verona Coding Defini-
tions of Emotional Sequence. Multilevel logistic regression
modelled the probability of the occurrence of consultant-
reduced space response as a function of patient distress cue
expression, controlling for consultation and patient-related
variables. An average of 3.5 cues/concerns (range 1–20)
was identified per consultation where 84 out of 152 total
cues/concerns were responded by reducing space. Cue type
did not impact on response; likewise for the quality of
patient emotional well-being. However, consultants were
more likely to reduce space to cues elicited by patients, as
opposed to those initiated by themselves. This reduced
space response was more pronounced as the consultation
continued. However, about 6 min into the consultation, this
effect (i.e. tendency to block patients) started to weaken.
Head and neck consultants’ responses to negative emotions
depended on source and timing of patient emotional
expressions. The findings are useful for training pro-
gramme development to encourage consultants to be more
flexible and open in the early stages of the consultation.
Keywords Head and neck cancer  Emotional distress 
The VR-CoDES  Multilevel
Abbreviations
HNC Head and neck cancer
NICE National Institute for Clinical Excellence
OSCE Objective and structured clinical
examination
VR-CoDES Verona Coding Definitions of Emotional
Sequence
QoL Quality of life
PCI Patient concerns inventory
Introduction
Head and neck cancer (HNC) patients suffer substantial
psychological distress [1–3]. Appropriate attendance to
patient emotional needs, a key feature of patient-centred
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care, has been found to be associated consistently with
many improved patient outcomes in both general medicine
[4] and oncology [5, 6]. In the United Kingdom, the
National Institute for Clinical Excellence (NICE) guide-
lines recommended that the psychosocial issues are rou-
tinely assessed and discussed in oncology practice [7].
Despite recognised patient benefits, national efforts and
many communication-training programmes [8, 9], research
evidence suggests a continued prevalence of unaddressed
psychological issues among cancer patients [10–14]. It is,
therefore, important to intricately investigate the factors
influencing oncologists’ positive responses to patients’
negative emotions in routine oncology practice.
Previous studies suggested that a number of variables,
at different levels of the consultation, impact on a clini-
cian’s response to patient emotional expressions. At the
conversation (i.e. utterance) level, source [15–17], type
[18, 19] and timing [17, 19] of emotional expression were
found to be important predictors for clinicians’ responses.
Regarding source of emotion (i.e. cues elicited by patients
versus clinicians), Pollak et al. [15] found that, when
patients initiated negative emotions, oncologists respon-
ded with a terminator statement 73 % of the time, to
discourage further disclosure of emotions. Similar findings
were reported in more recent studies, where a multilevel
approach was adopted to respect the clustered nature of
the data contained within the consultation [16, 17]. Del
Piccolo et al. [16] found that psychiatrists provided space
for further disclosure of a concern more frequently when
the concern had been initiated by the psychiatrist in the
first place. Finset et al. [17] supported this finding in a
cancer care setting that oncologists were more likely to
give room for further disclosure of cues/concerns that
were initiated by themselves. However, no published
evidence is available so far to support this relationship in
HNC consultations. With regard to the type of emotion,
Kennifer et al. [18] reported that oncologists responded
most empathically to intense emotions. A recent multi-
level study confirmed that certain cue types influenced the
way that medical students responded to the simulated
patients in the Objective Structured Clinical Examinations
(OSCE) [19]. In this study, the cue types and responses
were coded according the Verona Coding Definitions of
Emotional Sequence (VR-CoDES) [20, 21]. The impor-
tance of studying timing of cue expression in medical
consultations has been highlighted in a ground-breaking
review [22]. A number of recent multilevel sequential
studies have subsequently confirmed the significance of
timing in relation to provider responses. For example,
medical students were more likely to reduce space to
emotional cues expressed by simulated patients nearer the
end of the 5-min OSCE consultations [19]. In a similar
direction, oncologists were found to give more space for
emotional disclosure to the first cue/concern in real con-
sultations of more than 10 min [17]. Again, little is known
about how the cue type and the timing of cue expression
might impact on oncologists’ responses to emotions
expressed by HNC patients.
At the patient-level (i.e. consultation), female patients
with female oncologists were more likely to encourage
empathic responses from clinicians [17]. Emotion-related
quality of life of cancer patients has also been indicated
as a predictor influencing the discussion around emotion
during consultations [14]. There is little evidence showing
how HNC patients’ emotional well-being might relate to
the dynamics of emotional discussion with their
clinicians.
In the light of the studies discussed above, this study
aims to explore how utterance-level variables (source, type
and timing of emotional cues) and patient-level variables
(age, gender and emotional well-being) relate to oncolo-
gists’ responses to HNC patients’ emotional distress.
Methods and materials
Participants and procedures
Patient participants were 58 HNC survivors attending fol-
low-up outpatient consultations at Aintree University hos-
pital, Liverpool, UK. Those consultations without
emotional distress cues (n = 14) and those with unusually
frequent emotional cues (n = 1) were excluded, resulting
in 43 consultations included in the study. Generally
speaking, the cohort was a heterogeneous group having had
different treatment combinations. In addition, these
patients were all on longitudinal follow-up appointments
(up to 5 years post-treatment). However, none of the
patients received any specific intervention (e.g. psycho-
logical therapy) for emotional issues before the consulta-
tion. Staff participants were four head and neck
consultations (all male) with at least 3 years of working
experience. Each consultant had a minimum of ten con-
sultations. All patients completed a quality of life (QoL)
survey (84 % also completed a Patient Concerns Inventory
(PCI) [23]) prior to the consultation being audio recorded.
Informed written consent was obtained from both patient
and consultants. The study was part of a larger study
aiming to investigate patients’ concerns in head and neck
oncology settings, which was given a favourable ethical
opinion on 21st February 2011, by the North West 3
Research Ethics Committee—Liverpool East (approval
number: 11/H1002/7). Therefore, this study has been per-
formed in accordance with the ethical standards laid down
in an appropriate version of the 1964 Declaration of
Helsinki.
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Measures
The VR-CoDES, previously applied in the oncology setting
[17], was employed to code both patient expression of
emotional distress [20] and consultants’ responses [21]. It
is a well-validated scheme developed over 10 years by an
international expert group of researchers and practitioners.
According to the manual, an emotional cue is defined as a
hint suggesting an underlying negative emotion, whereas a
concern is an explicitly verbalised expression of negative
emotion. Examples of coded cues/concerns and responses
were presented in Table 1. In coding responses to emo-
tional cues/concerns, the dimension of providing space
versus reducing space (i.e. providing or reducing room for
further disclosure of emotion) has been considered in our
analysis. Two medical students, trained on the VR-CoDES,
coded the transcripts while listening to the tape to preserve
the voice tone. Coding was overseen by an experienced
coder (YZ) and a member of the VR-CoDES developer
(GH). Both inter- and intra-coder reliabilities were con-
sidered satisfactory according to Altman’s criteria [24]
(Table 2). The subscale of mood and anxiety from the
University of Washington Head and Neck Cancer Ques-
tionnaire (UW-QoL, V4 [25]) was used to indicate the
quality of patient emotional well-being.
Data analysis
A two-level logistic regression was conducted to
acknowledge the nested data structure, where utterances
(level 1) were nested within consultations (level 2). The
outcome variable was reduced space response. Explanatory
variables at level 1 were: specific type of cue and concern
(1 presence, 0 absence), time location when a cue/concern
was expressed relative to the first utterance start time,
patient elicitation (1 patient elicited, 0 consultant elicited).
Predictive variables at level 2 were: QoL scores on mood
and anxiety (0–200, with a higher score indicating a better
quality), patient age, gender (1 male, 0 female), cancer
stage (1–4, with a higher score describing increased disease
severity) and consultation duration (in seconds). Analysis
Table 1 Definitions of cues and concerns and examples from the
HNC consultations
Definitions Typical examples from the H&N
cancer consultations
CONCERN: a clear and
unambiguous expression of an
unpleasant current or recent
emotion where the emotion is
explicitly verbalised with or
without a stated issue of
importance
Are you sure it’s nothing else
though? That’s what I am
concerned about
I am now feeling quite anxious
I am concerned that it might be
like a…something there
CUE: a verbal or non-verbal hint suggests an underlying unpleasant
emotion and would need a clarification from the health provider
Instances included
Cue A: vague or unspecified
words or phrases in which the
patient uses to describe his/
her emotions
Well, I am really nervous now
I am so stressed out at the
moment
Just tightness sometimes isn’t it
You know sometimes I go ouch
you know
Cue B: verbal hints to hidden
concerns (emphasising,
unusual words, unusual
description of symptoms,
profanities, exclamations,
metaphors, ambiguous words,
double negations, expressions
of uncertainties and hope)
What the hell is wrong with me?
It wiped me out completely
And I’ve got this funny
sensation…creeping feeling
Cue C: words or phrases that
emphasises (verbally or non-
verbally) physiological or
cognitive correlates
(regarding sleep, appetite,
physical energy, excitement
or motor slowing down,
sexual desire, concentration)
of unpleasant emotional states
I’ve gone off my appetite; I am
not eating properly at all
I am still feeling a bit tired
I cannot seem to open my mouth
as wide as I used to
Cue D: neutral expressions that
mention issues of potential
emotional importance which
stand out from the narrative
background and refer to
stressful life events and
conditions
I’ve been made redundant, busy
suing my employer
I’m bad tempered all the time
I’m seeing a counsellor
If I’m having my tea, and
something gets stuck, then
that’s it. I can’t eat anymore
And that’s about it now
Cue E: a patient-elicited
repetition of a previous
neutral expression
(repetitions, reverberations or
echo of neutral expression
within a same turn are not
included)
Turn 1. It just feels tight
Turn 2. It just feels tight when I
swallow
Cue F: non-verbal cues
including clear expressions of
negative or unpleasant
emotions (crying) or hint to
hidden emotions (sighing,
silence after provider
question, frowning etc.)
Not available with audio data
Table 1 continued
Definitions Typical examples from the H&N
cancer consultations
Cue G: a clear and
unambiguous expression of
an unpleasant emotion which
occurred in the past (more
than 1 month ago) or is
without time frame
I was really worried at the time
I had a bit of a panic when I came
here last time…that little lump
I really had a rough time
HNC head and neck cancer
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followed three steps: (1) a null model with random inter-
cept, explored the variance composition at each level; (2)
predictive variables were entered at level 1 followed by
level 2, with variables with a significant effect at p\ 0.05
were retained for the next model; and (3) patient demo-
graphics and the consultation duration was controlled for in
the final model. Analyses were conducted in STATA/ICTM
10.0 for Windows using the xtmelogit procedure.
Results
Patient characteristics
Table 3 presents descriptive statistics of relevant clinical
and demographic information of the 43 participating
patients. The majority of patients were over 60 years of
age, with about 56 % males, and over half of the patients
never smoked or drank alcohol. Overall, these patients had
an average severity of cancer and about 30 % of them had
oral cavity cancer. Broadly speaking, 48.83 % received a
single modality treatment (i.e. surgery alone or radiother-
apy alone) and 51.17 % received a multimodality treatment
(i.e. chemo-radiotherapy, surgery plus radiotherapy, sur-
gery plus chemo-radiotherapy). The average consultation
duration was 5.5 min, ranging from 1.5 to 13.18 min. On
average, the time interval between completion of treatment
and inclusion into the study (i.e. date consultation took
place) was 25.44 months, ranging from 1 to 55 months.
Frequency of cues/concerns and responses
As shown in Table 4, a total number of 152 cues/concerns
were identified among 43 consultations, resulting in an
average number of 3.53 cues/concerns per consultation.
Cue B (verbal hints) was most frequently observed, fol-
lowed by Cue D (stressful life events); whereas Cue E, F
and G were rarely or never observed. Subsequent Chi-
square tests confirmed no significant difference between
provided versus reduced space response to specific cue
types. Within the reduced space response, patient- versus
clinician-elicited cue/concern, however, showed an initial
difference [v2(1) = 8.067, p\ 0.01], which warrants fur-
ther investigation when controlling for clustered effects of
the consultation.
Table 2 Results of inter- and intra-coder reliability (n = 44)
Type Occasion of check No. of transcripts Cohen’s Kappa (95 % CI)
Cues/concerns Elicitation (patient/clinician) Response (provide/reduce space)
Inter-coder Beginning 2 0.71 (0.64, 0.81) 0.82 (0.69, 0.97) 0.74 (0.54, 0.80)
Closer to the end 3 0.75 (0.48, 0.80) 0.78 (0.58, 0.88) 0.86 (0.69, 0.92)
Intra-coder Coder 1 2 0.79 (0.76, 0.85) 0.93 (0.81, 0.99) 0.79 (0.66, 0.84)
Coder 2 2 0.92 (0.81, 0.98) 0.86 (0.79, 0.98) 0.84 (0.67, 0.91)
Table 3 Patient characteristics (n = 43)
Clinical/demographic information Descriptive statistics
Age (year) Mean 62.86 (SD 15.10),
(range 21–91)
Gender
Male 24 (55.81 %)
Female 19 (44.19 %)
Smoking
Never smoked 26 (60.47 %)
Currently smoking 11 (25.58 %)
Previous smoked 6 (13.95 %)
Alcohol
Yes (including rarely) 17 (39.53 %)
No (never) 24 (55.81 %)
Previous alcoholic 2 (4.65 %)
Cancer stage Mean 2.19 (SD 1.20),
(range 1–4)
Tumour site
Oral cavity 13 (30.23 %)
Larynx 10 (23.26 %)
Oro-pharynx 11 (25.58 %)
Other (thyroid, nose, salivary gland,
unknown)
9 (20.93 %)
Treatment
Surgery alone 17 (39.53 %)
Radiotherapy alone (RT) 4 (9.30 %)
Chemo-radiotherapy (CRT) 3 (6.98 %)
Surgery ? RT 16 (37.21 %)
Surgery ? CRT 3 (6.98 %)
Follow-up appointment duration
(minutes)
Mean 5.50 (SD 2.84),
(range 1.5–13.18)
Time interval between treatment
completion and video consultation
(months)
Mean 25.44 (SD 14.43),
(range 1–55)
Categorical variables are presented with percentages with absolute
values, while continuous variables are presented with means, standard
deviations, minimum and maximum values
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Consultants’ responses to cues/concerns
Table 5 shows the descriptive statistics of the variables
included in the multilevel analyses, except for those
reported in Table 4. The frequency of the outcome variable
(reduced space response) accounted for about 55 % of the
entire utterances in level 1. As for the explanatory variables
at level 1(utterance), approximately 40 % of the cues/
concerns were initiated by patients; and on average they
occurred at about 3 min after the first utterance in the
consultation. Regarding predictors at level 2 (consultation),
a mean score of 148.26 on QoL mood and anxiety indi-
cated an overall satisfactory quality of emotional well-
being.
A number of findings emerged from the multilevel
logistic regress analyses (Table 6). (1) Overall, little vari-
ance (7.32 % in null model) was explained by the between-
consultation difference. (2) Cue type did not make any
impact on the occurrence possibility of the reduced space
response (Model 1 and 2). (3) A positive linear relationship
was found between cue time (in seconds) and the reduced
space response (OR 1.00, p\ 0.01 in Model 2, effect being
preserved at Model 4 with p\ 0.05). The model was sig-
nificantly improved when the cue time-squared term was
included [v2(1) = 4.44, p\ 0.05], suggesting that a cur-
vilinear relationship existed between the timing of cue
expression and the reduced space response (OR 0.99,
p\ 0.05). (4) Consultants reduced space to cues elicited
by patients (OR 2.25, p\ 0.05 in Model 4 with effects
being consistent in all models). (5) Patient emotional QoL
did not influence reduced space response (OR 0.99,
p[ 0.05).
Timing of cue expression and responses
Figure 1 shows the curvilinear relationship between the
timing of cue/concern expression and probability of
reduced space response occurrence. X-axis is the time
location of a cue/concern expressed by a patient in a typical
consultation up to 500 s (approximately 8.3 min, only six
consultations out of our sample of 43 had a duration of over
500 s). Y-axis is the predicted probability of a consultant’s
reduced space response (log odds). As can be seen from the
Fig. 1, the largest log odds occur when a cue/concern is
expressed at about 360 s (6 min). This figure suggested
that consultants were more likely to reduce space to emo-
tional distress expressed closer to the end of the consulta-
tion until about 6 min into the consultation. Further into the
consultation, this relationship appeared to weaken.
Table 4 Frequency of cues of
concerns and responses
(consultation n = 43)
No instance of Cue F was
observed
* p\ 0.01
Cue type/elicitation Response Cue/concern mean Chi square
Providing
space
Reducing
space
Total Per consultation Value df P
Concern 4 (26.67 %) 11 (73.33 %) 15 0.35 2.198 1 0.138
Cue A 5 (38.46 %) 8 (61.54 %) 13 0.30 0.226 1 0.634
Cue B 33 (43.42 %) 43 (56.58 %) 76 1.77 0.106 1 0.744
Cue C 10 (52.63 %) 9 (47.37 %) 19 0.44 0.547 1 0.459
Cue D 14 (58.33 %) 10 (41.67 %) 24 0.56 2.131 1 0.144
Cue E 0 (0 %) 1 (100 %) 1 0.02 N/A
Cue G 2 (50 %) 2 (50 %) 4 0.09 0.046 1 0.830
Total 68 (44.74 %) 84 (55.26 %) 152 3.53 1.684 1 0.194
Patient-elicited 19 (30.16 %) 44 (69.84 %) 63 1.47 8.067 1 0.005*
Clinician-elicited 49 (55.06 %) 40 (44.94 %) 89 2.07 0.910 1 0.340
Table 5 Description of variables included in the study
Outcome variable at level 1 (n = 152) Min–Max
Reduced space responsea 84 (55.26 %)
Explanatory variable
Level 1 (utterance, n = 152)
Cue timeb(s) 164.59 (SD 148.95) (2–702)
Patient elicitationa 63 (41.45 %)
Level 2 (consultation, n = 43)
UW-QoL mood ? anxietyb 148.26 (SD 43.64) (30–200)
Consultation durationb(s) 329.77 (SD 170.20) (90–791)
Patient ageb 62.86 (SD 15.10) (21–91)
Patient gender(male)a 24 (55.81 %)
Cancer stageb 2.19 (SD 1.20) (1–4)
QoL quality of life [25]
a Dichotomous variables are presented with percentages with abso-
lute values
b Continuous variables are presented with means, standard devia-
tions, minimum and maximum values
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Discussion
This is the first time a multilevel modelling approach has
been adopted in a head and neck cancer setting to study
oncologists’ responses to patients’ emotional distress. The
main finding regarding the curvilinear relationship between
the timing of cue expression and the reduced space
response is generally consistent with the findings in the
literature that, oncologists were less likely to give space for
disclosure of emotions that occurred later in the consulta-
tion [17]. Our contribution lies in the fact that these find-
ings help to explain the complexity of consultants’
strategies in dealing with subtle emotional issues expressed
by HNC patients, by highlighting a time point when con-
sultants started to open up for emotional disclosure. Most
consultants in our study are experienced oncologists, good
at working effectively in their provision of cancer care. It is
likely that discussion of emotions occurs, after symptoms
and technical issues have been dealt with in the initial
section of the consultation. It might be argued that this is
the most effective practice with HNC outpatients. It will be
beneficial for future researchers to collect outcome mea-
sures to test this hypothesis. It is also important, however,
not to take for granted that providing space for disclosure
of emotions is always appropriate during consultations. As
highlighted by Smith et al. [26], it is important that doctors
focus on both instrumental tasks, such as sharing decisions,
and emotion management in consultations. This is the first
time an evidence has been provided to support that timing,
that is, ‘when to do what’ rather than ‘what should be
done’, has become crucial to clinical practice, which has
the potential to influence patient outcomes.
It was not a surprise to find that consultants were more
likely to reduce space for disclosure of emotions initiated
by patients, compared to those raised by themselves,
considering what have already been reported in the litera-
ture in other oncology setting [17] and psychiatry consul-
tations [16]. Giving the majority of the HNC patients
completed a Patient Concerns Inventory, an instrument to
help identify and raise needs/concerns, it was, however, a
surprise to see that consultants, who were fully aware of the
expectation to address those issues, were actually less
active in acknowledging emotional issues when raised by
patients. A number of possibilities might help explain why
this happened. First, previous studies indicated that clini-
cians tended to focus more on controlling symptoms and
side effects and less on dealing with psychosocial issues
[10, 11]. Second, handling emotional concerns at an
appropriate time in a busy outpatient clinic might be more
effective than responding to emotional issues whenever
patients raise them, as indicated by our finding. Third, there
might be too many emotional issues raised by patients that
it may be more efficient for consultants to direct them to a
specialist, rather than addressing them at the consultation.
Unfortunately, due to unbalanced sample size in our patient
groups (adoption of PCI n = 36, non-adoption of PCI
n = 7), it was impossible to conduct meaningful statistical
analysis to test the usefulness of the PCI. Future
researchers are encouraged to explore further, with rigor-
ous design, possible impact of instruments, designed to
help identify patient concerns such as PCI, on the dynamics
of discussions around emotional issues during medical
consultations.
An average of 3.5 cues/concerns per consultations found
in our study is consistent with the mean frequency
(between three and four) of cue/concern occurrence in
oncology, where the same VR-CoDES was used [17, 28]. It
is important to note that a higher number of cue/concern
expressions does not suggest an effective consultation [28].
Our study failed to support the previous finding by Zhou
et al. [19] that responses differed according to cue types.
Medical students provided room for the disclosure of
emotional cues expressed in vague and unspecified words,
but reduced space to cues emphasising physiological/cog-
nitive correlates in the OSCE setting was not replicated in
our HNC setting, although a similar multilevel analysis
approach and the same coding scheme were adopted. On
the other hand, oncologists do appear to respond differently
to different types of emotions, as suggested by both cor-
relational [18] and experimental [29] studies that patient
expressions of sadness (compared to anger and fear) were
more likely to receive empathic responses from oncolo-
gists. It is worth noting that the VR-CoDES only captures
the manner in which the emotion is expressed (e.g.
explicitly or verbal hints using metaphors), rather than the
content of emotion (e.g. sadness or anger). It will be useful
for future research to investigate the impact of both vari-
ables of how and what emotion is expressed on clinician
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Fig. 1 Predicted probability of reduced space response as a function
of the timing of emotional distress cue/concern expression
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responses. Patient self-reported quality of emotional well-
being was, unsurprisingly, not found to be significantly
correlated with a consultant’s reduced space response.
Emotional functioning of patients prior to consultation is
commonly studied, as indicator of psychological distress,
to correlate with patient expressions of emotional distress
at consultations [28], through complex pathways from
preferences of discussing emotional issues to initiation of
emotional topics [14]. How patient-level variables, beyond
the common demographics, contributing to our under-
standing of emotional discussion, in particular clinician
responses, are still largely unexplored. Future researchers
are encouraged to explore further the role these important
variables (i.e. patient individual differences and other
social, economic and educational status factors) play in the
dynamics of consultation through rigorous research design
and theoretical grounding.
The reported findings should be interpreted in the light
of the following limitations. Firstly, due to a limited sample
size and thus low statistical power, type II errors are likely.
Future researchers are encouraged to replicate these
promising findings using a larger sample and with different
cancer patient groups, or even in other medical settings.
Secondly, the quality of non-verbal behaviours (both
emotional distress and responses) is limited due to the
nature of the audio data, despite the fact that the intonations
in speech have been preserved while coding. Thirdly, some
clinician level variables, such as gender [17] and quality of
rapport with patients [27], previously indicated as impor-
tant predictors for clinicians’ responses, were not included
in the multilevel models in our study. A much larger
sample size is required to conduct a three-level analysis
incorporating the clinician variables (at the level 3).
Finally, all findings are drawn in a correlational, rather than
causal, direction. Experimental studies, a relatively new
development in healthcare communication research, are
needed to establish causal relationships, for example,
manipulating the timing of cue expression and the type of
emotional cue provision [29] to study clinician responses.
Despite these limitations, this is the first time an evi-
dence was found to support a complex relationship
between the timing of patient emotional expressions and
clinicians’ responses. Moreover, this is the first study that
oncology consultants were found to close down emotional
disclosure when initiated by patient using a multilevel
approach in a clinical setting of head and neck cancer.
The implications of these findings may be stated tenta-
tively. Consultants in their outpatient follow-up appoint-
ments should be encouraged to allow patients to express
their emotional concerns when they arise and at an
appropriate timing. The current body of knowledge from
healthcare communication studies supports this more
flexible and engaged structure of clinician–patient
interaction. The positive outcomes of this approach within
the HNC field of healthcare that are expected should be an
important focus for future investigation.
Acknowledgments The authors would like to thank all patients and
consultants who participated in the study.
Conflict of interest We do not have financial disclosure or any
conflict of interest.
References
1. Hutton JM, Williams M (2001) An investigation of psychological
distress in patients who have been treated for head and neck
cancer. Br J Oral Maxillofac Surg 39:333–339
2. Frampton M (2001) Psychological distress in patients with head
and neck cancer: review. Br J Oral Maxillofac Surg 39:67–70
3. Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G (2004)
Screening for depression in head and neck cancer. Psychoon-
cology 13:269–280
4. Stewart M, Brown JB, Donner A et al (2000) The impact of
patient-centered care on outcomes. J Fam Pract 49:796–804
5. Ford S, Fallowfield L, Lewis S (1994) Can oncologists detect
distress in their outpatients and how satisfied are they with their
performance during bad news consultations? Br J Cancer
70:767–770
6. Epstein RM, Street RL Jr (2007) Patient-centered communication
in cancer care: promoting healing and reducing Suffering.
National Cancer Institute, Bethesda, NIH Publication No.
07–6225
7. NICE (2001) Improving Supportive and Palliative Care for
Adults with Cancer: The Manual, National Institute for Clinical
Excellence, Editor
8. Roter DL, Hall JA, Kern DE, Barker LR, Cole KA, Roca RP
(1995) Improving physicians’ interviewing skills and reducing
patients’ emotional distress. A randomized clinical trial. Arch
Intern Med 155:1877–1884
9. Fallowfield L, Jenkins V, Farewell V, Saul J, Duffy A, Eves R
(2002) Efficacy of a cancer research UK communication skills
training model for oncologists: a randomised controlled trial.
Lancet 359:650–656
10. Ford S, Fallowfield L, Lewis S (1996) Doctor-patient interactions
in oncology. Soc Sci Med 42:1511–1519
11. Detmar SB, Muller MJ, Wever LD, Schornagel JH, Aaronson NK
(2001) The patient–physician relationship. Patient-physician
communication during outpatient palliative treatment visits: an
observational study. J Am Med Assoc 285:1351–1357
12. Pruyn JFA, Heule-Dieleman HAG, Knegt PP et al (2004) On the
enhancement of efficiency in care for cancer patients in outpatient
clinics: an instrument to accelerate psychosocial screening and
referral. Patient Educ Couns 53:135–140
13. Strong V, Waters R, Hibberd C et al (2007) Emotional distress in
cancer patients: the Edinburgh cancer centre symptom study. Br J
Cancer 96:868–874
14. Taylor S et al (2011) Discussion of emotional and social impact
of cancer during outpatient oncology consultations. Psychoon-
cology 20:242–251
15. Pollak KI, Arnold RM, Jeffreys AS et al (2007) Oncologist
communication about emotion during visits with patients with
advanced cancer. J Clin Oncol 25:5748–5752
16. Del Piccolo L, Mazzi MA, Goss C, Rimondini M, Zimmermann
C (2012) How emotions emerge and are dealt with in first diag-
nostic consultations in psychiatry. Patient Educ Couns 88:29–35
2480 Eur Arch Otorhinolaryngol (2015) 272:2473–2481
123
17. Finset A, Heyn L, Ruland C (2013) Patterns in clinicians’
responses to patient emotion in cancer care. Patient Educ Couns
93:80–85
18. Kennifer SL, Alexander SC, Pollak KI et al (2008) Negative
emotions in cancer care: do oncologists’ responses depend on
severity and type of emotion? Patient Educ Couns 76:51–56
19. Zhou Y, Collinson A, Laidlaw A, Humphris G (2013) How do
medical students respond to emotional cues and concerns
expressed by simulated patients during OSCE consultations? A
multilevel study. PLoS One 8(10):e79166. doi:10.1371/journal.
pone.0079166
20. Zimmermann C, Del Piccolo L, Bensing J, Bergvik S, De Haes H
et al (2011) Coding patient emotional cues and concerns in
medical consultations: the Verona Coding Definitions of Emo-
tional Sequences (VR-CoDES). Patient Educ Couns 82:141–148
21. Del Piccolo L, de Haes H, Heaven C, Jansen J, Verheul W et al
(2011) Development of the Verona Coding Definitions of Emo-
tional Sequences to code health providers’ responses (VR-
CoDES-P) to patient cues and concerns. Patient Educ Couns
82:149–155
22. Zimmermann C, Del Piccolo L, Finset A (2007) Cues and con-
cerns by patients in medical consultations: a literature review.
Psychol Bull 133:438–463
23. Rogers SN, El-Sheikha J, Lowe D (2009) The development of a
Patient Concerns Inventory (PCI) to help reveal patients concerns
in the head and neck clinic. Oral Oncol 45:555–561
24. Altman DG (1991) Practical statistics for medical research.
Chapman and Hall, London, p 611
25. Rogers SN, Gwanne S, Lowe D et al (2002) The addition of mood
and anxiety domains to the University of Washington Quality of
Life scale. Head Neck 24:520–529
26. Smith A, Juraskova I, Butow P, Miguel C, Lopez AJ, Chang S
(2011) Sharing versus caring. The relative impact of sharing
decisions versus managing on patient outcomes. Patient Educ
Couns 82:233–239
27. Lelorain S, Bre´dart A, Dolbeault S, Cano A, Bonnaud-Antignac
A, Cousson-Ge´lie F, Sultan S (2014) How can we explain phy-
sician accuracy in assessing patient distress? A multilevel ana-
lysis in patients with advanced cancer. Patient Educ Couns
94:322–327
28. Oguchi M, Jansen J, Butow P, Colagiuri B, Divine R, Dhillon H
(2011) Measuring the impact of nurse cue-response behaviour on
cancer patients’ emotional cues. Patient Educ Couns 82:163–168
29. Sheldon LK, Ellington L, Barrett R, Dudley WN, Clayton MF,
Rinaldi K (2009) Nurse responsiveness to cancer patient
expressions of emotion. Patient Educ Couns 76:63–70
Eur Arch Otorhinolaryngol (2015) 272:2473–2481 2481
123
